data_6drg_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6drg _Structure_validation_residue.Date_analyzed 2018-12-21 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 108.781 -0.822 . . . . 72.34 108.781 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -70.02 -25.33 63.53 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.988 1.107 . . . . 74.21 113.988 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.2 t -52.77 115.08 1.64 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.058 2.143 . . . . 75.25 113.147 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.09 164.96 16.05 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 110.557 -1.017 . . . . 65.11 110.557 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.66 144.86 37.41 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.851 1.661 . . . . 74.12 110.399 175.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -140.81 141.15 34.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.998 1.319 . . . . 74.24 109.645 -173.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -107.93 148.04 30.2 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.538 1.135 . . . . 63.35 109.899 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.64 127.47 31.82 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.469 1.508 . . . . 71.32 111.207 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -109.4 -57.19 2.2 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.821 1.248 . . . . 65.5 110.973 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.5 p -152.86 172.16 17.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.563 1.145 . . . . 73.05 111.2 -174.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -168.27 148.59 4.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.876 1.271 . . . . 74.35 111.0 -165.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -140.04 143.23 36.27 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.873 1.269 . . . . 71.15 108.797 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 57.59 26.02 12.32 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.482 1.913 . . . . 63.12 113.616 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -61.5 -55.66 28.58 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-O 118.232 -0.889 . . . . 74.25 113.185 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -62.41 -43.48 98.72 Favored 'General case' 0 C--N 1.347 0.472 0 O-C-N 124.308 1.005 . . . . 60.04 112.919 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.92 -45.47 82.68 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.711 1.204 . . . . 53.45 113.566 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -68.08 -47.17 69.01 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.958 1.303 . . . . 70.13 113.187 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.5 mmt -65.9 -44.61 84.73 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.565 1.166 . . . . 61.43 113.049 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -60.71 -32.43 71.68 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.932 0.893 . . . . 62.13 113.032 171.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.56 -37.69 59.77 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.396 1.258 . . . . 71.32 114.396 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.1 pt -79.11 -5.14 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 113.427 0.899 . . . . 75.3 113.427 172.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.98 27.81 25.1 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 118.666 -1.074 . . . . 44.11 112.893 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.66 146.73 98.61 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 118.822 1.311 . . . . 72.05 111.122 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -68.31 140.83 49.75 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.05 1.834 . . . . 64.41 110.799 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.08 -21.88 64.09 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.63 1.344 . . . . 74.34 114.63 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.62 -49.94 74.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.351 1.06 . . . . 73.54 113.349 169.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.6 mt -63.92 -23.74 67.46 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 124.65 1.18 . . . . 75.44 113.569 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -83.15 -50.46 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.325 1.05 . . . . 64.11 110.602 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -60.94 -42.59 98.49 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 117.821 -1.085 . . . . 53.41 113.16 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -27.59 63.34 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 118.22 -0.895 . . . . 75.5 112.819 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.54 -30.04 57.06 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-O 119.077 -0.846 . . . . 20.32 112.552 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.79 -30.75 14.69 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.632 1.173 . . . . 72.43 112.789 173.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -72.78 -49.96 27.36 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.627 1.171 . . . . 75.45 111.52 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 mt -93.37 129.56 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.268 1.027 . . . . 62.42 108.347 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -80.44 110.17 15.63 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 124.135 0.897 . . . . 63.21 108.787 170.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.51 -172.97 41.75 Favored Glycine 0 CA--C 1.538 1.487 0 O-C-N 124.469 1.106 . . . . 74.13 110.429 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.5 t -129.82 153.79 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.709 1.204 . . . . 70.24 109.701 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.0 t -130.35 155.98 45.45 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.552 1.941 . . . . 70.22 109.164 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -141.02 143.67 34.56 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.752 1.221 . . . . 72.33 107.879 170.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.1 mt -132.07 130.36 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.08 -1.822 . . . . 62.45 106.08 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -134.74 135.5 53.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.15 -1.056 . . . . 74.23 108.15 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -126.92 130.82 50.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.819 1.248 . . . . 74.34 108.687 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -133.19 55.07 1.92 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.144 1.378 . . . . 73.54 109.289 -172.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.13 -115.96 5.69 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 108.718 -1.753 . . . . 50.4 108.718 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -70.69 -35.42 72.77 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.249 1.204 . . . . 73.31 114.249 173.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.63 156.09 37.11 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 124.021 0.825 . . . . 72.23 111.373 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -150.93 141.29 22.4 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.037 -1.468 . . . . 73.35 107.037 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -129.27 151.63 49.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.229 1.811 . . . . 75.04 109.153 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -148.79 126.23 11.61 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.686 -1.228 . . . . 70.41 107.686 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 m -109.18 126.61 53.45 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.688 1.243 . . . . 45.21 108.931 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.25 133.93 51.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.724 -1.584 . . . . 74.15 106.724 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.0 m -133.52 104.84 6.58 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 124.166 0.916 . . . . 51.0 109.394 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -107.38 77.49 1.15 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.918 0.887 . . . . 75.3 110.153 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.34 -49.41 4.23 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.513 1.53 . . . . 43.33 112.212 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.44 -39.65 0.09 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.171 0.986 . . . . 73.3 111.872 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -67.09 137.26 56.24 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.475 1.11 . . . . 75.41 111.684 172.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.6 t -125.31 130.47 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 O-C-N 124.612 1.195 . . . . 63.15 109.147 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.8 mt -119.34 128.67 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.871 1.269 . . . . 74.53 108.019 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -116.66 127.14 54.16 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 124.589 1.18 . . . . 63.21 108.693 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -121.94 145.04 48.5 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.413 1.485 . . . . 63.35 109.075 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -132.8 140.78 48.16 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 125.376 1.672 . . . . 73.05 108.995 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -149.46 166.93 27.64 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.033 1.333 . . . . 75.23 109.146 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.4 m -119.21 127.01 52.89 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.886 -1.153 . . . . 72.31 107.886 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.8 t -63.73 126.95 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.768 1.227 . . . . 63.33 111.324 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.14 -3.1 85.66 Favored Glycine 0 CA--C 1.542 1.764 0 CA-C-O 118.249 -1.306 . . . . 75.31 113.558 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -116.62 141.02 48.74 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.127 1.771 . . . . 71.42 109.859 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -66.45 118.57 10.28 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.04 1.336 . . . . 72.15 111.616 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 40.5 m -140.46 153.26 46.2 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.577 1.551 . . . . 74.14 109.153 -175.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -100.96 128.65 46.9 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.99 0.916 . . . . 74.33 109.77 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.3 mt -120.37 131.92 55.05 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.762 1.225 . . . . 71.33 110.467 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -90.43 130.92 36.45 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.277 1.831 . . . . 63.54 110.47 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.6 p -85.52 -179.93 7.01 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.572 1.149 . . . . 60.32 111.651 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.2 mtt -59.03 -30.83 68.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.18 1.548 . . . . 75.24 115.18 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.4 p -87.82 -7.51 57.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.368 1.467 . . . . 74.02 113.235 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.63 6.68 58.27 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 118.187 -1.34 . . . . 62.43 112.592 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -69.0 113.36 6.31 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 119.405 1.603 . . . . 74.34 110.791 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -94.44 124.95 38.78 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 124.612 1.195 . . . . 71.12 110.502 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.92 126.19 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.309 1.444 . . . . 71.33 110.361 -170.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -72.5 132.92 44.47 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.22 1.408 . . . . 75.51 111.885 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.3 t -161.93 170.02 20.13 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.267 1.427 . . . . 74.2 109.445 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.441 ' CG1' HE22 ' A' ' 84' ' ' GLN . 2.6 t -124.95 144.03 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 108.283 -1.006 . . . . 42.04 108.283 171.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.05 125.65 69.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 O-C-N 124.358 1.037 . . . . 70.35 108.252 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.441 HE22 ' CG1' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -112.91 141.78 46.35 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.805 1.642 . . . . 65.02 110.496 177.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.0 tp -92.95 136.82 32.92 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.426 1.079 . . . . 64.15 109.189 168.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.18 12.63 11.19 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.261 1.024 . . . . 62.4 113.318 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.9 14.12 80.33 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 125.131 1.348 . . . . 63.34 113.115 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -140.41 52.07 1.65 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.718 1.207 . . . . 62.51 109.697 -171.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.276 0.0 OUTLIER 58.04 21.78 8.21 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.905 1.682 . . . . 73.45 114.818 173.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -135.05 120.9 19.66 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.502 1.521 . . . . 74.52 109.714 -164.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.2 mt -105.55 132.39 51.77 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.895 1.278 . . . . 65.32 109.945 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.1 t -119.61 136.52 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.008 1.323 . . . . 61.13 109.157 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.0 t -154.37 149.08 26.48 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.27 1.028 . . . . 63.33 110.846 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.2 p -146.33 132.08 18.97 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.724 1.209 . . . . 75.11 109.783 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -97.96 -63.39 1.13 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.975 1.31 . . . . 65.02 110.396 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -140.17 -73.49 0.36 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.189 1.796 . . . . 65.23 108.237 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -127.38 -1.77 6.26 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.255 1.822 . . . . 74.45 112.305 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.6 mt -97.4 110.9 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.839 1.656 . . . . 51.44 108.384 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -102.61 98.76 8.77 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.765 1.226 . . . . 74.33 110.195 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.5 t -82.92 131.27 35.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.327 1.451 . . . . 52.41 110.882 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.8 t -135.69 101.82 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 106.844 -1.539 . . . . 53.11 106.844 172.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.0 m -84.89 148.9 26.02 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.186 1.394 . . . . 54.15 109.766 173.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -147.71 130.76 16.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.042 1.337 . . . . 73.43 109.313 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 tt -113.93 130.55 56.5 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.232 -1.396 . . . . 75.03 107.232 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -132.62 82.71 2.02 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.431 1.892 . . . . 71.04 106.702 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.25 -111.78 4.44 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.745 1.164 . . . . 53.43 111.287 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -83.72 -4.72 58.85 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.329 1.452 . . . . 71.13 113.535 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.8 mm -110.94 138.46 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 119.499 1.045 . . . . 60.11 109.666 -176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 36.6 mm -109.6 136.6 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.754 -1.202 . . . . 74.23 107.754 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.0 m -127.57 115.41 18.77 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 106.532 -1.655 . . . . 65.21 106.532 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -117.64 126.56 52.73 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.481 -0.933 . . . . 75.33 108.481 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 66.7 m -124.65 112.81 17.22 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 124.661 1.226 . . . . 75.43 108.386 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 95.1 mtp -105.86 149.86 26.14 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.873 1.269 . . . . 74.34 109.21 173.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.5 m -140.79 104.4 4.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.563 0.745 . . . . 60.32 109.21 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.0 tt -103.2 102.14 12.12 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.544 1.537 . . . . 71.2 107.55 175.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.27 -122.93 30.91 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 110.849 -0.9 . . . . 63.24 110.849 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -84.88 3.33 38.5 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.915 1.686 . . . . 71.45 115.173 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.8 mt -102.93 139.75 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.889 0.875 . . . . 75.42 108.995 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.38 96.85 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.205 1.002 . . . . 64.21 109.119 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -86.21 136.35 33.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.676 1.591 . . . . 74.24 112.48 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -119.65 150.19 40.74 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.049 1.34 . . . . 63.24 111.085 173.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 mmt-85 -141.98 136.1 29.98 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.503 1.921 . . . . 62.53 108.074 173.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.6 133.98 65.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.583 -1.266 . . . . 74.22 107.583 174.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.5 m -135.16 159.98 39.83 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.994 1.317 . . . . 75.33 109.648 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -137.79 143.3 41.0 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.489 1.116 . . . . 63.23 110.702 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.7 ttp85 -63.28 137.1 58.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.592 1.957 . . . . 72.42 113.768 -170.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 40.4 mt . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 106.039 -1.838 . . . . 72.13 106.039 -171.524 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 110.042 -0.355 . . . . 72.34 110.042 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -80.39 -16.82 53.57 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.549 1.314 . . . . 74.21 114.549 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.8 p -66.93 132.76 48.62 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.759 1.224 . . . . 75.25 113.483 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.1 168.34 14.67 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.285 0.945 . . . . 65.11 110.778 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -99.89 147.07 25.94 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.274 1.43 . . . . 74.12 111.137 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -138.41 155.08 48.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.593 1.557 . . . . 74.24 109.453 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -127.77 145.39 50.93 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.505 -0.924 . . . . 63.35 108.505 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 tt -61.96 131.24 49.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.22 1.408 . . . . 71.32 110.432 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -109.7 -50.06 3.03 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.609 1.164 . . . . 65.5 110.919 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.2 158.15 35.68 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 124.387 1.054 . . . . 73.05 111.109 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -128.08 155.83 43.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.844 1.257 . . . . 74.35 108.683 170.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -135.69 131.33 35.53 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.264 1.426 . . . . 71.15 108.175 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 58.23 39.27 25.94 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.352 1.861 . . . . 63.12 112.142 -169.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -64.11 -63.57 1.12 Allowed 'General case' 0 C--N 1.346 0.454 0 C-N-CA 124.875 1.27 . . . . 74.25 112.296 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.47 -28.43 69.66 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.566 0.95 . . . . 60.04 113.566 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.88 -51.9 65.17 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.102 0.961 . . . . 53.45 112.346 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -70.59 -48.47 55.04 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.831 1.252 . . . . 70.13 113.8 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.9 mmt -67.99 -39.83 83.2 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 124.374 1.046 . . . . 61.43 113.155 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -73.87 -27.68 61.2 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 118.137 -0.935 . . . . 62.13 112.513 173.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.75 -33.82 66.61 Favored 'General case' 0 C--N 1.349 0.562 0 N-CA-C 113.945 1.091 . . . . 71.32 113.945 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.8 pt -80.3 -4.6 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 N-CA-C 113.239 0.829 . . . . 75.3 113.239 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.03 21.69 41.27 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 118.202 -1.332 . . . . 44.11 113.522 167.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.0 mt -63.88 143.78 98.1 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 119.42 1.61 . . . . 72.05 111.212 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.18 143.72 84.66 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.396 2.064 . . . . 64.41 111.56 172.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.06 -22.48 62.73 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.123 1.527 . . . . 74.34 115.123 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.17 -43.16 99.31 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.245 1.018 . . . . 73.54 113.138 169.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.9 mt -72.0 -24.57 61.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.529 1.132 . . . . 75.44 113.621 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.69 -55.39 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 123.58 0.752 . . . . 64.11 111.176 168.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -65.99 -26.5 67.58 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 115.019 1.489 . . . . 53.41 115.019 -174.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.69 -23.15 31.83 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 124.237 0.961 . . . . 75.5 112.454 171.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.68 -23.81 37.99 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-O 118.964 -0.909 . . . . 20.32 112.298 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.13 -35.17 25.8 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 117.54 -1.219 . . . . 72.43 113.609 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -83.08 -49.75 9.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.79 0.723 . . . . 75.45 111.39 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.41 123.62 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.131 0.973 . . . . 62.42 109.263 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.28 107.17 18.38 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.018 -1.104 . . . . 63.21 108.018 171.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.61 165.81 51.95 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 124.612 1.195 . . . . 74.13 111.507 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 78.6 t -102.05 155.37 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.339 1.056 . . . . 70.24 108.697 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 97.6 p -145.42 167.36 23.12 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.599 1.16 . . . . 70.22 109.916 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -161.58 142.26 10.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.466 1.106 . . . . 72.33 108.682 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -129.48 142.12 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.929 -1.508 . . . . 62.45 106.929 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.69 100.96 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.699 -1.223 . . . . 74.23 107.699 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -77.31 129.9 36.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.039 0.936 . . . . 74.34 109.825 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -128.31 51.52 1.98 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.438 1.495 . . . . 73.54 109.282 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.33 -118.44 6.74 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 108.871 -1.692 . . . . 50.4 108.871 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -65.99 -34.71 78.72 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.937 1.295 . . . . 73.31 113.95 172.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -75.73 157.96 32.89 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.073 0.858 . . . . 72.23 111.599 171.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -156.57 125.23 5.85 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.908 -1.515 . . . . 73.35 106.908 -172.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 139.82 46.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.847 1.259 . . . . 75.04 109.103 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.28 132.37 55.29 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.772 1.629 . . . . 70.41 107.535 172.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.92 109.16 10.68 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.689 1.196 . . . . 45.21 108.16 176.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.92 132.75 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.736 1.214 . . . . 74.15 108.185 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.1 m -114.76 111.46 21.29 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.307 1.004 . . . . 51.0 108.984 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.14 76.15 1.89 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.691 1.196 . . . . 75.3 109.432 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.68 -96.95 1.99 Allowed Glycine 0 CA--C 1.531 1.079 0 N-CA-C 108.776 -1.73 . . . . 43.33 108.776 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.3 m -101.88 -40.7 6.79 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.726 1.21 . . . . 73.3 112.574 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -73.02 153.58 40.83 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.079 0.952 . . . . 75.41 112.066 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.21 131.43 67.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 124.536 1.148 . . . . 63.15 109.553 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.2 mt -105.17 134.6 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 126.468 1.907 . . . . 74.53 107.957 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -125.82 124.78 41.7 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.488 1.115 . . . . 63.21 108.38 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -137.71 133.08 33.77 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.552 1.141 . . . . 63.35 108.976 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -116.48 147.67 41.52 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 124.601 1.188 . . . . 73.05 109.711 172.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -150.86 160.66 43.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.102 1.361 . . . . 75.23 110.091 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.2 m -103.47 135.66 44.66 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 124.237 0.961 . . . . 72.31 108.517 169.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.07 119.29 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.948 1.299 . . . . 63.33 111.2 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.92 -13.59 65.89 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 117.967 -1.463 . . . . 75.31 113.326 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -99.11 148.52 23.97 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.522 1.661 . . . . 71.42 110.369 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -69.75 114.44 7.95 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 124.082 0.864 . . . . 72.15 110.793 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.7 m -129.32 151.74 49.63 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.344 1.458 . . . . 74.14 107.689 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -100.96 119.97 39.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.035 0.934 . . . . 74.33 110.276 -174.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.99 134.27 52.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.097 1.359 . . . . 71.33 110.411 -172.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -90.45 147.92 23.1 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.474 1.51 . . . . 63.54 110.336 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.3 p -112.45 178.31 4.34 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.47 1.508 . . . . 60.32 110.231 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -59.99 -29.78 68.69 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.575 1.324 . . . . 75.24 114.575 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.3 p -81.95 -8.21 59.66 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.527 1.531 . . . . 74.02 113.035 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.99 8.12 72.96 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-O 118.363 -1.243 . . . . 62.43 112.581 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -69.97 114.08 7.79 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 119.072 1.436 . . . . 74.34 110.921 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -100.86 121.41 41.67 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 124.943 1.402 . . . . 71.12 109.496 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.42 133.02 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 124.625 1.203 . . . . 71.33 110.877 -172.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -78.21 141.12 38.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.198 1.399 . . . . 75.51 112.177 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.0 t -167.07 153.86 8.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.713 1.205 . . . . 74.2 110.394 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.5 m -90.15 142.42 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.418 1.087 . . . . 42.04 109.431 165.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.56 124.72 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.253 -1.388 . . . . 70.35 107.253 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -135.75 136.81 41.08 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.357 1.063 . . . . 65.02 110.273 -170.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.403 HD22 ' H ' ' A' ' 87' ' ' GLY . 2.7 tt -79.41 129.77 34.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.489 1.115 . . . . 64.15 110.167 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -73.94 -9.5 58.7 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.477 1.911 . . . . 62.4 114.165 -173.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.403 ' H ' HD22 ' A' ' 85' ' ' LEU . . . 92.15 5.72 65.53 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.122 1.344 . . . . 63.34 112.189 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -147.6 57.05 1.11 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.77 1.285 . . . . 62.51 109.358 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 63.8 19.76 11.89 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.821 1.648 . . . . 73.45 114.101 171.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -128.76 142.68 50.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.706 1.602 . . . . 74.52 109.598 -166.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 74.1 mt -114.91 123.26 48.7 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.346 1.058 . . . . 65.32 109.204 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.7 t -104.65 140.14 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.364 1.466 . . . . 61.13 108.902 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.3 t -162.79 135.24 5.5 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.446 1.098 . . . . 63.33 110.084 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 78.5 p -131.36 122.3 26.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.523 1.129 . . . . 75.11 109.403 -176.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -81.9 -66.56 0.87 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.395 1.078 . . . . 65.02 111.221 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -144.14 -52.4 0.32 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.64 1.576 . . . . 65.23 109.491 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -142.8 3.22 1.42 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.577 1.551 . . . . 74.45 112.363 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 78.3 mt -99.73 110.91 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.702 1.601 . . . . 51.44 106.959 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -103.63 86.84 2.7 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.934 1.294 . . . . 74.33 109.575 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.7 m -79.36 127.72 32.44 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.186 1.395 . . . . 52.41 110.764 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.4 t -135.74 102.1 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 108.063 -1.088 . . . . 53.11 108.063 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.7 m -85.89 157.38 20.19 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.461 1.504 . . . . 54.15 110.478 176.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -148.71 143.56 26.52 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.612 1.565 . . . . 73.43 110.987 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.5 tt -129.98 128.03 41.23 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.317 1.447 . . . . 75.03 108.999 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -137.52 77.45 1.64 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.071 1.748 . . . . 71.04 107.604 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.8 -123.9 22.89 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 110.096 -1.202 . . . . 53.43 110.096 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -75.65 -12.33 60.18 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.239 1.415 . . . . 71.13 114.153 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mm -102.95 137.63 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 119.287 0.949 . . . . 60.11 109.534 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.2 mm -125.9 140.62 48.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 108.105 -1.072 . . . . 74.23 108.105 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.6 m -135.94 160.73 37.69 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.462 1.505 . . . . 65.21 108.743 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -154.58 147.67 24.72 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.57 1.148 . . . . 75.33 108.618 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.5 m -131.82 108.07 9.18 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 125.115 1.509 . . . . 75.43 108.22 171.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 72.8 mtp -96.21 144.71 26.17 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.826 1.651 . . . . 74.34 108.747 168.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 65.2 m -133.88 108.05 8.2 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.44 -0.948 . . . . 60.32 108.44 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.3 tp -111.86 99.36 8.06 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.477 1.511 . . . . 71.2 107.712 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.81 -122.82 27.15 Favored Glycine 0 CA--C 1.535 1.281 0 O-C-N 124.726 1.266 . . . . 63.24 110.429 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.87 -17.69 55.19 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.522 1.929 . . . . 71.45 114.48 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 75.9 mt -102.16 140.62 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.604 1.162 . . . . 75.42 110.381 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.4 t -122.76 90.0 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.361 1.064 . . . . 64.21 109.551 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -71.76 124.79 25.55 Favored 'General case' 0 C--N 1.345 0.394 0 C-N-CA 124.451 1.101 . . . . 74.24 111.729 174.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -120.62 148.74 43.5 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.879 1.271 . . . . 63.24 109.344 176.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.72 120.7 7.68 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.482 -0.933 . . . . 62.53 108.482 -166.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -118.83 141.69 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.164 1.386 . . . . 74.22 109.4 -172.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.6 m -144.21 166.62 24.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.232 1.413 . . . . 75.33 111.985 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -139.48 138.9 36.79 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.868 1.267 . . . . 63.23 109.952 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -69.31 131.7 45.27 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.262 2.225 . . . . 72.42 112.563 -174.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.8 mt . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 105.522 -2.029 . . . . 72.13 105.522 -174.238 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 109.499 -0.556 . . . . 72.34 109.499 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -80.16 -27.27 39.01 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.192 1.182 . . . . 74.21 114.192 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.9 m -57.1 111.17 0.98 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.244 1.818 . . . . 75.25 113.376 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.39 160.72 10.81 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.667 -1.373 . . . . 65.11 109.667 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -98.13 146.86 25.15 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 124.551 1.14 . . . . 74.12 110.973 176.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -139.69 146.37 39.56 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.057 1.343 . . . . 74.24 109.519 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -111.29 148.93 31.86 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.48 1.512 . . . . 63.35 109.79 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.466 HD12 ' H ' ' A' ' 37' ' ' GLY . 2.1 tt -61.78 128.71 37.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.885 1.274 . . . . 71.32 111.128 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -111.15 -50.57 2.93 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.17 1.388 . . . . 65.5 111.501 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.46 167.52 30.19 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.452 1.101 . . . . 73.05 111.27 -173.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -167.51 125.06 1.21 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.652 1.181 . . . . 74.35 110.918 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -111.52 143.99 41.48 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.214 1.406 . . . . 71.15 109.435 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 57.46 38.71 28.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.594 1.958 . . . . 63.12 111.832 -170.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -65.25 -58.39 6.07 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.451 -0.785 . . . . 74.25 111.409 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -62.09 -40.35 95.55 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 113.401 0.889 . . . . 60.04 113.401 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.6 -46.07 91.63 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 124.169 0.988 . . . . 53.45 113.019 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -70.91 -47.78 57.24 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-O 117.633 -1.175 . . . . 70.13 112.898 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.2 mtt -64.27 -35.59 81.35 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 124.926 1.391 . . . . 61.43 113.911 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -71.18 -30.76 66.82 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 118.167 -0.921 . . . . 62.13 113.159 169.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.17 -37.31 61.32 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.357 1.243 . . . . 71.32 114.357 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.9 pt -74.18 -12.88 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.877 0.871 . . . . 75.3 113.18 170.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.46 22.54 34.11 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.349 -1.251 . . . . 44.11 112.726 173.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.25 141.2 83.24 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.262 1.531 . . . . 72.05 110.562 172.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.78 152.37 81.77 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.59 2.193 . . . . 64.41 112.162 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -65.94 -20.48 66.23 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.35 1.241 . . . . 74.34 114.35 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.03 -46.12 82.63 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.309 1.044 . . . . 73.54 113.072 171.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.85 -30.11 71.25 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.553 1.141 . . . . 75.44 112.813 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.1 mt -71.37 -50.86 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.615 1.166 . . . . 64.11 111.781 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -58.72 -50.31 74.36 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 117.817 -1.087 . . . . 53.41 112.958 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -21.14 63.72 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.013 1.116 . . . . 75.5 114.013 174.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.38 -29.21 45.55 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 118.934 -0.926 . . . . 20.32 111.974 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 -29.26 14.05 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.763 1.225 . . . . 72.43 112.897 174.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -71.91 -35.61 69.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 118.022 -0.99 . . . . 75.45 113.432 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.3 mt -113.4 119.12 59.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.079 -1.082 . . . . 62.42 108.079 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -69.48 137.55 52.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.101 0.96 . . . . 63.21 111.55 171.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.466 ' H ' HD12 ' A' ' 9' ' ' LEU . . . -93.16 -179.82 39.7 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 124.687 1.242 . . . . 74.13 110.474 172.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.6 t -130.9 150.23 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 126.047 1.739 . . . . 70.24 107.843 174.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 t -144.83 108.0 4.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.409 0.683 . . . . 70.22 109.965 -170.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -91.96 147.07 23.24 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.061 0.944 . . . . 72.33 110.853 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 mt -132.6 128.02 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 106.29 -1.744 . . . . 62.45 106.29 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.8 t -134.18 127.14 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.021 -1.103 . . . . 74.23 108.021 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -122.16 136.07 54.86 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.013 1.325 . . . . 74.34 108.045 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -148.46 76.65 1.37 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.901 0.881 . . . . 73.54 109.024 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.6 -120.36 8.97 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 108.983 -1.647 . . . . 50.4 108.983 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.4 mmtt -75.67 -32.16 60.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.863 1.265 . . . . 73.31 114.258 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.71 155.83 35.28 Favored 'General case' 0 C--N 1.346 0.421 0 O-C-N 123.918 0.762 . . . . 72.23 112.093 175.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -154.91 128.43 8.52 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 106.989 -1.486 . . . . 73.35 106.989 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -114.37 151.95 32.26 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.707 1.203 . . . . 75.04 109.549 170.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -145.27 128.29 16.52 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.943 -1.503 . . . . 70.41 106.943 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.3 m -116.04 117.77 31.02 Favored 'General case' 0 C--N 1.344 0.352 0 O-C-N 124.511 1.132 . . . . 45.21 109.4 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 mp -97.88 121.56 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.207 1.403 . . . . 74.15 107.485 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.8 m -113.56 109.38 18.54 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.801 -1.185 . . . . 51.0 107.801 173.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.54 -164.01 0.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.705 1.602 . . . . 75.3 111.551 173.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.69 -25.23 70.26 Favored Glycine 0 CA--C 1.542 1.721 0 CA-C-O 118.735 -1.036 . . . . 43.33 113.797 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.5 p -161.85 20.17 0.11 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.357 1.463 . . . . 73.3 113.032 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.68 146.98 52.31 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 125.071 1.349 . . . . 75.41 110.122 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.9 t -124.93 124.02 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.082 -1.081 . . . . 63.15 108.082 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -134.46 123.95 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.101 -1.444 . . . . 74.53 107.101 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.16 149.06 43.36 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.071 0.948 . . . . 63.21 111.064 175.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -133.04 152.59 51.95 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.925 1.69 . . . . 63.35 108.908 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -125.74 142.75 51.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 125.114 1.509 . . . . 73.05 109.034 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -146.5 167.11 24.49 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.901 1.281 . . . . 75.23 109.351 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.8 m -118.38 129.21 55.29 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.557 -1.275 . . . . 72.31 107.557 173.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.02 121.02 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.908 1.283 . . . . 63.33 110.922 -175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.9 -4.37 78.43 Favored Glycine 0 CA--C 1.542 1.75 0 CA-C-O 118.353 -1.248 . . . . 75.31 113.285 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -112.59 137.81 50.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.149 1.78 . . . . 71.42 108.651 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.81 125.96 28.27 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.803 0.689 . . . . 72.15 110.919 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.4 m -138.41 163.4 31.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.58 1.552 . . . . 74.14 108.942 -175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -103.86 125.95 50.64 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.518 0.727 . . . . 74.33 110.023 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.7 mt -108.09 127.7 54.03 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.658 1.183 . . . . 71.33 109.393 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -88.34 153.56 21.1 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.589 1.556 . . . . 63.54 110.898 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.2 p -111.14 173.79 6.17 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.645 1.578 . . . . 60.32 111.786 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -60.33 -31.2 70.08 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.512 1.301 . . . . 75.24 114.512 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 42.5 p -88.73 -7.33 56.46 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.71 1.204 . . . . 74.02 113.248 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.15 9.81 63.14 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.346 -1.252 . . . . 62.43 113.042 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -64.72 146.12 55.22 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 119.254 1.527 . . . . 74.34 110.46 167.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -129.02 124.98 36.32 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.254 -1.017 . . . . 71.12 108.254 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 m -141.51 128.09 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 124.47 1.106 . . . . 71.33 110.8 -171.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -77.32 139.84 39.87 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.384 1.474 . . . . 75.51 111.6 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.3 t -169.61 154.43 5.52 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 124.906 1.379 . . . . 74.2 109.719 -165.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 t -121.28 133.75 66.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.972 -1.121 . . . . 42.04 107.972 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.8 t -106.83 126.53 62.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 108.322 -0.992 . . . . 70.35 108.322 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.31 135.67 53.82 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.347 1.459 . . . . 65.02 110.093 174.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.54 121.06 31.4 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.5 1.125 . . . . 64.15 108.958 169.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 6.5 tt0 -81.87 -168.57 1.97 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.002 1.321 . . . . 62.4 111.217 174.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.506 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -93.41 11.08 72.25 Favored Glycine 0 CA--C 1.539 1.571 0 CA-C-O 117.71 -1.606 . . . . 63.34 113.353 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -140.48 44.93 1.85 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.725 1.763 . . . . 62.51 110.925 -173.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 65.3 21.36 11.99 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.052 1.341 . . . . 73.45 113.395 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -120.98 126.5 50.11 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.918 1.287 . . . . 74.52 110.674 -164.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.0 mt -101.53 109.28 21.06 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 124.671 1.232 . . . . 65.32 109.1 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 86.6 t -95.99 132.63 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.86 1.264 . . . . 61.13 108.759 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.6 t -154.55 148.78 25.97 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 124.07 0.856 . . . . 63.33 110.977 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.4 p -147.26 133.38 19.33 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.786 1.234 . . . . 75.11 110.0 -173.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -93.53 -77.17 0.46 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.598 1.559 . . . . 65.02 109.727 -176.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -128.5 -58.85 1.17 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.066 1.747 . . . . 65.23 108.843 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -144.52 8.42 1.34 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.005 1.722 . . . . 74.45 112.223 -175.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mp -103.56 115.89 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.297 -1.371 . . . . 51.44 107.297 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -103.18 91.13 3.96 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 124.629 1.206 . . . . 74.33 108.962 -173.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.7 p -100.43 112.53 24.89 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.336 1.454 . . . . 52.41 111.927 -174.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.3 t -114.85 106.91 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.409 1.884 . . . . 53.11 107.794 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.5 m -84.32 151.51 24.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.716 1.206 . . . . 54.15 109.863 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -146.4 130.66 17.52 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.444 1.497 . . . . 73.43 109.164 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.3 tt -111.39 128.42 55.97 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.76 1.224 . . . . 75.03 108.079 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -130.26 82.32 2.06 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.348 1.859 . . . . 71.04 106.51 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.42 -117.42 10.62 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.495 -1.042 . . . . 53.43 110.495 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -85.78 9.59 16.1 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.014 1.726 . . . . 71.13 113.81 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.3 mm -122.61 134.23 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.53 1.132 . . . . 60.11 109.114 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.92 137.84 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.701 -1.222 . . . . 74.23 107.701 170.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.4 m -131.77 116.51 17.36 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.201 -1.407 . . . . 65.21 107.201 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.79 137.98 48.99 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.575 -0.898 . . . . 75.33 108.575 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 99.1 m -133.29 112.89 12.03 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 124.795 1.31 . . . . 75.43 108.247 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 33.1 mtp -111.04 146.87 35.96 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 126.0 1.72 . . . . 74.34 109.181 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.2 m -138.93 98.6 3.57 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 124.41 1.069 . . . . 60.32 109.258 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.2 tp -104.4 112.06 24.95 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.537 1.535 . . . . 71.2 108.354 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.43 -114.71 6.78 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 124.729 1.268 . . . . 63.24 110.871 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.54 8.0 44.85 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.452 1.901 . . . . 71.45 113.469 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.9 mp -124.16 143.17 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.689 1.195 . . . . 75.42 109.594 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.5 t -126.95 94.41 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.079 0.952 . . . . 64.21 110.297 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -75.83 132.61 40.48 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 123.677 0.791 . . . . 74.24 111.035 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -122.62 149.67 43.68 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 124.339 1.025 . . . . 63.24 109.499 173.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.13 133.64 23.43 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.043 1.337 . . . . 62.53 108.368 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -124.86 137.01 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.892 1.277 . . . . 74.22 108.053 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.1 m -137.98 156.86 47.4 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.691 1.196 . . . . 75.33 110.563 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -126.44 146.42 50.09 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.53 1.532 . . . . 63.23 109.744 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.3 tpp85 -56.92 142.15 42.52 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.459 2.303 . . . . 72.42 112.98 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 105.883 -1.895 . . . . 72.13 105.883 -175.814 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 110.067 -0.346 . . . . 72.34 110.067 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -63.74 -25.23 68.1 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.18 1.548 . . . . 74.21 115.18 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.5 p -57.65 119.58 6.85 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.244 1.817 . . . . 75.25 113.679 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.04 164.97 13.23 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 110.689 -0.964 . . . . 65.11 110.689 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -95.14 147.87 22.98 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.639 1.576 . . . . 74.12 111.68 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -143.08 133.91 25.36 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.032 1.333 . . . . 74.24 109.798 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -102.16 150.54 23.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.786 1.234 . . . . 63.35 110.267 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.89 128.97 38.35 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.101 1.36 . . . . 71.32 111.096 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -113.54 -51.58 2.8 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 124.796 1.238 . . . . 65.5 111.64 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -152.92 168.27 26.37 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.489 1.118 . . . . 73.05 111.259 -170.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -165.39 145.35 6.8 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.787 1.235 . . . . 74.35 111.049 -170.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -139.84 146.82 39.84 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.947 1.299 . . . . 71.15 109.508 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 55.12 27.68 9.87 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.513 1.925 . . . . 63.12 113.035 -173.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -63.43 -60.32 3.52 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-O 118.078 -0.963 . . . . 74.25 111.58 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -60.34 -41.87 94.49 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 124.281 0.988 . . . . 60.04 113.041 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.75 -48.93 71.99 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.556 1.143 . . . . 53.45 113.397 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -66.68 -47.2 73.2 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.193 1.397 . . . . 70.13 113.072 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.8 mmt -68.64 -39.63 80.63 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.545 1.138 . . . . 61.43 113.105 -175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -66.34 -34.13 77.28 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.932 0.893 . . . . 62.13 112.637 169.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.7 -34.9 67.45 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 114.415 1.265 . . . . 71.32 114.415 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.0 pt -77.67 -9.79 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 113.143 0.794 . . . . 75.3 113.143 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.19 26.71 20.62 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.235 -1.314 . . . . 44.11 112.988 168.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.1 mt -69.3 151.78 96.8 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 119.351 1.575 . . . . 72.05 111.711 172.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -69.88 147.72 62.7 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.192 1.928 . . . . 64.41 111.538 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -54.75 -30.91 57.67 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.025 1.33 . . . . 74.34 114.484 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -63.08 -45.57 91.5 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 117.877 -1.059 . . . . 73.54 113.702 175.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.0 mt -65.66 -26.88 67.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.186 0.994 . . . . 75.44 113.429 174.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.1 mt -78.79 -50.95 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.162 0.985 . . . . 64.11 110.677 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -62.48 -40.92 98.23 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 117.731 -1.128 . . . . 53.41 113.622 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -28.91 64.29 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.425 -0.797 . . . . 75.5 112.61 172.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.14 -31.53 57.39 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-O 118.957 -0.913 . . . . 20.32 112.617 -174.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -30.46 16.49 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.418 1.087 . . . . 72.43 112.945 173.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.79 -50.95 21.07 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.385 1.074 . . . . 75.45 111.063 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.1 mm -88.03 126.81 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 O-C-N 124.337 1.023 . . . . 62.42 109.196 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -82.61 135.19 35.12 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.265 0.978 . . . . 63.21 110.19 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.62 -171.16 34.49 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 109.829 -1.308 . . . . 74.13 109.829 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 76.0 t -135.3 161.94 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 126.342 1.857 . . . . 70.24 108.86 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.2 t -145.63 157.66 43.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.277 1.031 . . . . 70.22 110.125 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -137.74 131.4 31.23 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 108.422 -0.955 . . . . 72.33 108.422 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.3 mt -110.63 130.94 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 106.112 -1.811 . . . . 62.45 106.112 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.4 t -134.2 124.99 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.0 0.92 . . . . 74.23 108.569 -173.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -114.14 131.67 56.34 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.815 1.246 . . . . 74.34 108.994 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -133.55 52.86 2.05 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.243 1.417 . . . . 73.54 109.806 -174.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.65 -115.01 5.12 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 108.742 -1.743 . . . . 50.4 108.742 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -71.88 -38.1 70.07 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.961 1.097 . . . . 73.31 113.961 173.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.19 158.62 33.82 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 124.124 0.89 . . . . 72.23 111.864 172.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -158.63 135.5 9.68 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 106.217 -1.772 . . . . 73.35 106.217 -173.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -121.0 154.79 35.56 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.95 0.781 . . . . 75.04 110.089 171.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -137.38 125.26 22.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 124.532 1.145 . . . . 70.41 108.836 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.4 m -107.23 125.03 50.61 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.893 1.677 . . . . 45.21 108.166 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.8 mt -121.37 116.09 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.003 -1.11 . . . . 74.15 108.003 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -113.66 114.01 25.81 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 124.385 1.053 . . . . 51.0 110.073 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -146.93 145.73 29.89 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.834 0.853 . . . . 75.3 110.33 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.97 -90.9 0.59 Allowed Glycine 0 CA--C 1.532 1.102 0 N-CA-C 109.504 -1.438 . . . . 43.33 109.504 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.2 t -156.33 42.15 0.38 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.14 1.376 . . . . 73.3 110.155 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -154.23 159.77 41.49 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.273 1.029 . . . . 75.41 111.48 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.6 t -127.63 131.41 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 125.443 1.497 . . . . 63.15 109.222 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.2 mt -115.91 113.36 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.32 1.448 . . . . 74.53 108.363 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.22 119.91 40.47 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.198 -1.038 . . . . 63.21 108.198 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -114.13 166.01 12.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.413 1.085 . . . . 63.35 110.096 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -141.34 140.95 33.86 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.224 1.01 . . . . 73.05 109.732 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.727 ' HA ' ' HG ' ' A' ' 69' ' ' CYS . 46.3 p90 -151.19 152.6 33.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.99 1.316 . . . . 75.23 109.871 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.9 m -100.7 132.73 45.94 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.498 -0.927 . . . . 72.31 108.498 171.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.19 112.33 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.313 1.045 . . . . 63.33 110.654 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.83 -14.68 49.26 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.053 -1.415 . . . . 75.31 112.712 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -99.98 145.11 28.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.501 1.65 . . . . 71.42 110.461 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -66.99 127.53 32.93 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.129 1.371 . . . . 72.15 111.379 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.727 ' HG ' ' HA ' ' A' ' 63' ' ' PHE . 65.5 m -148.65 153.7 38.66 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.293 1.437 . . . . 74.14 109.332 -175.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -92.94 123.66 36.36 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.59 0.756 . . . . 74.33 110.649 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.5 138.5 40.79 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.279 1.432 . . . . 71.33 109.121 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -103.88 139.33 39.21 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.496 1.519 . . . . 63.54 109.68 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.4 m -88.25 163.93 15.87 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.399 1.48 . . . . 60.32 110.889 173.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 74.7 mtm -54.49 -29.16 49.34 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.729 1.381 . . . . 75.24 114.729 169.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 47.0 p -85.57 -10.89 55.28 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.916 2.086 . . . . 74.02 113.306 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.84 4.33 60.36 Favored Glycine 0 CA--C 1.538 1.524 0 CA-C-O 118.149 -1.362 . . . . 62.43 113.215 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -65.52 121.25 14.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.428 1.614 . . . . 74.34 110.442 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -108.21 129.3 55.2 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.06 0.85 . . . . 71.12 109.65 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.55 131.83 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.594 1.157 . . . . 71.33 111.124 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -75.09 125.94 29.99 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.356 1.462 . . . . 75.51 110.694 174.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.4 t -151.4 164.13 37.41 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.576 1.551 . . . . 74.2 109.642 -172.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.15 130.89 66.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.033 -1.099 . . . . 42.04 108.033 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.8 t -103.22 128.26 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 124.095 0.872 . . . . 70.35 109.313 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -114.55 171.4 7.65 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.968 2.107 . . . . 65.02 110.295 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -131.52 124.17 29.55 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.134 -1.432 . . . . 64.15 107.134 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.71 13.89 3.52 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.466 1.284 . . . . 62.4 114.466 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.71 13.79 81.88 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.371 1.462 . . . . 63.34 113.014 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -145.08 51.8 1.22 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.573 1.187 . . . . 62.51 109.978 -169.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.276 0.5 OUTLIER 51.65 30.85 7.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.437 1.895 . . . . 73.45 115.171 175.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -140.56 120.93 14.02 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.877 1.271 . . . . 74.52 108.822 -167.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.6 mt -91.92 118.68 30.98 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.148 0.979 . . . . 65.32 109.293 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 91.7 t -101.72 126.37 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.11 1.364 . . . . 61.13 108.819 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.5 m -141.22 149.88 41.96 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.143 0.977 . . . . 63.33 109.373 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.6 p -147.0 138.71 24.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.791 0.836 . . . . 75.11 109.922 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -98.08 -79.61 0.47 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.729 1.611 . . . . 65.02 108.892 -176.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -136.37 -44.7 0.62 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.923 1.289 . . . . 65.23 109.734 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -150.02 8.76 0.65 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.177 1.391 . . . . 74.45 112.64 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.4 mp -109.18 116.12 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.698 1.199 . . . . 51.44 107.769 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.2 tmtp? -98.2 87.81 4.02 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.056 1.342 . . . . 74.33 109.232 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.4 t -74.97 127.82 34.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.132 1.373 . . . . 52.41 111.743 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.6 t -138.24 95.98 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.698 1.599 . . . . 53.11 107.579 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 87.3 m -82.32 155.72 24.64 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.073 1.349 . . . . 54.15 110.285 173.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -145.37 141.64 28.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.422 1.489 . . . . 73.43 109.84 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 tp -119.46 124.14 45.76 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.945 2.098 . . . . 75.03 107.155 172.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -131.18 81.7 2.0 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 106.285 -1.746 . . . . 71.04 106.285 171.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.79 -116.82 9.69 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.946 1.26 . . . . 53.43 110.631 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -80.49 -0.98 39.77 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.977 1.311 . . . . 71.13 114.37 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.8 mm -115.55 131.91 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 119.466 1.03 . . . . 60.11 109.437 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.9 mm -108.84 138.23 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 125.095 1.358 . . . . 74.23 108.122 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.9 m -133.41 110.97 10.37 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 124.629 1.206 . . . . 65.21 107.751 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.9 135.67 45.82 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.912 -0.773 . . . . 75.33 108.912 175.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.4 m -131.76 117.65 18.87 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.845 1.258 . . . . 75.43 108.454 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -110.09 149.93 29.32 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.155 1.382 . . . . 74.34 109.456 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.9 m -133.34 98.93 4.37 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.194 0.934 . . . . 60.32 109.378 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.9 tp -102.01 109.79 21.6 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 125.175 1.39 . . . . 71.2 108.732 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.47 -114.86 6.94 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 124.864 1.353 . . . . 63.24 110.777 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.11 -0.74 53.17 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.583 1.953 . . . . 71.45 113.926 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.0 mt -118.06 143.5 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.813 1.245 . . . . 75.42 110.113 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.5 t -125.33 95.17 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.915 0.886 . . . . 64.21 110.053 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -70.86 137.68 49.6 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.833 1.653 . . . . 74.24 112.628 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -124.83 151.87 44.67 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.394 1.077 . . . . 63.24 111.253 170.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.8 mmt-85 -138.87 136.65 35.78 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.781 2.032 . . . . 62.53 108.111 172.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.35 133.72 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.522 -1.288 . . . . 74.22 107.522 173.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.4 m -137.34 156.76 47.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.866 1.266 . . . . 75.33 109.67 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -134.39 144.71 48.35 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.471 1.108 . . . . 63.23 110.657 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.8 ttp85 -64.11 143.61 57.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.352 1.861 . . . . 72.42 114.014 -170.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 105.462 -2.051 . . . . 72.13 105.462 -172.1 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 108.653 -0.869 . . . . 72.34 108.653 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -60.99 -34.55 74.97 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.469 1.507 . . . . 74.21 114.538 172.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 t -58.98 123.46 16.65 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.806 1.642 . . . . 75.25 113.295 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.66 164.79 13.25 Favored Glycine 0 CA--C 1.539 1.563 0 O-C-N 124.419 1.074 . . . . 65.11 110.529 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -98.97 148.3 24.13 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.031 1.732 . . . . 74.12 111.356 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -142.98 155.44 44.68 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.177 1.391 . . . . 74.24 109.528 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -127.14 144.04 51.12 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.527 -0.916 . . . . 63.35 108.527 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.2 tp -56.66 134.83 54.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.696 1.198 . . . . 71.32 111.742 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -115.46 -51.42 2.69 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 124.798 1.311 . . . . 65.5 110.116 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 t -159.66 162.68 35.18 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 124.409 1.068 . . . . 73.05 110.185 -173.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -155.78 159.82 39.75 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.554 1.542 . . . . 74.35 111.349 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -137.84 142.18 40.77 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.138 1.375 . . . . 71.15 108.619 176.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 57.4 28.33 15.22 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.276 1.831 . . . . 63.12 113.167 -174.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.67 -57.92 9.32 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.058 0.943 . . . . 74.25 112.163 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -52.69 -50.01 64.15 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.313 1.845 . . . . 60.04 112.348 173.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.91 -47.11 86.19 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.14 1.376 . . . . 53.45 113.956 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -69.43 -46.29 67.13 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 124.787 1.235 . . . . 70.13 113.567 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.5 mmt -65.81 -37.93 87.59 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 124.729 1.268 . . . . 61.43 112.975 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -71.94 -27.09 62.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.103 0.961 . . . . 62.13 112.482 171.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.03 -37.47 58.32 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.556 1.142 . . . . 71.32 113.721 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.9 pt -78.24 -8.27 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 113.391 0.886 . . . . 75.3 113.391 170.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.8 31.46 26.59 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.509 -1.162 . . . . 44.11 112.547 169.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.31 153.06 93.37 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 118.861 1.33 . . . . 72.05 111.704 173.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.7 142.22 69.45 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.18 1.92 . . . . 64.41 111.407 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -59.02 -24.84 63.16 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.514 1.301 . . . . 74.34 114.514 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -62.66 -47.23 84.59 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 117.266 -1.349 . . . . 73.54 113.55 171.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.2 mt -63.67 -28.04 69.63 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.306 1.042 . . . . 75.44 113.693 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.4 mt -76.95 -52.64 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.322 1.049 . . . . 64.11 111.394 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -62.7 -41.08 98.94 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 117.576 -1.202 . . . . 53.41 113.335 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -25.61 61.21 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 118.216 -0.897 . . . . 75.5 113.171 172.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.83 -32.28 50.48 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.148 -0.807 . . . . 20.32 111.978 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.0 -31.57 16.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.677 1.191 . . . . 72.43 113.066 173.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -72.27 -54.4 9.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.686 1.194 . . . . 75.45 110.854 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.9 mm -94.22 125.63 46.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 124.346 1.029 . . . . 62.42 108.636 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -73.79 104.75 4.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.452 1.101 . . . . 63.21 110.284 170.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.0 158.1 51.82 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 124.497 1.123 . . . . 74.13 110.592 176.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.3 t -100.91 152.19 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.119 0.968 . . . . 70.24 109.257 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.7 t -130.3 155.58 46.08 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.109 1.764 . . . . 70.22 108.563 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -158.05 143.25 16.7 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.493 -0.558 . . . . 72.33 109.493 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.3 mt -134.76 133.44 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 106.077 -1.823 . . . . 62.45 106.077 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.2 t -140.34 98.92 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 107.81 -1.181 . . . . 74.23 107.81 -175.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -82.37 133.14 35.22 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.667 1.187 . . . . 74.34 109.928 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -133.81 54.32 1.96 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.941 1.297 . . . . 73.54 110.153 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.9 -111.92 3.61 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 109.156 -1.578 . . . . 50.4 109.156 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -77.34 -33.03 55.5 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.373 1.069 . . . . 73.31 113.813 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.56 154.7 34.26 Favored 'General case' 0 C--N 1.346 0.421 0 O-C-N 124.147 0.904 . . . . 72.23 111.267 172.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -144.99 135.16 23.98 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.49 -1.67 . . . . 73.35 106.49 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -123.27 152.66 41.13 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.229 1.411 . . . . 75.04 110.058 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -143.24 135.35 26.98 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.231 -1.396 . . . . 70.41 107.231 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 m -123.1 107.26 11.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.529 1.131 . . . . 45.21 109.633 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.5 mt -95.31 136.38 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.609 1.164 . . . . 74.15 108.544 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.2 m -123.09 125.49 45.28 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.478 1.111 . . . . 51.0 108.763 172.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.74 70.73 0.72 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.292 1.037 . . . . 75.3 108.813 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.44 -37.86 1.83 Allowed Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.85 1.69 . . . . 43.33 113.894 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.0 p -157.05 -45.39 0.07 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.131 1.466 . . . . 73.3 112.137 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.99 139.28 48.53 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.27 1.028 . . . . 75.41 110.823 171.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.96 136.4 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 124.541 1.15 . . . . 63.15 109.315 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.6 mt -125.76 124.19 65.97 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 C-N-CA 124.669 1.188 . . . . 74.53 109.067 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -109.24 124.0 50.17 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 125.206 1.566 . . . . 63.21 107.749 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -122.09 144.82 48.69 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.976 1.31 . . . . 63.35 108.685 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -135.23 143.27 46.25 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 125.019 1.449 . . . . 73.05 109.407 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.76 162.74 40.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.509 1.123 . . . . 75.23 110.022 175.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.1 m -108.59 130.04 55.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.391 1.076 . . . . 72.31 108.35 172.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.9 116.82 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.239 1.016 . . . . 63.33 110.439 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.74 -8.16 39.53 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.006 -1.441 . . . . 75.31 112.413 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -121.32 154.01 36.97 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 119.155 1.478 . . . . 71.42 111.065 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.39 131.86 39.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.913 1.685 . . . . 72.15 110.422 174.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.8 m -143.32 156.69 44.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.442 1.497 . . . . 74.14 108.416 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -95.62 123.89 39.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.701 0.8 . . . . 74.33 110.289 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.01 135.27 51.12 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.193 1.797 . . . . 71.33 109.176 -174.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -100.26 145.22 28.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.355 1.462 . . . . 63.54 111.82 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.3 p -104.82 174.35 5.92 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.107 1.763 . . . . 60.32 112.069 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -54.8 -34.96 63.35 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.471 1.656 . . . . 75.24 115.471 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.5 p -91.47 -5.44 54.25 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.616 1.566 . . . . 74.02 112.983 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.27 13.35 54.48 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 118.337 -1.257 . . . . 62.43 112.954 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -65.38 130.02 41.81 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.188 1.494 . . . . 74.34 109.995 173.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.5 mtpt -114.57 120.27 39.63 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.488 -0.93 . . . . 71.12 108.488 -174.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 m -138.68 128.45 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.903 1.281 . . . . 71.33 111.226 -170.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.86 135.9 40.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.525 1.13 . . . . 75.51 112.296 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 t -161.49 151.9 17.59 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.295 1.438 . . . . 74.2 110.181 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.99 136.41 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.621 1.168 . . . . 42.04 107.958 170.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -106.77 132.24 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 108.249 -1.019 . . . . 70.35 108.249 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -132.04 147.73 52.46 Favored 'General case' 0 C--N 1.345 0.373 0 C-N-CA 124.94 1.296 . . . . 65.02 112.646 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tt -109.44 128.43 55.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.693 1.597 . . . . 64.15 109.094 -174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.47 11.59 21.23 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.164 1.385 . . . . 62.4 114.134 -176.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.21 -1.52 84.81 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.833 1.682 . . . . 63.34 113.137 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -121.94 38.19 4.18 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.747 1.619 . . . . 62.51 111.63 -168.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.326 0.3 OUTLIER 52.38 41.23 30.57 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.572 1.949 . . . . 73.45 113.917 178.753 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -138.81 141.91 38.72 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.263 1.825 . . . . 74.52 108.353 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.2 mt -121.63 119.43 31.84 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 124.302 1.001 . . . . 65.32 110.245 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -102.36 133.81 44.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.271 1.428 . . . . 61.13 108.883 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 t -153.03 135.67 15.25 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.457 1.103 . . . . 63.33 110.576 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.9 p -137.86 126.49 23.66 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.005 1.322 . . . . 75.11 110.155 -172.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -92.27 -61.26 1.65 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.917 1.287 . . . . 65.02 110.145 -175.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -143.15 -70.12 0.33 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.263 1.425 . . . . 65.23 108.43 -174.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -123.77 -20.58 5.41 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.977 1.711 . . . . 74.45 111.186 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -79.32 121.78 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.71 1.204 . . . . 51.44 109.275 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -112.28 93.31 4.38 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.108 1.363 . . . . 74.33 108.722 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.2 t -95.09 112.3 24.02 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.872 1.669 . . . . 52.41 110.205 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.4 t -113.82 116.33 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.143 1.377 . . . . 53.11 108.347 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.0 m -94.72 152.54 18.37 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.812 1.645 . . . . 54.15 109.92 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -145.17 140.9 28.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.799 1.64 . . . . 73.43 109.383 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 tp -122.36 126.46 48.09 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.292 1.837 . . . . 75.03 107.05 173.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -133.49 87.18 2.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.552 1.941 . . . . 71.04 106.84 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.94 -114.79 6.88 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 110.58 -1.008 . . . . 53.43 110.58 175.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.56 3.69 49.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.424 1.49 . . . . 71.13 113.798 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.7 mm -116.27 131.68 68.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.282 0.946 . . . . 60.11 109.054 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 42.9 mm -106.38 136.12 42.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.264 0 N-CA-C 107.527 -1.286 . . . . 74.23 107.527 168.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.9 m -123.27 137.66 54.81 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.168 -1.419 . . . . 65.21 107.168 172.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -134.71 135.09 41.72 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.405 -0.961 . . . . 75.33 108.405 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 90.7 m -132.81 116.03 16.03 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.605 1.191 . . . . 75.43 108.547 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 94.0 mtp -107.62 142.37 37.67 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.431 1.492 . . . . 74.34 108.935 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.7 m -132.58 108.25 8.96 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.288 0.993 . . . . 60.32 108.639 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.8 tp -121.1 112.76 19.1 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.529 1.531 . . . . 71.2 108.117 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.3 -118.61 15.47 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 124.657 1.223 . . . . 63.24 110.129 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.47 3.92 50.64 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.502 1.521 . . . . 71.45 113.114 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mp -111.45 135.43 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.056 0.942 . . . . 75.42 109.273 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.14 96.08 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.035 0.934 . . . . 64.21 109.421 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -76.34 131.05 38.94 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.636 1.574 . . . . 74.24 112.193 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -113.67 152.52 30.33 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.601 1.161 . . . . 63.24 109.825 167.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -150.48 138.65 20.25 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.837 1.255 . . . . 62.53 109.038 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -130.22 137.05 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.82 1.248 . . . . 74.22 108.534 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 42.3 m -132.2 160.99 34.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.285 1.434 . . . . 75.33 110.273 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -136.2 144.46 44.94 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.799 1.24 . . . . 63.23 110.227 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -62.63 139.05 58.63 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 126.136 1.775 . . . . 72.42 113.765 -171.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.1 mt . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 105.776 -1.935 . . . . 72.13 105.776 -174.687 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 108.583 -0.895 . . . . 72.34 108.583 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -62.6 -27.7 69.37 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 115.355 1.613 . . . . 74.21 115.355 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.0 p -58.3 119.95 7.83 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.565 1.546 . . . . 75.25 113.974 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.08 160.32 9.48 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 110.121 -1.192 . . . . 65.11 110.121 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -92.39 149.25 21.52 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.82 1.248 . . . . 74.12 112.072 172.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -139.89 152.08 46.14 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.622 1.569 . . . . 74.24 109.353 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -125.1 148.13 48.69 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.264 1.425 . . . . 63.35 109.297 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.2 129.96 42.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.167 0.987 . . . . 71.32 111.722 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -114.24 -50.42 2.81 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.655 1.582 . . . . 65.5 111.23 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.8 t -152.7 170.58 19.9 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 124.259 0.974 . . . . 73.05 110.804 -171.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -167.83 149.94 5.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.148 1.379 . . . . 74.35 111.412 -166.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -142.47 140.69 31.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.203 1.401 . . . . 71.15 108.673 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 57.52 26.59 12.91 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.465 1.906 . . . . 63.12 113.952 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -62.48 -56.36 18.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.089 0.955 . . . . 74.25 112.263 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -49.91 -55.44 14.42 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.971 1.708 . . . . 60.04 111.996 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.1 -51.22 64.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.067 1.747 . . . . 53.45 114.351 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -67.39 -45.59 75.75 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.379 1.072 . . . . 70.13 113.377 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.4 mmt -68.35 -35.61 78.01 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 124.76 1.287 . . . . 61.43 112.666 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -64.27 -36.0 82.67 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.809 0.843 . . . . 62.13 113.138 167.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.52 -35.82 60.65 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 114.679 1.363 . . . . 71.32 114.679 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.5 pt -76.28 -10.56 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.679 0.792 . . . . 75.3 113.108 170.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.4 27.07 26.15 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 118.41 -1.216 . . . . 44.11 112.862 170.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 mp -67.58 147.26 98.74 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 119.112 1.456 . . . . 72.05 111.159 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -66.77 145.97 76.93 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.162 1.908 . . . . 64.41 111.433 172.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -55.78 -29.2 59.25 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.47 1.285 . . . . 74.34 114.47 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -63.56 -45.42 90.57 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 117.772 -1.109 . . . . 73.54 113.827 174.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.2 mt -64.6 -27.41 68.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.227 1.011 . . . . 75.44 113.339 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.8 mt -77.93 -54.98 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.221 1.008 . . . . 64.11 110.09 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -58.9 -40.79 85.54 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.951 1.093 . . . . 53.41 113.951 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -29.44 62.7 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 118.431 -0.795 . . . . 75.5 112.732 173.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.69 -21.43 71.95 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-O 118.715 -1.047 . . . . 20.32 112.787 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -102.02 -24.98 13.91 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 124.661 1.184 . . . . 72.43 113.14 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -68.94 -52.6 27.54 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.941 1.296 . . . . 75.45 110.687 172.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.1 mm -96.39 137.06 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.755 1.222 . . . . 62.42 109.431 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -90.87 126.77 36.14 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.723 1.209 . . . . 63.21 110.042 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.37 175.97 46.36 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 124.475 1.109 . . . . 74.13 110.707 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.26 151.3 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.546 1.538 . . . . 70.24 108.213 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.3 t -148.82 105.53 3.57 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.852 0.861 . . . . 70.22 109.771 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -81.19 143.5 32.3 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 125.081 1.352 . . . . 72.33 110.801 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.8 mt -127.0 132.02 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 107.178 -1.415 . . . . 62.45 107.178 174.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.4 m -139.34 143.32 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.126 0.57 . . . . 74.23 109.931 172.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -121.73 128.24 51.57 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.219 1.808 . . . . 74.34 106.913 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -139.89 77.81 1.63 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.032 0.933 . . . . 73.54 108.891 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.18 -121.54 10.39 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 108.741 -1.744 . . . . 50.4 108.741 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -79.37 -26.66 41.98 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.387 1.254 . . . . 73.31 114.387 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.9 154.38 28.38 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 123.876 0.87 . . . . 72.23 111.442 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -146.02 134.11 21.55 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.834 -1.543 . . . . 73.35 106.834 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -123.01 159.14 29.0 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.302 1.041 . . . . 75.04 110.122 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.47 123.12 7.95 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.076 1.35 . . . . 70.41 108.687 -174.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -119.81 107.13 12.8 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.271 1.029 . . . . 45.21 108.994 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.17 117.34 54.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.322 1.049 . . . . 74.15 108.708 -173.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.4 m -99.0 133.01 43.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.973 1.309 . . . . 51.0 109.089 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.25 81.17 1.87 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.645 1.178 . . . . 75.3 109.035 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.08 -79.36 1.92 Allowed Glycine 0 CA--C 1.531 1.045 0 N-CA-C 109.412 -1.475 . . . . 43.33 109.412 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 t -136.3 -30.04 0.95 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.847 1.259 . . . . 73.3 112.06 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -73.12 139.41 46.41 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 123.656 0.782 . . . . 75.41 110.837 170.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.01 117.64 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.002 -1.11 . . . . 63.15 108.002 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.0 mt -107.15 124.41 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.582 -1.266 . . . . 74.53 107.582 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -108.4 128.85 55.13 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 124.696 1.248 . . . . 63.21 108.703 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -132.58 154.12 50.34 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.144 1.378 . . . . 63.35 108.787 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.84 148.98 25.92 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 124.421 1.076 . . . . 73.05 109.969 -173.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.574 ' HA ' ' HG ' ' A' ' 69' ' ' CYS . 52.5 p90 -156.96 154.07 29.08 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 124.668 1.23 . . . . 75.23 110.267 -175.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -96.24 129.96 43.44 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.631 1.207 . . . . 72.31 108.307 170.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.87 125.39 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.37 1.068 . . . . 63.33 110.515 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.69 -35.02 5.2 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 118.381 -1.233 . . . . 75.31 111.553 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -97.4 143.18 28.39 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 118.861 1.33 . . . . 71.42 111.762 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.72 126.55 30.07 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.71 1.604 . . . . 72.15 111.067 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.574 ' HG ' ' HA ' ' A' ' 63' ' ' PHE . 66.4 m -141.79 153.29 44.44 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.853 1.261 . . . . 74.14 108.78 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.48 120.15 37.34 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.826 1.25 . . . . 74.33 108.761 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -111.37 116.15 30.48 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 124.415 1.086 . . . . 71.33 109.031 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -76.04 152.21 36.95 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 124.548 1.155 . . . . 63.54 111.084 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.1 p -114.94 179.67 3.88 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.795 1.638 . . . . 60.32 109.929 173.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 43.7 mtm -56.26 -29.23 60.83 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.811 1.782 . . . . 75.24 115.811 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.2 p -86.24 -13.03 48.03 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.507 1.523 . . . . 74.02 113.325 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.53 -1.9 60.42 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 118.287 -1.285 . . . . 62.43 112.074 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -67.68 115.06 6.83 Favored 'General case' 0 C--N 1.349 0.547 0 CA-C-N 119.294 1.547 . . . . 74.34 110.984 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -111.8 136.0 51.66 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 124.791 1.307 . . . . 71.12 109.361 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.96 128.64 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.827 1.251 . . . . 71.33 110.316 -169.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.54 128.83 38.05 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 124.44 1.088 . . . . 75.51 111.939 174.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.1 t -158.05 157.62 33.24 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.076 1.35 . . . . 74.2 109.433 172.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.1 m -101.2 151.93 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.875 1.27 . . . . 42.04 109.663 169.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.52 127.0 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.763 -1.199 . . . . 70.35 107.763 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -117.51 172.38 7.37 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.814 1.646 . . . . 65.02 109.67 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.3 tt -130.11 129.06 43.06 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.611 1.164 . . . . 64.15 108.624 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -86.16 15.53 5.09 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.196 1.398 . . . . 62.4 114.602 -174.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.76 12.05 78.08 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 125.291 1.424 . . . . 63.34 113.161 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -143.36 51.88 1.36 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.648 1.179 . . . . 62.51 109.019 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.296 0.3 OUTLIER 48.72 38.29 11.34 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.892 2.077 . . . . 73.45 114.437 171.445 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -143.51 133.49 24.15 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 125.55 1.54 . . . . 74.52 108.431 -170.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.1 mt -103.91 124.27 48.67 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 124.525 1.141 . . . . 65.32 109.742 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.9 t -106.91 133.34 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.407 1.483 . . . . 61.13 108.617 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.7 t -164.98 140.8 5.52 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.201 1.0 . . . . 63.33 110.476 -168.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.5 m -146.72 128.97 15.72 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.666 0.604 . . . . 75.11 110.542 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -86.89 -154.75 0.24 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.773 1.629 . . . . 65.02 110.675 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.45 -34.1 74.86 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.639 1.576 . . . . 65.23 113.952 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -162.47 12.2 0.07 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.343 1.457 . . . . 74.45 112.47 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.9 mt -116.22 117.07 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.263 -1.384 . . . . 51.44 107.263 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -85.17 146.94 26.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.543 1.137 . . . . 74.33 108.687 169.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.7 m -150.43 125.99 10.23 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 123.857 0.723 . . . . 52.41 110.321 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.08 110.44 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.801 -1.185 . . . . 53.11 107.801 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.7 m -92.32 152.37 19.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.424 1.09 . . . . 54.15 109.511 172.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -143.74 138.38 28.77 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.979 1.712 . . . . 73.43 109.927 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.4 tp -118.58 125.14 49.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.84 2.056 . . . . 75.03 106.762 172.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -129.87 78.81 1.87 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.658 1.983 . . . . 71.04 106.293 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.99 -111.78 4.27 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.588 1.09 . . . . 53.43 110.58 176.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.74 -17.23 56.16 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.888 1.275 . . . . 71.13 113.536 175.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.8 mm -102.39 132.41 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 119.027 0.83 . . . . 60.11 110.161 -174.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.2 mm -108.53 140.39 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.022 1.329 . . . . 74.23 108.4 170.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.7 m -133.02 141.77 48.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.778 1.231 . . . . 65.21 107.719 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -132.95 142.0 48.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.565 1.146 . . . . 75.33 107.911 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.2 m -135.08 105.6 6.41 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 124.91 1.381 . . . . 75.43 108.206 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.6 mtp -98.58 148.28 23.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.901 1.68 . . . . 74.34 108.963 173.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.6 m -138.7 109.55 6.71 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.135 0.974 . . . . 60.32 108.83 173.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.7 tp -114.37 109.4 18.28 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.545 1.538 . . . . 71.2 108.14 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.47 -112.33 4.89 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 124.822 1.326 . . . . 63.24 110.465 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.83 2.37 41.01 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.74 2.016 . . . . 71.45 113.706 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.1 mt -122.5 142.83 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.709 1.204 . . . . 75.42 110.346 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.6 t -123.85 90.99 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.559 1.144 . . . . 64.21 110.164 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -73.57 128.92 36.83 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.4 1.08 . . . . 74.24 112.111 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -123.99 152.4 42.59 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.285 1.034 . . . . 63.24 110.716 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -140.61 144.3 35.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.965 1.306 . . . . 62.53 109.002 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -135.1 126.89 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.464 1.106 . . . . 74.22 108.109 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.8 m -129.87 159.43 36.63 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.74 1.216 . . . . 75.33 110.102 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -135.73 146.28 47.53 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.484 1.114 . . . . 63.23 110.626 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.3 ttp85 -62.79 139.52 58.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.242 2.217 . . . . 72.42 114.067 -172.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.0 mt . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 105.792 -1.929 . . . . 72.13 105.792 -175.067 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.9 p . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 108.946 -0.761 . . . . 72.34 108.946 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -60.24 -33.23 72.0 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.874 1.435 . . . . 74.21 114.874 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.2 p -57.61 133.3 55.17 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.168 1.787 . . . . 75.25 114.564 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.54 165.25 10.23 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.742 1.163 . . . . 65.11 110.217 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -92.97 145.23 24.53 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 124.694 1.198 . . . . 74.12 112.004 173.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -135.94 147.67 48.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.508 1.523 . . . . 74.24 109.506 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -116.69 148.73 40.78 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.303 1.441 . . . . 63.35 109.454 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.84 121.88 20.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.71 1.204 . . . . 71.32 111.716 -175.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -96.31 -56.47 2.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.72 1.208 . . . . 65.5 111.85 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.5 t -161.77 159.05 26.64 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.15 0.98 . . . . 73.05 110.448 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -135.4 147.19 48.93 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.251 1.42 . . . . 74.35 108.698 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -123.32 138.05 54.7 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.1 1.36 . . . . 71.15 108.476 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 56.37 32.79 21.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.262 1.825 . . . . 63.12 112.616 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -61.74 -60.72 3.23 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.324 1.05 . . . . 74.25 110.594 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.47 -39.05 89.48 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 124.478 1.111 . . . . 60.04 113.559 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.68 -48.26 81.69 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.45 1.1 . . . . 53.45 112.965 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -68.32 -45.43 72.97 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.948 1.299 . . . . 70.13 113.072 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.9 mmt -69.19 -37.38 78.12 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.32 1.048 . . . . 61.43 113.118 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -67.01 -35.42 79.91 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.904 0.882 . . . . 62.13 112.754 169.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.56 -34.18 69.75 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.386 1.254 . . . . 71.32 114.386 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.9 pt -79.06 -9.72 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 113.204 0.816 . . . . 75.3 113.204 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.89 22.64 22.77 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 118.099 -1.389 . . . . 44.11 113.52 167.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.68 151.5 97.21 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 119.629 1.715 . . . . 72.05 111.866 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.26 147.51 59.81 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.291 1.994 . . . . 64.41 111.789 172.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -57.11 -29.64 63.69 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.028 1.492 . . . . 74.34 115.028 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -62.27 -44.67 96.01 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.383 0.882 . . . . 73.54 113.383 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -65.8 -27.6 68.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.549 1.539 . . . . 75.44 112.763 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.5 mt -79.95 -47.5 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.64 1.176 . . . . 64.11 111.085 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -65.23 -40.56 94.22 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-O 117.76 -1.114 . . . . 53.41 113.395 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.62 -25.38 61.28 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 118.262 -0.875 . . . . 75.5 112.854 172.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.57 -37.45 46.28 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 123.894 0.759 . . . . 20.32 111.953 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -28.47 21.79 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.517 1.127 . . . . 72.43 113.203 175.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.86 -57.63 3.93 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.59 1.156 . . . . 75.45 111.059 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.8 mm -81.86 119.11 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 124.328 1.017 . . . . 62.42 109.195 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.2 132.95 35.04 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 124.529 1.143 . . . . 63.21 111.054 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -97.75 -179.62 33.29 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 124.917 1.385 . . . . 74.13 110.996 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.4 t -129.44 147.35 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.393 1.877 . . . . 70.24 107.881 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.4 t -145.69 107.69 4.34 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.356 0.662 . . . . 70.22 110.022 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -85.22 148.72 25.94 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.573 1.149 . . . . 72.33 110.723 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.6 mt -126.84 133.67 67.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 124.943 1.402 . . . . 62.45 107.356 175.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.5 t -140.57 97.85 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.661 -0.866 . . . . 74.23 108.661 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -80.56 140.62 35.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.289 0.636 . . . . 74.34 109.519 168.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -146.74 71.63 1.24 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.067 0.947 . . . . 73.54 109.198 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.56 -127.0 11.5 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 109.311 -1.516 . . . . 50.4 109.311 -177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -65.49 -35.52 81.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.239 1.416 . . . . 73.31 113.843 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -76.42 156.31 33.26 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 124.166 0.986 . . . . 72.23 112.14 174.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -151.98 126.41 9.38 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.711 -1.218 . . . . 73.35 107.711 -172.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -112.11 154.82 24.86 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.842 2.057 . . . . 75.04 109.926 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.95 143.15 25.04 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.535 1.534 . . . . 70.41 108.196 175.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.4 m -135.99 98.07 3.79 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.33 1.052 . . . . 45.21 108.564 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.1 mt -93.39 114.79 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.907 1.283 . . . . 74.15 109.368 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.0 m -104.92 118.1 35.69 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.831 1.653 . . . . 51.0 108.602 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -169.48 155.96 6.45 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.94 0.896 . . . . 75.3 111.462 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.39 -82.81 1.45 Allowed Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.071 -1.212 . . . . 43.33 110.071 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.9 p -157.0 12.4 0.24 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.584 1.554 . . . . 73.3 112.727 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.35 179.74 8.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.147 0.979 . . . . 75.41 111.577 -172.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.9 t -130.41 126.04 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.555 1.142 . . . . 63.15 108.723 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.3 mt -108.56 128.7 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.821 1.249 . . . . 74.53 108.827 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -114.5 133.61 55.64 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 124.859 1.35 . . . . 63.21 108.661 176.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -133.23 144.63 49.9 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.14 1.376 . . . . 63.35 108.694 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -132.28 145.13 51.08 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 124.882 1.364 . . . . 73.05 109.778 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -157.17 151.07 24.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.568 1.547 . . . . 75.23 108.204 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.4 m -93.69 140.53 29.53 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.708 0.803 . . . . 72.31 108.928 167.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.06 107.1 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.986 0.914 . . . . 63.33 110.064 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.06 -4.42 30.24 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 117.533 -1.704 . . . . 75.31 113.17 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -98.25 147.69 24.38 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.903 1.851 . . . . 71.42 109.409 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -84.87 125.68 32.83 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.749 1.22 . . . . 72.15 109.616 172.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.1 m -146.24 151.72 38.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.924 1.29 . . . . 74.14 109.61 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.55 116.59 28.57 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.905 1.282 . . . . 74.33 109.071 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.72 116.12 31.37 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.559 1.144 . . . . 71.33 109.848 -170.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -79.22 131.82 36.31 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.662 1.226 . . . . 63.54 111.484 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.8 p -90.82 169.67 10.75 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.572 1.549 . . . . 60.32 110.99 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.3 mtm -57.24 -27.47 62.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.929 1.692 . . . . 75.24 115.18 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 p -82.68 -14.55 54.43 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.246 1.818 . . . . 74.02 113.072 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.02 -4.55 59.0 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.289 1.423 . . . . 62.43 112.341 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -69.85 135.48 49.65 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 119.099 1.449 . . . . 74.34 110.439 173.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -138.41 136.5 36.34 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.969 0.793 . . . . 71.12 109.693 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.0 m -149.1 138.66 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.231 1.412 . . . . 71.33 110.089 -170.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 136.19 46.61 Favored 'General case' 0 C--N 1.346 0.416 0 O-C-N 124.213 0.946 . . . . 75.51 112.081 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.4 t -164.8 149.49 9.4 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.552 1.541 . . . . 74.2 109.384 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.3 t -99.32 138.48 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.516 1.126 . . . . 42.04 108.582 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 52.7 t -108.73 125.32 65.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 124.451 1.095 . . . . 70.35 108.254 172.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -120.15 157.16 29.6 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.892 1.677 . . . . 65.02 110.978 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.7 tt -124.63 125.59 44.38 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.937 1.295 . . . . 64.15 108.137 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.01 13.08 5.34 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.307 1.443 . . . . 62.4 114.87 -173.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.13 8.25 83.0 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 125.247 1.403 . . . . 63.34 113.031 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -142.28 61.77 1.44 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.978 1.311 . . . . 62.51 108.858 -171.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 48.02 35.24 4.88 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.155 2.182 . . . . 73.45 115.929 167.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -143.8 139.8 29.53 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.664 1.586 . . . . 74.52 108.691 -172.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.5 mt -113.56 122.63 47.82 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 124.362 1.039 . . . . 65.32 109.684 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.4 t -105.63 134.93 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.472 1.509 . . . . 61.13 108.92 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 t -163.38 144.98 9.57 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.237 1.415 . . . . 63.33 109.969 -171.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 83.9 m -147.86 129.35 14.92 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.809 0.844 . . . . 75.11 110.105 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -69.37 -75.12 0.12 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.831 1.252 . . . . 65.02 111.261 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -138.32 -41.07 0.51 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.328 1.851 . . . . 65.23 110.447 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -154.92 21.16 0.44 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.25 1.42 . . . . 74.45 111.825 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.89 91.05 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.069 1.347 . . . . 51.44 107.697 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -70.06 109.49 4.59 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.051 0.94 . . . . 74.33 111.313 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.6 m -116.88 114.45 23.9 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 124.872 1.358 . . . . 52.41 109.332 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.1 t -117.46 110.16 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.962 1.305 . . . . 53.11 107.898 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.2 m -86.17 153.14 22.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.369 1.468 . . . . 54.15 109.688 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -148.11 138.88 23.07 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.816 1.246 . . . . 73.43 109.802 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.0 tp -116.28 126.57 53.74 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.824 2.05 . . . . 75.03 107.704 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -126.46 70.42 1.25 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.001 1.721 . . . . 71.04 106.766 170.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.41 -110.14 3.31 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.913 1.244 . . . . 53.43 110.417 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.03 4.51 14.24 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.476 1.511 . . . . 71.13 113.903 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.8 mm -123.92 140.5 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.118 0.967 . . . . 60.11 109.165 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.7 mm -120.3 137.27 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 125.123 1.369 . . . . 74.23 107.966 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.7 m -134.65 115.61 14.01 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 124.671 1.232 . . . . 65.21 107.84 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -106.08 139.64 40.3 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.436 -0.95 . . . . 75.33 108.436 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.7 m -131.28 120.69 23.54 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.873 1.358 . . . . 75.43 108.358 174.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.4 mtm -112.72 150.19 31.89 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.884 1.674 . . . . 74.34 109.594 173.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.1 m -138.87 96.3 3.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.556 1.142 . . . . 60.32 108.862 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.2 tp -104.73 111.01 23.57 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.443 1.497 . . . . 71.2 108.883 175.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.34 -112.87 5.36 Favored Glycine 0 CA--C 1.533 1.193 0 O-C-N 124.574 1.171 . . . . 63.24 110.413 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -110.9 18.74 19.23 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.91 1.684 . . . . 71.45 111.29 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.4 mt -129.4 136.88 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.015 1.326 . . . . 75.42 109.026 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.6 t -121.99 95.69 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 124.237 0.961 . . . . 64.21 109.565 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -75.05 128.24 35.09 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.814 1.245 . . . . 74.24 112.317 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.04 153.34 34.88 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 124.094 0.871 . . . . 63.24 110.835 169.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -135.29 139.06 44.07 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 126.362 1.865 . . . . 62.53 108.199 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.32 133.71 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 O-C-N 124.802 1.314 . . . . 74.22 107.622 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.9 m -137.37 158.51 44.24 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.122 1.369 . . . . 75.33 110.116 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -139.11 142.77 38.08 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.583 1.153 . . . . 63.23 110.755 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -68.06 136.82 54.38 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.969 2.108 . . . . 72.42 113.005 -168.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.5 mt . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 105.494 -2.039 . . . . 72.13 105.494 -174.344 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 110.078 -0.341 . . . . 72.34 110.078 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -68.18 -30.95 70.18 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 117.625 -1.179 . . . . 74.21 113.621 169.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.5 p -58.88 103.1 0.14 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.488 1.515 . . . . 75.25 112.968 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.75 174.11 37.77 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 108.958 -1.657 . . . . 65.11 108.958 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.53 146.11 48.36 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.686 -1.227 . . . . 74.12 107.686 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -143.1 130.24 20.78 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.798 0.839 . . . . 74.24 110.397 -168.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -87.9 149.21 24.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.988 0.915 . . . . 63.35 110.532 174.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.0 tp -68.64 132.31 46.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.6 0.76 . . . . 71.32 111.131 173.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -106.08 -53.53 2.62 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 124.67 1.231 . . . . 65.5 110.829 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.25 157.66 15.61 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 124.447 1.092 . . . . 73.05 110.382 -175.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -135.98 137.69 41.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.562 1.145 . . . . 74.35 108.582 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -112.86 137.15 51.64 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.217 1.407 . . . . 71.15 108.406 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 57.39 30.19 18.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.124 1.77 . . . . 63.12 112.964 -171.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.21 -58.36 8.63 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 124.177 0.991 . . . . 74.25 112.111 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -52.59 -52.15 56.57 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.344 1.858 . . . . 60.04 112.42 173.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.96 -48.78 77.54 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.332 1.453 . . . . 53.45 114.037 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -67.72 -45.7 74.29 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.862 1.265 . . . . 70.13 113.593 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 7.3 mmt -65.38 -40.22 93.23 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 124.699 1.25 . . . . 61.43 112.829 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -67.84 -28.3 67.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.187 0.995 . . . . 62.13 113.052 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.63 -34.71 40.33 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 114.099 1.148 . . . . 71.32 114.099 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.0 pt -77.12 -6.82 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 113.065 0.765 . . . . 75.3 113.065 169.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.59 31.24 24.96 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.604 -1.109 . . . . 44.11 112.345 169.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.01 151.57 97.09 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 118.636 1.218 . . . . 72.05 111.774 177.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.51 139.48 59.03 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.01 1.807 . . . . 64.41 110.763 169.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -63.45 -20.33 65.48 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.4 1.259 . . . . 74.34 114.4 -174.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.58 -45.71 91.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 117.881 -1.057 . . . . 73.54 113.435 168.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.8 mt -66.81 -26.96 67.19 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 124.212 1.005 . . . . 75.44 113.518 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.5 mt -75.93 -51.22 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.033 0.933 . . . . 64.11 111.376 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -62.08 -48.24 81.07 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.111 -0.947 . . . . 53.41 112.646 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -27.03 68.59 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.426 0.898 . . . . 75.5 113.426 174.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.23 -29.23 51.04 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 118.69 -1.061 . . . . 20.32 112.395 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.37 -30.6 13.83 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.471 1.135 . . . . 72.43 112.732 175.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -72.9 -39.39 66.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.687 1.195 . . . . 75.45 113.335 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.6 mt -111.06 130.05 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.483 -0.932 . . . . 62.42 108.483 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -88.02 134.13 33.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.928 1.291 . . . . 63.21 110.642 172.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.7 -168.15 26.38 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 109.683 -1.367 . . . . 74.13 109.683 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.2 t -134.97 153.96 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.885 1.274 . . . . 70.24 108.317 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.4 p -128.6 160.48 32.28 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.465 1.506 . . . . 70.22 110.622 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -133.75 148.84 51.44 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 107.452 -1.314 . . . . 72.33 107.452 169.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.405 HG12 ' CE2' ' A' ' 50' ' ' PHE . 7.8 mt -138.72 129.91 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 105.963 -1.866 . . . . 62.45 105.963 176.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.2 m -139.28 138.95 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 123.426 0.454 . . . . 74.23 110.029 175.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -109.94 117.17 33.09 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.083 1.753 . . . . 74.34 107.277 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -116.08 51.33 0.97 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.181 1.392 . . . . 73.54 109.162 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.95 -116.62 5.67 Favored Glycine 0 CA--C 1.534 1.227 0 N-CA-C 107.977 -2.049 . . . . 50.4 107.977 -171.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -72.59 -34.91 67.73 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.154 1.168 . . . . 73.31 114.154 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.44 161.75 29.51 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.856 0.723 . . . . 72.23 111.829 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -159.26 131.46 6.58 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 106.886 -1.524 . . . . 73.35 106.886 -173.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -121.07 149.2 43.08 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.978 1.311 . . . . 75.04 108.824 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.405 ' CE2' HG12 ' A' ' 41' ' ' ILE . 5.5 t80 -141.82 119.75 11.98 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.351 -1.352 . . . . 70.41 107.351 177.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 34.3 m -96.09 134.07 39.58 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.592 1.157 . . . . 45.21 108.909 172.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.58 107.0 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.939 -1.504 . . . . 74.15 106.939 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 m -99.33 100.63 11.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.717 1.207 . . . . 51.0 108.426 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.94 178.02 7.08 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.238 1.015 . . . . 75.3 111.325 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.47 29.55 2.57 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 125.216 1.388 . . . . 43.33 113.356 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -158.28 -33.48 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.35 1.575 . . . . 73.3 112.566 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.68 170.05 19.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.953 1.301 . . . . 75.41 110.37 -176.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.416 HG12 HE21 ' A' ' 60' ' ' GLN . 21.9 t -119.23 132.47 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 O-C-N 124.173 0.921 . . . . 63.15 109.181 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.4 mt -122.97 135.29 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.292 1.437 . . . . 74.53 107.926 172.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.416 HE21 HG12 ' A' ' 58' ' ' VAL . 3.4 mp0 -119.6 143.34 47.71 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 124.175 0.922 . . . . 63.21 108.812 176.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -133.38 132.0 40.7 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.627 1.171 . . . . 63.35 109.734 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -113.02 143.57 44.08 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 125.427 1.704 . . . . 73.05 109.476 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -148.19 164.73 33.05 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.186 1.394 . . . . 75.23 108.659 173.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.7 m -113.51 131.28 56.12 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.434 -0.95 . . . . 72.31 108.434 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.0 t -62.76 119.37 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 125.011 1.324 . . . . 63.33 111.213 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.44 ' HA2' HE21 ' A' ' 84' ' ' GLN . . . 92.91 -10.47 73.85 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-O 117.906 -1.497 . . . . 75.31 113.668 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -107.52 139.46 42.01 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.64 1.72 . . . . 71.42 109.355 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.77 120.14 13.02 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 123.606 0.762 . . . . 72.15 111.736 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.5 m -138.92 140.58 38.37 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.263 1.425 . . . . 74.14 108.28 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -67.44 131.11 45.04 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.87 0.731 . . . . 74.33 111.214 168.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 mt -120.77 109.31 15.01 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.543 1.537 . . . . 71.33 107.921 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -74.82 154.52 38.25 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.536 1.135 . . . . 63.54 111.178 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.9 m -110.59 169.56 8.67 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.882 1.673 . . . . 60.32 109.208 175.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -53.06 -25.68 13.49 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.769 1.628 . . . . 75.24 115.022 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 66.5 p -82.09 -18.74 41.97 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 128.548 2.739 . . . . 74.02 113.968 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.56 0.63 55.47 Favored Glycine 0 CA--C 1.543 1.786 0 CA-C-O 118.549 -1.139 . . . . 62.43 112.564 -174.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -75.63 105.06 6.46 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.525 1.53 . . . . 74.34 111.98 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -99.93 133.2 44.64 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.54 1.136 . . . . 71.12 111.079 176.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -147.03 131.47 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.455 1.502 . . . . 71.33 109.908 -172.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -79.47 129.61 34.63 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.577 1.551 . . . . 75.51 110.218 -172.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.6 t -162.69 159.24 24.11 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 124.25 0.969 . . . . 74.2 111.146 -173.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.9 m -104.15 146.31 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 125.287 1.435 . . . . 42.04 109.872 167.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.5 t -122.57 126.84 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 106.962 -1.496 . . . . 70.35 106.962 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.44 HE21 ' HA2' ' A' ' 66' ' ' GLY . 2.4 mt-30 -129.22 139.98 51.65 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.632 1.173 . . . . 65.02 111.522 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.7 tp -84.78 136.97 33.46 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.832 1.332 . . . . 64.15 109.567 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.95 16.12 5.26 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.198 0.999 . . . . 62.4 113.208 173.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.76 12.4 78.26 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.159 1.362 . . . . 63.34 113.081 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -143.91 57.29 1.34 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.862 1.265 . . . . 62.51 108.491 -171.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.276 0.8 OUTLIER 49.49 32.71 4.97 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.84 2.056 . . . . 73.45 115.327 169.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -142.48 127.57 18.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.478 1.911 . . . . 74.52 108.275 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.3 mt -107.17 134.24 50.58 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.593 1.157 . . . . 65.32 109.647 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.8 t -118.91 135.65 58.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.817 1.247 . . . . 61.13 109.181 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.5 t -155.92 142.4 18.57 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.211 1.004 . . . . 63.33 111.576 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.8 p -143.68 136.96 27.87 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.625 1.57 . . . . 75.11 110.121 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -102.78 -61.2 1.43 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.927 1.291 . . . . 65.02 109.613 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -140.88 -63.84 0.46 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 125.881 1.672 . . . . 65.23 109.15 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -140.78 10.63 2.22 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.673 1.589 . . . . 74.45 112.283 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.2 mt -111.53 108.79 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 125.477 1.511 . . . . 51.44 106.95 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -101.58 99.94 10.29 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.404 1.082 . . . . 74.33 110.306 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.63 127.5 35.92 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.091 1.356 . . . . 52.41 108.561 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.3 t -130.41 104.73 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.201 -1.407 . . . . 53.11 107.201 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.3 m -82.68 150.57 26.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.488 1.515 . . . . 54.15 109.842 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -147.09 139.93 25.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.979 1.311 . . . . 73.43 108.933 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.41 124.32 39.9 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.543 1.537 . . . . 75.03 107.418 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -127.55 84.76 2.28 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.555 1.942 . . . . 71.04 106.518 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.69 -114.89 7.19 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.266 1.412 . . . . 53.43 110.461 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -88.18 15.48 7.48 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.77 1.628 . . . . 71.13 114.087 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.8 mm -129.25 132.05 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.248 1.019 . . . . 60.11 108.815 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.1 mm -104.83 140.14 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.792 -1.188 . . . . 74.23 107.792 169.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.2 m -133.98 112.29 11.1 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.077 -1.453 . . . . 65.21 107.077 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -103.14 146.91 27.68 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.419 -0.586 . . . . 75.33 109.419 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.0 m -140.45 99.77 3.72 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.975 1.31 . . . . 75.43 109.265 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.6 mmm -92.19 150.59 20.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.103 1.761 . . . . 74.34 110.241 170.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.8 m -140.44 105.38 4.97 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.306 1.042 . . . . 60.32 108.898 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.6 tp -113.88 110.75 20.6 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.871 1.668 . . . . 71.2 108.583 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.31 -123.33 29.32 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 109.776 -1.33 . . . . 63.24 109.776 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -97.49 12.68 32.52 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.248 1.419 . . . . 71.45 113.18 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.4 mt -119.28 136.82 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.992 0.917 . . . . 75.42 109.865 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.5 t -119.72 96.71 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 124.33 1.019 . . . . 64.21 109.068 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -75.45 127.41 33.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.322 1.049 . . . . 74.24 111.475 172.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 157.21 29.58 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 123.921 0.763 . . . . 63.24 110.065 168.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -149.36 129.53 13.63 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.261 1.024 . . . . 62.53 109.099 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.63 137.36 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.93 1.292 . . . . 74.22 108.565 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.6 m -134.97 158.39 44.46 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.432 1.093 . . . . 75.33 110.136 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -123.09 134.9 54.22 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 125.345 1.458 . . . . 63.23 108.931 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -68.83 146.83 52.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.912 1.685 . . . . 72.42 112.745 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 105.653 -1.981 . . . . 72.13 105.653 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 109.527 -0.546 . . . . 72.34 109.527 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -78.35 56.38 1.72 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.056 1.743 . . . . 74.21 112.056 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -129.02 120.6 26.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.982 1.313 . . . . 75.25 109.515 -175.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.72 164.44 10.58 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 110.022 -1.231 . . . . 65.11 110.022 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.26 142.85 32.09 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.178 1.391 . . . . 74.12 110.213 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -136.53 150.46 48.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.426 1.09 . . . . 74.24 109.818 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -121.75 143.82 49.15 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.6 1.16 . . . . 63.35 108.839 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.9 tp -55.17 137.91 45.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.477 1.511 . . . . 71.32 112.937 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -122.3 -50.88 1.99 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.44 1.496 . . . . 65.5 111.204 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.1 153.88 41.19 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 124.405 1.066 . . . . 73.05 111.719 -172.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -140.66 132.67 27.79 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.761 1.624 . . . . 74.35 108.997 -170.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -138.54 133.73 32.96 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.32 1.048 . . . . 71.15 109.255 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 54.72 27.73 9.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.097 1.759 . . . . 63.12 113.178 -173.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -62.55 -54.5 38.83 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-O 117.84 -1.076 . . . . 74.25 112.131 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -61.1 -47.0 88.32 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-O 118.072 -0.966 . . . . 60.04 113.257 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.54 -47.05 73.64 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.669 1.187 . . . . 53.45 113.667 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -69.83 -45.48 67.76 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.669 1.187 . . . . 70.13 113.419 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.7 mmt -62.83 -48.2 80.09 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 124.502 1.126 . . . . 61.43 112.717 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -59.84 -31.15 69.48 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.468 0.914 . . . . 62.13 113.468 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.2 54.63 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.469 1.285 . . . . 71.32 114.469 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.3 pt -79.73 -7.87 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 113.344 0.868 . . . . 75.3 113.344 172.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.68 24.08 37.07 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.736 -1.035 . . . . 44.11 112.72 172.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.65 141.01 98.18 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.851 1.26 . . . . 72.05 110.264 172.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -66.04 143.01 70.49 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.434 2.089 . . . . 64.41 111.901 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.44 -27.07 62.11 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.664 1.357 . . . . 74.34 114.664 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -64.51 -45.44 87.22 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 117.885 -1.055 . . . . 73.54 113.568 172.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.8 mt -64.76 -25.12 67.78 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.154 0.981 . . . . 75.44 113.291 173.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.7 mt -80.63 -50.86 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.298 1.039 . . . . 64.11 110.802 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -61.94 -42.76 99.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 117.816 -1.087 . . . . 53.41 113.007 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -27.18 62.6 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 118.236 -0.888 . . . . 75.5 112.728 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.67 -27.42 61.01 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.846 -0.975 . . . . 20.32 112.382 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.01 -26.05 14.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.846 1.258 . . . . 72.43 113.147 174.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -80.33 -44.45 19.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.041 0.936 . . . . 75.45 111.156 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.7 mt -102.67 127.64 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.351 1.06 . . . . 62.42 108.165 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -76.96 118.16 19.27 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.896 1.278 . . . . 63.21 109.975 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.2 170.16 37.13 Favored Glycine 0 CA--C 1.531 1.091 0 O-C-N 124.247 0.967 . . . . 74.13 110.72 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.8 t -124.58 149.93 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.081 1.352 . . . . 70.24 108.819 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.0 p -126.41 165.95 18.11 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.73 1.612 . . . . 70.22 110.164 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -152.3 141.64 21.53 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.801 -1.185 . . . . 72.33 107.801 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.14 132.69 50.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.395 -1.706 . . . . 62.45 106.395 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.7 t -140.09 100.98 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.827 0.851 . . . . 74.23 108.96 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -87.29 141.58 28.54 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.494 1.118 . . . . 74.34 109.229 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -152.03 77.13 1.2 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.018 0.927 . . . . 73.54 109.002 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.37 -120.52 8.41 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 109.377 -1.489 . . . . 50.4 109.377 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -75.48 -32.17 60.47 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.717 1.207 . . . . 73.31 114.073 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.56 148.83 38.57 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 124.124 0.89 . . . . 72.23 111.861 175.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -138.26 133.08 32.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.95 1.7 . . . . 73.35 106.674 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -125.41 160.05 30.37 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.87 1.668 . . . . 75.04 110.37 173.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -155.97 145.94 21.35 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.559 -1.275 . . . . 70.41 107.559 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.6 m -129.05 117.86 21.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 124.235 0.959 . . . . 45.21 109.849 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.4 mt -90.56 139.49 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.045 1.338 . . . . 74.15 108.456 172.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.2 m -135.9 112.75 10.24 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.616 1.166 . . . . 51.0 108.079 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -120.15 74.76 1.06 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.465 1.106 . . . . 75.3 109.988 -174.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.82 -91.21 1.39 Allowed Glycine 0 CA--C 1.532 1.126 0 N-CA-C 108.847 -1.701 . . . . 43.33 108.847 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.8 m -105.67 -43.09 5.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.94 1.296 . . . . 73.3 112.08 -176.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -72.72 146.02 46.74 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.95 1.3 . . . . 75.41 112.215 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.2 t -133.92 130.31 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.644 1.177 . . . . 63.15 108.78 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.7 mt -130.71 111.62 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.743 1.217 . . . . 74.53 108.581 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.54 149.47 24.07 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.379 0.672 . . . . 63.21 110.975 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -139.31 153.67 47.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.084 1.753 . . . . 63.35 108.245 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -137.08 141.1 42.38 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 124.815 1.322 . . . . 73.05 109.072 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -145.74 168.01 21.76 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.443 1.097 . . . . 75.23 109.851 173.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.2 m -118.92 130.0 55.48 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.685 -1.228 . . . . 72.31 107.685 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.15 123.15 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.298 1.039 . . . . 63.33 110.782 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.31 2.07 77.58 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 118.267 -1.296 . . . . 75.31 113.396 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -115.31 152.16 33.27 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.571 1.548 . . . . 71.42 109.701 171.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -77.11 127.63 33.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.73 1.612 . . . . 72.15 110.61 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.7 m -146.59 149.47 33.61 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.153 1.381 . . . . 74.14 109.739 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -77.5 145.62 36.89 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 112.688 0.625 . . . . 74.33 112.688 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 mt -122.35 127.85 50.27 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.605 1.562 . . . . 71.33 108.291 173.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -95.29 142.66 27.44 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.43 1.092 . . . . 63.54 110.313 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 p -103.26 -177.57 3.41 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.385 1.474 . . . . 60.32 111.663 173.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.7 mtt -60.02 -38.43 82.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.74 1.616 . . . . 75.24 115.04 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.4 p -89.84 -1.63 58.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.454 1.502 . . . . 74.02 112.838 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.59 19.24 32.74 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 118.249 -1.306 . . . . 62.43 112.722 172.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -69.37 113.98 7.19 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.152 1.476 . . . . 74.34 109.963 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -104.24 125.44 50.51 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 124.153 0.908 . . . . 71.12 109.092 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -146.12 123.27 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 124.427 1.079 . . . . 71.33 110.983 -170.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -72.8 140.59 47.78 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 124.3 1.04 . . . . 75.51 112.351 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.8 t -171.09 163.02 7.26 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.493 1.517 . . . . 74.2 109.692 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.1 t -103.06 136.0 37.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.259 1.024 . . . . 42.04 108.461 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.9 t -103.52 127.8 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 107.996 -1.112 . . . . 70.35 107.996 171.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -125.51 151.67 46.01 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.264 1.425 . . . . 65.02 111.647 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 tp -101.33 137.02 40.23 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 124.757 1.286 . . . . 64.15 109.509 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -87.54 15.56 6.55 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.567 1.147 . . . . 62.4 113.258 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.96 13.83 80.62 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.95 1.262 . . . . 63.34 113.257 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -143.22 57.11 1.39 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.727 1.211 . . . . 62.51 108.561 -173.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.274 0.3 OUTLIER 44.15 37.0 1.67 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.198 2.199 . . . . 73.45 114.97 175.194 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -140.88 121.99 14.7 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 125.622 1.569 . . . . 74.52 109.02 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.3 mt -95.99 142.84 27.73 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 124.718 1.262 . . . . 65.32 109.721 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.9 t -132.56 137.92 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.471 1.508 . . . . 61.13 108.653 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 t -155.13 149.99 26.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.865 0.866 . . . . 63.33 110.734 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.0 p -143.56 130.74 20.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.942 1.297 . . . . 75.11 109.708 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -95.08 -60.2 1.73 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.312 1.045 . . . . 65.02 110.373 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -143.78 -75.57 0.25 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.682 1.593 . . . . 65.23 108.631 -173.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -116.95 -17.03 10.49 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.245 1.818 . . . . 74.45 111.232 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.5 mt -88.86 111.21 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.935 1.294 . . . . 51.44 108.455 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.0 tmmt? -101.27 115.41 30.43 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 124.389 1.075 . . . . 74.33 108.974 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.4 m -117.03 124.36 49.12 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 124.846 1.341 . . . . 52.41 109.073 -169.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.8 t -131.89 117.14 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.528 1.131 . . . . 53.11 109.407 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.1 m -102.92 155.13 18.56 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.769 1.228 . . . . 54.15 109.643 173.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -139.15 144.89 38.81 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.639 1.976 . . . . 73.43 109.661 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 tp -124.85 118.06 25.5 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.863 2.065 . . . . 75.03 106.994 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -122.0 69.2 0.94 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.041 1.337 . . . . 71.04 108.136 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.11 -110.96 3.63 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 110.065 -1.214 . . . . 53.43 110.065 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -79.51 -6.58 57.27 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 117.254 -1.355 . . . . 71.13 113.461 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.2 mm -112.65 136.94 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 119.91 1.232 . . . . 60.11 109.385 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.9 mm -115.54 142.69 27.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.041 1.337 . . . . 74.23 108.151 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.0 m -133.43 124.83 27.79 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.371 1.045 . . . . 65.21 108.235 172.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -108.46 134.95 50.54 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.555 1.142 . . . . 75.33 107.946 170.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 62.6 m -136.41 117.79 14.68 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.303 1.441 . . . . 75.43 108.255 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 33.1 mtm -123.17 142.45 50.89 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.09 0.956 . . . . 74.34 109.715 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.9 m -125.54 113.44 17.44 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.332 1.453 . . . . 60.32 108.662 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.6 tp -121.18 107.5 12.65 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.361 1.464 . . . . 71.2 108.048 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.37 -111.67 4.21 Favored Glycine 0 CA--C 1.533 1.199 0 O-C-N 124.837 1.336 . . . . 63.24 110.442 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -99.6 1.36 43.62 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.733 2.013 . . . . 71.45 113.665 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 91.4 mt -120.68 139.51 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.677 1.191 . . . . 75.42 109.967 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.2 t -125.19 101.08 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 124.187 0.929 . . . . 64.21 109.772 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -68.55 138.45 55.14 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.307 1.443 . . . . 74.24 112.099 169.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.5 mppt? -136.37 157.33 47.06 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 124.486 1.116 . . . . 63.24 110.778 167.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.03 141.84 12.88 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.846 1.258 . . . . 62.53 108.996 -177.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.21 139.7 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.702 1.201 . . . . 74.22 108.368 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 45.0 m -133.05 160.56 36.81 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.479 1.512 . . . . 75.33 109.312 173.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.64 144.91 39.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.63 1.172 . . . . 63.23 110.695 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -63.03 145.34 55.65 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.79 2.036 . . . . 72.42 113.7 -171.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.8 mt . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 103.886 -2.635 . . . . 72.13 103.886 -175.126 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.4 p . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 109.658 -0.497 . . . . 72.34 109.658 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -63.3 -30.82 71.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.265 1.426 . . . . 74.21 114.271 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.1 p -52.72 121.62 7.54 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.063 2.145 . . . . 75.25 113.933 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.49 166.23 14.85 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 109.522 -1.431 . . . . 65.11 109.522 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.16 144.51 37.14 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.378 1.071 . . . . 74.12 108.65 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -137.48 155.82 48.86 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.855 1.262 . . . . 74.24 110.437 -172.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -129.0 146.17 51.05 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.473 1.109 . . . . 63.35 109.581 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.82 129.6 41.16 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.7 1.2 . . . . 71.32 111.517 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 65.6 mm-40 -111.36 -56.59 2.36 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.035 1.334 . . . . 65.5 110.743 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.37 155.47 45.91 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 124.615 1.197 . . . . 73.05 112.056 -170.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -142.38 122.62 13.86 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.087 1.755 . . . . 74.35 107.797 -168.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -129.09 140.94 51.37 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.524 0.73 . . . . 71.15 109.668 170.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 56.17 33.48 22.14 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.632 1.973 . . . . 63.12 112.46 -171.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.0 -62.37 1.6 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.103 -0.951 . . . . 74.25 111.676 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.99 -34.04 75.44 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 113.671 0.989 . . . . 60.04 113.671 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.66 -52.7 64.38 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.079 0.951 . . . . 53.45 112.652 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -67.34 -49.53 63.67 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.656 1.182 . . . . 70.13 113.165 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.1 mmt -67.1 -36.94 83.05 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.745 1.278 . . . . 61.43 113.139 -173.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -77.95 -25.52 48.28 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 118.047 -0.978 . . . . 62.13 112.534 173.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.37 -35.96 63.54 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 113.739 1.015 . . . . 71.32 113.739 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.6 pt -77.44 -10.27 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 O-C-N 123.917 0.76 . . . . 75.3 112.966 170.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.72 29.43 23.86 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.382 -1.232 . . . . 44.11 113.073 167.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.6 mt -65.39 152.17 92.67 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 119.125 1.463 . . . . 72.05 111.718 172.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -64.61 140.69 69.72 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.244 1.963 . . . . 64.41 111.269 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.59 -21.63 53.79 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.686 1.365 . . . . 74.34 114.686 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -59.54 -52.21 66.53 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 117.586 -1.197 . . . . 73.54 113.328 166.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.6 mt -61.12 -30.36 70.32 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.943 1.09 . . . . 75.44 113.943 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.13 -54.2 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 O-C-N 124.17 0.919 . . . . 64.11 111.707 171.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -66.92 -27.55 67.58 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.961 1.467 . . . . 53.41 114.961 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.17 -21.25 31.37 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.759 1.224 . . . . 75.5 112.257 171.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.44 -15.7 52.25 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 118.564 -1.131 . . . . 20.32 112.275 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.12 -31.8 15.37 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.739 1.269 . . . . 72.43 113.079 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -83.48 -45.55 13.49 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.954 0.797 . . . . 75.45 111.032 177.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.4 mm -89.71 125.4 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.06 0.944 . . . . 62.42 109.402 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -85.42 146.46 26.96 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.531 1.144 . . . . 63.21 110.248 166.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -101.84 -168.85 27.38 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 109.753 -1.339 . . . . 74.13 109.753 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.4 t -129.86 158.47 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 126.693 1.997 . . . . 70.24 108.583 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.0 t -137.4 161.04 37.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.071 1.349 . . . . 70.22 110.125 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -143.35 147.81 35.26 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 123.76 0.824 . . . . 72.33 109.287 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.7 mt -132.03 126.01 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.461 -1.681 . . . . 62.45 106.461 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.9 t -136.87 92.2 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.197 -1.038 . . . . 74.23 108.197 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -79.98 138.68 37.12 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.128 0.971 . . . . 74.34 109.577 171.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -148.6 74.79 1.29 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.094 0.958 . . . . 73.54 109.298 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.43 -125.02 11.37 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.277 -1.529 . . . . 50.4 109.277 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mmpp? -70.26 -32.36 70.16 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.894 1.277 . . . . 73.31 114.377 173.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.0 157.22 31.33 Favored 'General case' 0 C--N 1.345 0.399 0 O-C-N 124.046 0.841 . . . . 72.23 111.893 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -157.05 127.33 6.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.039 -1.467 . . . . 73.35 107.039 -173.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -115.75 151.55 34.93 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.873 1.669 . . . . 75.04 109.886 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -147.44 119.81 8.42 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.057 -1.09 . . . . 70.41 108.057 -176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.1 m -102.07 129.97 48.53 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 124.49 1.119 . . . . 45.21 108.576 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.0 mt -113.63 120.16 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 106.839 -1.541 . . . . 74.15 106.839 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.5 m -113.88 104.07 11.81 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.644 1.215 . . . . 51.0 107.799 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.2 -162.29 0.11 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.813 1.645 . . . . 75.3 111.933 172.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.94 -27.03 69.65 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-O 118.788 -1.006 . . . . 43.33 113.738 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.0 p -163.75 25.37 0.08 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.429 1.492 . . . . 73.3 112.648 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -139.47 142.58 37.35 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.408 1.083 . . . . 75.41 109.967 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.29 128.89 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 124.293 0.996 . . . . 63.15 108.823 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.8 mt -130.95 123.11 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.766 1.626 . . . . 74.53 107.467 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.43 138.81 49.55 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.125 0.97 . . . . 63.21 109.034 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -134.48 145.19 48.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.037 1.335 . . . . 63.35 108.658 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -125.05 145.98 49.66 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 124.817 1.323 . . . . 73.05 109.195 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -149.21 161.02 42.84 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.65 1.18 . . . . 75.23 109.88 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.3 m -108.86 130.0 55.41 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.347 1.03 . . . . 72.31 108.467 172.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 80.3 t -66.78 115.27 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.763 1.225 . . . . 63.33 110.578 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.25 -9.56 50.02 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-O 117.971 -1.46 . . . . 75.31 112.963 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -114.52 149.13 36.9 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.422 1.611 . . . . 71.42 109.916 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -71.41 133.37 45.88 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.93 0.769 . . . . 72.15 110.725 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.5 m -139.02 168.16 20.45 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.717 1.607 . . . . 74.14 108.936 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -110.89 133.26 53.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.867 0.867 . . . . 74.33 109.901 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -122.02 138.48 54.42 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.443 1.497 . . . . 71.33 109.292 -171.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -109.75 141.86 41.78 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.327 1.451 . . . . 63.54 111.912 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 m -99.63 167.06 10.81 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.91 1.684 . . . . 60.32 111.61 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 65.3 mtm -57.56 -26.75 61.9 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.947 1.699 . . . . 75.24 114.986 170.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.1 t -83.62 -10.83 57.97 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.645 1.178 . . . . 74.02 113.557 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.84 4.46 67.32 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 118.457 -1.19 . . . . 62.43 113.296 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -71.06 136.48 48.3 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.277 1.538 . . . . 74.34 109.648 172.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -120.66 135.38 55.13 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.295 0.997 . . . . 71.12 108.609 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.14 132.1 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.591 1.156 . . . . 71.33 110.562 -171.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -74.42 141.2 45.06 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 124.283 0.989 . . . . 75.51 111.85 173.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.5 t -164.94 154.05 12.73 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.586 1.555 . . . . 74.2 110.003 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.73 133.61 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 107.865 -1.161 . . . . 42.04 107.865 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -112.17 129.04 68.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 108.311 -0.996 . . . . 70.35 108.311 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -141.11 147.39 38.42 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.054 1.342 . . . . 65.02 111.712 -173.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 tp -75.54 138.63 41.64 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.349 1.059 . . . . 64.15 111.492 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -89.45 6.35 41.17 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.889 1.275 . . . . 62.4 112.415 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.74 16.55 77.96 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.798 1.19 . . . . 63.34 112.948 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -150.22 48.25 0.9 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.249 1.42 . . . . 62.51 108.86 -172.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.302 0.0 OUTLIER 53.13 33.51 15.28 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.642 1.577 . . . . 73.45 114.079 178.059 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -130.5 141.56 50.49 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 125.787 1.635 . . . . 74.52 108.748 -171.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.1 mt -117.66 113.27 21.65 Favored 'General case' 0 C--N 1.343 0.312 0 O-C-N 124.539 1.149 . . . . 65.32 109.414 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.0 t -95.01 136.93 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.877 1.671 . . . . 61.13 109.137 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.13 147.32 22.38 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.54 1.536 . . . . 63.33 110.62 -174.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.6 p -150.67 132.78 15.3 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.392 1.477 . . . . 75.11 109.725 -175.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -98.15 -70.15 0.73 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.09 1.356 . . . . 65.02 108.895 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -135.3 -57.17 0.8 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.702 1.601 . . . . 65.23 108.887 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -149.09 10.29 0.79 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.415 1.486 . . . . 74.45 112.564 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.48 104.8 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.549 -1.278 . . . . 51.44 107.549 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -86.88 106.64 17.9 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 124.121 0.888 . . . . 74.33 109.253 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 55.7 p -111.45 123.55 50.45 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.757 1.285 . . . . 52.41 111.141 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.5 t -126.1 105.32 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 126.037 1.735 . . . . 53.11 107.495 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.6 m -82.13 152.42 26.53 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.012 1.325 . . . . 54.15 109.769 172.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -142.28 139.06 31.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.856 1.662 . . . . 73.43 108.953 174.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.1 tp -117.71 126.73 53.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.917 2.087 . . . . 75.03 106.734 173.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -133.97 81.19 1.9 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.474 1.91 . . . . 71.04 106.285 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.13 -116.62 9.08 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 110.202 -1.159 . . . . 53.43 110.202 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -88.52 17.74 5.14 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.205 1.802 . . . . 71.13 114.221 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.4 mm -129.99 132.79 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.178 0.991 . . . . 60.11 108.932 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 49.8 mm -111.36 136.2 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 125.09 1.356 . . . . 74.23 107.849 171.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.8 m -127.34 122.88 34.93 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.151 -1.425 . . . . 65.21 107.151 173.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -113.75 134.04 55.0 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.274 -1.009 . . . . 75.33 108.274 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.2 m -133.69 108.12 8.34 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 124.539 1.15 . . . . 75.43 108.533 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.1 mtp -108.27 146.52 32.75 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.541 1.937 . . . . 74.34 109.246 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.4 m -137.59 94.38 2.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.293 1.037 . . . . 60.32 109.587 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.2 tp -98.77 109.1 21.91 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.32 1.448 . . . . 71.2 108.846 173.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.45 -111.1 3.73 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 124.807 1.317 . . . . 63.24 110.817 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -101.53 1.37 37.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.722 2.009 . . . . 71.45 113.648 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 89.5 mt -120.85 143.78 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.123 1.369 . . . . 75.42 110.143 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.7 t -123.01 91.3 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 O-C-N 124.23 0.956 . . . . 64.21 110.24 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -68.47 127.14 31.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.334 1.054 . . . . 74.24 112.1 173.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -125.2 146.38 49.54 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.738 1.215 . . . . 63.24 110.465 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -142.94 132.54 23.75 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.896 1.278 . . . . 62.53 108.326 -174.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.69 133.26 67.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.556 -1.276 . . . . 74.22 107.556 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.1 m -134.55 150.18 50.72 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 124.626 1.204 . . . . 75.33 110.025 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -120.01 141.42 49.73 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.547 1.539 . . . . 63.23 109.727 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -67.74 141.18 56.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.264 1.826 . . . . 72.42 112.103 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.4 mt . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 106.295 -1.742 . . . . 72.13 106.295 -173.351 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 . . . . . 0 N--CA 1.502 2.128 0 N-CA-C 102.544 -3.132 . . . . 74.42 102.544 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 2.3 m170 50.91 95.7 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 127.345 2.258 . . . . 63.42 113.969 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -123.32 119.85 31.33 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.068 0.947 . . . . 55.23 109.415 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -155.4 158.3 38.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.861 1.664 . . . . 74.33 110.067 175.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -166.4 124.54 1.43 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.584 1.554 . . . . 71.43 108.646 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -176.82 154.63 1.18 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.632 1.573 . . . . 75.21 110.423 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 84.9 t -77.68 -61.09 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 124.828 1.251 . . . . 73.0 111.148 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -92.29 177.55 6.11 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.378 1.471 . . . . 33.23 110.965 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -111.9 157.09 21.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.996 0.919 . . . . 64.11 111.827 175.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.0 m -99.78 110.59 22.97 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.702 1.601 . . . . 72.34 108.781 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -70.02 -25.33 63.53 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.988 1.107 . . . . 74.21 113.988 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.2 t -52.77 115.08 1.64 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.058 2.143 . . . . 75.25 113.147 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.09 164.96 16.05 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 110.557 -1.017 . . . . 65.11 110.557 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -109.66 144.86 37.41 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.851 1.661 . . . . 74.12 110.399 175.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -140.81 141.15 34.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.998 1.319 . . . . 74.24 109.645 -173.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -107.93 148.04 30.2 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.538 1.135 . . . . 63.35 109.899 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.64 127.47 31.82 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.469 1.508 . . . . 71.32 111.207 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -109.4 -57.19 2.2 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.821 1.248 . . . . 65.5 110.973 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.5 p -152.86 172.16 17.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.563 1.145 . . . . 73.05 111.2 -174.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -168.27 148.59 4.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.876 1.271 . . . . 74.35 111.0 -165.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -140.04 143.23 36.27 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.873 1.269 . . . . 71.15 108.797 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 57.59 26.02 12.32 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.482 1.913 . . . . 63.12 113.616 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -61.5 -55.66 28.58 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-O 118.232 -0.889 . . . . 74.25 113.185 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -62.41 -43.48 98.72 Favored 'General case' 0 C--N 1.347 0.472 0 O-C-N 124.308 1.005 . . . . 60.04 112.919 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.92 -45.47 82.68 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.711 1.204 . . . . 53.45 113.566 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -68.08 -47.17 69.01 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.958 1.303 . . . . 70.13 113.187 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.5 mmt -65.9 -44.61 84.73 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.565 1.166 . . . . 61.43 113.049 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -60.71 -32.43 71.68 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.932 0.893 . . . . 62.13 113.032 171.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.56 -37.69 59.77 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.396 1.258 . . . . 71.32 114.396 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.1 pt -79.11 -5.14 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 113.427 0.899 . . . . 75.3 113.427 172.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.98 27.81 25.1 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 118.666 -1.074 . . . . 44.11 112.893 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.66 146.73 98.61 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 118.822 1.311 . . . . 72.05 111.122 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -68.31 140.83 49.75 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.05 1.834 . . . . 64.41 110.799 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.08 -21.88 64.09 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.63 1.344 . . . . 74.34 114.63 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.62 -49.94 74.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.351 1.06 . . . . 73.54 113.349 169.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.6 mt -63.92 -23.74 67.46 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 124.65 1.18 . . . . 75.44 113.569 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -83.15 -50.46 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.325 1.05 . . . . 64.11 110.602 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -60.94 -42.59 98.49 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 117.821 -1.085 . . . . 53.41 113.16 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -27.59 63.34 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 118.22 -0.895 . . . . 75.5 112.819 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.54 -30.04 57.06 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-O 119.077 -0.846 . . . . 20.32 112.552 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.79 -30.75 14.69 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.632 1.173 . . . . 72.43 112.789 173.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -72.78 -49.96 27.36 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.627 1.171 . . . . 75.45 111.52 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 mt -93.37 129.56 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.268 1.027 . . . . 62.42 108.347 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -80.44 110.17 15.63 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 124.135 0.897 . . . . 63.21 108.787 170.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.51 -172.97 41.75 Favored Glycine 0 CA--C 1.538 1.487 0 O-C-N 124.469 1.106 . . . . 74.13 110.429 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.5 t -129.82 153.79 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.709 1.204 . . . . 70.24 109.701 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.0 t -130.35 155.98 45.45 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.552 1.941 . . . . 70.22 109.164 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -141.02 143.67 34.56 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.752 1.221 . . . . 72.33 107.879 170.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.1 mt -132.07 130.36 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.08 -1.822 . . . . 62.45 106.08 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -134.74 135.5 53.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.15 -1.056 . . . . 74.23 108.15 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -126.92 130.82 50.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.819 1.248 . . . . 74.34 108.687 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -133.19 55.07 1.92 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.144 1.378 . . . . 73.54 109.289 -172.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.13 -115.96 5.69 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 108.718 -1.753 . . . . 50.4 108.718 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -70.69 -35.42 72.77 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.249 1.204 . . . . 73.31 114.249 173.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.63 156.09 37.11 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 124.021 0.825 . . . . 72.23 111.373 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -150.93 141.29 22.4 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.037 -1.468 . . . . 73.35 107.037 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -129.27 151.63 49.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.229 1.811 . . . . 75.04 109.153 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -148.79 126.23 11.61 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.686 -1.228 . . . . 70.41 107.686 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 m -109.18 126.61 53.45 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.688 1.243 . . . . 45.21 108.931 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.25 133.93 51.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.724 -1.584 . . . . 74.15 106.724 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.0 m -133.52 104.84 6.58 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 124.166 0.916 . . . . 51.0 109.394 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -107.38 77.49 1.15 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.918 0.887 . . . . 75.3 110.153 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.34 -49.41 4.23 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.513 1.53 . . . . 43.33 112.212 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.44 -39.65 0.09 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.171 0.986 . . . . 73.3 111.872 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -67.09 137.26 56.24 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.475 1.11 . . . . 75.41 111.684 172.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.6 t -125.31 130.47 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 O-C-N 124.612 1.195 . . . . 63.15 109.147 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.8 mt -119.34 128.67 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.871 1.269 . . . . 74.53 108.019 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -116.66 127.14 54.16 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 124.589 1.18 . . . . 63.21 108.693 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -121.94 145.04 48.5 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.413 1.485 . . . . 63.35 109.075 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -132.8 140.78 48.16 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 125.376 1.672 . . . . 73.05 108.995 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -149.46 166.93 27.64 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.033 1.333 . . . . 75.23 109.146 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.4 m -119.21 127.01 52.89 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.886 -1.153 . . . . 72.31 107.886 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.8 t -63.73 126.95 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.768 1.227 . . . . 63.33 111.324 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.14 -3.1 85.66 Favored Glycine 0 CA--C 1.542 1.764 0 CA-C-O 118.249 -1.306 . . . . 75.31 113.558 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -116.62 141.02 48.74 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.127 1.771 . . . . 71.42 109.859 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -66.45 118.57 10.28 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.04 1.336 . . . . 72.15 111.616 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 40.5 m -140.46 153.26 46.2 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.577 1.551 . . . . 74.14 109.153 -175.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -100.96 128.65 46.9 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.99 0.916 . . . . 74.33 109.77 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.3 mt -120.37 131.92 55.05 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.762 1.225 . . . . 71.33 110.467 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -90.43 130.92 36.45 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.277 1.831 . . . . 63.54 110.47 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.6 p -85.52 -179.93 7.01 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.572 1.149 . . . . 60.32 111.651 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.2 mtt -59.03 -30.83 68.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.18 1.548 . . . . 75.24 115.18 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.4 p -87.82 -7.51 57.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.368 1.467 . . . . 74.02 113.235 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.63 6.68 58.27 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 118.187 -1.34 . . . . 62.43 112.592 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -69.0 113.36 6.31 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 119.405 1.603 . . . . 74.34 110.791 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -94.44 124.95 38.78 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 124.612 1.195 . . . . 71.12 110.502 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.92 126.19 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.309 1.444 . . . . 71.33 110.361 -170.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -72.5 132.92 44.47 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.22 1.408 . . . . 75.51 111.885 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.3 t -161.93 170.02 20.13 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.267 1.427 . . . . 74.2 109.445 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.441 ' CG1' HE22 ' A' ' 84' ' ' GLN . 2.6 t -124.95 144.03 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 108.283 -1.006 . . . . 42.04 108.283 171.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.05 125.65 69.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 O-C-N 124.358 1.037 . . . . 70.35 108.252 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.441 HE22 ' CG1' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -112.91 141.78 46.35 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.805 1.642 . . . . 65.02 110.496 177.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.0 tp -92.95 136.82 32.92 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.426 1.079 . . . . 64.15 109.189 168.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.18 12.63 11.19 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.261 1.024 . . . . 62.4 113.318 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.9 14.12 80.33 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 125.131 1.348 . . . . 63.34 113.115 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -140.41 52.07 1.65 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.718 1.207 . . . . 62.51 109.697 -171.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.276 0.0 OUTLIER 58.04 21.78 8.21 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.905 1.682 . . . . 73.45 114.818 173.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -135.05 120.9 19.66 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.502 1.521 . . . . 74.52 109.714 -164.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.2 mt -105.55 132.39 51.77 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.895 1.278 . . . . 65.32 109.945 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.1 t -119.61 136.52 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.008 1.323 . . . . 61.13 109.157 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.0 t -154.37 149.08 26.48 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.27 1.028 . . . . 63.33 110.846 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.2 p -146.33 132.08 18.97 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.724 1.209 . . . . 75.11 109.783 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -97.96 -63.39 1.13 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.975 1.31 . . . . 65.02 110.396 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -140.17 -73.49 0.36 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.189 1.796 . . . . 65.23 108.237 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -127.38 -1.77 6.26 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.255 1.822 . . . . 74.45 112.305 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.6 mt -97.4 110.9 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.839 1.656 . . . . 51.44 108.384 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -102.61 98.76 8.77 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.765 1.226 . . . . 74.33 110.195 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.5 t -82.92 131.27 35.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.327 1.451 . . . . 52.41 110.882 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.8 t -135.69 101.82 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 106.844 -1.539 . . . . 53.11 106.844 172.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.0 m -84.89 148.9 26.02 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.186 1.394 . . . . 54.15 109.766 173.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -147.71 130.76 16.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.042 1.337 . . . . 73.43 109.313 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 tt -113.93 130.55 56.5 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.232 -1.396 . . . . 75.03 107.232 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -132.62 82.71 2.02 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.431 1.892 . . . . 71.04 106.702 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.25 -111.78 4.44 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.745 1.164 . . . . 53.43 111.287 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -83.72 -4.72 58.85 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.329 1.452 . . . . 71.13 113.535 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.8 mm -110.94 138.46 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 119.499 1.045 . . . . 60.11 109.666 -176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 36.6 mm -109.6 136.6 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.754 -1.202 . . . . 74.23 107.754 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.0 m -127.57 115.41 18.77 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 106.532 -1.655 . . . . 65.21 106.532 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -117.64 126.56 52.73 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.481 -0.933 . . . . 75.33 108.481 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 66.7 m -124.65 112.81 17.22 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 124.661 1.226 . . . . 75.43 108.386 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 95.1 mtp -105.86 149.86 26.14 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.873 1.269 . . . . 74.34 109.21 173.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.5 m -140.79 104.4 4.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.563 0.745 . . . . 60.32 109.21 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 7.0 tt -103.2 102.14 12.12 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.544 1.537 . . . . 71.2 107.55 175.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.27 -122.93 30.91 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 110.849 -0.9 . . . . 63.24 110.849 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -84.88 3.33 38.5 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.915 1.686 . . . . 71.45 115.173 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.8 mt -102.93 139.75 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.889 0.875 . . . . 75.42 108.995 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.38 96.85 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.205 1.002 . . . . 64.21 109.119 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -86.21 136.35 33.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.676 1.591 . . . . 74.24 112.48 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -119.65 150.19 40.74 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.049 1.34 . . . . 63.24 111.085 173.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 mmt-85 -141.98 136.1 29.98 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.503 1.921 . . . . 62.53 108.074 173.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.6 133.98 65.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.583 -1.266 . . . . 74.22 107.583 174.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.5 m -135.16 159.98 39.83 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.994 1.317 . . . . 75.33 109.648 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -137.79 143.3 41.0 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.489 1.116 . . . . 63.23 110.702 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.7 ttp85 -63.28 137.1 58.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.592 1.957 . . . . 72.42 113.768 -170.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 40.4 mt . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 106.039 -1.838 . . . . 72.13 106.039 -171.524 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 . . . . . 0 N--CA 1.5 2.033 0 N-CA-C 102.88 -3.007 . . . . 74.42 102.88 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -165.68 71.85 0.16 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.063 1.345 . . . . 63.42 108.001 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -142.98 158.98 43.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.05 1.34 . . . . 55.23 110.381 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -134.91 87.71 2.36 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.872 1.269 . . . . 74.33 108.854 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -160.47 158.38 29.24 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.782 1.633 . . . . 71.43 110.017 174.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -133.7 60.05 1.72 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.227 1.411 . . . . 75.21 109.552 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 28.3 m -134.75 166.53 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.598 1.559 . . . . 73.0 110.346 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -65.84 145.31 56.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.116 1.366 . . . . 33.23 112.811 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.5 mmm -77.04 147.4 36.75 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.452 1.101 . . . . 64.11 112.384 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.7 p -94.41 132.75 38.71 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.854 1.262 . . . . 72.34 110.042 171.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -80.39 -16.82 53.57 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.549 1.314 . . . . 74.21 114.549 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.8 p -66.93 132.76 48.62 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.759 1.224 . . . . 75.25 113.483 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.1 168.34 14.67 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.285 0.945 . . . . 65.11 110.778 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -99.89 147.07 25.94 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.274 1.43 . . . . 74.12 111.137 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -138.41 155.08 48.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.593 1.557 . . . . 74.24 109.453 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -127.77 145.39 50.93 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.505 -0.924 . . . . 63.35 108.505 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 tt -61.96 131.24 49.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.22 1.408 . . . . 71.32 110.432 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -109.7 -50.06 3.03 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.609 1.164 . . . . 65.5 110.919 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.2 158.15 35.68 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 124.387 1.054 . . . . 73.05 111.109 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -128.08 155.83 43.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.844 1.257 . . . . 74.35 108.683 170.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -135.69 131.33 35.53 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.264 1.426 . . . . 71.15 108.175 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 58.23 39.27 25.94 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.352 1.861 . . . . 63.12 112.142 -169.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -64.11 -63.57 1.12 Allowed 'General case' 0 C--N 1.346 0.454 0 C-N-CA 124.875 1.27 . . . . 74.25 112.296 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.47 -28.43 69.66 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.566 0.95 . . . . 60.04 113.566 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.88 -51.9 65.17 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.102 0.961 . . . . 53.45 112.346 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -70.59 -48.47 55.04 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.831 1.252 . . . . 70.13 113.8 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.9 mmt -67.99 -39.83 83.2 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 124.374 1.046 . . . . 61.43 113.155 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -73.87 -27.68 61.2 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 118.137 -0.935 . . . . 62.13 112.513 173.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.75 -33.82 66.61 Favored 'General case' 0 C--N 1.349 0.562 0 N-CA-C 113.945 1.091 . . . . 71.32 113.945 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.8 pt -80.3 -4.6 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 N-CA-C 113.239 0.829 . . . . 75.3 113.239 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.03 21.69 41.27 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 118.202 -1.332 . . . . 44.11 113.522 167.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.0 mt -63.88 143.78 98.1 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 119.42 1.61 . . . . 72.05 111.212 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.18 143.72 84.66 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.396 2.064 . . . . 64.41 111.56 172.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.06 -22.48 62.73 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.123 1.527 . . . . 74.34 115.123 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.17 -43.16 99.31 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.245 1.018 . . . . 73.54 113.138 169.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.9 mt -72.0 -24.57 61.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.529 1.132 . . . . 75.44 113.621 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.69 -55.39 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 123.58 0.752 . . . . 64.11 111.176 168.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -65.99 -26.5 67.58 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 115.019 1.489 . . . . 53.41 115.019 -174.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.69 -23.15 31.83 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 124.237 0.961 . . . . 75.5 112.454 171.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.68 -23.81 37.99 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-O 118.964 -0.909 . . . . 20.32 112.298 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.13 -35.17 25.8 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 117.54 -1.219 . . . . 72.43 113.609 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -83.08 -49.75 9.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.79 0.723 . . . . 75.45 111.39 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.41 123.62 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.131 0.973 . . . . 62.42 109.263 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.28 107.17 18.38 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.018 -1.104 . . . . 63.21 108.018 171.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.61 165.81 51.95 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 124.612 1.195 . . . . 74.13 111.507 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 78.6 t -102.05 155.37 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.339 1.056 . . . . 70.24 108.697 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 97.6 p -145.42 167.36 23.12 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.599 1.16 . . . . 70.22 109.916 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -161.58 142.26 10.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.466 1.106 . . . . 72.33 108.682 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -129.48 142.12 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.929 -1.508 . . . . 62.45 106.929 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.69 100.96 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.699 -1.223 . . . . 74.23 107.699 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -77.31 129.9 36.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.039 0.936 . . . . 74.34 109.825 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -128.31 51.52 1.98 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.438 1.495 . . . . 73.54 109.282 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.33 -118.44 6.74 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 108.871 -1.692 . . . . 50.4 108.871 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -65.99 -34.71 78.72 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.937 1.295 . . . . 73.31 113.95 172.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -75.73 157.96 32.89 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.073 0.858 . . . . 72.23 111.599 171.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -156.57 125.23 5.85 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.908 -1.515 . . . . 73.35 106.908 -172.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 139.82 46.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.847 1.259 . . . . 75.04 109.103 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.28 132.37 55.29 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.772 1.629 . . . . 70.41 107.535 172.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.92 109.16 10.68 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.689 1.196 . . . . 45.21 108.16 176.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.92 132.75 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.736 1.214 . . . . 74.15 108.185 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.1 m -114.76 111.46 21.29 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.307 1.004 . . . . 51.0 108.984 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.14 76.15 1.89 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.691 1.196 . . . . 75.3 109.432 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.68 -96.95 1.99 Allowed Glycine 0 CA--C 1.531 1.079 0 N-CA-C 108.776 -1.73 . . . . 43.33 108.776 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.3 m -101.88 -40.7 6.79 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.726 1.21 . . . . 73.3 112.574 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -73.02 153.58 40.83 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.079 0.952 . . . . 75.41 112.066 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.21 131.43 67.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 124.536 1.148 . . . . 63.15 109.553 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.2 mt -105.17 134.6 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 126.468 1.907 . . . . 74.53 107.957 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -125.82 124.78 41.7 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.488 1.115 . . . . 63.21 108.38 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -137.71 133.08 33.77 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.552 1.141 . . . . 63.35 108.976 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -116.48 147.67 41.52 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 124.601 1.188 . . . . 73.05 109.711 172.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -150.86 160.66 43.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.102 1.361 . . . . 75.23 110.091 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.2 m -103.47 135.66 44.66 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 124.237 0.961 . . . . 72.31 108.517 169.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.07 119.29 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.948 1.299 . . . . 63.33 111.2 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.92 -13.59 65.89 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 117.967 -1.463 . . . . 75.31 113.326 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -99.11 148.52 23.97 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.522 1.661 . . . . 71.42 110.369 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -69.75 114.44 7.95 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 124.082 0.864 . . . . 72.15 110.793 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.7 m -129.32 151.74 49.63 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.344 1.458 . . . . 74.14 107.689 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -100.96 119.97 39.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.035 0.934 . . . . 74.33 110.276 -174.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.99 134.27 52.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.097 1.359 . . . . 71.33 110.411 -172.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -90.45 147.92 23.1 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.474 1.51 . . . . 63.54 110.336 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.3 p -112.45 178.31 4.34 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.47 1.508 . . . . 60.32 110.231 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -59.99 -29.78 68.69 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.575 1.324 . . . . 75.24 114.575 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.3 p -81.95 -8.21 59.66 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.527 1.531 . . . . 74.02 113.035 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.99 8.12 72.96 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-O 118.363 -1.243 . . . . 62.43 112.581 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -69.97 114.08 7.79 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 119.072 1.436 . . . . 74.34 110.921 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -100.86 121.41 41.67 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 124.943 1.402 . . . . 71.12 109.496 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.42 133.02 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 124.625 1.203 . . . . 71.33 110.877 -172.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -78.21 141.12 38.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.198 1.399 . . . . 75.51 112.177 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.0 t -167.07 153.86 8.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.713 1.205 . . . . 74.2 110.394 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.5 m -90.15 142.42 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.418 1.087 . . . . 42.04 109.431 165.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.56 124.72 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.253 -1.388 . . . . 70.35 107.253 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -135.75 136.81 41.08 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.357 1.063 . . . . 65.02 110.273 -170.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.403 HD22 ' H ' ' A' ' 87' ' ' GLY . 2.7 tt -79.41 129.77 34.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.489 1.115 . . . . 64.15 110.167 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -73.94 -9.5 58.7 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.477 1.911 . . . . 62.4 114.165 -173.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.403 ' H ' HD22 ' A' ' 85' ' ' LEU . . . 92.15 5.72 65.53 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.122 1.344 . . . . 63.34 112.189 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -147.6 57.05 1.11 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.77 1.285 . . . . 62.51 109.358 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 63.8 19.76 11.89 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.821 1.648 . . . . 73.45 114.101 171.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -128.76 142.68 50.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.706 1.602 . . . . 74.52 109.598 -166.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 74.1 mt -114.91 123.26 48.7 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.346 1.058 . . . . 65.32 109.204 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.7 t -104.65 140.14 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.364 1.466 . . . . 61.13 108.902 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.3 t -162.79 135.24 5.5 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.446 1.098 . . . . 63.33 110.084 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 78.5 p -131.36 122.3 26.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.523 1.129 . . . . 75.11 109.403 -176.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -81.9 -66.56 0.87 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.395 1.078 . . . . 65.02 111.221 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -144.14 -52.4 0.32 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.64 1.576 . . . . 65.23 109.491 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -142.8 3.22 1.42 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.577 1.551 . . . . 74.45 112.363 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 78.3 mt -99.73 110.91 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.702 1.601 . . . . 51.44 106.959 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -103.63 86.84 2.7 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.934 1.294 . . . . 74.33 109.575 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 69.7 m -79.36 127.72 32.44 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.186 1.395 . . . . 52.41 110.764 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.4 t -135.74 102.1 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 108.063 -1.088 . . . . 53.11 108.063 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.7 m -85.89 157.38 20.19 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.461 1.504 . . . . 54.15 110.478 176.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -148.71 143.56 26.52 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.612 1.565 . . . . 73.43 110.987 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.5 tt -129.98 128.03 41.23 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.317 1.447 . . . . 75.03 108.999 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -137.52 77.45 1.64 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.071 1.748 . . . . 71.04 107.604 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.8 -123.9 22.89 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 110.096 -1.202 . . . . 53.43 110.096 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -75.65 -12.33 60.18 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.239 1.415 . . . . 71.13 114.153 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mm -102.95 137.63 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 119.287 0.949 . . . . 60.11 109.534 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.2 mm -125.9 140.62 48.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 108.105 -1.072 . . . . 74.23 108.105 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.6 m -135.94 160.73 37.69 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.462 1.505 . . . . 65.21 108.743 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -154.58 147.67 24.72 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.57 1.148 . . . . 75.33 108.618 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.5 m -131.82 108.07 9.18 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 125.115 1.509 . . . . 75.43 108.22 171.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 72.8 mtp -96.21 144.71 26.17 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.826 1.651 . . . . 74.34 108.747 168.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 65.2 m -133.88 108.05 8.2 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.44 -0.948 . . . . 60.32 108.44 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.3 tp -111.86 99.36 8.06 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.477 1.511 . . . . 71.2 107.712 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.81 -122.82 27.15 Favored Glycine 0 CA--C 1.535 1.281 0 O-C-N 124.726 1.266 . . . . 63.24 110.429 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.87 -17.69 55.19 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.522 1.929 . . . . 71.45 114.48 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 75.9 mt -102.16 140.62 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.604 1.162 . . . . 75.42 110.381 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.4 t -122.76 90.0 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.361 1.064 . . . . 64.21 109.551 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -71.76 124.79 25.55 Favored 'General case' 0 C--N 1.345 0.394 0 C-N-CA 124.451 1.101 . . . . 74.24 111.729 174.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -120.62 148.74 43.5 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.879 1.271 . . . . 63.24 109.344 176.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.72 120.7 7.68 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.482 -0.933 . . . . 62.53 108.482 -166.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -118.83 141.69 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.164 1.386 . . . . 74.22 109.4 -172.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.6 m -144.21 166.62 24.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.232 1.413 . . . . 75.33 111.985 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -139.48 138.9 36.79 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.868 1.267 . . . . 63.23 109.952 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -69.31 131.7 45.27 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.262 2.225 . . . . 72.42 112.563 -174.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.8 mt . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 105.522 -2.029 . . . . 72.13 105.522 -174.238 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 29.7 p80 . . . . . 0 N--CA 1.503 2.213 0 N-CA-C 105.588 -2.004 . . . . 74.42 105.588 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.81 151.64 31.78 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 124.509 1.124 . . . . 63.42 111.065 -178.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -69.3 161.08 30.04 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.949 1.7 . . . . 55.23 112.411 174.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -132.35 85.52 2.24 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.739 1.216 . . . . 74.33 108.82 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -98.01 -81.87 0.43 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.703 1.201 . . . . 71.43 108.764 172.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.9 169.63 12.34 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.596 1.159 . . . . 75.21 111.867 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.32 21.04 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 125.232 1.413 . . . . 73.0 111.976 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -164.02 166.84 21.11 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.948 1.299 . . . . 33.23 111.11 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mmm -131.27 169.01 16.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.043 1.737 . . . . 64.11 110.31 173.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t -136.71 144.33 43.82 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.915 1.286 . . . . 72.34 109.499 176.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -80.16 -27.27 39.01 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.192 1.182 . . . . 74.21 114.192 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.9 m -57.1 111.17 0.98 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.244 1.818 . . . . 75.25 113.376 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.39 160.72 10.81 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.667 -1.373 . . . . 65.11 109.667 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -98.13 146.86 25.15 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 124.551 1.14 . . . . 74.12 110.973 176.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -139.69 146.37 39.56 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.057 1.343 . . . . 74.24 109.519 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -111.29 148.93 31.86 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.48 1.512 . . . . 63.35 109.79 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.466 HD12 ' H ' ' A' ' 37' ' ' GLY . 2.1 tt -61.78 128.71 37.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.885 1.274 . . . . 71.32 111.128 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -111.15 -50.57 2.93 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.17 1.388 . . . . 65.5 111.501 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.46 167.52 30.19 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.452 1.101 . . . . 73.05 111.27 -173.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -167.51 125.06 1.21 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.652 1.181 . . . . 74.35 110.918 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -111.52 143.99 41.48 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.214 1.406 . . . . 71.15 109.435 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 57.46 38.71 28.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.594 1.958 . . . . 63.12 111.832 -170.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -65.25 -58.39 6.07 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.451 -0.785 . . . . 74.25 111.409 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -62.09 -40.35 95.55 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 113.401 0.889 . . . . 60.04 113.401 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.6 -46.07 91.63 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 124.169 0.988 . . . . 53.45 113.019 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -70.91 -47.78 57.24 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-O 117.633 -1.175 . . . . 70.13 112.898 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.2 mtt -64.27 -35.59 81.35 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 124.926 1.391 . . . . 61.43 113.911 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -71.18 -30.76 66.82 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 118.167 -0.921 . . . . 62.13 113.159 169.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.17 -37.31 61.32 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.357 1.243 . . . . 71.32 114.357 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.9 pt -74.18 -12.88 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.877 0.871 . . . . 75.3 113.18 170.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.46 22.54 34.11 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.349 -1.251 . . . . 44.11 112.726 173.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 mp -72.25 141.2 83.24 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.262 1.531 . . . . 72.05 110.562 172.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.78 152.37 81.77 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.59 2.193 . . . . 64.41 112.162 176.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -65.94 -20.48 66.23 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.35 1.241 . . . . 74.34 114.35 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.03 -46.12 82.63 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.309 1.044 . . . . 73.54 113.072 171.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.85 -30.11 71.25 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.553 1.141 . . . . 75.44 112.813 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.1 mt -71.37 -50.86 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.615 1.166 . . . . 64.11 111.781 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -58.72 -50.31 74.36 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 117.817 -1.087 . . . . 53.41 112.958 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -21.14 63.72 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.013 1.116 . . . . 75.5 114.013 174.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.38 -29.21 45.55 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 118.934 -0.926 . . . . 20.32 111.974 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 -29.26 14.05 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.763 1.225 . . . . 72.43 112.897 174.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -71.91 -35.61 69.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 118.022 -0.99 . . . . 75.45 113.432 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.3 mt -113.4 119.12 59.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.079 -1.082 . . . . 62.42 108.079 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -69.48 137.55 52.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.101 0.96 . . . . 63.21 111.55 171.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.466 ' H ' HD12 ' A' ' 9' ' ' LEU . . . -93.16 -179.82 39.7 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 124.687 1.242 . . . . 74.13 110.474 172.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.6 t -130.9 150.23 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 126.047 1.739 . . . . 70.24 107.843 174.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 t -144.83 108.0 4.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.409 0.683 . . . . 70.22 109.965 -170.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -91.96 147.07 23.24 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.061 0.944 . . . . 72.33 110.853 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 mt -132.6 128.02 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 106.29 -1.744 . . . . 62.45 106.29 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.8 t -134.18 127.14 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.021 -1.103 . . . . 74.23 108.021 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -122.16 136.07 54.86 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.013 1.325 . . . . 74.34 108.045 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -148.46 76.65 1.37 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.901 0.881 . . . . 73.54 109.024 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.6 -120.36 8.97 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 108.983 -1.647 . . . . 50.4 108.983 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.4 mmtt -75.67 -32.16 60.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.863 1.265 . . . . 73.31 114.258 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.71 155.83 35.28 Favored 'General case' 0 C--N 1.346 0.421 0 O-C-N 123.918 0.762 . . . . 72.23 112.093 175.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -154.91 128.43 8.52 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 106.989 -1.486 . . . . 73.35 106.989 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -114.37 151.95 32.26 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.707 1.203 . . . . 75.04 109.549 170.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -145.27 128.29 16.52 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.943 -1.503 . . . . 70.41 106.943 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.3 m -116.04 117.77 31.02 Favored 'General case' 0 C--N 1.344 0.352 0 O-C-N 124.511 1.132 . . . . 45.21 109.4 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 mp -97.88 121.56 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.207 1.403 . . . . 74.15 107.485 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.8 m -113.56 109.38 18.54 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.801 -1.185 . . . . 51.0 107.801 173.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.54 -164.01 0.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.705 1.602 . . . . 75.3 111.551 173.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.69 -25.23 70.26 Favored Glycine 0 CA--C 1.542 1.721 0 CA-C-O 118.735 -1.036 . . . . 43.33 113.797 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.5 p -161.85 20.17 0.11 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.357 1.463 . . . . 73.3 113.032 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.68 146.98 52.31 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 125.071 1.349 . . . . 75.41 110.122 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.9 t -124.93 124.02 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.082 -1.081 . . . . 63.15 108.082 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -134.46 123.95 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.101 -1.444 . . . . 74.53 107.101 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.16 149.06 43.36 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.071 0.948 . . . . 63.21 111.064 175.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -133.04 152.59 51.95 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.925 1.69 . . . . 63.35 108.908 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -125.74 142.75 51.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 125.114 1.509 . . . . 73.05 109.034 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -146.5 167.11 24.49 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.901 1.281 . . . . 75.23 109.351 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.8 m -118.38 129.21 55.29 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.557 -1.275 . . . . 72.31 107.557 173.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.02 121.02 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.908 1.283 . . . . 63.33 110.922 -175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.9 -4.37 78.43 Favored Glycine 0 CA--C 1.542 1.75 0 CA-C-O 118.353 -1.248 . . . . 75.31 113.285 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -112.59 137.81 50.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.149 1.78 . . . . 71.42 108.651 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.81 125.96 28.27 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.803 0.689 . . . . 72.15 110.919 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.4 m -138.41 163.4 31.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.58 1.552 . . . . 74.14 108.942 -175.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -103.86 125.95 50.64 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.518 0.727 . . . . 74.33 110.023 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.7 mt -108.09 127.7 54.03 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.658 1.183 . . . . 71.33 109.393 177.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -88.34 153.56 21.1 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.589 1.556 . . . . 63.54 110.898 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.2 p -111.14 173.79 6.17 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.645 1.578 . . . . 60.32 111.786 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -60.33 -31.2 70.08 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.512 1.301 . . . . 75.24 114.512 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 42.5 p -88.73 -7.33 56.46 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.71 1.204 . . . . 74.02 113.248 176.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.15 9.81 63.14 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.346 -1.252 . . . . 62.43 113.042 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -64.72 146.12 55.22 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 119.254 1.527 . . . . 74.34 110.46 167.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -129.02 124.98 36.32 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.254 -1.017 . . . . 71.12 108.254 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 m -141.51 128.09 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 124.47 1.106 . . . . 71.33 110.8 -171.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -77.32 139.84 39.87 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.384 1.474 . . . . 75.51 111.6 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.3 t -169.61 154.43 5.52 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 124.906 1.379 . . . . 74.2 109.719 -165.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 t -121.28 133.75 66.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.972 -1.121 . . . . 42.04 107.972 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.8 t -106.83 126.53 62.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 108.322 -0.992 . . . . 70.35 108.322 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.31 135.67 53.82 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.347 1.459 . . . . 65.02 110.093 174.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.54 121.06 31.4 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.5 1.125 . . . . 64.15 108.958 169.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 6.5 tt0 -81.87 -168.57 1.97 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.002 1.321 . . . . 62.4 111.217 174.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.506 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -93.41 11.08 72.25 Favored Glycine 0 CA--C 1.539 1.571 0 CA-C-O 117.71 -1.606 . . . . 63.34 113.353 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -140.48 44.93 1.85 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.725 1.763 . . . . 62.51 110.925 -173.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 65.3 21.36 11.99 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.052 1.341 . . . . 73.45 113.395 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -120.98 126.5 50.11 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.918 1.287 . . . . 74.52 110.674 -164.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.0 mt -101.53 109.28 21.06 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 124.671 1.232 . . . . 65.32 109.1 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 86.6 t -95.99 132.63 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.86 1.264 . . . . 61.13 108.759 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.6 t -154.55 148.78 25.97 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 124.07 0.856 . . . . 63.33 110.977 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.4 p -147.26 133.38 19.33 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.786 1.234 . . . . 75.11 110.0 -173.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -93.53 -77.17 0.46 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.598 1.559 . . . . 65.02 109.727 -176.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -128.5 -58.85 1.17 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.066 1.747 . . . . 65.23 108.843 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -144.52 8.42 1.34 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.005 1.722 . . . . 74.45 112.223 -175.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.5 mp -103.56 115.89 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.297 -1.371 . . . . 51.44 107.297 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -103.18 91.13 3.96 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 124.629 1.206 . . . . 74.33 108.962 -173.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.7 p -100.43 112.53 24.89 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.336 1.454 . . . . 52.41 111.927 -174.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.3 t -114.85 106.91 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.409 1.884 . . . . 53.11 107.794 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.5 m -84.32 151.51 24.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.716 1.206 . . . . 54.15 109.863 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -146.4 130.66 17.52 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.444 1.497 . . . . 73.43 109.164 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.3 tt -111.39 128.42 55.97 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.76 1.224 . . . . 75.03 108.079 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -130.26 82.32 2.06 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.348 1.859 . . . . 71.04 106.51 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.42 -117.42 10.62 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.495 -1.042 . . . . 53.43 110.495 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -85.78 9.59 16.1 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.014 1.726 . . . . 71.13 113.81 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.3 mm -122.61 134.23 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.53 1.132 . . . . 60.11 109.114 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.92 137.84 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.701 -1.222 . . . . 74.23 107.701 170.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.4 m -131.77 116.51 17.36 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.201 -1.407 . . . . 65.21 107.201 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.79 137.98 48.99 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.575 -0.898 . . . . 75.33 108.575 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 99.1 m -133.29 112.89 12.03 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 124.795 1.31 . . . . 75.43 108.247 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 33.1 mtp -111.04 146.87 35.96 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 126.0 1.72 . . . . 74.34 109.181 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.2 m -138.93 98.6 3.57 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 124.41 1.069 . . . . 60.32 109.258 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.2 tp -104.4 112.06 24.95 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.537 1.535 . . . . 71.2 108.354 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.43 -114.71 6.78 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 124.729 1.268 . . . . 63.24 110.871 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.54 8.0 44.85 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.452 1.901 . . . . 71.45 113.469 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.9 mp -124.16 143.17 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.689 1.195 . . . . 75.42 109.594 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.5 t -126.95 94.41 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.079 0.952 . . . . 64.21 110.297 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -75.83 132.61 40.48 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 123.677 0.791 . . . . 74.24 111.035 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -122.62 149.67 43.68 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 124.339 1.025 . . . . 63.24 109.499 173.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.13 133.64 23.43 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.043 1.337 . . . . 62.53 108.368 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -124.86 137.01 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.892 1.277 . . . . 74.22 108.053 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.1 m -137.98 156.86 47.4 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.691 1.196 . . . . 75.33 110.563 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -126.44 146.42 50.09 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.53 1.532 . . . . 63.23 109.744 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.3 tpp85 -56.92 142.15 42.52 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.459 2.303 . . . . 72.42 112.98 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 105.883 -1.895 . . . . 72.13 105.883 -175.814 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 33.6 m170 . . . . . 0 N--CA 1.501 2.078 0 N-CA-C 107.71 -1.218 . . . . 74.42 107.71 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 2.0 m80 66.18 -172.52 0.19 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.616 1.567 . . . . 63.42 112.913 -167.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -137.53 169.3 18.02 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.833 1.253 . . . . 55.23 109.724 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -146.42 174.28 11.52 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.507 1.523 . . . . 74.33 110.825 -175.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -106.5 76.52 1.14 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.061 0.944 . . . . 71.43 109.497 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.25 151.32 6.72 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.279 1.432 . . . . 75.21 109.671 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.64 -40.88 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 124.754 1.284 . . . . 73.0 111.647 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . 61.64 161.63 0.07 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.436 2.294 . . . . 33.23 113.789 -173.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.0 mmm -126.95 140.05 52.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.642 0.777 . . . . 64.11 109.982 -175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.9 p -137.85 94.91 2.95 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.958 1.303 . . . . 72.34 110.067 -170.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -63.74 -25.23 68.1 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.18 1.548 . . . . 74.21 115.18 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.5 p -57.65 119.58 6.85 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.244 1.817 . . . . 75.25 113.679 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.04 164.97 13.23 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 110.689 -0.964 . . . . 65.11 110.689 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -95.14 147.87 22.98 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.639 1.576 . . . . 74.12 111.68 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -143.08 133.91 25.36 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.032 1.333 . . . . 74.24 109.798 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -102.16 150.54 23.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.786 1.234 . . . . 63.35 110.267 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.89 128.97 38.35 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.101 1.36 . . . . 71.32 111.096 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -113.54 -51.58 2.8 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 124.796 1.238 . . . . 65.5 111.64 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -152.92 168.27 26.37 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.489 1.118 . . . . 73.05 111.259 -170.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -165.39 145.35 6.8 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.787 1.235 . . . . 74.35 111.049 -170.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -139.84 146.82 39.84 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.947 1.299 . . . . 71.15 109.508 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 55.12 27.68 9.87 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.513 1.925 . . . . 63.12 113.035 -173.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -63.43 -60.32 3.52 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-O 118.078 -0.963 . . . . 74.25 111.58 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -60.34 -41.87 94.49 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 124.281 0.988 . . . . 60.04 113.041 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.75 -48.93 71.99 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.556 1.143 . . . . 53.45 113.397 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -66.68 -47.2 73.2 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.193 1.397 . . . . 70.13 113.072 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.8 mmt -68.64 -39.63 80.63 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.545 1.138 . . . . 61.43 113.105 -175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -66.34 -34.13 77.28 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.932 0.893 . . . . 62.13 112.637 169.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.7 -34.9 67.45 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 114.415 1.265 . . . . 71.32 114.415 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.0 pt -77.67 -9.79 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 113.143 0.794 . . . . 75.3 113.143 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.19 26.71 20.62 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.235 -1.314 . . . . 44.11 112.988 168.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.1 mt -69.3 151.78 96.8 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 119.351 1.575 . . . . 72.05 111.711 172.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -69.88 147.72 62.7 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.192 1.928 . . . . 64.41 111.538 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -54.75 -30.91 57.67 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.025 1.33 . . . . 74.34 114.484 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -63.08 -45.57 91.5 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 117.877 -1.059 . . . . 73.54 113.702 175.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.0 mt -65.66 -26.88 67.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.186 0.994 . . . . 75.44 113.429 174.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.1 mt -78.79 -50.95 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.162 0.985 . . . . 64.11 110.677 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -62.48 -40.92 98.23 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 117.731 -1.128 . . . . 53.41 113.622 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -28.91 64.29 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.425 -0.797 . . . . 75.5 112.61 172.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.14 -31.53 57.39 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-O 118.957 -0.913 . . . . 20.32 112.617 -174.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -30.46 16.49 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.418 1.087 . . . . 72.43 112.945 173.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.79 -50.95 21.07 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.385 1.074 . . . . 75.45 111.063 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.1 mm -88.03 126.81 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 O-C-N 124.337 1.023 . . . . 62.42 109.196 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -82.61 135.19 35.12 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.265 0.978 . . . . 63.21 110.19 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.62 -171.16 34.49 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 109.829 -1.308 . . . . 74.13 109.829 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 76.0 t -135.3 161.94 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 126.342 1.857 . . . . 70.24 108.86 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.2 t -145.63 157.66 43.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.277 1.031 . . . . 70.22 110.125 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -137.74 131.4 31.23 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 108.422 -0.955 . . . . 72.33 108.422 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.3 mt -110.63 130.94 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 106.112 -1.811 . . . . 62.45 106.112 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.4 t -134.2 124.99 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.0 0.92 . . . . 74.23 108.569 -173.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -114.14 131.67 56.34 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.815 1.246 . . . . 74.34 108.994 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -133.55 52.86 2.05 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.243 1.417 . . . . 73.54 109.806 -174.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.65 -115.01 5.12 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 108.742 -1.743 . . . . 50.4 108.742 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -71.88 -38.1 70.07 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.961 1.097 . . . . 73.31 113.961 173.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.19 158.62 33.82 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 124.124 0.89 . . . . 72.23 111.864 172.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -158.63 135.5 9.68 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 106.217 -1.772 . . . . 73.35 106.217 -173.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -121.0 154.79 35.56 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.95 0.781 . . . . 75.04 110.089 171.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -137.38 125.26 22.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 124.532 1.145 . . . . 70.41 108.836 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.4 m -107.23 125.03 50.61 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.893 1.677 . . . . 45.21 108.166 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.8 mt -121.37 116.09 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.003 -1.11 . . . . 74.15 108.003 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -113.66 114.01 25.81 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 124.385 1.053 . . . . 51.0 110.073 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -146.93 145.73 29.89 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.834 0.853 . . . . 75.3 110.33 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.97 -90.9 0.59 Allowed Glycine 0 CA--C 1.532 1.102 0 N-CA-C 109.504 -1.438 . . . . 43.33 109.504 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.2 t -156.33 42.15 0.38 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.14 1.376 . . . . 73.3 110.155 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -154.23 159.77 41.49 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.273 1.029 . . . . 75.41 111.48 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.6 t -127.63 131.41 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 125.443 1.497 . . . . 63.15 109.222 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.2 mt -115.91 113.36 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.32 1.448 . . . . 74.53 108.363 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.22 119.91 40.47 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.198 -1.038 . . . . 63.21 108.198 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -114.13 166.01 12.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.413 1.085 . . . . 63.35 110.096 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -141.34 140.95 33.86 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.224 1.01 . . . . 73.05 109.732 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.727 ' HA ' ' HG ' ' A' ' 69' ' ' CYS . 46.3 p90 -151.19 152.6 33.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.99 1.316 . . . . 75.23 109.871 175.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.9 m -100.7 132.73 45.94 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.498 -0.927 . . . . 72.31 108.498 171.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.19 112.33 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.313 1.045 . . . . 63.33 110.654 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.83 -14.68 49.26 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.053 -1.415 . . . . 75.31 112.712 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -99.98 145.11 28.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.501 1.65 . . . . 71.42 110.461 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -66.99 127.53 32.93 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.129 1.371 . . . . 72.15 111.379 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.727 ' HG ' ' HA ' ' A' ' 63' ' ' PHE . 65.5 m -148.65 153.7 38.66 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.293 1.437 . . . . 74.14 109.332 -175.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -92.94 123.66 36.36 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.59 0.756 . . . . 74.33 110.649 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.5 138.5 40.79 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.279 1.432 . . . . 71.33 109.121 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -103.88 139.33 39.21 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.496 1.519 . . . . 63.54 109.68 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.4 m -88.25 163.93 15.87 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.399 1.48 . . . . 60.32 110.889 173.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 74.7 mtm -54.49 -29.16 49.34 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.729 1.381 . . . . 75.24 114.729 169.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 47.0 p -85.57 -10.89 55.28 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.916 2.086 . . . . 74.02 113.306 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.84 4.33 60.36 Favored Glycine 0 CA--C 1.538 1.524 0 CA-C-O 118.149 -1.362 . . . . 62.43 113.215 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -65.52 121.25 14.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.428 1.614 . . . . 74.34 110.442 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -108.21 129.3 55.2 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.06 0.85 . . . . 71.12 109.65 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.55 131.83 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.594 1.157 . . . . 71.33 111.124 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -75.09 125.94 29.99 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.356 1.462 . . . . 75.51 110.694 174.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.4 t -151.4 164.13 37.41 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.576 1.551 . . . . 74.2 109.642 -172.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.15 130.89 66.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.033 -1.099 . . . . 42.04 108.033 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.8 t -103.22 128.26 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 124.095 0.872 . . . . 70.35 109.313 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -114.55 171.4 7.65 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.968 2.107 . . . . 65.02 110.295 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -131.52 124.17 29.55 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.134 -1.432 . . . . 64.15 107.134 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.71 13.89 3.52 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.466 1.284 . . . . 62.4 114.466 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.71 13.79 81.88 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.371 1.462 . . . . 63.34 113.014 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -145.08 51.8 1.22 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.573 1.187 . . . . 62.51 109.978 -169.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.276 0.5 OUTLIER 51.65 30.85 7.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.437 1.895 . . . . 73.45 115.171 175.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -140.56 120.93 14.02 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.877 1.271 . . . . 74.52 108.822 -167.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.6 mt -91.92 118.68 30.98 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.148 0.979 . . . . 65.32 109.293 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 91.7 t -101.72 126.37 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.11 1.364 . . . . 61.13 108.819 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.5 m -141.22 149.88 41.96 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.143 0.977 . . . . 63.33 109.373 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.6 p -147.0 138.71 24.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.791 0.836 . . . . 75.11 109.922 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -98.08 -79.61 0.47 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.729 1.611 . . . . 65.02 108.892 -176.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -136.37 -44.7 0.62 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.923 1.289 . . . . 65.23 109.734 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -150.02 8.76 0.65 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.177 1.391 . . . . 74.45 112.64 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.4 mp -109.18 116.12 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.698 1.199 . . . . 51.44 107.769 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.2 tmtp? -98.2 87.81 4.02 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.056 1.342 . . . . 74.33 109.232 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.4 t -74.97 127.82 34.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.132 1.373 . . . . 52.41 111.743 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.6 t -138.24 95.98 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.698 1.599 . . . . 53.11 107.579 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 87.3 m -82.32 155.72 24.64 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.073 1.349 . . . . 54.15 110.285 173.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -145.37 141.64 28.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.422 1.489 . . . . 73.43 109.84 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 tp -119.46 124.14 45.76 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.945 2.098 . . . . 75.03 107.155 172.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -131.18 81.7 2.0 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 106.285 -1.746 . . . . 71.04 106.285 171.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.79 -116.82 9.69 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.946 1.26 . . . . 53.43 110.631 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -80.49 -0.98 39.77 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.977 1.311 . . . . 71.13 114.37 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.8 mm -115.55 131.91 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 119.466 1.03 . . . . 60.11 109.437 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.9 mm -108.84 138.23 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 125.095 1.358 . . . . 74.23 108.122 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.9 m -133.41 110.97 10.37 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 124.629 1.206 . . . . 65.21 107.751 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.9 135.67 45.82 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.912 -0.773 . . . . 75.33 108.912 175.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.4 m -131.76 117.65 18.87 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.845 1.258 . . . . 75.43 108.454 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -110.09 149.93 29.32 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.155 1.382 . . . . 74.34 109.456 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.9 m -133.34 98.93 4.37 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.194 0.934 . . . . 60.32 109.378 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.9 tp -102.01 109.79 21.6 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 125.175 1.39 . . . . 71.2 108.732 174.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.47 -114.86 6.94 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 124.864 1.353 . . . . 63.24 110.777 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.11 -0.74 53.17 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.583 1.953 . . . . 71.45 113.926 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.0 mt -118.06 143.5 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.813 1.245 . . . . 75.42 110.113 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.5 t -125.33 95.17 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.915 0.886 . . . . 64.21 110.053 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -70.86 137.68 49.6 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.833 1.653 . . . . 74.24 112.628 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -124.83 151.87 44.67 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.394 1.077 . . . . 63.24 111.253 170.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.8 mmt-85 -138.87 136.65 35.78 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.781 2.032 . . . . 62.53 108.111 172.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.35 133.72 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.522 -1.288 . . . . 74.22 107.522 173.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.4 m -137.34 156.76 47.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.866 1.266 . . . . 75.33 109.67 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -134.39 144.71 48.35 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.471 1.108 . . . . 63.23 110.657 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.8 ttp85 -64.11 143.61 57.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.352 1.861 . . . . 72.42 114.014 -170.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 105.462 -2.051 . . . . 72.13 105.462 -172.1 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 . . . . . 0 N--CA 1.501 2.085 0 N-CA-C 107.833 -1.173 . . . . 74.42 107.833 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 22.5 p80 56.13 29.58 14.89 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.146 2.178 . . . . 63.42 114.572 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -62.69 136.06 57.68 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.559 1.544 . . . . 55.23 112.21 -175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 74.9 t60 64.22 74.18 0.41 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.903 2.081 . . . . 74.33 111.584 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -158.17 147.67 19.66 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.004 1.321 . . . . 71.43 109.716 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -69.72 125.65 27.35 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.686 1.194 . . . . 75.21 110.695 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 20.3 m -117.86 -32.76 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 124.793 1.308 . . . . 73.0 112.223 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . 57.86 -152.54 0.4 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.641 1.977 . . . . 33.23 113.238 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -137.14 142.69 42.23 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.719 1.208 . . . . 64.11 109.241 171.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 t -161.27 130.79 4.75 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.762 1.225 . . . . 72.34 108.653 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -60.99 -34.55 74.97 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.469 1.507 . . . . 74.21 114.538 172.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 t -58.98 123.46 16.65 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.806 1.642 . . . . 75.25 113.295 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.66 164.79 13.25 Favored Glycine 0 CA--C 1.539 1.563 0 O-C-N 124.419 1.074 . . . . 65.11 110.529 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -98.97 148.3 24.13 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.031 1.732 . . . . 74.12 111.356 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -142.98 155.44 44.68 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.177 1.391 . . . . 74.24 109.528 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -127.14 144.04 51.12 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.527 -0.916 . . . . 63.35 108.527 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 58.2 tp -56.66 134.83 54.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.696 1.198 . . . . 71.32 111.742 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -115.46 -51.42 2.69 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 124.798 1.311 . . . . 65.5 110.116 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 t -159.66 162.68 35.18 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 124.409 1.068 . . . . 73.05 110.185 -173.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -155.78 159.82 39.75 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.554 1.542 . . . . 74.35 111.349 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -137.84 142.18 40.77 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.138 1.375 . . . . 71.15 108.619 176.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 57.4 28.33 15.22 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.276 1.831 . . . . 63.12 113.167 -174.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.67 -57.92 9.32 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.058 0.943 . . . . 74.25 112.163 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -52.69 -50.01 64.15 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.313 1.845 . . . . 60.04 112.348 173.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.91 -47.11 86.19 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.14 1.376 . . . . 53.45 113.956 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -69.43 -46.29 67.13 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 124.787 1.235 . . . . 70.13 113.567 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.5 mmt -65.81 -37.93 87.59 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 124.729 1.268 . . . . 61.43 112.975 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.1 mmmm -71.94 -27.09 62.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.103 0.961 . . . . 62.13 112.482 171.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.03 -37.47 58.32 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.556 1.142 . . . . 71.32 113.721 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.9 pt -78.24 -8.27 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 113.391 0.886 . . . . 75.3 113.391 170.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.8 31.46 26.59 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.509 -1.162 . . . . 44.11 112.547 169.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.31 153.06 93.37 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 118.861 1.33 . . . . 72.05 111.704 173.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.7 142.22 69.45 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.18 1.92 . . . . 64.41 111.407 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -59.02 -24.84 63.16 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.514 1.301 . . . . 74.34 114.514 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -62.66 -47.23 84.59 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 117.266 -1.349 . . . . 73.54 113.55 171.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.2 mt -63.67 -28.04 69.63 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.306 1.042 . . . . 75.44 113.693 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.4 mt -76.95 -52.64 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.322 1.049 . . . . 64.11 111.394 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -62.7 -41.08 98.94 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 117.576 -1.202 . . . . 53.41 113.335 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -25.61 61.21 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 118.216 -0.897 . . . . 75.5 113.171 172.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.83 -32.28 50.48 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.148 -0.807 . . . . 20.32 111.978 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.0 -31.57 16.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.677 1.191 . . . . 72.43 113.066 173.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -72.27 -54.4 9.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.686 1.194 . . . . 75.45 110.854 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.9 mm -94.22 125.63 46.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 124.346 1.029 . . . . 62.42 108.636 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -73.79 104.75 4.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.452 1.101 . . . . 63.21 110.284 170.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.0 158.1 51.82 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 124.497 1.123 . . . . 74.13 110.592 176.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.3 t -100.91 152.19 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.119 0.968 . . . . 70.24 109.257 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.7 t -130.3 155.58 46.08 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.109 1.764 . . . . 70.22 108.563 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -158.05 143.25 16.7 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.493 -0.558 . . . . 72.33 109.493 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.3 mt -134.76 133.44 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 106.077 -1.823 . . . . 62.45 106.077 -173.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.2 t -140.34 98.92 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 107.81 -1.181 . . . . 74.23 107.81 -175.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -82.37 133.14 35.22 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.667 1.187 . . . . 74.34 109.928 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -133.81 54.32 1.96 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.941 1.297 . . . . 73.54 110.153 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.9 -111.92 3.61 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 109.156 -1.578 . . . . 50.4 109.156 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -77.34 -33.03 55.5 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.373 1.069 . . . . 73.31 113.813 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.56 154.7 34.26 Favored 'General case' 0 C--N 1.346 0.421 0 O-C-N 124.147 0.904 . . . . 72.23 111.267 172.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -144.99 135.16 23.98 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.49 -1.67 . . . . 73.35 106.49 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -123.27 152.66 41.13 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.229 1.411 . . . . 75.04 110.058 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -143.24 135.35 26.98 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.231 -1.396 . . . . 70.41 107.231 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 m -123.1 107.26 11.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.529 1.131 . . . . 45.21 109.633 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.5 mt -95.31 136.38 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.609 1.164 . . . . 74.15 108.544 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.2 m -123.09 125.49 45.28 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.478 1.111 . . . . 51.0 108.763 172.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.74 70.73 0.72 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.292 1.037 . . . . 75.3 108.813 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.44 -37.86 1.83 Allowed Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.85 1.69 . . . . 43.33 113.894 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.0 p -157.05 -45.39 0.07 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.131 1.466 . . . . 73.3 112.137 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.99 139.28 48.53 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.27 1.028 . . . . 75.41 110.823 171.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.96 136.4 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 124.541 1.15 . . . . 63.15 109.315 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.6 mt -125.76 124.19 65.97 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 C-N-CA 124.669 1.188 . . . . 74.53 109.067 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -109.24 124.0 50.17 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 125.206 1.566 . . . . 63.21 107.749 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -122.09 144.82 48.69 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.976 1.31 . . . . 63.35 108.685 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -135.23 143.27 46.25 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 125.019 1.449 . . . . 73.05 109.407 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.76 162.74 40.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.509 1.123 . . . . 75.23 110.022 175.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.1 m -108.59 130.04 55.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.391 1.076 . . . . 72.31 108.35 172.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.9 116.82 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.239 1.016 . . . . 63.33 110.439 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.74 -8.16 39.53 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.006 -1.441 . . . . 75.31 112.413 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -121.32 154.01 36.97 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 119.155 1.478 . . . . 71.42 111.065 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.39 131.86 39.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.913 1.685 . . . . 72.15 110.422 174.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.8 m -143.32 156.69 44.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.442 1.497 . . . . 74.14 108.416 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -95.62 123.89 39.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.701 0.8 . . . . 74.33 110.289 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.01 135.27 51.12 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.193 1.797 . . . . 71.33 109.176 -174.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -100.26 145.22 28.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.355 1.462 . . . . 63.54 111.82 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.3 p -104.82 174.35 5.92 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.107 1.763 . . . . 60.32 112.069 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -54.8 -34.96 63.35 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.471 1.656 . . . . 75.24 115.471 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.5 p -91.47 -5.44 54.25 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.616 1.566 . . . . 74.02 112.983 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.27 13.35 54.48 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 118.337 -1.257 . . . . 62.43 112.954 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -65.38 130.02 41.81 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.188 1.494 . . . . 74.34 109.995 173.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.5 mtpt -114.57 120.27 39.63 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.488 -0.93 . . . . 71.12 108.488 -174.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 m -138.68 128.45 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.903 1.281 . . . . 71.33 111.226 -170.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.86 135.9 40.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.525 1.13 . . . . 75.51 112.296 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 t -161.49 151.9 17.59 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.295 1.438 . . . . 74.2 110.181 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.99 136.41 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.621 1.168 . . . . 42.04 107.958 170.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -106.77 132.24 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 108.249 -1.019 . . . . 70.35 108.249 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -132.04 147.73 52.46 Favored 'General case' 0 C--N 1.345 0.373 0 C-N-CA 124.94 1.296 . . . . 65.02 112.646 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.3 tt -109.44 128.43 55.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.693 1.597 . . . . 64.15 109.094 -174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.47 11.59 21.23 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.164 1.385 . . . . 62.4 114.134 -176.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.21 -1.52 84.81 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.833 1.682 . . . . 63.34 113.137 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -121.94 38.19 4.18 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.747 1.619 . . . . 62.51 111.63 -168.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.326 0.3 OUTLIER 52.38 41.23 30.57 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.572 1.949 . . . . 73.45 113.917 178.753 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -138.81 141.91 38.72 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.263 1.825 . . . . 74.52 108.353 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.2 mt -121.63 119.43 31.84 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 124.302 1.001 . . . . 65.32 110.245 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -102.36 133.81 44.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.271 1.428 . . . . 61.13 108.883 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 t -153.03 135.67 15.25 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.457 1.103 . . . . 63.33 110.576 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.9 p -137.86 126.49 23.66 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.005 1.322 . . . . 75.11 110.155 -172.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -92.27 -61.26 1.65 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.917 1.287 . . . . 65.02 110.145 -175.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -143.15 -70.12 0.33 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.263 1.425 . . . . 65.23 108.43 -174.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -123.77 -20.58 5.41 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.977 1.711 . . . . 74.45 111.186 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -79.32 121.78 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.71 1.204 . . . . 51.44 109.275 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -112.28 93.31 4.38 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.108 1.363 . . . . 74.33 108.722 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.2 t -95.09 112.3 24.02 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.872 1.669 . . . . 52.41 110.205 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.4 t -113.82 116.33 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.143 1.377 . . . . 53.11 108.347 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.0 m -94.72 152.54 18.37 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.812 1.645 . . . . 54.15 109.92 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -145.17 140.9 28.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.799 1.64 . . . . 73.43 109.383 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 tp -122.36 126.46 48.09 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.292 1.837 . . . . 75.03 107.05 173.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -133.49 87.18 2.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.552 1.941 . . . . 71.04 106.84 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.94 -114.79 6.88 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 110.58 -1.008 . . . . 53.43 110.58 175.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.56 3.69 49.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.424 1.49 . . . . 71.13 113.798 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.7 mm -116.27 131.68 68.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.282 0.946 . . . . 60.11 109.054 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 42.9 mm -106.38 136.12 42.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.264 0 N-CA-C 107.527 -1.286 . . . . 74.23 107.527 168.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.9 m -123.27 137.66 54.81 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.168 -1.419 . . . . 65.21 107.168 172.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -134.71 135.09 41.72 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.405 -0.961 . . . . 75.33 108.405 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 90.7 m -132.81 116.03 16.03 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.605 1.191 . . . . 75.43 108.547 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 94.0 mtp -107.62 142.37 37.67 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.431 1.492 . . . . 74.34 108.935 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.7 m -132.58 108.25 8.96 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.288 0.993 . . . . 60.32 108.639 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.8 tp -121.1 112.76 19.1 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.529 1.531 . . . . 71.2 108.117 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.3 -118.61 15.47 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 124.657 1.223 . . . . 63.24 110.129 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.47 3.92 50.64 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.502 1.521 . . . . 71.45 113.114 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mp -111.45 135.43 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.056 0.942 . . . . 75.42 109.273 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.14 96.08 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.035 0.934 . . . . 64.21 109.421 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -76.34 131.05 38.94 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.636 1.574 . . . . 74.24 112.193 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -113.67 152.52 30.33 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.601 1.161 . . . . 63.24 109.825 167.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -150.48 138.65 20.25 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.837 1.255 . . . . 62.53 109.038 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -130.22 137.05 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.82 1.248 . . . . 74.22 108.534 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 42.3 m -132.2 160.99 34.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.285 1.434 . . . . 75.33 110.273 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -136.2 144.46 44.94 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.799 1.24 . . . . 63.23 110.227 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -62.63 139.05 58.63 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 126.136 1.775 . . . . 72.42 113.765 -171.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 23.1 mt . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 105.776 -1.935 . . . . 72.13 105.776 -174.687 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 69.7 m80 . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 103.842 -2.651 . . . . 74.42 103.842 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -146.32 137.25 24.31 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 125.334 1.454 . . . . 63.42 109.109 172.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -126.28 179.66 5.17 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.034 1.733 . . . . 55.23 109.316 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 64.65 77.42 0.31 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.278 1.831 . . . . 74.33 111.563 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -141.85 163.06 33.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.243 1.417 . . . . 71.43 110.51 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -134.98 52.73 2.03 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.906 1.282 . . . . 75.21 109.695 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 16.2 m -143.95 141.8 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.045 1.338 . . . . 73.0 109.679 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -84.3 157.27 21.58 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.825 1.25 . . . . 33.23 111.101 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.02 156.96 25.64 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.958 0.786 . . . . 64.11 111.531 171.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 t -161.57 145.61 12.86 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.066 1.347 . . . . 72.34 108.583 174.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -62.6 -27.7 69.37 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 115.355 1.613 . . . . 74.21 115.355 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.0 p -58.3 119.95 7.83 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.565 1.546 . . . . 75.25 113.974 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.08 160.32 9.48 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 110.121 -1.192 . . . . 65.11 110.121 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -92.39 149.25 21.52 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.82 1.248 . . . . 74.12 112.072 172.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -139.89 152.08 46.14 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.622 1.569 . . . . 74.24 109.353 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -125.1 148.13 48.69 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.264 1.425 . . . . 63.35 109.297 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.2 129.96 42.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.167 0.987 . . . . 71.32 111.722 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -114.24 -50.42 2.81 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.655 1.582 . . . . 65.5 111.23 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.8 t -152.7 170.58 19.9 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 124.259 0.974 . . . . 73.05 110.804 -171.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -167.83 149.94 5.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.148 1.379 . . . . 74.35 111.412 -166.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -142.47 140.69 31.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.203 1.401 . . . . 71.15 108.673 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 57.52 26.59 12.91 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.465 1.906 . . . . 63.12 113.952 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -62.48 -56.36 18.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.089 0.955 . . . . 74.25 112.263 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -49.91 -55.44 14.42 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.971 1.708 . . . . 60.04 111.996 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.1 -51.22 64.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.067 1.747 . . . . 53.45 114.351 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -67.39 -45.59 75.75 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.379 1.072 . . . . 70.13 113.377 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.4 mmt -68.35 -35.61 78.01 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 124.76 1.287 . . . . 61.43 112.666 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -64.27 -36.0 82.67 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.809 0.843 . . . . 62.13 113.138 167.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.52 -35.82 60.65 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 114.679 1.363 . . . . 71.32 114.679 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.5 pt -76.28 -10.56 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.679 0.792 . . . . 75.3 113.108 170.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.4 27.07 26.15 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 118.41 -1.216 . . . . 44.11 112.862 170.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 mp -67.58 147.26 98.74 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 119.112 1.456 . . . . 72.05 111.159 173.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -66.77 145.97 76.93 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.162 1.908 . . . . 64.41 111.433 172.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -55.78 -29.2 59.25 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.47 1.285 . . . . 74.34 114.47 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -63.56 -45.42 90.57 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 117.772 -1.109 . . . . 73.54 113.827 174.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.2 mt -64.6 -27.41 68.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.227 1.011 . . . . 75.44 113.339 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.8 mt -77.93 -54.98 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.221 1.008 . . . . 64.11 110.09 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -58.9 -40.79 85.54 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.951 1.093 . . . . 53.41 113.951 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -29.44 62.7 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 118.431 -0.795 . . . . 75.5 112.732 173.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.69 -21.43 71.95 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-O 118.715 -1.047 . . . . 20.32 112.787 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -102.02 -24.98 13.91 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 124.661 1.184 . . . . 72.43 113.14 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -68.94 -52.6 27.54 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.941 1.296 . . . . 75.45 110.687 172.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.1 mm -96.39 137.06 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.755 1.222 . . . . 62.42 109.431 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -90.87 126.77 36.14 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.723 1.209 . . . . 63.21 110.042 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.37 175.97 46.36 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 124.475 1.109 . . . . 74.13 110.707 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.26 151.3 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.546 1.538 . . . . 70.24 108.213 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.3 t -148.82 105.53 3.57 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.852 0.861 . . . . 70.22 109.771 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -81.19 143.5 32.3 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 125.081 1.352 . . . . 72.33 110.801 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.8 mt -127.0 132.02 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 107.178 -1.415 . . . . 62.45 107.178 174.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.4 m -139.34 143.32 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.126 0.57 . . . . 74.23 109.931 172.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -121.73 128.24 51.57 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.219 1.808 . . . . 74.34 106.913 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -139.89 77.81 1.63 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.032 0.933 . . . . 73.54 108.891 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.18 -121.54 10.39 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 108.741 -1.744 . . . . 50.4 108.741 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -79.37 -26.66 41.98 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.387 1.254 . . . . 73.31 114.387 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.9 154.38 28.38 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 123.876 0.87 . . . . 72.23 111.442 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -146.02 134.11 21.55 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.834 -1.543 . . . . 73.35 106.834 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -123.01 159.14 29.0 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.302 1.041 . . . . 75.04 110.122 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.424 ' CE1' ' H19' ' A' ' 201' ' ' 2VN . 0.2 OUTLIER -151.47 123.12 7.95 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.076 1.35 . . . . 70.41 108.687 -174.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -119.81 107.13 12.8 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.271 1.029 . . . . 45.21 108.994 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.17 117.34 54.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.322 1.049 . . . . 74.15 108.708 -173.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.4 m -99.0 133.01 43.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.973 1.309 . . . . 51.0 109.089 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.25 81.17 1.87 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.645 1.178 . . . . 75.3 109.035 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.08 -79.36 1.92 Allowed Glycine 0 CA--C 1.531 1.045 0 N-CA-C 109.412 -1.475 . . . . 43.33 109.412 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 t -136.3 -30.04 0.95 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.847 1.259 . . . . 73.3 112.06 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -73.12 139.41 46.41 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 123.656 0.782 . . . . 75.41 110.837 170.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.01 117.64 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.002 -1.11 . . . . 63.15 108.002 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.0 mt -107.15 124.41 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.582 -1.266 . . . . 74.53 107.582 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -108.4 128.85 55.13 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 124.696 1.248 . . . . 63.21 108.703 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -132.58 154.12 50.34 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.144 1.378 . . . . 63.35 108.787 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.84 148.98 25.92 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 124.421 1.076 . . . . 73.05 109.969 -173.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.574 ' HA ' ' HG ' ' A' ' 69' ' ' CYS . 52.5 p90 -156.96 154.07 29.08 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 124.668 1.23 . . . . 75.23 110.267 -175.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -96.24 129.96 43.44 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.631 1.207 . . . . 72.31 108.307 170.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.87 125.39 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.37 1.068 . . . . 63.33 110.515 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.69 -35.02 5.2 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 118.381 -1.233 . . . . 75.31 111.553 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -97.4 143.18 28.39 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 118.861 1.33 . . . . 71.42 111.762 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.72 126.55 30.07 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.71 1.604 . . . . 72.15 111.067 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.574 ' HG ' ' HA ' ' A' ' 63' ' ' PHE . 66.4 m -141.79 153.29 44.44 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.853 1.261 . . . . 74.14 108.78 -176.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.48 120.15 37.34 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.826 1.25 . . . . 74.33 108.761 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -111.37 116.15 30.48 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 124.415 1.086 . . . . 71.33 109.031 -176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -76.04 152.21 36.95 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 124.548 1.155 . . . . 63.54 111.084 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.1 p -114.94 179.67 3.88 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.795 1.638 . . . . 60.32 109.929 173.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 43.7 mtm -56.26 -29.23 60.83 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.811 1.782 . . . . 75.24 115.811 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.2 p -86.24 -13.03 48.03 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.507 1.523 . . . . 74.02 113.325 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.53 -1.9 60.42 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 118.287 -1.285 . . . . 62.43 112.074 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -67.68 115.06 6.83 Favored 'General case' 0 C--N 1.349 0.547 0 CA-C-N 119.294 1.547 . . . . 74.34 110.984 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -111.8 136.0 51.66 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 124.791 1.307 . . . . 71.12 109.361 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.96 128.64 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.827 1.251 . . . . 71.33 110.316 -169.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.54 128.83 38.05 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 124.44 1.088 . . . . 75.51 111.939 174.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.1 t -158.05 157.62 33.24 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.076 1.35 . . . . 74.2 109.433 172.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.1 m -101.2 151.93 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.875 1.27 . . . . 42.04 109.663 169.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.52 127.0 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.763 -1.199 . . . . 70.35 107.763 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -117.51 172.38 7.37 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.814 1.646 . . . . 65.02 109.67 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 5.3 tt -130.11 129.06 43.06 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.611 1.164 . . . . 64.15 108.624 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -86.16 15.53 5.09 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.196 1.398 . . . . 62.4 114.602 -174.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.76 12.05 78.08 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 125.291 1.424 . . . . 63.34 113.161 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -143.36 51.88 1.36 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.648 1.179 . . . . 62.51 109.019 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.296 0.3 OUTLIER 48.72 38.29 11.34 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.892 2.077 . . . . 73.45 114.437 171.445 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -143.51 133.49 24.15 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 125.55 1.54 . . . . 74.52 108.431 -170.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.1 mt -103.91 124.27 48.67 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 124.525 1.141 . . . . 65.32 109.742 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.9 t -106.91 133.34 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.407 1.483 . . . . 61.13 108.617 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.7 t -164.98 140.8 5.52 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.201 1.0 . . . . 63.33 110.476 -168.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.5 m -146.72 128.97 15.72 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.666 0.604 . . . . 75.11 110.542 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -86.89 -154.75 0.24 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.773 1.629 . . . . 65.02 110.675 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.45 -34.1 74.86 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.639 1.576 . . . . 65.23 113.952 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -162.47 12.2 0.07 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.343 1.457 . . . . 74.45 112.47 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.9 mt -116.22 117.07 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.263 -1.384 . . . . 51.44 107.263 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -85.17 146.94 26.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.543 1.137 . . . . 74.33 108.687 169.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.7 m -150.43 125.99 10.23 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 123.857 0.723 . . . . 52.41 110.321 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.08 110.44 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.801 -1.185 . . . . 53.11 107.801 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.7 m -92.32 152.37 19.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.424 1.09 . . . . 54.15 109.511 172.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -143.74 138.38 28.77 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.979 1.712 . . . . 73.43 109.927 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.4 tp -118.58 125.14 49.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.84 2.056 . . . . 75.03 106.762 172.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -129.87 78.81 1.87 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.658 1.983 . . . . 71.04 106.293 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.99 -111.78 4.27 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.588 1.09 . . . . 53.43 110.58 176.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.74 -17.23 56.16 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.888 1.275 . . . . 71.13 113.536 175.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.8 mm -102.39 132.41 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 119.027 0.83 . . . . 60.11 110.161 -174.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.2 mm -108.53 140.39 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.022 1.329 . . . . 74.23 108.4 170.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.7 m -133.02 141.77 48.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.778 1.231 . . . . 65.21 107.719 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -132.95 142.0 48.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.565 1.146 . . . . 75.33 107.911 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.2 m -135.08 105.6 6.41 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 124.91 1.381 . . . . 75.43 108.206 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.6 mtp -98.58 148.28 23.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.901 1.68 . . . . 74.34 108.963 173.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.6 m -138.7 109.55 6.71 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.135 0.974 . . . . 60.32 108.83 173.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.7 tp -114.37 109.4 18.28 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.545 1.538 . . . . 71.2 108.14 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.47 -112.33 4.89 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 124.822 1.326 . . . . 63.24 110.465 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.83 2.37 41.01 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.74 2.016 . . . . 71.45 113.706 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.1 mt -122.5 142.83 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.709 1.204 . . . . 75.42 110.346 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.6 t -123.85 90.99 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.559 1.144 . . . . 64.21 110.164 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -73.57 128.92 36.83 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.4 1.08 . . . . 74.24 112.111 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -123.99 152.4 42.59 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.285 1.034 . . . . 63.24 110.716 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -140.61 144.3 35.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.965 1.306 . . . . 62.53 109.002 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -135.1 126.89 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.464 1.106 . . . . 74.22 108.109 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.8 m -129.87 159.43 36.63 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.74 1.216 . . . . 75.33 110.102 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -135.73 146.28 47.53 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.484 1.114 . . . . 63.23 110.626 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.3 ttp85 -62.79 139.52 58.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.242 2.217 . . . . 72.42 114.067 -172.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.0 mt . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 105.792 -1.929 . . . . 72.13 105.792 -175.067 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' 2VN . . . . . 0.424 ' H19' ' CE1' ' A' ' 50' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 . . . . . 0 N--CA 1.502 2.145 0 N-CA-C 108.11 -1.07 . . . . 74.42 108.11 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.45 149.28 33.39 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 125.336 1.454 . . . . 63.42 109.655 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 62.76 89.16 0.09 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.33 2.252 . . . . 55.23 112.52 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -154.21 42.32 0.51 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.972 0.909 . . . . 74.33 111.824 -171.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -133.34 152.23 51.91 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.65 1.18 . . . . 71.43 111.009 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -166.58 157.97 12.94 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.886 1.674 . . . . 75.21 109.575 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 26.2 m -100.25 140.81 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.157 0.983 . . . . 73.0 109.913 172.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -171.35 147.76 2.5 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.761 1.624 . . . . 33.23 108.909 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.3 mmm -118.55 117.23 28.43 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 124.384 1.052 . . . . 64.11 108.556 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.9 p -140.79 116.47 10.25 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.955 1.302 . . . . 72.34 108.946 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -60.24 -33.23 72.0 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.874 1.435 . . . . 74.21 114.874 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.2 p -57.61 133.3 55.17 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.168 1.787 . . . . 75.25 114.564 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.54 165.25 10.23 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.742 1.163 . . . . 65.11 110.217 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.3 mtmt -92.97 145.23 24.53 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 124.694 1.198 . . . . 74.12 112.004 173.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -135.94 147.67 48.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.508 1.523 . . . . 74.24 109.506 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -116.69 148.73 40.78 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.303 1.441 . . . . 63.35 109.454 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.84 121.88 20.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.71 1.204 . . . . 71.32 111.716 -175.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -96.31 -56.47 2.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.72 1.208 . . . . 65.5 111.85 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.5 t -161.77 159.05 26.64 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.15 0.98 . . . . 73.05 110.448 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -135.4 147.19 48.93 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.251 1.42 . . . . 74.35 108.698 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -123.32 138.05 54.7 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.1 1.36 . . . . 71.15 108.476 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 56.37 32.79 21.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.262 1.825 . . . . 63.12 112.616 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -61.74 -60.72 3.23 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.324 1.05 . . . . 74.25 110.594 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.47 -39.05 89.48 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 124.478 1.111 . . . . 60.04 113.559 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.68 -48.26 81.69 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.45 1.1 . . . . 53.45 112.965 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -68.32 -45.43 72.97 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.948 1.299 . . . . 70.13 113.072 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.9 mmt -69.19 -37.38 78.12 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.32 1.048 . . . . 61.43 113.118 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -67.01 -35.42 79.91 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.904 0.882 . . . . 62.13 112.754 169.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.56 -34.18 69.75 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.386 1.254 . . . . 71.32 114.386 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.9 pt -79.06 -9.72 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 113.204 0.816 . . . . 75.3 113.204 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.89 22.64 22.77 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 118.099 -1.389 . . . . 44.11 113.52 167.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.68 151.5 97.21 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 119.629 1.715 . . . . 72.05 111.866 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.26 147.51 59.81 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.291 1.994 . . . . 64.41 111.789 172.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -57.11 -29.64 63.69 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.028 1.492 . . . . 74.34 115.028 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -62.27 -44.67 96.01 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.383 0.882 . . . . 73.54 113.383 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -65.8 -27.6 68.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.549 1.539 . . . . 75.44 112.763 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.5 mt -79.95 -47.5 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.64 1.176 . . . . 64.11 111.085 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -65.23 -40.56 94.22 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-O 117.76 -1.114 . . . . 53.41 113.395 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.62 -25.38 61.28 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 118.262 -0.875 . . . . 75.5 112.854 172.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.57 -37.45 46.28 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 123.894 0.759 . . . . 20.32 111.953 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -28.47 21.79 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.517 1.127 . . . . 72.43 113.203 175.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.86 -57.63 3.93 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.59 1.156 . . . . 75.45 111.059 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.8 mm -81.86 119.11 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 124.328 1.017 . . . . 62.42 109.195 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.2 132.95 35.04 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 124.529 1.143 . . . . 63.21 111.054 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -97.75 -179.62 33.29 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 124.917 1.385 . . . . 74.13 110.996 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.4 t -129.44 147.35 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.393 1.877 . . . . 70.24 107.881 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.4 t -145.69 107.69 4.34 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.356 0.662 . . . . 70.22 110.022 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -85.22 148.72 25.94 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.573 1.149 . . . . 72.33 110.723 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.6 mt -126.84 133.67 67.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 124.943 1.402 . . . . 62.45 107.356 175.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.5 t -140.57 97.85 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.661 -0.866 . . . . 74.23 108.661 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -80.56 140.62 35.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.289 0.636 . . . . 74.34 109.519 168.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -146.74 71.63 1.24 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.067 0.947 . . . . 73.54 109.198 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.56 -127.0 11.5 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 109.311 -1.516 . . . . 50.4 109.311 -177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -65.49 -35.52 81.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.239 1.416 . . . . 73.31 113.843 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -76.42 156.31 33.26 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 124.166 0.986 . . . . 72.23 112.14 174.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -151.98 126.41 9.38 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.711 -1.218 . . . . 73.35 107.711 -172.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -112.11 154.82 24.86 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.842 2.057 . . . . 75.04 109.926 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.95 143.15 25.04 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.535 1.534 . . . . 70.41 108.196 175.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.4 m -135.99 98.07 3.79 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.33 1.052 . . . . 45.21 108.564 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.1 mt -93.39 114.79 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.907 1.283 . . . . 74.15 109.368 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.0 m -104.92 118.1 35.69 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.831 1.653 . . . . 51.0 108.602 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -169.48 155.96 6.45 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.94 0.896 . . . . 75.3 111.462 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.39 -82.81 1.45 Allowed Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.071 -1.212 . . . . 43.33 110.071 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.9 p -157.0 12.4 0.24 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.584 1.554 . . . . 73.3 112.727 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.35 179.74 8.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.147 0.979 . . . . 75.41 111.577 -172.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.9 t -130.41 126.04 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.555 1.142 . . . . 63.15 108.723 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.3 mt -108.56 128.7 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.821 1.249 . . . . 74.53 108.827 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -114.5 133.61 55.64 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 124.859 1.35 . . . . 63.21 108.661 176.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -133.23 144.63 49.9 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.14 1.376 . . . . 63.35 108.694 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -132.28 145.13 51.08 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 124.882 1.364 . . . . 73.05 109.778 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -157.17 151.07 24.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.568 1.547 . . . . 75.23 108.204 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.4 m -93.69 140.53 29.53 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.708 0.803 . . . . 72.31 108.928 167.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.06 107.1 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.986 0.914 . . . . 63.33 110.064 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.06 -4.42 30.24 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 117.533 -1.704 . . . . 75.31 113.17 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -98.25 147.69 24.38 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.903 1.851 . . . . 71.42 109.409 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -84.87 125.68 32.83 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.749 1.22 . . . . 72.15 109.616 172.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.1 m -146.24 151.72 38.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.924 1.29 . . . . 74.14 109.61 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.55 116.59 28.57 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.905 1.282 . . . . 74.33 109.071 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.72 116.12 31.37 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.559 1.144 . . . . 71.33 109.848 -170.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -79.22 131.82 36.31 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.662 1.226 . . . . 63.54 111.484 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.8 p -90.82 169.67 10.75 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.572 1.549 . . . . 60.32 110.99 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.3 mtm -57.24 -27.47 62.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.929 1.692 . . . . 75.24 115.18 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 p -82.68 -14.55 54.43 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.246 1.818 . . . . 74.02 113.072 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.02 -4.55 59.0 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.289 1.423 . . . . 62.43 112.341 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -69.85 135.48 49.65 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 119.099 1.449 . . . . 74.34 110.439 173.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -138.41 136.5 36.34 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.969 0.793 . . . . 71.12 109.693 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.0 m -149.1 138.66 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.231 1.412 . . . . 71.33 110.089 -170.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 136.19 46.61 Favored 'General case' 0 C--N 1.346 0.416 0 O-C-N 124.213 0.946 . . . . 75.51 112.081 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.4 t -164.8 149.49 9.4 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.552 1.541 . . . . 74.2 109.384 -178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.3 t -99.32 138.48 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.516 1.126 . . . . 42.04 108.582 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 52.7 t -108.73 125.32 65.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 124.451 1.095 . . . . 70.35 108.254 172.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -120.15 157.16 29.6 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.892 1.677 . . . . 65.02 110.978 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.7 tt -124.63 125.59 44.38 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.937 1.295 . . . . 64.15 108.137 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.01 13.08 5.34 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.307 1.443 . . . . 62.4 114.87 -173.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.13 8.25 83.0 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 125.247 1.403 . . . . 63.34 113.031 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -142.28 61.77 1.44 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.978 1.311 . . . . 62.51 108.858 -171.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 48.02 35.24 4.88 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.155 2.182 . . . . 73.45 115.929 167.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -143.8 139.8 29.53 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.664 1.586 . . . . 74.52 108.691 -172.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.5 mt -113.56 122.63 47.82 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 124.362 1.039 . . . . 65.32 109.684 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.4 t -105.63 134.93 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.472 1.509 . . . . 61.13 108.92 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 t -163.38 144.98 9.57 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.237 1.415 . . . . 63.33 109.969 -171.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 83.9 m -147.86 129.35 14.92 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.809 0.844 . . . . 75.11 110.105 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -69.37 -75.12 0.12 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.831 1.252 . . . . 65.02 111.261 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -138.32 -41.07 0.51 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.328 1.851 . . . . 65.23 110.447 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -154.92 21.16 0.44 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.25 1.42 . . . . 74.45 111.825 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.89 91.05 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.069 1.347 . . . . 51.44 107.697 -178.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -70.06 109.49 4.59 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.051 0.94 . . . . 74.33 111.313 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.6 m -116.88 114.45 23.9 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 124.872 1.358 . . . . 52.41 109.332 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.1 t -117.46 110.16 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.962 1.305 . . . . 53.11 107.898 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.2 m -86.17 153.14 22.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.369 1.468 . . . . 54.15 109.688 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -148.11 138.88 23.07 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.816 1.246 . . . . 73.43 109.802 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.0 tp -116.28 126.57 53.74 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.824 2.05 . . . . 75.03 107.704 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -126.46 70.42 1.25 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.001 1.721 . . . . 71.04 106.766 170.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.41 -110.14 3.31 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.913 1.244 . . . . 53.43 110.417 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.03 4.51 14.24 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.476 1.511 . . . . 71.13 113.903 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.8 mm -123.92 140.5 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.118 0.967 . . . . 60.11 109.165 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.7 mm -120.3 137.27 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 125.123 1.369 . . . . 74.23 107.966 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.7 m -134.65 115.61 14.01 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 124.671 1.232 . . . . 65.21 107.84 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -106.08 139.64 40.3 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.436 -0.95 . . . . 75.33 108.436 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.7 m -131.28 120.69 23.54 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.873 1.358 . . . . 75.43 108.358 174.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.4 mtm -112.72 150.19 31.89 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.884 1.674 . . . . 74.34 109.594 173.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.1 m -138.87 96.3 3.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.556 1.142 . . . . 60.32 108.862 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.2 tp -104.73 111.01 23.57 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.443 1.497 . . . . 71.2 108.883 175.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.34 -112.87 5.36 Favored Glycine 0 CA--C 1.533 1.193 0 O-C-N 124.574 1.171 . . . . 63.24 110.413 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -110.9 18.74 19.23 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.91 1.684 . . . . 71.45 111.29 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.4 mt -129.4 136.88 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.015 1.326 . . . . 75.42 109.026 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.6 t -121.99 95.69 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 124.237 0.961 . . . . 64.21 109.565 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -75.05 128.24 35.09 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.814 1.245 . . . . 74.24 112.317 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.04 153.34 34.88 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 124.094 0.871 . . . . 63.24 110.835 169.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -135.29 139.06 44.07 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 126.362 1.865 . . . . 62.53 108.199 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.32 133.71 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 O-C-N 124.802 1.314 . . . . 74.22 107.622 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.9 m -137.37 158.51 44.24 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.122 1.369 . . . . 75.33 110.116 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -139.11 142.77 38.08 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.583 1.153 . . . . 63.23 110.755 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -68.06 136.82 54.38 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.969 2.108 . . . . 72.42 113.005 -168.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.5 mt . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 105.494 -2.039 . . . . 72.13 105.494 -174.344 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' 2VN . . . . . 0.429 ' H12' ' H18' ' A' ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 74.2 m80 . . . . . 0 N--CA 1.501 2.082 0 N-CA-C 103.149 -2.908 . . . . 74.42 103.149 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 49.5 m80 55.52 -157.29 0.24 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.707 2.003 . . . . 63.42 113.662 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -98.83 76.66 2.18 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.947 1.299 . . . . 55.23 109.25 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -89.41 93.03 9.37 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.908 0.883 . . . . 74.33 110.019 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -162.96 128.69 3.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.67 1.188 . . . . 71.43 108.565 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 6.9 m80 56.98 84.5 0.09 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.91 2.084 . . . . 75.21 113.023 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 26.9 m -105.06 19.64 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 125.114 1.365 . . . . 73.0 112.405 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -161.61 167.03 25.99 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.479 1.512 . . . . 33.23 110.622 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptm -67.8 161.74 25.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.575 1.55 . . . . 64.11 112.259 171.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.0 t -153.05 151.47 30.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.719 0.808 . . . . 72.34 110.078 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -68.18 -30.95 70.18 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 117.625 -1.179 . . . . 74.21 113.621 169.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.5 p -58.88 103.1 0.14 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.488 1.515 . . . . 75.25 112.968 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.75 174.11 37.77 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 108.958 -1.657 . . . . 65.11 108.958 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.53 146.11 48.36 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.686 -1.227 . . . . 74.12 107.686 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -143.1 130.24 20.78 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.798 0.839 . . . . 74.24 110.397 -168.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -87.9 149.21 24.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.988 0.915 . . . . 63.35 110.532 174.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.0 tp -68.64 132.31 46.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.6 0.76 . . . . 71.32 111.131 173.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -106.08 -53.53 2.62 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 124.67 1.231 . . . . 65.5 110.829 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.25 157.66 15.61 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 124.447 1.092 . . . . 73.05 110.382 -175.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -135.98 137.69 41.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.562 1.145 . . . . 74.35 108.582 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -112.86 137.15 51.64 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.217 1.407 . . . . 71.15 108.406 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 57.39 30.19 18.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.124 1.77 . . . . 63.12 112.964 -171.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.21 -58.36 8.63 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 124.177 0.991 . . . . 74.25 112.111 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -52.59 -52.15 56.57 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.344 1.858 . . . . 60.04 112.42 173.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.96 -48.78 77.54 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.332 1.453 . . . . 53.45 114.037 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -67.72 -45.7 74.29 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.862 1.265 . . . . 70.13 113.593 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 7.3 mmt -65.38 -40.22 93.23 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 124.699 1.25 . . . . 61.43 112.829 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -67.84 -28.3 67.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.187 0.995 . . . . 62.13 113.052 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.63 -34.71 40.33 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 114.099 1.148 . . . . 71.32 114.099 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.0 pt -77.12 -6.82 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 113.065 0.765 . . . . 75.3 113.065 169.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.59 31.24 24.96 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.604 -1.109 . . . . 44.11 112.345 169.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.01 151.57 97.09 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 118.636 1.218 . . . . 72.05 111.774 177.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.51 139.48 59.03 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.01 1.807 . . . . 64.41 110.763 169.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -63.45 -20.33 65.48 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.4 1.259 . . . . 74.34 114.4 -174.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.58 -45.71 91.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 117.881 -1.057 . . . . 73.54 113.435 168.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.8 mt -66.81 -26.96 67.19 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 124.212 1.005 . . . . 75.44 113.518 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.5 mt -75.93 -51.22 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.033 0.933 . . . . 64.11 111.376 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -62.08 -48.24 81.07 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.111 -0.947 . . . . 53.41 112.646 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -27.03 68.59 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.426 0.898 . . . . 75.5 113.426 174.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.23 -29.23 51.04 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 118.69 -1.061 . . . . 20.32 112.395 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.37 -30.6 13.83 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.471 1.135 . . . . 72.43 112.732 175.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -72.9 -39.39 66.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.687 1.195 . . . . 75.45 113.335 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.6 mt -111.06 130.05 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.483 -0.932 . . . . 62.42 108.483 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -88.02 134.13 33.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.928 1.291 . . . . 63.21 110.642 172.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.7 -168.15 26.38 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 109.683 -1.367 . . . . 74.13 109.683 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.2 t -134.97 153.96 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.885 1.274 . . . . 70.24 108.317 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.4 p -128.6 160.48 32.28 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.465 1.506 . . . . 70.22 110.622 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -133.75 148.84 51.44 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 107.452 -1.314 . . . . 72.33 107.452 169.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.405 HG12 ' CE2' ' A' ' 50' ' ' PHE . 7.8 mt -138.72 129.91 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 105.963 -1.866 . . . . 62.45 105.963 176.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.2 m -139.28 138.95 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 123.426 0.454 . . . . 74.23 110.029 175.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -109.94 117.17 33.09 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.083 1.753 . . . . 74.34 107.277 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -116.08 51.33 0.97 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.181 1.392 . . . . 73.54 109.162 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.95 -116.62 5.67 Favored Glycine 0 CA--C 1.534 1.227 0 N-CA-C 107.977 -2.049 . . . . 50.4 107.977 -171.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -72.59 -34.91 67.73 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.154 1.168 . . . . 73.31 114.154 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.44 161.75 29.51 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.856 0.723 . . . . 72.23 111.829 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -159.26 131.46 6.58 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 106.886 -1.524 . . . . 73.35 106.886 -173.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -121.07 149.2 43.08 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.978 1.311 . . . . 75.04 108.824 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.405 ' CE2' HG12 ' A' ' 41' ' ' ILE . 5.5 t80 -141.82 119.75 11.98 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.351 -1.352 . . . . 70.41 107.351 177.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 34.3 m -96.09 134.07 39.58 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.592 1.157 . . . . 45.21 108.909 172.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.58 107.0 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.939 -1.504 . . . . 74.15 106.939 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 m -99.33 100.63 11.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.717 1.207 . . . . 51.0 108.426 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.94 178.02 7.08 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.238 1.015 . . . . 75.3 111.325 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.47 29.55 2.57 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 125.216 1.388 . . . . 43.33 113.356 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -158.28 -33.48 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.35 1.575 . . . . 73.3 112.566 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.68 170.05 19.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.953 1.301 . . . . 75.41 110.37 -176.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.416 HG12 HE21 ' A' ' 60' ' ' GLN . 21.9 t -119.23 132.47 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 O-C-N 124.173 0.921 . . . . 63.15 109.181 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.4 mt -122.97 135.29 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.292 1.437 . . . . 74.53 107.926 172.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.416 HE21 HG12 ' A' ' 58' ' ' VAL . 3.4 mp0 -119.6 143.34 47.71 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 124.175 0.922 . . . . 63.21 108.812 176.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -133.38 132.0 40.7 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.627 1.171 . . . . 63.35 109.734 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -113.02 143.57 44.08 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 125.427 1.704 . . . . 73.05 109.476 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -148.19 164.73 33.05 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.186 1.394 . . . . 75.23 108.659 173.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.7 m -113.51 131.28 56.12 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.434 -0.95 . . . . 72.31 108.434 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.0 t -62.76 119.37 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 125.011 1.324 . . . . 63.33 111.213 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.44 ' HA2' HE21 ' A' ' 84' ' ' GLN . . . 92.91 -10.47 73.85 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-O 117.906 -1.497 . . . . 75.31 113.668 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -107.52 139.46 42.01 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.64 1.72 . . . . 71.42 109.355 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.77 120.14 13.02 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 123.606 0.762 . . . . 72.15 111.736 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.5 m -138.92 140.58 38.37 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.263 1.425 . . . . 74.14 108.28 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -67.44 131.11 45.04 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.87 0.731 . . . . 74.33 111.214 168.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 mt -120.77 109.31 15.01 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.543 1.537 . . . . 71.33 107.921 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -74.82 154.52 38.25 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.536 1.135 . . . . 63.54 111.178 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.9 m -110.59 169.56 8.67 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.882 1.673 . . . . 60.32 109.208 175.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -53.06 -25.68 13.49 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.769 1.628 . . . . 75.24 115.022 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 66.5 p -82.09 -18.74 41.97 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 128.548 2.739 . . . . 74.02 113.968 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.56 0.63 55.47 Favored Glycine 0 CA--C 1.543 1.786 0 CA-C-O 118.549 -1.139 . . . . 62.43 112.564 -174.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -75.63 105.06 6.46 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.525 1.53 . . . . 74.34 111.98 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -99.93 133.2 44.64 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.54 1.136 . . . . 71.12 111.079 176.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -147.03 131.47 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.455 1.502 . . . . 71.33 109.908 -172.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -79.47 129.61 34.63 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.577 1.551 . . . . 75.51 110.218 -172.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.6 t -162.69 159.24 24.11 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 124.25 0.969 . . . . 74.2 111.146 -173.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.9 m -104.15 146.31 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 125.287 1.435 . . . . 42.04 109.872 167.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.5 t -122.57 126.84 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 106.962 -1.496 . . . . 70.35 106.962 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.44 HE21 ' HA2' ' A' ' 66' ' ' GLY . 2.4 mt-30 -129.22 139.98 51.65 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.632 1.173 . . . . 65.02 111.522 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.7 tp -84.78 136.97 33.46 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.832 1.332 . . . . 64.15 109.567 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.95 16.12 5.26 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.198 0.999 . . . . 62.4 113.208 173.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.76 12.4 78.26 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.159 1.362 . . . . 63.34 113.081 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -143.91 57.29 1.34 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.862 1.265 . . . . 62.51 108.491 -171.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.276 0.8 OUTLIER 49.49 32.71 4.97 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.84 2.056 . . . . 73.45 115.327 169.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -142.48 127.57 18.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.478 1.911 . . . . 74.52 108.275 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 49.3 mt -107.17 134.24 50.58 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.593 1.157 . . . . 65.32 109.647 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.8 t -118.91 135.65 58.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.817 1.247 . . . . 61.13 109.181 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.5 t -155.92 142.4 18.57 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.211 1.004 . . . . 63.33 111.576 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.8 p -143.68 136.96 27.87 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.625 1.57 . . . . 75.11 110.121 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -102.78 -61.2 1.43 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.927 1.291 . . . . 65.02 109.613 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -140.88 -63.84 0.46 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 125.881 1.672 . . . . 65.23 109.15 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -140.78 10.63 2.22 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.673 1.589 . . . . 74.45 112.283 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.2 mt -111.53 108.79 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 125.477 1.511 . . . . 51.44 106.95 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -101.58 99.94 10.29 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.404 1.082 . . . . 74.33 110.306 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.63 127.5 35.92 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.091 1.356 . . . . 52.41 108.561 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.3 t -130.41 104.73 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.201 -1.407 . . . . 53.11 107.201 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.3 m -82.68 150.57 26.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.488 1.515 . . . . 54.15 109.842 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -147.09 139.93 25.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.979 1.311 . . . . 73.43 108.933 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.41 124.32 39.9 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.543 1.537 . . . . 75.03 107.418 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -127.55 84.76 2.28 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.555 1.942 . . . . 71.04 106.518 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.69 -114.89 7.19 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.266 1.412 . . . . 53.43 110.461 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -88.18 15.48 7.48 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.77 1.628 . . . . 71.13 114.087 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.8 mm -129.25 132.05 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.248 1.019 . . . . 60.11 108.815 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.1 mm -104.83 140.14 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.792 -1.188 . . . . 74.23 107.792 169.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.2 m -133.98 112.29 11.1 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.077 -1.453 . . . . 65.21 107.077 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -103.14 146.91 27.68 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.419 -0.586 . . . . 75.33 109.419 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.0 m -140.45 99.77 3.72 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.975 1.31 . . . . 75.43 109.265 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.6 mmm -92.19 150.59 20.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.103 1.761 . . . . 74.34 110.241 170.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.8 m -140.44 105.38 4.97 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.306 1.042 . . . . 60.32 108.898 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.6 tp -113.88 110.75 20.6 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.871 1.668 . . . . 71.2 108.583 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.31 -123.33 29.32 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 109.776 -1.33 . . . . 63.24 109.776 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -97.49 12.68 32.52 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.248 1.419 . . . . 71.45 113.18 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.4 mt -119.28 136.82 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.992 0.917 . . . . 75.42 109.865 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.5 t -119.72 96.71 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 124.33 1.019 . . . . 64.21 109.068 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -75.45 127.41 33.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.322 1.049 . . . . 74.24 111.475 172.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 157.21 29.58 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 123.921 0.763 . . . . 63.24 110.065 168.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -149.36 129.53 13.63 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.261 1.024 . . . . 62.53 109.099 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.63 137.36 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.93 1.292 . . . . 74.22 108.565 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.6 m -134.97 158.39 44.46 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.432 1.093 . . . . 75.33 110.136 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -123.09 134.9 54.22 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 125.345 1.458 . . . . 63.23 108.931 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -68.83 146.83 52.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.912 1.685 . . . . 72.42 112.745 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 105.653 -1.981 . . . . 72.13 105.653 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 19.6 p80 . . . . . 0 N--CA 1.501 2.086 0 N-CA-C 103.88 -2.637 . . . . 74.42 103.88 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -150.92 163.96 37.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.187 1.795 . . . . 63.42 109.998 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -132.46 -33.52 1.26 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.006 1.322 . . . . 55.23 111.679 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -67.28 170.28 7.45 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.226 1.411 . . . . 74.33 112.302 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 75.34 -61.21 0.48 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 127.658 2.383 . . . . 71.43 112.622 -172.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -66.4 145.87 55.2 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.714 1.206 . . . . 75.21 112.835 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.6 m -135.44 47.83 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 125.625 1.57 . . . . 73.0 110.372 -175.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -160.4 155.93 25.31 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 124.526 1.13 . . . . 33.23 111.345 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ppp? -92.98 166.54 12.32 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.456 1.502 . . . . 64.11 110.559 168.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -165.39 147.9 7.81 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.278 1.031 . . . . 72.34 109.527 173.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -78.35 56.38 1.72 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.056 1.743 . . . . 74.21 112.056 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -129.02 120.6 26.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.982 1.313 . . . . 75.25 109.515 -175.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.72 164.44 10.58 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 110.022 -1.231 . . . . 65.11 110.022 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.26 142.85 32.09 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.178 1.391 . . . . 74.12 110.213 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -136.53 150.46 48.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.426 1.09 . . . . 74.24 109.818 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -121.75 143.82 49.15 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.6 1.16 . . . . 63.35 108.839 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.9 tp -55.17 137.91 45.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.477 1.511 . . . . 71.32 112.937 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -122.3 -50.88 1.99 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.44 1.496 . . . . 65.5 111.204 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.1 153.88 41.19 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 124.405 1.066 . . . . 73.05 111.719 -172.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -140.66 132.67 27.79 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.761 1.624 . . . . 74.35 108.997 -170.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -138.54 133.73 32.96 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.32 1.048 . . . . 71.15 109.255 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 54.72 27.73 9.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.097 1.759 . . . . 63.12 113.178 -173.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -62.55 -54.5 38.83 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-O 117.84 -1.076 . . . . 74.25 112.131 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -61.1 -47.0 88.32 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-O 118.072 -0.966 . . . . 60.04 113.257 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.54 -47.05 73.64 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.669 1.187 . . . . 53.45 113.667 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -69.83 -45.48 67.76 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.669 1.187 . . . . 70.13 113.419 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.7 mmt -62.83 -48.2 80.09 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 124.502 1.126 . . . . 61.43 112.717 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -59.84 -31.15 69.48 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.468 0.914 . . . . 62.13 113.468 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.2 54.63 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.469 1.285 . . . . 71.32 114.469 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.3 pt -79.73 -7.87 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 113.344 0.868 . . . . 75.3 113.344 172.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.68 24.08 37.07 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.736 -1.035 . . . . 44.11 112.72 172.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.65 141.01 98.18 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.851 1.26 . . . . 72.05 110.264 172.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -66.04 143.01 70.49 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.434 2.089 . . . . 64.41 111.901 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -57.44 -27.07 62.11 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.664 1.357 . . . . 74.34 114.664 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -64.51 -45.44 87.22 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 117.885 -1.055 . . . . 73.54 113.568 172.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.8 mt -64.76 -25.12 67.78 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.154 0.981 . . . . 75.44 113.291 173.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.7 mt -80.63 -50.86 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.298 1.039 . . . . 64.11 110.802 177.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -61.94 -42.76 99.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 117.816 -1.087 . . . . 53.41 113.007 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -27.18 62.6 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 118.236 -0.888 . . . . 75.5 112.728 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.67 -27.42 61.01 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.846 -0.975 . . . . 20.32 112.382 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.01 -26.05 14.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.846 1.258 . . . . 72.43 113.147 174.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -80.33 -44.45 19.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.041 0.936 . . . . 75.45 111.156 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.7 mt -102.67 127.64 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.351 1.06 . . . . 62.42 108.165 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -76.96 118.16 19.27 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.896 1.278 . . . . 63.21 109.975 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.2 170.16 37.13 Favored Glycine 0 CA--C 1.531 1.091 0 O-C-N 124.247 0.967 . . . . 74.13 110.72 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.8 t -124.58 149.93 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.081 1.352 . . . . 70.24 108.819 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.0 p -126.41 165.95 18.11 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.73 1.612 . . . . 70.22 110.164 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -152.3 141.64 21.53 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.801 -1.185 . . . . 72.33 107.801 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.14 132.69 50.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.395 -1.706 . . . . 62.45 106.395 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.7 t -140.09 100.98 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.827 0.851 . . . . 74.23 108.96 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -87.29 141.58 28.54 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.494 1.118 . . . . 74.34 109.229 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -152.03 77.13 1.2 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.018 0.927 . . . . 73.54 109.002 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.37 -120.52 8.41 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 109.377 -1.489 . . . . 50.4 109.377 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -75.48 -32.17 60.47 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.717 1.207 . . . . 73.31 114.073 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.56 148.83 38.57 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 124.124 0.89 . . . . 72.23 111.861 175.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -138.26 133.08 32.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.95 1.7 . . . . 73.35 106.674 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -125.41 160.05 30.37 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.87 1.668 . . . . 75.04 110.37 173.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -155.97 145.94 21.35 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.559 -1.275 . . . . 70.41 107.559 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.6 m -129.05 117.86 21.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 124.235 0.959 . . . . 45.21 109.849 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.4 mt -90.56 139.49 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.045 1.338 . . . . 74.15 108.456 172.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.2 m -135.9 112.75 10.24 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.616 1.166 . . . . 51.0 108.079 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -120.15 74.76 1.06 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.465 1.106 . . . . 75.3 109.988 -174.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.82 -91.21 1.39 Allowed Glycine 0 CA--C 1.532 1.126 0 N-CA-C 108.847 -1.701 . . . . 43.33 108.847 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.8 m -105.67 -43.09 5.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.94 1.296 . . . . 73.3 112.08 -176.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -72.72 146.02 46.74 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.95 1.3 . . . . 75.41 112.215 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.2 t -133.92 130.31 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.644 1.177 . . . . 63.15 108.78 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.7 mt -130.71 111.62 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.743 1.217 . . . . 74.53 108.581 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.54 149.47 24.07 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.379 0.672 . . . . 63.21 110.975 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -139.31 153.67 47.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.084 1.753 . . . . 63.35 108.245 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -137.08 141.1 42.38 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 124.815 1.322 . . . . 73.05 109.072 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -145.74 168.01 21.76 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.443 1.097 . . . . 75.23 109.851 173.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.2 m -118.92 130.0 55.48 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.685 -1.228 . . . . 72.31 107.685 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.15 123.15 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.298 1.039 . . . . 63.33 110.782 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.31 2.07 77.58 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 118.267 -1.296 . . . . 75.31 113.396 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -115.31 152.16 33.27 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.571 1.548 . . . . 71.42 109.701 171.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -77.11 127.63 33.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.73 1.612 . . . . 72.15 110.61 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.7 m -146.59 149.47 33.61 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.153 1.381 . . . . 74.14 109.739 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -77.5 145.62 36.89 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 112.688 0.625 . . . . 74.33 112.688 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 mt -122.35 127.85 50.27 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.605 1.562 . . . . 71.33 108.291 173.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -95.29 142.66 27.44 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.43 1.092 . . . . 63.54 110.313 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 p -103.26 -177.57 3.41 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.385 1.474 . . . . 60.32 111.663 173.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.7 mtt -60.02 -38.43 82.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.74 1.616 . . . . 75.24 115.04 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.4 p -89.84 -1.63 58.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.454 1.502 . . . . 74.02 112.838 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.59 19.24 32.74 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 118.249 -1.306 . . . . 62.43 112.722 172.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -69.37 113.98 7.19 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.152 1.476 . . . . 74.34 109.963 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -104.24 125.44 50.51 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 124.153 0.908 . . . . 71.12 109.092 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -146.12 123.27 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 124.427 1.079 . . . . 71.33 110.983 -170.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -72.8 140.59 47.78 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 124.3 1.04 . . . . 75.51 112.351 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.8 t -171.09 163.02 7.26 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.493 1.517 . . . . 74.2 109.692 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.1 t -103.06 136.0 37.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.259 1.024 . . . . 42.04 108.461 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.9 t -103.52 127.8 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 107.996 -1.112 . . . . 70.35 107.996 171.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.8 mm-40 -125.51 151.67 46.01 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.264 1.425 . . . . 65.02 111.647 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 tp -101.33 137.02 40.23 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 124.757 1.286 . . . . 64.15 109.509 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -87.54 15.56 6.55 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.567 1.147 . . . . 62.4 113.258 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.96 13.83 80.62 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.95 1.262 . . . . 63.34 113.257 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -143.22 57.11 1.39 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.727 1.211 . . . . 62.51 108.561 -173.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.274 0.3 OUTLIER 44.15 37.0 1.67 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.198 2.199 . . . . 73.45 114.97 175.194 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -140.88 121.99 14.7 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 125.622 1.569 . . . . 74.52 109.02 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.3 mt -95.99 142.84 27.73 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 124.718 1.262 . . . . 65.32 109.721 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.9 t -132.56 137.92 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.471 1.508 . . . . 61.13 108.653 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 t -155.13 149.99 26.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.865 0.866 . . . . 63.33 110.734 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.0 p -143.56 130.74 20.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.942 1.297 . . . . 75.11 109.708 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -95.08 -60.2 1.73 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.312 1.045 . . . . 65.02 110.373 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -143.78 -75.57 0.25 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.682 1.593 . . . . 65.23 108.631 -173.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -116.95 -17.03 10.49 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.245 1.818 . . . . 74.45 111.232 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 21.5 mt -88.86 111.21 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.935 1.294 . . . . 51.44 108.455 -175.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.0 tmmt? -101.27 115.41 30.43 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 124.389 1.075 . . . . 74.33 108.974 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.4 m -117.03 124.36 49.12 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 124.846 1.341 . . . . 52.41 109.073 -169.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.8 t -131.89 117.14 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.528 1.131 . . . . 53.11 109.407 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.1 m -102.92 155.13 18.56 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.769 1.228 . . . . 54.15 109.643 173.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -139.15 144.89 38.81 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.639 1.976 . . . . 73.43 109.661 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 tp -124.85 118.06 25.5 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.863 2.065 . . . . 75.03 106.994 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -122.0 69.2 0.94 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.041 1.337 . . . . 71.04 108.136 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.11 -110.96 3.63 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 110.065 -1.214 . . . . 53.43 110.065 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -79.51 -6.58 57.27 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 117.254 -1.355 . . . . 71.13 113.461 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.2 mm -112.65 136.94 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 119.91 1.232 . . . . 60.11 109.385 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.9 mm -115.54 142.69 27.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.041 1.337 . . . . 74.23 108.151 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.0 m -133.43 124.83 27.79 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.371 1.045 . . . . 65.21 108.235 172.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -108.46 134.95 50.54 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.555 1.142 . . . . 75.33 107.946 170.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 62.6 m -136.41 117.79 14.68 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.303 1.441 . . . . 75.43 108.255 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 33.1 mtm -123.17 142.45 50.89 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.09 0.956 . . . . 74.34 109.715 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.9 m -125.54 113.44 17.44 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.332 1.453 . . . . 60.32 108.662 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 11.6 tp -121.18 107.5 12.65 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.361 1.464 . . . . 71.2 108.048 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.37 -111.67 4.21 Favored Glycine 0 CA--C 1.533 1.199 0 O-C-N 124.837 1.336 . . . . 63.24 110.442 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -99.6 1.36 43.62 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.733 2.013 . . . . 71.45 113.665 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 91.4 mt -120.68 139.51 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.677 1.191 . . . . 75.42 109.967 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.2 t -125.19 101.08 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 124.187 0.929 . . . . 64.21 109.772 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -68.55 138.45 55.14 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.307 1.443 . . . . 74.24 112.099 169.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.5 mppt? -136.37 157.33 47.06 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 124.486 1.116 . . . . 63.24 110.778 167.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.03 141.84 12.88 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.846 1.258 . . . . 62.53 108.996 -177.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.21 139.7 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.702 1.201 . . . . 74.22 108.368 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 45.0 m -133.05 160.56 36.81 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.479 1.512 . . . . 75.33 109.312 173.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.64 144.91 39.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.63 1.172 . . . . 63.23 110.695 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -63.03 145.34 55.65 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.79 2.036 . . . . 72.42 113.7 -171.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.8 mt . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 103.886 -2.635 . . . . 72.13 103.886 -175.126 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 102.296 -3.224 . . . . 74.42 102.296 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -166.61 -45.38 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.334 1.054 . . . . 63.42 111.032 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -67.04 155.55 38.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.646 1.179 . . . . 55.23 112.444 175.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -130.25 -83.34 0.54 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.698 1.199 . . . . 74.33 109.385 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -165.38 161.54 18.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.316 1.446 . . . . 71.43 110.026 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -157.46 71.97 0.66 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 123.942 0.776 . . . . 75.21 110.005 174.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 92.3 t 69.29 -71.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 128.26 2.624 . . . . 73.0 112.085 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -85.29 179.46 7.2 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.915 1.686 . . . . 33.23 111.065 169.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -112.32 157.41 21.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.86 1.264 . . . . 64.11 111.518 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.4 p -118.12 108.83 15.67 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.326 1.85 . . . . 72.34 109.658 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -63.3 -30.82 71.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.265 1.426 . . . . 74.21 114.271 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.1 p -52.72 121.62 7.54 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.063 2.145 . . . . 75.25 113.933 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.49 166.23 14.85 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 109.522 -1.431 . . . . 65.11 109.522 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.16 144.51 37.14 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.378 1.071 . . . . 74.12 108.65 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -137.48 155.82 48.86 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.855 1.262 . . . . 74.24 110.437 -172.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -129.0 146.17 51.05 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.473 1.109 . . . . 63.35 109.581 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.82 129.6 41.16 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.7 1.2 . . . . 71.32 111.517 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 65.6 mm-40 -111.36 -56.59 2.36 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.035 1.334 . . . . 65.5 110.743 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.37 155.47 45.91 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 124.615 1.197 . . . . 73.05 112.056 -170.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -142.38 122.62 13.86 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.087 1.755 . . . . 74.35 107.797 -168.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -129.09 140.94 51.37 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.524 0.73 . . . . 71.15 109.668 170.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 56.17 33.48 22.14 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.632 1.973 . . . . 63.12 112.46 -171.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.0 -62.37 1.6 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.103 -0.951 . . . . 74.25 111.676 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.99 -34.04 75.44 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 113.671 0.989 . . . . 60.04 113.671 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.66 -52.7 64.38 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.079 0.951 . . . . 53.45 112.652 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -67.34 -49.53 63.67 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.656 1.182 . . . . 70.13 113.165 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.1 mmt -67.1 -36.94 83.05 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.745 1.278 . . . . 61.43 113.139 -173.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -77.95 -25.52 48.28 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 118.047 -0.978 . . . . 62.13 112.534 173.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.37 -35.96 63.54 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 113.739 1.015 . . . . 71.32 113.739 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.6 pt -77.44 -10.27 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 O-C-N 123.917 0.76 . . . . 75.3 112.966 170.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.72 29.43 23.86 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.382 -1.232 . . . . 44.11 113.073 167.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.6 mt -65.39 152.17 92.67 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 119.125 1.463 . . . . 72.05 111.718 172.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -64.61 140.69 69.72 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.244 1.963 . . . . 64.41 111.269 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.59 -21.63 53.79 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.686 1.365 . . . . 74.34 114.686 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -59.54 -52.21 66.53 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 117.586 -1.197 . . . . 73.54 113.328 166.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.6 mt -61.12 -30.36 70.32 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.943 1.09 . . . . 75.44 113.943 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.13 -54.2 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 O-C-N 124.17 0.919 . . . . 64.11 111.707 171.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -66.92 -27.55 67.58 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.961 1.467 . . . . 53.41 114.961 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.17 -21.25 31.37 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.759 1.224 . . . . 75.5 112.257 171.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.44 -15.7 52.25 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 118.564 -1.131 . . . . 20.32 112.275 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.12 -31.8 15.37 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.739 1.269 . . . . 72.43 113.079 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -83.48 -45.55 13.49 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.954 0.797 . . . . 75.45 111.032 177.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.4 mm -89.71 125.4 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.06 0.944 . . . . 62.42 109.402 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -85.42 146.46 26.96 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.531 1.144 . . . . 63.21 110.248 166.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -101.84 -168.85 27.38 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 109.753 -1.339 . . . . 74.13 109.753 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.4 t -129.86 158.47 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 126.693 1.997 . . . . 70.24 108.583 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.0 t -137.4 161.04 37.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.071 1.349 . . . . 70.22 110.125 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -143.35 147.81 35.26 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 123.76 0.824 . . . . 72.33 109.287 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.7 mt -132.03 126.01 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.461 -1.681 . . . . 62.45 106.461 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.9 t -136.87 92.2 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.197 -1.038 . . . . 74.23 108.197 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -79.98 138.68 37.12 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.128 0.971 . . . . 74.34 109.577 171.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -148.6 74.79 1.29 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.094 0.958 . . . . 73.54 109.298 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.43 -125.02 11.37 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.277 -1.529 . . . . 50.4 109.277 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mmpp? -70.26 -32.36 70.16 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.894 1.277 . . . . 73.31 114.377 173.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.0 157.22 31.33 Favored 'General case' 0 C--N 1.345 0.399 0 O-C-N 124.046 0.841 . . . . 72.23 111.893 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -157.05 127.33 6.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.039 -1.467 . . . . 73.35 107.039 -173.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -115.75 151.55 34.93 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.873 1.669 . . . . 75.04 109.886 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -147.44 119.81 8.42 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.057 -1.09 . . . . 70.41 108.057 -176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.1 m -102.07 129.97 48.53 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 124.49 1.119 . . . . 45.21 108.576 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.0 mt -113.63 120.16 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 106.839 -1.541 . . . . 74.15 106.839 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.5 m -113.88 104.07 11.81 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.644 1.215 . . . . 51.0 107.799 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.2 -162.29 0.11 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.813 1.645 . . . . 75.3 111.933 172.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.94 -27.03 69.65 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-O 118.788 -1.006 . . . . 43.33 113.738 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.0 p -163.75 25.37 0.08 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.429 1.492 . . . . 73.3 112.648 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -139.47 142.58 37.35 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.408 1.083 . . . . 75.41 109.967 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.29 128.89 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 124.293 0.996 . . . . 63.15 108.823 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.8 mt -130.95 123.11 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.766 1.626 . . . . 74.53 107.467 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.43 138.81 49.55 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.125 0.97 . . . . 63.21 109.034 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -134.48 145.19 48.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.037 1.335 . . . . 63.35 108.658 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -125.05 145.98 49.66 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 124.817 1.323 . . . . 73.05 109.195 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -149.21 161.02 42.84 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.65 1.18 . . . . 75.23 109.88 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.3 m -108.86 130.0 55.41 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.347 1.03 . . . . 72.31 108.467 172.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 80.3 t -66.78 115.27 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.763 1.225 . . . . 63.33 110.578 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.25 -9.56 50.02 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-O 117.971 -1.46 . . . . 75.31 112.963 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -114.52 149.13 36.9 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.422 1.611 . . . . 71.42 109.916 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -71.41 133.37 45.88 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.93 0.769 . . . . 72.15 110.725 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.5 m -139.02 168.16 20.45 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.717 1.607 . . . . 74.14 108.936 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -110.89 133.26 53.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.867 0.867 . . . . 74.33 109.901 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -122.02 138.48 54.42 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.443 1.497 . . . . 71.33 109.292 -171.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -109.75 141.86 41.78 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.327 1.451 . . . . 63.54 111.912 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 m -99.63 167.06 10.81 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.91 1.684 . . . . 60.32 111.61 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 65.3 mtm -57.56 -26.75 61.9 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.947 1.699 . . . . 75.24 114.986 170.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.1 t -83.62 -10.83 57.97 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.645 1.178 . . . . 74.02 113.557 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.84 4.46 67.32 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 118.457 -1.19 . . . . 62.43 113.296 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -71.06 136.48 48.3 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.277 1.538 . . . . 74.34 109.648 172.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -120.66 135.38 55.13 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.295 0.997 . . . . 71.12 108.609 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.14 132.1 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.591 1.156 . . . . 71.33 110.562 -171.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -74.42 141.2 45.06 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 124.283 0.989 . . . . 75.51 111.85 173.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.5 t -164.94 154.05 12.73 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.586 1.555 . . . . 74.2 110.003 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.73 133.61 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 107.865 -1.161 . . . . 42.04 107.865 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -112.17 129.04 68.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 108.311 -0.996 . . . . 70.35 108.311 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -141.11 147.39 38.42 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.054 1.342 . . . . 65.02 111.712 -173.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 tp -75.54 138.63 41.64 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.349 1.059 . . . . 64.15 111.492 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -89.45 6.35 41.17 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.889 1.275 . . . . 62.4 112.415 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.74 16.55 77.96 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.798 1.19 . . . . 63.34 112.948 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -150.22 48.25 0.9 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.249 1.42 . . . . 62.51 108.86 -172.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.302 0.0 OUTLIER 53.13 33.51 15.28 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.642 1.577 . . . . 73.45 114.079 178.059 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -130.5 141.56 50.49 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 125.787 1.635 . . . . 74.52 108.748 -171.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.1 mt -117.66 113.27 21.65 Favored 'General case' 0 C--N 1.343 0.312 0 O-C-N 124.539 1.149 . . . . 65.32 109.414 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.0 t -95.01 136.93 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.877 1.671 . . . . 61.13 109.137 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.13 147.32 22.38 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.54 1.536 . . . . 63.33 110.62 -174.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.6 p -150.67 132.78 15.3 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.392 1.477 . . . . 75.11 109.725 -175.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -98.15 -70.15 0.73 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.09 1.356 . . . . 65.02 108.895 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -135.3 -57.17 0.8 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.702 1.601 . . . . 65.23 108.887 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -149.09 10.29 0.79 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.415 1.486 . . . . 74.45 112.564 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -108.48 104.8 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.549 -1.278 . . . . 51.44 107.549 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -86.88 106.64 17.9 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 124.121 0.888 . . . . 74.33 109.253 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 55.7 p -111.45 123.55 50.45 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.757 1.285 . . . . 52.41 111.141 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.5 t -126.1 105.32 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 126.037 1.735 . . . . 53.11 107.495 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.6 m -82.13 152.42 26.53 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.012 1.325 . . . . 54.15 109.769 172.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -142.28 139.06 31.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.856 1.662 . . . . 73.43 108.953 174.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.1 tp -117.71 126.73 53.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.917 2.087 . . . . 75.03 106.734 173.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -133.97 81.19 1.9 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.474 1.91 . . . . 71.04 106.285 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.13 -116.62 9.08 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 110.202 -1.159 . . . . 53.43 110.202 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -88.52 17.74 5.14 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.205 1.802 . . . . 71.13 114.221 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.4 mm -129.99 132.79 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.178 0.991 . . . . 60.11 108.932 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 49.8 mm -111.36 136.2 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 125.09 1.356 . . . . 74.23 107.849 171.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.8 m -127.34 122.88 34.93 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.151 -1.425 . . . . 65.21 107.151 173.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -113.75 134.04 55.0 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.274 -1.009 . . . . 75.33 108.274 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.2 m -133.69 108.12 8.34 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 124.539 1.15 . . . . 75.43 108.533 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.1 mtp -108.27 146.52 32.75 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.541 1.937 . . . . 74.34 109.246 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.4 m -137.59 94.38 2.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.293 1.037 . . . . 60.32 109.587 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.2 tp -98.77 109.1 21.91 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.32 1.448 . . . . 71.2 108.846 173.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.45 -111.1 3.73 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 124.807 1.317 . . . . 63.24 110.817 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -101.53 1.37 37.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.722 2.009 . . . . 71.45 113.648 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 89.5 mt -120.85 143.78 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.123 1.369 . . . . 75.42 110.143 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.7 t -123.01 91.3 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 O-C-N 124.23 0.956 . . . . 64.21 110.24 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -68.47 127.14 31.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.334 1.054 . . . . 74.24 112.1 173.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -125.2 146.38 49.54 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.738 1.215 . . . . 63.24 110.465 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -142.94 132.54 23.75 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.896 1.278 . . . . 62.53 108.326 -174.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.69 133.26 67.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.556 -1.276 . . . . 74.22 107.556 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.1 m -134.55 150.18 50.72 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 124.626 1.204 . . . . 75.33 110.025 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -120.01 141.42 49.73 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.547 1.539 . . . . 63.23 109.727 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -67.74 141.18 56.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.264 1.826 . . . . 72.42 112.103 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.4 mt . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 106.295 -1.742 . . . . 72.13 106.295 -173.351 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 108.781 -0.822 . . . . 72.34 108.781 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -70.02 -25.33 63.53 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.988 1.107 . . . . 74.21 113.988 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.2 t -52.77 115.08 1.64 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.058 2.143 . . . . 75.25 113.147 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.09 164.96 16.05 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 110.557 -1.017 . . . . 65.11 110.557 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.423 ' HB3' HD12 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -109.66 144.86 37.41 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.851 1.661 . . . . 74.12 110.399 175.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.494 ' CZ ' HD11 ' A' ' 109' ' ' ILE . 37.0 m-85 -140.81 141.15 34.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.998 1.319 . . . . 74.24 109.645 -173.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -107.93 148.04 30.2 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.538 1.135 . . . . 63.35 109.899 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.64 127.47 31.82 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.469 1.508 . . . . 71.32 111.207 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -109.4 -57.19 2.2 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.821 1.248 . . . . 65.5 110.973 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.5 p -152.86 172.16 17.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.563 1.145 . . . . 73.05 111.2 -174.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -168.27 148.59 4.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.876 1.271 . . . . 74.35 111.0 -165.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -140.04 143.23 36.27 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.873 1.269 . . . . 71.15 108.797 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 57.59 26.02 12.32 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.482 1.913 . . . . 63.12 113.616 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -61.5 -55.66 28.58 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-O 118.232 -0.889 . . . . 74.25 113.185 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -62.41 -43.48 98.72 Favored 'General case' 0 C--N 1.347 0.472 0 O-C-N 124.308 1.005 . . . . 60.04 112.919 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.92 -45.47 82.68 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.711 1.204 . . . . 53.45 113.566 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -68.08 -47.17 69.01 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.958 1.303 . . . . 70.13 113.187 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.5 mmt -65.9 -44.61 84.73 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.565 1.166 . . . . 61.43 113.049 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.505 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.3 mptm? -60.71 -32.43 71.68 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.932 0.893 . . . . 62.13 113.032 171.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.56 -37.69 59.77 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.396 1.258 . . . . 71.32 114.396 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.1 pt -79.11 -5.14 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 113.427 0.899 . . . . 75.3 113.427 172.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.98 27.81 25.1 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 118.666 -1.074 . . . . 44.11 112.893 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.66 146.73 98.61 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 118.822 1.311 . . . . 72.05 111.122 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -68.31 140.83 49.75 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.05 1.834 . . . . 64.41 110.799 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.08 -21.88 64.09 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.63 1.344 . . . . 74.34 114.63 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.62 -49.94 74.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.351 1.06 . . . . 73.54 113.349 169.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.6 mt -63.92 -23.74 67.46 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 124.65 1.18 . . . . 75.44 113.569 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.505 HD13 ' HD2' ' A' ' 20' ' ' LYS . 68.6 mt -83.15 -50.46 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.325 1.05 . . . . 64.11 110.602 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -60.94 -42.59 98.49 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 117.821 -1.085 . . . . 53.41 113.16 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -27.59 63.34 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 118.22 -0.895 . . . . 75.5 112.819 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.54 -30.04 57.06 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-O 119.077 -0.846 . . . . 20.32 112.552 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.79 -30.75 14.69 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.632 1.173 . . . . 72.43 112.789 173.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -72.78 -49.96 27.36 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.627 1.171 . . . . 75.45 111.52 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 mt -93.37 129.56 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.268 1.027 . . . . 62.42 108.347 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -80.44 110.17 15.63 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 124.135 0.897 . . . . 63.21 108.787 170.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.51 -172.97 41.75 Favored Glycine 0 CA--C 1.538 1.487 0 O-C-N 124.469 1.106 . . . . 74.13 110.429 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.5 t -129.82 153.79 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.709 1.204 . . . . 70.24 109.701 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.0 t -130.35 155.98 45.45 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.552 1.941 . . . . 70.22 109.164 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -141.02 143.67 34.56 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.752 1.221 . . . . 72.33 107.879 170.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.1 mt -132.07 130.36 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.08 -1.822 . . . . 62.45 106.08 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -134.74 135.5 53.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.15 -1.056 . . . . 74.23 108.15 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -126.92 130.82 50.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.819 1.248 . . . . 74.34 108.687 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -133.19 55.07 1.92 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.144 1.378 . . . . 73.54 109.289 -172.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.13 -115.96 5.69 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 108.718 -1.753 . . . . 50.4 108.718 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -70.69 -35.42 72.77 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.249 1.204 . . . . 73.31 114.249 173.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.63 156.09 37.11 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 124.021 0.825 . . . . 72.23 111.373 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -150.93 141.29 22.4 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.037 -1.468 . . . . 73.35 107.037 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -129.27 151.63 49.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.229 1.811 . . . . 75.04 109.153 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -148.79 126.23 11.61 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.686 -1.228 . . . . 70.41 107.686 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 m -109.18 126.61 53.45 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.688 1.243 . . . . 45.21 108.931 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.25 133.93 51.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.724 -1.584 . . . . 74.15 106.724 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.0 m -133.52 104.84 6.58 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 124.166 0.916 . . . . 51.0 109.394 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -107.38 77.49 1.15 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.918 0.887 . . . . 75.3 110.153 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.34 -49.41 4.23 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.513 1.53 . . . . 43.33 112.212 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.44 -39.65 0.09 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.171 0.986 . . . . 73.3 111.872 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -67.09 137.26 56.24 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.475 1.11 . . . . 75.41 111.684 172.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.6 t -125.31 130.47 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 O-C-N 124.612 1.195 . . . . 63.15 109.147 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.8 mt -119.34 128.67 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.871 1.269 . . . . 74.53 108.019 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -116.66 127.14 54.16 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 124.589 1.18 . . . . 63.21 108.693 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -121.94 145.04 48.5 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.413 1.485 . . . . 63.35 109.075 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -132.8 140.78 48.16 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 125.376 1.672 . . . . 73.05 108.995 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -149.46 166.93 27.64 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.033 1.333 . . . . 75.23 109.146 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.4 m -119.21 127.01 52.89 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.886 -1.153 . . . . 72.31 107.886 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.8 t -63.73 126.95 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.768 1.227 . . . . 63.33 111.324 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.14 -3.1 85.66 Favored Glycine 0 CA--C 1.542 1.764 0 CA-C-O 118.249 -1.306 . . . . 75.31 113.558 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -116.62 141.02 48.74 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.127 1.771 . . . . 71.42 109.859 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -66.45 118.57 10.28 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.04 1.336 . . . . 72.15 111.616 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 40.5 m -140.46 153.26 46.2 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.577 1.551 . . . . 74.14 109.153 -175.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -100.96 128.65 46.9 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.99 0.916 . . . . 74.33 109.77 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.3 mt -120.37 131.92 55.05 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.762 1.225 . . . . 71.33 110.467 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -90.43 130.92 36.45 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.277 1.831 . . . . 63.54 110.47 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.6 p -85.52 -179.93 7.01 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.572 1.149 . . . . 60.32 111.651 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.2 mtt -59.03 -30.83 68.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.18 1.548 . . . . 75.24 115.18 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.4 p -87.82 -7.51 57.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.368 1.467 . . . . 74.02 113.235 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.63 6.68 58.27 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 118.187 -1.34 . . . . 62.43 112.592 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -69.0 113.36 6.31 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 119.405 1.603 . . . . 74.34 110.791 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -94.44 124.95 38.78 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 124.612 1.195 . . . . 71.12 110.502 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.92 126.19 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.309 1.444 . . . . 71.33 110.361 -170.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -72.5 132.92 44.47 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.22 1.408 . . . . 75.51 111.885 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.3 t -161.93 170.02 20.13 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.267 1.427 . . . . 74.2 109.445 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.95 144.03 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 108.283 -1.006 . . . . 42.04 108.283 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.563 HG12 HD22 ' A' ' 91' ' ' LEU . 22.3 t -112.05 125.65 69.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 O-C-N 124.358 1.037 . . . . 70.35 108.252 177.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.91 141.78 46.35 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.805 1.642 . . . . 65.02 110.496 177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.0 tp -92.95 136.82 32.92 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.426 1.079 . . . . 64.15 109.189 168.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.18 12.63 11.19 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.261 1.024 . . . . 62.4 113.318 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.9 14.12 80.33 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 125.131 1.348 . . . . 63.34 113.115 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -140.41 52.07 1.65 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.718 1.207 . . . . 62.51 109.697 -171.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.276 0.0 OUTLIER 58.04 21.78 8.21 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.905 1.682 . . . . 73.45 114.818 173.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -135.05 120.9 19.66 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.502 1.521 . . . . 74.52 109.714 -164.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.563 HD22 HG12 ' A' ' 83' ' ' VAL . 56.2 mt -105.55 132.39 51.77 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.895 1.278 . . . . 65.32 109.945 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.1 t -119.61 136.52 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.008 1.323 . . . . 61.13 109.157 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.0 t -154.37 149.08 26.48 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.27 1.028 . . . . 63.33 110.846 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.2 p -146.33 132.08 18.97 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.724 1.209 . . . . 75.11 109.783 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -97.96 -63.39 1.13 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.975 1.31 . . . . 65.02 110.396 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -140.17 -73.49 0.36 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.189 1.796 . . . . 65.23 108.237 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -127.38 -1.77 6.26 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.255 1.822 . . . . 74.45 112.305 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.451 HG12 HD12 ' A' ' 115' ' ' LEU . 37.6 mt -97.4 110.9 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.839 1.656 . . . . 51.44 108.384 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -102.61 98.76 8.77 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.765 1.226 . . . . 74.33 110.195 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.5 t -82.92 131.27 35.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.327 1.451 . . . . 52.41 110.882 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.8 t -135.69 101.82 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 106.844 -1.539 . . . . 53.11 106.844 172.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.0 m -84.89 148.9 26.02 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.186 1.394 . . . . 54.15 109.766 173.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -147.71 130.76 16.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.042 1.337 . . . . 73.43 109.313 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 tt -113.93 130.55 56.5 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.232 -1.396 . . . . 75.03 107.232 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -132.62 82.71 2.02 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.431 1.892 . . . . 71.04 106.702 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.25 -111.78 4.44 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.745 1.164 . . . . 53.43 111.287 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -83.72 -4.72 58.85 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.329 1.452 . . . . 71.13 113.535 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.8 mm -110.94 138.46 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 119.499 1.045 . . . . 60.11 109.666 -176.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.494 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 36.6 mm -109.6 136.6 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.754 -1.202 . . . . 74.23 107.754 169.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.0 m -127.57 115.41 18.77 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 106.532 -1.655 . . . . 65.21 106.532 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -117.64 126.56 52.73 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.481 -0.933 . . . . 75.33 108.481 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 66.7 m -124.65 112.81 17.22 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 124.661 1.226 . . . . 75.43 108.386 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 95.1 mtp -105.86 149.86 26.14 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.873 1.269 . . . . 74.34 109.21 173.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.5 m -140.79 104.4 4.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.563 0.745 . . . . 60.32 109.21 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.451 HD12 HG12 ' A' ' 98' ' ' ILE . 7.0 tt -103.2 102.14 12.12 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.544 1.537 . . . . 71.2 107.55 175.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.27 -122.93 30.91 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 110.849 -0.9 . . . . 63.24 110.849 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -84.88 3.33 38.5 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.915 1.686 . . . . 71.45 115.173 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.8 mt -102.93 139.75 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.889 0.875 . . . . 75.42 108.995 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.38 96.85 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.205 1.002 . . . . 64.21 109.119 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -86.21 136.35 33.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.676 1.591 . . . . 74.24 112.48 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -119.65 150.19 40.74 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.049 1.34 . . . . 63.24 111.085 173.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 mmt-85 -141.98 136.1 29.98 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.503 1.921 . . . . 62.53 108.074 173.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.6 133.98 65.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.583 -1.266 . . . . 74.22 107.583 174.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.5 m -135.16 159.98 39.83 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.994 1.317 . . . . 75.33 109.648 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -137.79 143.3 41.0 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.489 1.116 . . . . 63.23 110.702 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.7 ttp85 -63.28 137.1 58.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.592 1.957 . . . . 72.42 113.768 -170.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.423 HD12 ' HB3' ' A' ' 6' ' ' LYS . 40.4 mt . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 106.039 -1.838 . . . . 72.13 106.039 -171.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 110.042 -0.355 . . . . 72.34 110.042 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -80.39 -16.82 53.57 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.549 1.314 . . . . 74.21 114.549 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.8 p -66.93 132.76 48.62 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.759 1.224 . . . . 75.25 113.483 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.1 168.34 14.67 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.285 0.945 . . . . 65.11 110.778 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -99.89 147.07 25.94 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.274 1.43 . . . . 74.12 111.137 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.496 ' CE2' HD11 ' A' ' 109' ' ' ILE . 31.5 m-85 -138.41 155.08 48.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.593 1.557 . . . . 74.24 109.453 -176.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -127.77 145.39 50.93 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.505 -0.924 . . . . 63.35 108.505 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 tt -61.96 131.24 49.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.22 1.408 . . . . 71.32 110.432 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -109.7 -50.06 3.03 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.609 1.164 . . . . 65.5 110.919 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.2 158.15 35.68 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 124.387 1.054 . . . . 73.05 111.109 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -128.08 155.83 43.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.844 1.257 . . . . 74.35 108.683 170.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -135.69 131.33 35.53 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.264 1.426 . . . . 71.15 108.175 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 58.23 39.27 25.94 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.352 1.861 . . . . 63.12 112.142 -169.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -64.11 -63.57 1.12 Allowed 'General case' 0 C--N 1.346 0.454 0 C-N-CA 124.875 1.27 . . . . 74.25 112.296 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.47 -28.43 69.66 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.566 0.95 . . . . 60.04 113.566 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.88 -51.9 65.17 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.102 0.961 . . . . 53.45 112.346 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -70.59 -48.47 55.04 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.831 1.252 . . . . 70.13 113.8 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.9 mmt -67.99 -39.83 83.2 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 124.374 1.046 . . . . 61.43 113.155 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -73.87 -27.68 61.2 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 118.137 -0.935 . . . . 62.13 112.513 173.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.75 -33.82 66.61 Favored 'General case' 0 C--N 1.349 0.562 0 N-CA-C 113.945 1.091 . . . . 71.32 113.945 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.8 pt -80.3 -4.6 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 N-CA-C 113.239 0.829 . . . . 75.3 113.239 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.03 21.69 41.27 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 118.202 -1.332 . . . . 44.11 113.522 167.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.0 mt -63.88 143.78 98.1 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 119.42 1.61 . . . . 72.05 111.212 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.18 143.72 84.66 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.396 2.064 . . . . 64.41 111.56 172.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.06 -22.48 62.73 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.123 1.527 . . . . 74.34 115.123 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.17 -43.16 99.31 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.245 1.018 . . . . 73.54 113.138 169.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.9 mt -72.0 -24.57 61.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.529 1.132 . . . . 75.44 113.621 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.69 -55.39 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 123.58 0.752 . . . . 64.11 111.176 168.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -65.99 -26.5 67.58 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 115.019 1.489 . . . . 53.41 115.019 -174.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.69 -23.15 31.83 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 124.237 0.961 . . . . 75.5 112.454 171.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.68 -23.81 37.99 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-O 118.964 -0.909 . . . . 20.32 112.298 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.13 -35.17 25.8 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 117.54 -1.219 . . . . 72.43 113.609 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -83.08 -49.75 9.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.79 0.723 . . . . 75.45 111.39 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.41 123.62 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.131 0.973 . . . . 62.42 109.263 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.28 107.17 18.38 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.018 -1.104 . . . . 63.21 108.018 171.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.61 165.81 51.95 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 124.612 1.195 . . . . 74.13 111.507 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 78.6 t -102.05 155.37 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.339 1.056 . . . . 70.24 108.697 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 97.6 p -145.42 167.36 23.12 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.599 1.16 . . . . 70.22 109.916 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -161.58 142.26 10.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.466 1.106 . . . . 72.33 108.682 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -129.48 142.12 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.929 -1.508 . . . . 62.45 106.929 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.69 100.96 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.699 -1.223 . . . . 74.23 107.699 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -77.31 129.9 36.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.039 0.936 . . . . 74.34 109.825 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -128.31 51.52 1.98 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.438 1.495 . . . . 73.54 109.282 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.33 -118.44 6.74 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 108.871 -1.692 . . . . 50.4 108.871 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -65.99 -34.71 78.72 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.937 1.295 . . . . 73.31 113.95 172.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -75.73 157.96 32.89 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.073 0.858 . . . . 72.23 111.599 171.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -156.57 125.23 5.85 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.908 -1.515 . . . . 73.35 106.908 -172.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 139.82 46.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.847 1.259 . . . . 75.04 109.103 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.28 132.37 55.29 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.772 1.629 . . . . 70.41 107.535 172.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.92 109.16 10.68 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.689 1.196 . . . . 45.21 108.16 176.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.92 132.75 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.736 1.214 . . . . 74.15 108.185 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.1 m -114.76 111.46 21.29 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.307 1.004 . . . . 51.0 108.984 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.14 76.15 1.89 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.691 1.196 . . . . 75.3 109.432 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.68 -96.95 1.99 Allowed Glycine 0 CA--C 1.531 1.079 0 N-CA-C 108.776 -1.73 . . . . 43.33 108.776 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.3 m -101.88 -40.7 6.79 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.726 1.21 . . . . 73.3 112.574 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -73.02 153.58 40.83 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.079 0.952 . . . . 75.41 112.066 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.21 131.43 67.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 124.536 1.148 . . . . 63.15 109.553 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.2 mt -105.17 134.6 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 126.468 1.907 . . . . 74.53 107.957 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -125.82 124.78 41.7 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.488 1.115 . . . . 63.21 108.38 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -137.71 133.08 33.77 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.552 1.141 . . . . 63.35 108.976 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -116.48 147.67 41.52 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 124.601 1.188 . . . . 73.05 109.711 172.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -150.86 160.66 43.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.102 1.361 . . . . 75.23 110.091 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.2 m -103.47 135.66 44.66 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 124.237 0.961 . . . . 72.31 108.517 169.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.07 119.29 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.948 1.299 . . . . 63.33 111.2 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.92 -13.59 65.89 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 117.967 -1.463 . . . . 75.31 113.326 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -99.11 148.52 23.97 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.522 1.661 . . . . 71.42 110.369 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -69.75 114.44 7.95 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 124.082 0.864 . . . . 72.15 110.793 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.7 m -129.32 151.74 49.63 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.344 1.458 . . . . 74.14 107.689 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -100.96 119.97 39.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.035 0.934 . . . . 74.33 110.276 -174.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.99 134.27 52.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.097 1.359 . . . . 71.33 110.411 -172.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -90.45 147.92 23.1 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.474 1.51 . . . . 63.54 110.336 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.3 p -112.45 178.31 4.34 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.47 1.508 . . . . 60.32 110.231 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -59.99 -29.78 68.69 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.575 1.324 . . . . 75.24 114.575 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.3 p -81.95 -8.21 59.66 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.527 1.531 . . . . 74.02 113.035 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.99 8.12 72.96 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-O 118.363 -1.243 . . . . 62.43 112.581 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -69.97 114.08 7.79 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 119.072 1.436 . . . . 74.34 110.921 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -100.86 121.41 41.67 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 124.943 1.402 . . . . 71.12 109.496 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.42 133.02 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 124.625 1.203 . . . . 71.33 110.877 -172.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -78.21 141.12 38.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.198 1.399 . . . . 75.51 112.177 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.0 t -167.07 153.86 8.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.713 1.205 . . . . 74.2 110.394 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.5 m -90.15 142.42 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.418 1.087 . . . . 42.04 109.431 165.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.56 124.72 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.253 -1.388 . . . . 70.35 107.253 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -135.75 136.81 41.08 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.357 1.063 . . . . 65.02 110.273 -170.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.625 HD23 ' H ' ' A' ' 87' ' ' GLY . 2.7 tt -79.41 129.77 34.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.489 1.115 . . . . 64.15 110.167 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -73.94 -9.5 58.7 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.477 1.911 . . . . 62.4 114.165 -173.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.625 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 92.15 5.72 65.53 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.122 1.344 . . . . 63.34 112.189 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -147.6 57.05 1.11 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.77 1.285 . . . . 62.51 109.358 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 63.8 19.76 11.89 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.821 1.648 . . . . 73.45 114.101 171.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -128.76 142.68 50.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.706 1.602 . . . . 74.52 109.598 -166.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 74.1 mt -114.91 123.26 48.7 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.346 1.058 . . . . 65.32 109.204 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.7 t -104.65 140.14 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.364 1.466 . . . . 61.13 108.902 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 100' ' ' SER . 6.3 t -162.79 135.24 5.5 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.446 1.098 . . . . 63.33 110.084 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 78.5 p -131.36 122.3 26.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.523 1.129 . . . . 75.11 109.403 -176.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -81.9 -66.56 0.87 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.395 1.078 . . . . 65.02 111.221 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -144.14 -52.4 0.32 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.64 1.576 . . . . 65.23 109.491 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -142.8 3.22 1.42 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.577 1.551 . . . . 74.45 112.363 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.428 ' CG1' HD13 ' A' ' 115' ' ' LEU . 78.3 mt -99.73 110.91 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.702 1.601 . . . . 51.44 106.959 174.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -103.63 86.84 2.7 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.934 1.294 . . . . 74.33 109.575 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.432 ' HB2' HG23 ' A' ' 93' ' ' THR . 69.7 m -79.36 127.72 32.44 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.186 1.395 . . . . 52.41 110.764 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.4 t -135.74 102.1 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 108.063 -1.088 . . . . 53.11 108.063 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.7 m -85.89 157.38 20.19 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.461 1.504 . . . . 54.15 110.478 176.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -148.71 143.56 26.52 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.612 1.565 . . . . 73.43 110.987 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.5 tt -129.98 128.03 41.23 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.317 1.447 . . . . 75.03 108.999 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -137.52 77.45 1.64 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.071 1.748 . . . . 71.04 107.604 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.8 -123.9 22.89 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 110.096 -1.202 . . . . 53.43 110.096 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -75.65 -12.33 60.18 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.239 1.415 . . . . 71.13 114.153 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mm -102.95 137.63 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 119.287 0.949 . . . . 60.11 109.534 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.496 HD11 ' CE2' ' A' ' 7' ' ' TYR . 11.2 mm -125.9 140.62 48.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 108.105 -1.072 . . . . 74.23 108.105 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.6 m -135.94 160.73 37.69 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.462 1.505 . . . . 65.21 108.743 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -154.58 147.67 24.72 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.57 1.148 . . . . 75.33 108.618 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.5 m -131.82 108.07 9.18 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 125.115 1.509 . . . . 75.43 108.22 171.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 72.8 mtp -96.21 144.71 26.17 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.826 1.651 . . . . 74.34 108.747 168.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 65.2 m -133.88 108.05 8.2 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.44 -0.948 . . . . 60.32 108.44 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.428 HD13 ' CG1' ' A' ' 98' ' ' ILE . 17.3 tp -111.86 99.36 8.06 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.477 1.511 . . . . 71.2 107.712 175.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.81 -122.82 27.15 Favored Glycine 0 CA--C 1.535 1.281 0 O-C-N 124.726 1.266 . . . . 63.24 110.429 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.87 -17.69 55.19 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.522 1.929 . . . . 71.45 114.48 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 75.9 mt -102.16 140.62 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.604 1.162 . . . . 75.42 110.381 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.4 t -122.76 90.0 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.361 1.064 . . . . 64.21 109.551 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -71.76 124.79 25.55 Favored 'General case' 0 C--N 1.345 0.394 0 C-N-CA 124.451 1.101 . . . . 74.24 111.729 174.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -120.62 148.74 43.5 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.879 1.271 . . . . 63.24 109.344 176.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.72 120.7 7.68 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.482 -0.933 . . . . 62.53 108.482 -166.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -118.83 141.69 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.164 1.386 . . . . 74.22 109.4 -172.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.6 m -144.21 166.62 24.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.232 1.413 . . . . 75.33 111.985 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -139.48 138.9 36.79 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.868 1.267 . . . . 63.23 109.952 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -69.31 131.7 45.27 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.262 2.225 . . . . 72.42 112.563 -174.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.8 mt . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 105.522 -2.029 . . . . 72.13 105.522 -174.238 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 109.499 -0.556 . . . . 72.34 109.499 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -80.16 -27.27 39.01 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.192 1.182 . . . . 74.21 114.192 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.9 m -57.1 111.17 0.98 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.244 1.818 . . . . 75.25 113.376 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.39 160.72 10.81 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.667 -1.373 . . . . 65.11 109.667 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -98.13 146.86 25.15 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 124.551 1.14 . . . . 74.12 110.973 176.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -139.69 146.37 39.56 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.057 1.343 . . . . 74.24 109.519 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -111.29 148.93 31.86 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.48 1.512 . . . . 63.35 109.79 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.78 128.71 37.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.885 1.274 . . . . 71.32 111.128 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -111.15 -50.57 2.93 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.17 1.388 . . . . 65.5 111.501 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.46 167.52 30.19 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.452 1.101 . . . . 73.05 111.27 -173.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -167.51 125.06 1.21 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.652 1.181 . . . . 74.35 110.918 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -111.52 143.99 41.48 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.214 1.406 . . . . 71.15 109.435 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 57.46 38.71 28.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.594 1.958 . . . . 63.12 111.832 -170.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -65.25 -58.39 6.07 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.451 -0.785 . . . . 74.25 111.409 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -62.09 -40.35 95.55 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 113.401 0.889 . . . . 60.04 113.401 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.6 -46.07 91.63 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 124.169 0.988 . . . . 53.45 113.019 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -70.91 -47.78 57.24 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-O 117.633 -1.175 . . . . 70.13 112.898 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.2 mtt -64.27 -35.59 81.35 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 124.926 1.391 . . . . 61.43 113.911 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -71.18 -30.76 66.82 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 118.167 -0.921 . . . . 62.13 113.159 169.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.17 -37.31 61.32 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.357 1.243 . . . . 71.32 114.357 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.549 ' CD1' HD13 ' A' ' 24' ' ' LEU . 41.9 pt -74.18 -12.88 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.877 0.871 . . . . 75.3 113.18 170.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.46 22.54 34.11 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.349 -1.251 . . . . 44.11 112.726 173.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.597 HD11 HG21 ' A' ' 75' ' ' THR . 6.0 mp -72.25 141.2 83.24 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.262 1.531 . . . . 72.05 110.562 172.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.528 ' HD2' HD12 ' A' ' 28' ' ' LEU . 71.8 Cg_endo -65.78 152.37 81.77 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.59 2.193 . . . . 64.41 112.162 176.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -65.94 -20.48 66.23 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.35 1.241 . . . . 74.34 114.35 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.03 -46.12 82.63 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.309 1.044 . . . . 73.54 113.072 171.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 25' ' ' PRO . 74.8 mt -62.85 -30.11 71.25 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.553 1.141 . . . . 75.44 112.813 174.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.1 mt -71.37 -50.86 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.615 1.166 . . . . 64.11 111.781 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -58.72 -50.31 74.36 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 117.817 -1.087 . . . . 53.41 112.958 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -21.14 63.72 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.013 1.116 . . . . 75.5 114.013 174.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.38 -29.21 45.55 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 118.934 -0.926 . . . . 20.32 111.974 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 -29.26 14.05 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.763 1.225 . . . . 72.43 112.897 174.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -71.91 -35.61 69.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 118.022 -0.99 . . . . 75.45 113.432 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.3 mt -113.4 119.12 59.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.079 -1.082 . . . . 62.42 108.079 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -69.48 137.55 52.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.101 0.96 . . . . 63.21 111.55 171.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.16 -179.82 39.7 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 124.687 1.242 . . . . 74.13 110.474 172.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.6 t -130.9 150.23 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 126.047 1.739 . . . . 70.24 107.843 174.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 t -144.83 108.0 4.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.409 0.683 . . . . 70.22 109.965 -170.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -91.96 147.07 23.24 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.061 0.944 . . . . 72.33 110.853 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 mt -132.6 128.02 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 106.29 -1.744 . . . . 62.45 106.29 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.8 t -134.18 127.14 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.021 -1.103 . . . . 74.23 108.021 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -122.16 136.07 54.86 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.013 1.325 . . . . 74.34 108.045 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -148.46 76.65 1.37 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.901 0.881 . . . . 73.54 109.024 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.6 -120.36 8.97 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 108.983 -1.647 . . . . 50.4 108.983 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.4 mmtt -75.67 -32.16 60.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.863 1.265 . . . . 73.31 114.258 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.71 155.83 35.28 Favored 'General case' 0 C--N 1.346 0.421 0 O-C-N 123.918 0.762 . . . . 72.23 112.093 175.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -154.91 128.43 8.52 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 106.989 -1.486 . . . . 73.35 106.989 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -114.37 151.95 32.26 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.707 1.203 . . . . 75.04 109.549 170.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -145.27 128.29 16.52 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.943 -1.503 . . . . 70.41 106.943 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.3 m -116.04 117.77 31.02 Favored 'General case' 0 C--N 1.344 0.352 0 O-C-N 124.511 1.132 . . . . 45.21 109.4 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 mp -97.88 121.56 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.207 1.403 . . . . 74.15 107.485 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.8 m -113.56 109.38 18.54 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.801 -1.185 . . . . 51.0 107.801 173.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.54 -164.01 0.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.705 1.602 . . . . 75.3 111.551 173.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.69 -25.23 70.26 Favored Glycine 0 CA--C 1.542 1.721 0 CA-C-O 118.735 -1.036 . . . . 43.33 113.797 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.5 p -161.85 20.17 0.11 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.357 1.463 . . . . 73.3 113.032 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.68 146.98 52.31 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 125.071 1.349 . . . . 75.41 110.122 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.9 t -124.93 124.02 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.082 -1.081 . . . . 63.15 108.082 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -134.46 123.95 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.101 -1.444 . . . . 74.53 107.101 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.16 149.06 43.36 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.071 0.948 . . . . 63.21 111.064 175.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -133.04 152.59 51.95 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.925 1.69 . . . . 63.35 108.908 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -125.74 142.75 51.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 125.114 1.509 . . . . 73.05 109.034 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -146.5 167.11 24.49 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.901 1.281 . . . . 75.23 109.351 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.8 m -118.38 129.21 55.29 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.557 -1.275 . . . . 72.31 107.557 173.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.02 121.02 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.908 1.283 . . . . 63.33 110.922 -175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.9 -4.37 78.43 Favored Glycine 0 CA--C 1.542 1.75 0 CA-C-O 118.353 -1.248 . . . . 75.31 113.285 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -112.59 137.81 50.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.149 1.78 . . . . 71.42 108.651 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.81 125.96 28.27 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.803 0.689 . . . . 72.15 110.919 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.4 m -138.41 163.4 31.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.58 1.552 . . . . 74.14 108.942 -175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -103.86 125.95 50.64 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.518 0.727 . . . . 74.33 110.023 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.497 HD12 HG21 ' A' ' 81' ' ' THR . 64.7 mt -108.09 127.7 54.03 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.658 1.183 . . . . 71.33 109.393 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -88.34 153.56 21.1 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.589 1.556 . . . . 63.54 110.898 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.2 p -111.14 173.79 6.17 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.645 1.578 . . . . 60.32 111.786 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -60.33 -31.2 70.08 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.512 1.301 . . . . 75.24 114.512 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.597 HG21 HD11 ' A' ' 24' ' ' LEU . 42.5 p -88.73 -7.33 56.46 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.71 1.204 . . . . 74.02 113.248 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.15 9.81 63.14 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.346 -1.252 . . . . 62.43 113.042 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -64.72 146.12 55.22 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 119.254 1.527 . . . . 74.34 110.46 167.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -129.02 124.98 36.32 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.254 -1.017 . . . . 71.12 108.254 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 m -141.51 128.09 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 124.47 1.106 . . . . 71.33 110.8 -171.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -77.32 139.84 39.87 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.384 1.474 . . . . 75.51 111.6 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.497 HG21 HD12 ' A' ' 71' ' ' LEU . 8.3 t -169.61 154.43 5.52 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 124.906 1.379 . . . . 74.2 109.719 -165.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 t -121.28 133.75 66.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.972 -1.121 . . . . 42.04 107.972 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.8 t -106.83 126.53 62.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 108.322 -0.992 . . . . 70.35 108.322 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.31 135.67 53.82 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.347 1.459 . . . . 65.02 110.093 174.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.54 121.06 31.4 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.5 1.125 . . . . 64.15 108.958 169.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.509 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 6.5 tt0 -81.87 -168.57 1.97 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.002 1.321 . . . . 62.4 111.217 174.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.509 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -93.41 11.08 72.25 Favored Glycine 0 CA--C 1.539 1.571 0 CA-C-O 117.71 -1.606 . . . . 63.34 113.353 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -140.48 44.93 1.85 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.725 1.763 . . . . 62.51 110.925 -173.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 65.3 21.36 11.99 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.052 1.341 . . . . 73.45 113.395 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -120.98 126.5 50.11 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.918 1.287 . . . . 74.52 110.674 -164.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.0 mt -101.53 109.28 21.06 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 124.671 1.232 . . . . 65.32 109.1 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 86.6 t -95.99 132.63 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.86 1.264 . . . . 61.13 108.759 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.6 t -154.55 148.78 25.97 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 124.07 0.856 . . . . 63.33 110.977 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.4 p -147.26 133.38 19.33 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.786 1.234 . . . . 75.11 110.0 -173.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -93.53 -77.17 0.46 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.598 1.559 . . . . 65.02 109.727 -176.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -128.5 -58.85 1.17 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.066 1.747 . . . . 65.23 108.843 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -144.52 8.42 1.34 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.005 1.722 . . . . 74.45 112.223 -175.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.521 HG13 HD13 ' A' ' 115' ' ' LEU . 4.5 mp -103.56 115.89 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.297 -1.371 . . . . 51.44 107.297 177.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -103.18 91.13 3.96 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 124.629 1.206 . . . . 74.33 108.962 -173.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.7 p -100.43 112.53 24.89 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.336 1.454 . . . . 52.41 111.927 -174.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.3 t -114.85 106.91 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.409 1.884 . . . . 53.11 107.794 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.5 m -84.32 151.51 24.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.716 1.206 . . . . 54.15 109.863 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -146.4 130.66 17.52 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.444 1.497 . . . . 73.43 109.164 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.3 tt -111.39 128.42 55.97 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.76 1.224 . . . . 75.03 108.079 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -130.26 82.32 2.06 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.348 1.859 . . . . 71.04 106.51 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.42 -117.42 10.62 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.495 -1.042 . . . . 53.43 110.495 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -85.78 9.59 16.1 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.014 1.726 . . . . 71.13 113.81 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.3 mm -122.61 134.23 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.53 1.132 . . . . 60.11 109.114 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.92 137.84 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.701 -1.222 . . . . 74.23 107.701 170.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.4 m -131.77 116.51 17.36 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.201 -1.407 . . . . 65.21 107.201 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.79 137.98 48.99 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.575 -0.898 . . . . 75.33 108.575 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 99.1 m -133.29 112.89 12.03 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 124.795 1.31 . . . . 75.43 108.247 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 33.1 mtp -111.04 146.87 35.96 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 126.0 1.72 . . . . 74.34 109.181 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.2 m -138.93 98.6 3.57 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 124.41 1.069 . . . . 60.32 109.258 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.521 HD13 HG13 ' A' ' 98' ' ' ILE . 9.2 tp -104.4 112.06 24.95 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.537 1.535 . . . . 71.2 108.354 174.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.43 -114.71 6.78 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 124.729 1.268 . . . . 63.24 110.871 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.54 8.0 44.85 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.452 1.901 . . . . 71.45 113.469 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.9 mp -124.16 143.17 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.689 1.195 . . . . 75.42 109.594 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.5 t -126.95 94.41 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.079 0.952 . . . . 64.21 110.297 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -75.83 132.61 40.48 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 123.677 0.791 . . . . 74.24 111.035 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -122.62 149.67 43.68 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 124.339 1.025 . . . . 63.24 109.499 173.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.13 133.64 23.43 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.043 1.337 . . . . 62.53 108.368 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -124.86 137.01 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.892 1.277 . . . . 74.22 108.053 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.1 m -137.98 156.86 47.4 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.691 1.196 . . . . 75.33 110.563 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -126.44 146.42 50.09 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.53 1.532 . . . . 63.23 109.744 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.3 tpp85 -56.92 142.15 42.52 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.459 2.303 . . . . 72.42 112.98 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 105.883 -1.895 . . . . 72.13 105.883 -175.814 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 110.067 -0.346 . . . . 72.34 110.067 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -63.74 -25.23 68.1 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.18 1.548 . . . . 74.21 115.18 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.5 p -57.65 119.58 6.85 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.244 1.817 . . . . 75.25 113.679 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.04 164.97 13.23 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 110.689 -0.964 . . . . 65.11 110.689 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.49 ' HB3' HD12 ' A' ' 127' ' ' ILE . 2.5 mtmt -95.14 147.87 22.98 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.639 1.576 . . . . 74.12 111.68 173.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -143.08 133.91 25.36 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.032 1.333 . . . . 74.24 109.798 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -102.16 150.54 23.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.786 1.234 . . . . 63.35 110.267 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.89 128.97 38.35 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.101 1.36 . . . . 71.32 111.096 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -113.54 -51.58 2.8 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 124.796 1.238 . . . . 65.5 111.64 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -152.92 168.27 26.37 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.489 1.118 . . . . 73.05 111.259 -170.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -165.39 145.35 6.8 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.787 1.235 . . . . 74.35 111.049 -170.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -139.84 146.82 39.84 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.947 1.299 . . . . 71.15 109.508 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 55.12 27.68 9.87 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.513 1.925 . . . . 63.12 113.035 -173.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -63.43 -60.32 3.52 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-O 118.078 -0.963 . . . . 74.25 111.58 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -60.34 -41.87 94.49 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 124.281 0.988 . . . . 60.04 113.041 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.75 -48.93 71.99 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.556 1.143 . . . . 53.45 113.397 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -66.68 -47.2 73.2 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.193 1.397 . . . . 70.13 113.072 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.8 mmt -68.64 -39.63 80.63 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.545 1.138 . . . . 61.43 113.105 -175.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.497 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.3 mptm? -66.34 -34.13 77.28 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.932 0.893 . . . . 62.13 112.637 169.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.7 -34.9 67.45 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 114.415 1.265 . . . . 71.32 114.415 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.0 pt -77.67 -9.79 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 113.143 0.794 . . . . 75.3 113.143 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.19 26.71 20.62 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.235 -1.314 . . . . 44.11 112.988 168.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 75' ' ' THR . 79.1 mt -69.3 151.78 96.8 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 119.351 1.575 . . . . 72.05 111.711 172.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -69.88 147.72 62.7 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.192 1.928 . . . . 64.41 111.538 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.404 ' HA ' HD12 ' A' ' 29' ' ' ILE . 63.0 tt0 -54.75 -30.91 57.67 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.025 1.33 . . . . 74.34 114.484 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -63.08 -45.57 91.5 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 117.877 -1.059 . . . . 73.54 113.702 175.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.0 mt -65.66 -26.88 67.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.186 0.994 . . . . 75.44 113.429 174.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.497 HD13 ' HD2' ' A' ' 20' ' ' LYS . 54.1 mt -78.79 -50.95 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.162 0.985 . . . . 64.11 110.677 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -62.48 -40.92 98.23 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 117.731 -1.128 . . . . 53.41 113.622 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -28.91 64.29 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.425 -0.797 . . . . 75.5 112.61 172.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.14 -31.53 57.39 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-O 118.957 -0.913 . . . . 20.32 112.617 -174.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -30.46 16.49 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.418 1.087 . . . . 72.43 112.945 173.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.79 -50.95 21.07 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.385 1.074 . . . . 75.45 111.063 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.1 mm -88.03 126.81 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 O-C-N 124.337 1.023 . . . . 62.42 109.196 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -82.61 135.19 35.12 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.265 0.978 . . . . 63.21 110.19 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.62 -171.16 34.49 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 109.829 -1.308 . . . . 74.13 109.829 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 76.0 t -135.3 161.94 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 126.342 1.857 . . . . 70.24 108.86 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.2 t -145.63 157.66 43.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.277 1.031 . . . . 70.22 110.125 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -137.74 131.4 31.23 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 108.422 -0.955 . . . . 72.33 108.422 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.3 mt -110.63 130.94 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 106.112 -1.811 . . . . 62.45 106.112 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.4 t -134.2 124.99 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.0 0.92 . . . . 74.23 108.569 -173.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -114.14 131.67 56.34 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.815 1.246 . . . . 74.34 108.994 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -133.55 52.86 2.05 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.243 1.417 . . . . 73.54 109.806 -174.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.65 -115.01 5.12 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 108.742 -1.743 . . . . 50.4 108.742 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -71.88 -38.1 70.07 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.961 1.097 . . . . 73.31 113.961 173.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.19 158.62 33.82 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 124.124 0.89 . . . . 72.23 111.864 172.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -158.63 135.5 9.68 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 106.217 -1.772 . . . . 73.35 106.217 -173.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -121.0 154.79 35.56 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.95 0.781 . . . . 75.04 110.089 171.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -137.38 125.26 22.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 124.532 1.145 . . . . 70.41 108.836 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.4 m -107.23 125.03 50.61 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.893 1.677 . . . . 45.21 108.166 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.8 mt -121.37 116.09 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.003 -1.11 . . . . 74.15 108.003 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -113.66 114.01 25.81 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 124.385 1.053 . . . . 51.0 110.073 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -146.93 145.73 29.89 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.834 0.853 . . . . 75.3 110.33 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.97 -90.9 0.59 Allowed Glycine 0 CA--C 1.532 1.102 0 N-CA-C 109.504 -1.438 . . . . 43.33 109.504 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.2 t -156.33 42.15 0.38 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.14 1.376 . . . . 73.3 110.155 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -154.23 159.77 41.49 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.273 1.029 . . . . 75.41 111.48 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.6 t -127.63 131.41 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 125.443 1.497 . . . . 63.15 109.222 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.2 mt -115.91 113.36 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.32 1.448 . . . . 74.53 108.363 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.22 119.91 40.47 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.198 -1.038 . . . . 63.21 108.198 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -114.13 166.01 12.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.413 1.085 . . . . 63.35 110.096 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -141.34 140.95 33.86 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.224 1.01 . . . . 73.05 109.732 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -151.19 152.6 33.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.99 1.316 . . . . 75.23 109.871 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.9 m -100.7 132.73 45.94 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.498 -0.927 . . . . 72.31 108.498 171.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.19 112.33 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.313 1.045 . . . . 63.33 110.654 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.83 -14.68 49.26 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.053 -1.415 . . . . 75.31 112.712 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -99.98 145.11 28.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.501 1.65 . . . . 71.42 110.461 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -66.99 127.53 32.93 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.129 1.371 . . . . 72.15 111.379 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.5 m -148.65 153.7 38.66 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.293 1.437 . . . . 74.14 109.332 -175.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -92.94 123.66 36.36 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.59 0.756 . . . . 74.33 110.649 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.5 138.5 40.79 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.279 1.432 . . . . 71.33 109.121 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -103.88 139.33 39.21 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.496 1.519 . . . . 63.54 109.68 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.4 m -88.25 163.93 15.87 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.399 1.48 . . . . 60.32 110.889 173.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 74.7 mtm -54.49 -29.16 49.34 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.729 1.381 . . . . 75.24 114.729 169.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.516 HG21 HD21 ' A' ' 24' ' ' LEU . 47.0 p -85.57 -10.89 55.28 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.916 2.086 . . . . 74.02 113.306 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.84 4.33 60.36 Favored Glycine 0 CA--C 1.538 1.524 0 CA-C-O 118.149 -1.362 . . . . 62.43 113.215 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -65.52 121.25 14.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.428 1.614 . . . . 74.34 110.442 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -108.21 129.3 55.2 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.06 0.85 . . . . 71.12 109.65 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.55 131.83 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.594 1.157 . . . . 71.33 111.124 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -75.09 125.94 29.99 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.356 1.462 . . . . 75.51 110.694 174.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.4 t -151.4 164.13 37.41 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.576 1.551 . . . . 74.2 109.642 -172.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.15 130.89 66.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.033 -1.099 . . . . 42.04 108.033 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.8 t -103.22 128.26 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 124.095 0.872 . . . . 70.35 109.313 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -114.55 171.4 7.65 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.968 2.107 . . . . 65.02 110.295 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.473 HD13 ' H ' ' A' ' 87' ' ' GLY . 1.7 tm? -131.52 124.17 29.55 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.134 -1.432 . . . . 64.15 107.134 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.71 13.89 3.52 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.466 1.284 . . . . 62.4 114.466 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.473 ' H ' HD13 ' A' ' 85' ' ' LEU . . . 74.71 13.79 81.88 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.371 1.462 . . . . 63.34 113.014 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -145.08 51.8 1.22 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.573 1.187 . . . . 62.51 109.978 -169.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.276 0.5 OUTLIER 51.65 30.85 7.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.437 1.895 . . . . 73.45 115.171 175.369 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -140.56 120.93 14.02 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.877 1.271 . . . . 74.52 108.822 -167.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.6 mt -91.92 118.68 30.98 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.148 0.979 . . . . 65.32 109.293 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 91.7 t -101.72 126.37 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.11 1.364 . . . . 61.13 108.819 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.5 m -141.22 149.88 41.96 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.143 0.977 . . . . 63.33 109.373 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.6 p -147.0 138.71 24.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.791 0.836 . . . . 75.11 109.922 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -98.08 -79.61 0.47 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.729 1.611 . . . . 65.02 108.892 -176.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -136.37 -44.7 0.62 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.923 1.289 . . . . 65.23 109.734 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -150.02 8.76 0.65 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.177 1.391 . . . . 74.45 112.64 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.466 HG13 HD13 ' A' ' 115' ' ' LEU . 4.4 mp -109.18 116.12 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.698 1.199 . . . . 51.44 107.769 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.2 tmtp? -98.2 87.81 4.02 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.056 1.342 . . . . 74.33 109.232 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.4 t -74.97 127.82 34.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.132 1.373 . . . . 52.41 111.743 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.6 t -138.24 95.98 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.698 1.599 . . . . 53.11 107.579 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 87.3 m -82.32 155.72 24.64 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.073 1.349 . . . . 54.15 110.285 173.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -145.37 141.64 28.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.422 1.489 . . . . 73.43 109.84 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 tp -119.46 124.14 45.76 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.945 2.098 . . . . 75.03 107.155 172.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -131.18 81.7 2.0 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 106.285 -1.746 . . . . 71.04 106.285 171.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.79 -116.82 9.69 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.946 1.26 . . . . 53.43 110.631 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -80.49 -0.98 39.77 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.977 1.311 . . . . 71.13 114.37 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.8 mm -115.55 131.91 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 119.466 1.03 . . . . 60.11 109.437 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.9 mm -108.84 138.23 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 125.095 1.358 . . . . 74.23 108.122 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.9 m -133.41 110.97 10.37 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 124.629 1.206 . . . . 65.21 107.751 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.9 135.67 45.82 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.912 -0.773 . . . . 75.33 108.912 175.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.4 m -131.76 117.65 18.87 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.845 1.258 . . . . 75.43 108.454 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -110.09 149.93 29.32 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.155 1.382 . . . . 74.34 109.456 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.9 m -133.34 98.93 4.37 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.194 0.934 . . . . 60.32 109.378 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.466 HD13 HG13 ' A' ' 98' ' ' ILE . 8.9 tp -102.01 109.79 21.6 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 125.175 1.39 . . . . 71.2 108.732 174.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.47 -114.86 6.94 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 124.864 1.353 . . . . 63.24 110.777 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.11 -0.74 53.17 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.583 1.953 . . . . 71.45 113.926 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.0 mt -118.06 143.5 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.813 1.245 . . . . 75.42 110.113 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.5 t -125.33 95.17 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.915 0.886 . . . . 64.21 110.053 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -70.86 137.68 49.6 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.833 1.653 . . . . 74.24 112.628 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -124.83 151.87 44.67 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.394 1.077 . . . . 63.24 111.253 170.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.8 mmt-85 -138.87 136.65 35.78 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.781 2.032 . . . . 62.53 108.111 172.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.35 133.72 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.522 -1.288 . . . . 74.22 107.522 173.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.4 m -137.34 156.76 47.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.866 1.266 . . . . 75.33 109.67 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -134.39 144.71 48.35 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.471 1.108 . . . . 63.23 110.657 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.8 ttp85 -64.11 143.61 57.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.352 1.861 . . . . 72.42 114.014 -170.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 6' ' ' LYS . 15.3 mt . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 105.462 -2.051 . . . . 72.13 105.462 -172.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 108.653 -0.869 . . . . 72.34 108.653 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.434 ' HA ' HD22 ' A' ' 104' ' ' LEU . 27.5 m-85 -60.99 -34.55 74.97 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.469 1.507 . . . . 74.21 114.538 172.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 t -58.98 123.46 16.65 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.806 1.642 . . . . 75.25 113.295 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.66 164.79 13.25 Favored Glycine 0 CA--C 1.539 1.563 0 O-C-N 124.419 1.074 . . . . 65.11 110.529 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HB3' HD12 ' A' ' 127' ' ' ILE . 1.4 mmmt -98.97 148.3 24.13 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.031 1.732 . . . . 74.12 111.356 174.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -142.98 155.44 44.68 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.177 1.391 . . . . 74.24 109.528 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -127.14 144.04 51.12 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.527 -0.916 . . . . 63.35 108.527 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 36' ' ' LYS . 58.2 tp -56.66 134.83 54.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.696 1.198 . . . . 71.32 111.742 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -115.46 -51.42 2.69 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 124.798 1.311 . . . . 65.5 110.116 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 t -159.66 162.68 35.18 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 124.409 1.068 . . . . 73.05 110.185 -173.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -155.78 159.82 39.75 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.554 1.542 . . . . 74.35 111.349 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -137.84 142.18 40.77 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.138 1.375 . . . . 71.15 108.619 176.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 57.4 28.33 15.22 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.276 1.831 . . . . 63.12 113.167 -174.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.67 -57.92 9.32 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.058 0.943 . . . . 74.25 112.163 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -52.69 -50.01 64.15 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.313 1.845 . . . . 60.04 112.348 173.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.91 -47.11 86.19 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.14 1.376 . . . . 53.45 113.956 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -69.43 -46.29 67.13 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 124.787 1.235 . . . . 70.13 113.567 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.5 mmt -65.81 -37.93 87.59 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 124.729 1.268 . . . . 61.43 112.975 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.465 ' HD3' HD13 ' A' ' 29' ' ' ILE . 8.1 mmmm -71.94 -27.09 62.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.103 0.961 . . . . 62.13 112.482 171.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.03 -37.47 58.32 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.556 1.142 . . . . 71.32 113.721 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.9 pt -78.24 -8.27 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 113.391 0.886 . . . . 75.3 113.391 170.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.8 31.46 26.59 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.509 -1.162 . . . . 44.11 112.547 169.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.31 153.06 93.37 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 118.861 1.33 . . . . 72.05 111.704 173.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.7 142.22 69.45 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.18 1.92 . . . . 64.41 111.407 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -59.02 -24.84 63.16 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.514 1.301 . . . . 74.34 114.514 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -62.66 -47.23 84.59 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 117.266 -1.349 . . . . 73.54 113.55 171.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.2 mt -63.67 -28.04 69.63 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.306 1.042 . . . . 75.44 113.693 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.465 HD13 ' HD3' ' A' ' 20' ' ' LYS . 15.4 mt -76.95 -52.64 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.322 1.049 . . . . 64.11 111.394 176.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -62.7 -41.08 98.94 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 117.576 -1.202 . . . . 53.41 113.335 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -25.61 61.21 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 118.216 -0.897 . . . . 75.5 113.171 172.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.83 -32.28 50.48 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.148 -0.807 . . . . 20.32 111.978 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.0 -31.57 16.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.677 1.191 . . . . 72.43 113.066 173.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -72.27 -54.4 9.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.686 1.194 . . . . 75.45 110.854 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.9 mm -94.22 125.63 46.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 124.346 1.029 . . . . 62.42 108.636 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.498 ' HA ' HD23 ' A' ' 9' ' ' LEU . 13.7 mptt -73.79 104.75 4.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.452 1.101 . . . . 63.21 110.284 170.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.0 158.1 51.82 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 124.497 1.123 . . . . 74.13 110.592 176.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.3 t -100.91 152.19 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.119 0.968 . . . . 70.24 109.257 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.7 t -130.3 155.58 46.08 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.109 1.764 . . . . 70.22 108.563 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -158.05 143.25 16.7 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.493 -0.558 . . . . 72.33 109.493 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.407 HG12 ' CE1' ' A' ' 50' ' ' PHE . 11.3 mt -134.76 133.44 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 106.077 -1.823 . . . . 62.45 106.077 -173.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.2 t -140.34 98.92 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 107.81 -1.181 . . . . 74.23 107.81 -175.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -82.37 133.14 35.22 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.667 1.187 . . . . 74.34 109.928 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -133.81 54.32 1.96 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.941 1.297 . . . . 73.54 110.153 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.9 -111.92 3.61 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 109.156 -1.578 . . . . 50.4 109.156 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -77.34 -33.03 55.5 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.373 1.069 . . . . 73.31 113.813 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.56 154.7 34.26 Favored 'General case' 0 C--N 1.346 0.421 0 O-C-N 124.147 0.904 . . . . 72.23 111.267 172.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -144.99 135.16 23.98 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.49 -1.67 . . . . 73.35 106.49 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -123.27 152.66 41.13 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.229 1.411 . . . . 75.04 110.058 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.407 ' CE1' HG12 ' A' ' 41' ' ' ILE . 8.0 t80 -143.24 135.35 26.98 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.231 -1.396 . . . . 70.41 107.231 177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 m -123.1 107.26 11.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.529 1.131 . . . . 45.21 109.633 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.5 mt -95.31 136.38 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.609 1.164 . . . . 74.15 108.544 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.2 m -123.09 125.49 45.28 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.478 1.111 . . . . 51.0 108.763 172.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.74 70.73 0.72 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.292 1.037 . . . . 75.3 108.813 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.44 -37.86 1.83 Allowed Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.85 1.69 . . . . 43.33 113.894 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.0 p -157.05 -45.39 0.07 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.131 1.466 . . . . 73.3 112.137 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.99 139.28 48.53 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.27 1.028 . . . . 75.41 110.823 171.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.96 136.4 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 124.541 1.15 . . . . 63.15 109.315 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.6 mt -125.76 124.19 65.97 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 C-N-CA 124.669 1.188 . . . . 74.53 109.067 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -109.24 124.0 50.17 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 125.206 1.566 . . . . 63.21 107.749 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -122.09 144.82 48.69 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.976 1.31 . . . . 63.35 108.685 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -135.23 143.27 46.25 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 125.019 1.449 . . . . 73.05 109.407 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.76 162.74 40.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.509 1.123 . . . . 75.23 110.022 175.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.1 m -108.59 130.04 55.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.391 1.076 . . . . 72.31 108.35 172.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.9 116.82 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.239 1.016 . . . . 63.33 110.439 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.74 -8.16 39.53 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.006 -1.441 . . . . 75.31 112.413 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -121.32 154.01 36.97 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 119.155 1.478 . . . . 71.42 111.065 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.39 131.86 39.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.913 1.685 . . . . 72.15 110.422 174.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.8 m -143.32 156.69 44.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.442 1.497 . . . . 74.14 108.416 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -95.62 123.89 39.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.701 0.8 . . . . 74.33 110.289 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.01 135.27 51.12 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.193 1.797 . . . . 71.33 109.176 -174.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -100.26 145.22 28.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.355 1.462 . . . . 63.54 111.82 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.3 p -104.82 174.35 5.92 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.107 1.763 . . . . 60.32 112.069 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -54.8 -34.96 63.35 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.471 1.656 . . . . 75.24 115.471 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.5 p -91.47 -5.44 54.25 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.616 1.566 . . . . 74.02 112.983 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.27 13.35 54.48 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 118.337 -1.257 . . . . 62.43 112.954 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -65.38 130.02 41.81 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.188 1.494 . . . . 74.34 109.995 173.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.5 mtpt -114.57 120.27 39.63 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.488 -0.93 . . . . 71.12 108.488 -174.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 m -138.68 128.45 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.903 1.281 . . . . 71.33 111.226 -170.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.86 135.9 40.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.525 1.13 . . . . 75.51 112.296 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 t -161.49 151.9 17.59 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.295 1.438 . . . . 74.2 110.181 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.99 136.41 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.621 1.168 . . . . 42.04 107.958 170.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -106.77 132.24 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 108.249 -1.019 . . . . 70.35 108.249 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -132.04 147.73 52.46 Favored 'General case' 0 C--N 1.345 0.373 0 C-N-CA 124.94 1.296 . . . . 65.02 112.646 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.842 HD23 ' H ' ' A' ' 87' ' ' GLY . 3.3 tt -109.44 128.43 55.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.693 1.597 . . . . 64.15 109.094 -174.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.47 11.59 21.23 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.164 1.385 . . . . 62.4 114.134 -176.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.842 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 81.21 -1.52 84.81 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.833 1.682 . . . . 63.34 113.137 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -121.94 38.19 4.18 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.747 1.619 . . . . 62.51 111.63 -168.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.326 0.3 OUTLIER 52.38 41.23 30.57 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.572 1.949 . . . . 73.45 113.917 178.753 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -138.81 141.91 38.72 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.263 1.825 . . . . 74.52 108.353 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.2 mt -121.63 119.43 31.84 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 124.302 1.001 . . . . 65.32 110.245 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -102.36 133.81 44.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.271 1.428 . . . . 61.13 108.883 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 t -153.03 135.67 15.25 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.457 1.103 . . . . 63.33 110.576 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.9 p -137.86 126.49 23.66 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.005 1.322 . . . . 75.11 110.155 -172.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -92.27 -61.26 1.65 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.917 1.287 . . . . 65.02 110.145 -175.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -143.15 -70.12 0.33 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.263 1.425 . . . . 65.23 108.43 -174.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -123.77 -20.58 5.41 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.977 1.711 . . . . 74.45 111.186 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.57 HG13 HD13 ' A' ' 115' ' ' LEU . 4.3 mp -79.32 121.78 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.71 1.204 . . . . 51.44 109.275 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -112.28 93.31 4.38 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.108 1.363 . . . . 74.33 108.722 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.2 t -95.09 112.3 24.02 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.872 1.669 . . . . 52.41 110.205 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.4 t -113.82 116.33 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.143 1.377 . . . . 53.11 108.347 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.0 m -94.72 152.54 18.37 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.812 1.645 . . . . 54.15 109.92 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -145.17 140.9 28.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.799 1.64 . . . . 73.43 109.383 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 3' ' ' PHE . 13.6 tp -122.36 126.46 48.09 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.292 1.837 . . . . 75.03 107.05 173.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -133.49 87.18 2.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.552 1.941 . . . . 71.04 106.84 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.94 -114.79 6.88 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 110.58 -1.008 . . . . 53.43 110.58 175.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.56 3.69 49.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.424 1.49 . . . . 71.13 113.798 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.7 mm -116.27 131.68 68.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.282 0.946 . . . . 60.11 109.054 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 42.9 mm -106.38 136.12 42.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.264 0 N-CA-C 107.527 -1.286 . . . . 74.23 107.527 168.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.9 m -123.27 137.66 54.81 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.168 -1.419 . . . . 65.21 107.168 172.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.71 135.09 41.72 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.405 -0.961 . . . . 75.33 108.405 176.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 90.7 m -132.81 116.03 16.03 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.605 1.191 . . . . 75.43 108.547 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 94.0 mtp -107.62 142.37 37.67 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.431 1.492 . . . . 74.34 108.935 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.7 m -132.58 108.25 8.96 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.288 0.993 . . . . 60.32 108.639 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.57 HD13 HG13 ' A' ' 98' ' ' ILE . 12.8 tp -121.1 112.76 19.1 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.529 1.531 . . . . 71.2 108.117 177.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.3 -118.61 15.47 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 124.657 1.223 . . . . 63.24 110.129 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.47 3.92 50.64 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.502 1.521 . . . . 71.45 113.114 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mp -111.45 135.43 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.056 0.942 . . . . 75.42 109.273 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.14 96.08 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.035 0.934 . . . . 64.21 109.421 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -76.34 131.05 38.94 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.636 1.574 . . . . 74.24 112.193 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -113.67 152.52 30.33 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.601 1.161 . . . . 63.24 109.825 167.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -150.48 138.65 20.25 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.837 1.255 . . . . 62.53 109.038 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -130.22 137.05 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.82 1.248 . . . . 74.22 108.534 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 42.3 m -132.2 160.99 34.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.285 1.434 . . . . 75.33 110.273 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -136.2 144.46 44.94 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.799 1.24 . . . . 63.23 110.227 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -62.63 139.05 58.63 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 126.136 1.775 . . . . 72.42 113.765 -171.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 6' ' ' LYS . 23.1 mt . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 105.776 -1.935 . . . . 72.13 105.776 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 108.583 -0.895 . . . . 72.34 108.583 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -62.6 -27.7 69.37 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 115.355 1.613 . . . . 74.21 115.355 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.0 p -58.3 119.95 7.83 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.565 1.546 . . . . 75.25 113.974 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.08 160.32 9.48 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 110.121 -1.192 . . . . 65.11 110.121 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HB3' HD12 ' A' ' 127' ' ' ILE . 6.2 mtmt -92.39 149.25 21.52 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.82 1.248 . . . . 74.12 112.072 172.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -139.89 152.08 46.14 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.622 1.569 . . . . 74.24 109.353 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -125.1 148.13 48.69 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.264 1.425 . . . . 63.35 109.297 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.2 129.96 42.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.167 0.987 . . . . 71.32 111.722 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -114.24 -50.42 2.81 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.655 1.582 . . . . 65.5 111.23 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.8 t -152.7 170.58 19.9 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 124.259 0.974 . . . . 73.05 110.804 -171.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -167.83 149.94 5.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.148 1.379 . . . . 74.35 111.412 -166.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -142.47 140.69 31.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.203 1.401 . . . . 71.15 108.673 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 57.52 26.59 12.91 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.465 1.906 . . . . 63.12 113.952 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -62.48 -56.36 18.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.089 0.955 . . . . 74.25 112.263 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -49.91 -55.44 14.42 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.971 1.708 . . . . 60.04 111.996 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.1 -51.22 64.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.067 1.747 . . . . 53.45 114.351 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -67.39 -45.59 75.75 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.379 1.072 . . . . 70.13 113.377 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.4 mmt -68.35 -35.61 78.01 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 124.76 1.287 . . . . 61.43 112.666 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.7 mptm? -64.27 -36.0 82.67 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.809 0.843 . . . . 62.13 113.138 167.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.52 -35.82 60.65 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 114.679 1.363 . . . . 71.32 114.679 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.46 ' CD1' HD13 ' A' ' 24' ' ' LEU . 42.5 pt -76.28 -10.56 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.679 0.792 . . . . 75.3 113.108 170.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.4 27.07 26.15 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 118.41 -1.216 . . . . 44.11 112.862 170.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.525 HD11 ' CG2' ' A' ' 75' ' ' THR . 4.5 mp -67.58 147.26 98.74 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 119.112 1.456 . . . . 72.05 111.159 173.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -66.77 145.97 76.93 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.162 1.908 . . . . 64.41 111.433 172.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.463 ' HA ' HD12 ' A' ' 29' ' ' ILE . 42.5 tt0 -55.78 -29.2 59.25 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.47 1.285 . . . . 74.34 114.47 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -63.56 -45.42 90.57 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 117.772 -1.109 . . . . 73.54 113.827 174.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.2 mt -64.6 -27.41 68.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.227 1.011 . . . . 75.44 113.339 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.516 HD13 ' HD2' ' A' ' 20' ' ' LYS . 42.8 mt -77.93 -54.98 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.221 1.008 . . . . 64.11 110.09 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -58.9 -40.79 85.54 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.951 1.093 . . . . 53.41 113.951 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -29.44 62.7 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 118.431 -0.795 . . . . 75.5 112.732 173.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.69 -21.43 71.95 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-O 118.715 -1.047 . . . . 20.32 112.787 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -102.02 -24.98 13.91 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 124.661 1.184 . . . . 72.43 113.14 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -68.94 -52.6 27.54 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.941 1.296 . . . . 75.45 110.687 172.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.1 mm -96.39 137.06 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.755 1.222 . . . . 62.42 109.431 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -90.87 126.77 36.14 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.723 1.209 . . . . 63.21 110.042 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.37 175.97 46.36 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 124.475 1.109 . . . . 74.13 110.707 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.26 151.3 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.546 1.538 . . . . 70.24 108.213 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.3 t -148.82 105.53 3.57 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.852 0.861 . . . . 70.22 109.771 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -81.19 143.5 32.3 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 125.081 1.352 . . . . 72.33 110.801 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.41 HG12 ' CE1' ' A' ' 50' ' ' PHE . 13.8 mt -127.0 132.02 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 107.178 -1.415 . . . . 62.45 107.178 174.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.4 m -139.34 143.32 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.126 0.57 . . . . 74.23 109.931 172.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -121.73 128.24 51.57 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.219 1.808 . . . . 74.34 106.913 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -139.89 77.81 1.63 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.032 0.933 . . . . 73.54 108.891 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.18 -121.54 10.39 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 108.741 -1.744 . . . . 50.4 108.741 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -79.37 -26.66 41.98 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.387 1.254 . . . . 73.31 114.387 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.9 154.38 28.38 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 123.876 0.87 . . . . 72.23 111.442 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -146.02 134.11 21.55 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.834 -1.543 . . . . 73.35 106.834 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -123.01 159.14 29.0 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.302 1.041 . . . . 75.04 110.122 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.41 ' CE1' HG12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -151.47 123.12 7.95 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.076 1.35 . . . . 70.41 108.687 -174.813 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -119.81 107.13 12.8 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.271 1.029 . . . . 45.21 108.994 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.17 117.34 54.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.322 1.049 . . . . 74.15 108.708 -173.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.4 m -99.0 133.01 43.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.973 1.309 . . . . 51.0 109.089 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.25 81.17 1.87 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.645 1.178 . . . . 75.3 109.035 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.08 -79.36 1.92 Allowed Glycine 0 CA--C 1.531 1.045 0 N-CA-C 109.412 -1.475 . . . . 43.33 109.412 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 t -136.3 -30.04 0.95 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.847 1.259 . . . . 73.3 112.06 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -73.12 139.41 46.41 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 123.656 0.782 . . . . 75.41 110.837 170.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.01 117.64 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.002 -1.11 . . . . 63.15 108.002 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.0 mt -107.15 124.41 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.582 -1.266 . . . . 74.53 107.582 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -108.4 128.85 55.13 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 124.696 1.248 . . . . 63.21 108.703 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -132.58 154.12 50.34 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.144 1.378 . . . . 63.35 108.787 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.84 148.98 25.92 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 124.421 1.076 . . . . 73.05 109.969 -173.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -156.96 154.07 29.08 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 124.668 1.23 . . . . 75.23 110.267 -175.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -96.24 129.96 43.44 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.631 1.207 . . . . 72.31 108.307 170.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.87 125.39 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.37 1.068 . . . . 63.33 110.515 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.69 -35.02 5.2 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 118.381 -1.233 . . . . 75.31 111.553 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -97.4 143.18 28.39 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 118.861 1.33 . . . . 71.42 111.762 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.72 126.55 30.07 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.71 1.604 . . . . 72.15 111.067 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.4 m -141.79 153.29 44.44 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.853 1.261 . . . . 74.14 108.78 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.48 120.15 37.34 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.826 1.25 . . . . 74.33 108.761 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.43 HD23 HG22 ' A' ' 81' ' ' THR . 2.9 mm? -111.37 116.15 30.48 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 124.415 1.086 . . . . 71.33 109.031 -176.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -76.04 152.21 36.95 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 124.548 1.155 . . . . 63.54 111.084 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.1 p -114.94 179.67 3.88 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.795 1.638 . . . . 60.32 109.929 173.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 43.7 mtm -56.26 -29.23 60.83 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.811 1.782 . . . . 75.24 115.811 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.525 ' CG2' HD11 ' A' ' 24' ' ' LEU . 63.2 p -86.24 -13.03 48.03 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.507 1.523 . . . . 74.02 113.325 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.53 -1.9 60.42 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 118.287 -1.285 . . . . 62.43 112.074 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -67.68 115.06 6.83 Favored 'General case' 0 C--N 1.349 0.547 0 CA-C-N 119.294 1.547 . . . . 74.34 110.984 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -111.8 136.0 51.66 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 124.791 1.307 . . . . 71.12 109.361 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.96 128.64 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.827 1.251 . . . . 71.33 110.316 -169.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.54 128.83 38.05 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 124.44 1.088 . . . . 75.51 111.939 174.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.43 HG22 HD23 ' A' ' 71' ' ' LEU . 12.1 t -158.05 157.62 33.24 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.076 1.35 . . . . 74.2 109.433 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.1 m -101.2 151.93 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.875 1.27 . . . . 42.04 109.663 169.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.52 127.0 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.763 -1.199 . . . . 70.35 107.763 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -117.51 172.38 7.37 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.814 1.646 . . . . 65.02 109.67 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 87' ' ' GLY . 5.3 tt -130.11 129.06 43.06 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.611 1.164 . . . . 64.15 108.624 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -86.16 15.53 5.09 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.196 1.398 . . . . 62.4 114.602 -174.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.576 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 72.76 12.05 78.08 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 125.291 1.424 . . . . 63.34 113.161 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -143.36 51.88 1.36 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.648 1.179 . . . . 62.51 109.019 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.296 0.3 OUTLIER 48.72 38.29 11.34 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.892 2.077 . . . . 73.45 114.437 171.445 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -143.51 133.49 24.15 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 125.55 1.54 . . . . 74.52 108.431 -170.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.1 mt -103.91 124.27 48.67 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 124.525 1.141 . . . . 65.32 109.742 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.9 t -106.91 133.34 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.407 1.483 . . . . 61.13 108.617 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.7 t -164.98 140.8 5.52 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.201 1.0 . . . . 63.33 110.476 -168.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.5 m -146.72 128.97 15.72 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.666 0.604 . . . . 75.11 110.542 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -86.89 -154.75 0.24 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.773 1.629 . . . . 65.02 110.675 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.45 -34.1 74.86 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.639 1.576 . . . . 65.23 113.952 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -162.47 12.2 0.07 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.343 1.457 . . . . 74.45 112.47 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.432 HG12 HD13 ' A' ' 115' ' ' LEU . 21.9 mt -116.22 117.07 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.263 -1.384 . . . . 51.44 107.263 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -85.17 146.94 26.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.543 1.137 . . . . 74.33 108.687 169.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.7 m -150.43 125.99 10.23 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 123.857 0.723 . . . . 52.41 110.321 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.08 110.44 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.801 -1.185 . . . . 53.11 107.801 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.7 m -92.32 152.37 19.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.424 1.09 . . . . 54.15 109.511 172.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -143.74 138.38 28.77 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.979 1.712 . . . . 73.43 109.927 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.4 tp -118.58 125.14 49.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.84 2.056 . . . . 75.03 106.762 172.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -129.87 78.81 1.87 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.658 1.983 . . . . 71.04 106.293 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.99 -111.78 4.27 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.588 1.09 . . . . 53.43 110.58 176.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.74 -17.23 56.16 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.888 1.275 . . . . 71.13 113.536 175.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.8 mm -102.39 132.41 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 119.027 0.83 . . . . 60.11 110.161 -174.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.2 mm -108.53 140.39 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.022 1.329 . . . . 74.23 108.4 170.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.7 m -133.02 141.77 48.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.778 1.231 . . . . 65.21 107.719 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -132.95 142.0 48.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.565 1.146 . . . . 75.33 107.911 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.2 m -135.08 105.6 6.41 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 124.91 1.381 . . . . 75.43 108.206 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.6 mtp -98.58 148.28 23.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.901 1.68 . . . . 74.34 108.963 173.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.6 m -138.7 109.55 6.71 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.135 0.974 . . . . 60.32 108.83 173.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.432 HD13 HG12 ' A' ' 98' ' ' ILE . 12.7 tp -114.37 109.4 18.28 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.545 1.538 . . . . 71.2 108.14 176.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.47 -112.33 4.89 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 124.822 1.326 . . . . 63.24 110.465 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.83 2.37 41.01 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.74 2.016 . . . . 71.45 113.706 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.1 mt -122.5 142.83 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.709 1.204 . . . . 75.42 110.346 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.6 t -123.85 90.99 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.559 1.144 . . . . 64.21 110.164 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -73.57 128.92 36.83 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.4 1.08 . . . . 74.24 112.111 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -123.99 152.4 42.59 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.285 1.034 . . . . 63.24 110.716 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -140.61 144.3 35.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.965 1.306 . . . . 62.53 109.002 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -135.1 126.89 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.464 1.106 . . . . 74.22 108.109 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.8 m -129.87 159.43 36.63 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.74 1.216 . . . . 75.33 110.102 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -135.73 146.28 47.53 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.484 1.114 . . . . 63.23 110.626 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.3 ttp85 -62.79 139.52 58.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.242 2.217 . . . . 72.42 114.067 -172.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 6' ' ' LYS . 5.0 mt . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 105.792 -1.929 . . . . 72.13 105.792 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.9 p . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 108.946 -0.761 . . . . 72.34 108.946 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -60.24 -33.23 72.0 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.874 1.435 . . . . 74.21 114.874 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.2 p -57.61 133.3 55.17 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.168 1.787 . . . . 75.25 114.564 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.54 165.25 10.23 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.742 1.163 . . . . 65.11 110.217 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.486 ' HB3' HD12 ' A' ' 127' ' ' ILE . 8.3 mtmt -92.97 145.23 24.53 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 124.694 1.198 . . . . 74.12 112.004 173.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -135.94 147.67 48.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.508 1.523 . . . . 74.24 109.506 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -116.69 148.73 40.78 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.303 1.441 . . . . 63.35 109.454 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.481 HD13 ' HG3' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -72.84 121.88 20.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.71 1.204 . . . . 71.32 111.716 -175.109 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -96.31 -56.47 2.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.72 1.208 . . . . 65.5 111.85 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.5 t -161.77 159.05 26.64 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.15 0.98 . . . . 73.05 110.448 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -135.4 147.19 48.93 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.251 1.42 . . . . 74.35 108.698 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -123.32 138.05 54.7 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.1 1.36 . . . . 71.15 108.476 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 56.37 32.79 21.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.262 1.825 . . . . 63.12 112.616 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -61.74 -60.72 3.23 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.324 1.05 . . . . 74.25 110.594 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.47 -39.05 89.48 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 124.478 1.111 . . . . 60.04 113.559 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.68 -48.26 81.69 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.45 1.1 . . . . 53.45 112.965 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -68.32 -45.43 72.97 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.948 1.299 . . . . 70.13 113.072 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.9 mmt -69.19 -37.38 78.12 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.32 1.048 . . . . 61.43 113.118 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.542 ' HD2' HD13 ' A' ' 29' ' ' ILE . 6.3 mptt -67.01 -35.42 79.91 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.904 0.882 . . . . 62.13 112.754 169.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.56 -34.18 69.75 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.386 1.254 . . . . 71.32 114.386 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.9 pt -79.06 -9.72 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 113.204 0.816 . . . . 75.3 113.204 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.89 22.64 22.77 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 118.099 -1.389 . . . . 44.11 113.52 167.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.68 151.5 97.21 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 119.629 1.715 . . . . 72.05 111.866 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.26 147.51 59.81 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.291 1.994 . . . . 64.41 111.789 172.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.401 ' HA ' HD12 ' A' ' 29' ' ' ILE . 44.1 tt0 -57.11 -29.64 63.69 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.028 1.492 . . . . 74.34 115.028 -177.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -62.27 -44.67 96.01 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.383 0.882 . . . . 73.54 113.383 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -65.8 -27.6 68.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.549 1.539 . . . . 75.44 112.763 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.542 HD13 ' HD2' ' A' ' 20' ' ' LYS . 68.5 mt -79.95 -47.5 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.64 1.176 . . . . 64.11 111.085 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -65.23 -40.56 94.22 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-O 117.76 -1.114 . . . . 53.41 113.395 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.62 -25.38 61.28 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 118.262 -0.875 . . . . 75.5 112.854 172.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.57 -37.45 46.28 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 123.894 0.759 . . . . 20.32 111.953 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -28.47 21.79 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.517 1.127 . . . . 72.43 113.203 175.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.86 -57.63 3.93 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.59 1.156 . . . . 75.45 111.059 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.8 mm -81.86 119.11 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 124.328 1.017 . . . . 62.42 109.195 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.481 ' HG3' HD13 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -83.2 132.95 35.04 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 124.529 1.143 . . . . 63.21 111.054 177.459 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -97.75 -179.62 33.29 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 124.917 1.385 . . . . 74.13 110.996 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.4 t -129.44 147.35 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.393 1.877 . . . . 70.24 107.881 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.4 t -145.69 107.69 4.34 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.356 0.662 . . . . 70.22 110.022 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -85.22 148.72 25.94 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.573 1.149 . . . . 72.33 110.723 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.6 mt -126.84 133.67 67.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 124.943 1.402 . . . . 62.45 107.356 175.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.5 t -140.57 97.85 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.661 -0.866 . . . . 74.23 108.661 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -80.56 140.62 35.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.289 0.636 . . . . 74.34 109.519 168.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -146.74 71.63 1.24 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.067 0.947 . . . . 73.54 109.198 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.56 -127.0 11.5 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 109.311 -1.516 . . . . 50.4 109.311 -177.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -65.49 -35.52 81.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.239 1.416 . . . . 73.31 113.843 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -76.42 156.31 33.26 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 124.166 0.986 . . . . 72.23 112.14 174.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -151.98 126.41 9.38 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.711 -1.218 . . . . 73.35 107.711 -172.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -112.11 154.82 24.86 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.842 2.057 . . . . 75.04 109.926 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.95 143.15 25.04 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.535 1.534 . . . . 70.41 108.196 175.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.4 m -135.99 98.07 3.79 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.33 1.052 . . . . 45.21 108.564 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.1 mt -93.39 114.79 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.907 1.283 . . . . 74.15 109.368 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.0 m -104.92 118.1 35.69 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.831 1.653 . . . . 51.0 108.602 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -169.48 155.96 6.45 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.94 0.896 . . . . 75.3 111.462 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.39 -82.81 1.45 Allowed Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.071 -1.212 . . . . 43.33 110.071 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.9 p -157.0 12.4 0.24 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.584 1.554 . . . . 73.3 112.727 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.35 179.74 8.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.147 0.979 . . . . 75.41 111.577 -172.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.9 t -130.41 126.04 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.555 1.142 . . . . 63.15 108.723 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.3 mt -108.56 128.7 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.821 1.249 . . . . 74.53 108.827 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -114.5 133.61 55.64 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 124.859 1.35 . . . . 63.21 108.661 176.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -133.23 144.63 49.9 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.14 1.376 . . . . 63.35 108.694 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -132.28 145.13 51.08 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 124.882 1.364 . . . . 73.05 109.778 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -157.17 151.07 24.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.568 1.547 . . . . 75.23 108.204 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.4 m -93.69 140.53 29.53 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.708 0.803 . . . . 72.31 108.928 167.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.06 107.1 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.986 0.914 . . . . 63.33 110.064 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.06 -4.42 30.24 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 117.533 -1.704 . . . . 75.31 113.17 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -98.25 147.69 24.38 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.903 1.851 . . . . 71.42 109.409 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -84.87 125.68 32.83 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.749 1.22 . . . . 72.15 109.616 172.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.1 m -146.24 151.72 38.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.924 1.29 . . . . 74.14 109.61 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.55 116.59 28.57 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.905 1.282 . . . . 74.33 109.071 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.417 HD12 ' CG2' ' A' ' 81' ' ' THR . 83.0 mt -108.72 116.12 31.37 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.559 1.144 . . . . 71.33 109.848 -170.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -79.22 131.82 36.31 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.662 1.226 . . . . 63.54 111.484 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.8 p -90.82 169.67 10.75 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.572 1.549 . . . . 60.32 110.99 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.3 mtm -57.24 -27.47 62.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.929 1.692 . . . . 75.24 115.18 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 p -82.68 -14.55 54.43 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.246 1.818 . . . . 74.02 113.072 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.02 -4.55 59.0 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.289 1.423 . . . . 62.43 112.341 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -69.85 135.48 49.65 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 119.099 1.449 . . . . 74.34 110.439 173.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -138.41 136.5 36.34 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.969 0.793 . . . . 71.12 109.693 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.0 m -149.1 138.66 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.231 1.412 . . . . 71.33 110.089 -170.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 136.19 46.61 Favored 'General case' 0 C--N 1.346 0.416 0 O-C-N 124.213 0.946 . . . . 75.51 112.081 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.417 ' CG2' HD12 ' A' ' 71' ' ' LEU . 6.4 t -164.8 149.49 9.4 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.552 1.541 . . . . 74.2 109.384 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.3 t -99.32 138.48 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.516 1.126 . . . . 42.04 108.582 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 52.7 t -108.73 125.32 65.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 124.451 1.095 . . . . 70.35 108.254 172.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -120.15 157.16 29.6 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.892 1.677 . . . . 65.02 110.978 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.742 HD23 ' H ' ' A' ' 87' ' ' GLY . 6.7 tt -124.63 125.59 44.38 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.937 1.295 . . . . 64.15 108.137 -175.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.01 13.08 5.34 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.307 1.443 . . . . 62.4 114.87 -173.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.742 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 75.13 8.25 83.0 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 125.247 1.403 . . . . 63.34 113.031 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -142.28 61.77 1.44 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.978 1.311 . . . . 62.51 108.858 -171.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 48.02 35.24 4.88 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.155 2.182 . . . . 73.45 115.929 167.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -143.8 139.8 29.53 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.664 1.586 . . . . 74.52 108.691 -172.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.5 mt -113.56 122.63 47.82 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 124.362 1.039 . . . . 65.32 109.684 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.4 t -105.63 134.93 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.472 1.509 . . . . 61.13 108.92 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 t -163.38 144.98 9.57 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.237 1.415 . . . . 63.33 109.969 -171.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 83.9 m -147.86 129.35 14.92 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.809 0.844 . . . . 75.11 110.105 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -69.37 -75.12 0.12 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.831 1.252 . . . . 65.02 111.261 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -138.32 -41.07 0.51 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.328 1.851 . . . . 65.23 110.447 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -154.92 21.16 0.44 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.25 1.42 . . . . 74.45 111.825 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.478 HG13 HD13 ' A' ' 115' ' ' LEU . 5.1 mp -120.89 91.05 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.069 1.347 . . . . 51.44 107.697 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -70.06 109.49 4.59 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.051 0.94 . . . . 74.33 111.313 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.6 m -116.88 114.45 23.9 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 124.872 1.358 . . . . 52.41 109.332 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.1 t -117.46 110.16 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.962 1.305 . . . . 53.11 107.898 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.2 m -86.17 153.14 22.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.369 1.468 . . . . 54.15 109.688 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -148.11 138.88 23.07 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.816 1.246 . . . . 73.43 109.802 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.0 tp -116.28 126.57 53.74 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.824 2.05 . . . . 75.03 107.704 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -126.46 70.42 1.25 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.001 1.721 . . . . 71.04 106.766 170.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.41 -110.14 3.31 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.913 1.244 . . . . 53.43 110.417 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.03 4.51 14.24 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.476 1.511 . . . . 71.13 113.903 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.8 mm -123.92 140.5 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.118 0.967 . . . . 60.11 109.165 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.7 mm -120.3 137.27 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 125.123 1.369 . . . . 74.23 107.966 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.7 m -134.65 115.61 14.01 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 124.671 1.232 . . . . 65.21 107.84 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -106.08 139.64 40.3 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.436 -0.95 . . . . 75.33 108.436 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.7 m -131.28 120.69 23.54 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.873 1.358 . . . . 75.43 108.358 174.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.4 mtm -112.72 150.19 31.89 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.884 1.674 . . . . 74.34 109.594 173.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.1 m -138.87 96.3 3.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.556 1.142 . . . . 60.32 108.862 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.478 HD13 HG13 ' A' ' 98' ' ' ILE . 9.2 tp -104.73 111.01 23.57 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.443 1.497 . . . . 71.2 108.883 175.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.34 -112.87 5.36 Favored Glycine 0 CA--C 1.533 1.193 0 O-C-N 124.574 1.171 . . . . 63.24 110.413 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -110.9 18.74 19.23 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.91 1.684 . . . . 71.45 111.29 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.4 mt -129.4 136.88 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.015 1.326 . . . . 75.42 109.026 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.6 t -121.99 95.69 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 124.237 0.961 . . . . 64.21 109.565 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -75.05 128.24 35.09 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.814 1.245 . . . . 74.24 112.317 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.04 153.34 34.88 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 124.094 0.871 . . . . 63.24 110.835 169.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -135.29 139.06 44.07 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 126.362 1.865 . . . . 62.53 108.199 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.32 133.71 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 O-C-N 124.802 1.314 . . . . 74.22 107.622 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.9 m -137.37 158.51 44.24 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.122 1.369 . . . . 75.33 110.116 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -139.11 142.77 38.08 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.583 1.153 . . . . 63.23 110.755 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -68.06 136.82 54.38 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.969 2.108 . . . . 72.42 113.005 -168.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 6' ' ' LYS . 17.5 mt . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 105.494 -2.039 . . . . 72.13 105.494 -174.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 110.078 -0.341 . . . . 72.34 110.078 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -68.18 -30.95 70.18 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 117.625 -1.179 . . . . 74.21 113.621 169.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.5 p -58.88 103.1 0.14 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.488 1.515 . . . . 75.25 112.968 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.75 174.11 37.77 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 108.958 -1.657 . . . . 65.11 108.958 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.53 146.11 48.36 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.686 -1.227 . . . . 74.12 107.686 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.435 ' CE1' HD11 ' A' ' 109' ' ' ILE . 8.1 m-85 -143.1 130.24 20.78 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.798 0.839 . . . . 74.24 110.397 -168.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.9 149.21 24.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.988 0.915 . . . . 63.35 110.532 174.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 36' ' ' LYS . 61.0 tp -68.64 132.31 46.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.6 0.76 . . . . 71.32 111.131 173.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -106.08 -53.53 2.62 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 124.67 1.231 . . . . 65.5 110.829 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.25 157.66 15.61 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 124.447 1.092 . . . . 73.05 110.382 -175.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.412 ' HG3' HD11 ' A' ' 9' ' ' LEU . 3.5 mp0 -135.98 137.69 41.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.562 1.145 . . . . 74.35 108.582 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -112.86 137.15 51.64 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.217 1.407 . . . . 71.15 108.406 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 57.39 30.19 18.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.124 1.77 . . . . 63.12 112.964 -171.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.21 -58.36 8.63 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 124.177 0.991 . . . . 74.25 112.111 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -52.59 -52.15 56.57 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.344 1.858 . . . . 60.04 112.42 173.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.96 -48.78 77.54 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.332 1.453 . . . . 53.45 114.037 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -67.72 -45.7 74.29 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.862 1.265 . . . . 70.13 113.593 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 7.3 mmt -65.38 -40.22 93.23 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 124.699 1.25 . . . . 61.43 112.829 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -67.84 -28.3 67.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.187 0.995 . . . . 62.13 113.052 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.63 -34.71 40.33 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 114.099 1.148 . . . . 71.32 114.099 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.0 pt -77.12 -6.82 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 113.065 0.765 . . . . 75.3 113.065 169.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.59 31.24 24.96 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.604 -1.109 . . . . 44.11 112.345 169.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.486 HD21 HG21 ' A' ' 75' ' ' THR . 0.1 OUTLIER -68.01 151.57 97.09 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 118.636 1.218 . . . . 72.05 111.774 177.64 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.51 139.48 59.03 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.01 1.807 . . . . 64.41 110.763 169.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.452 ' HA ' HD12 ' A' ' 29' ' ' ILE . 20.3 tt0 -63.45 -20.33 65.48 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.4 1.259 . . . . 74.34 114.4 -174.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.58 -45.71 91.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 117.881 -1.057 . . . . 73.54 113.435 168.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.8 mt -66.81 -26.96 67.19 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 124.212 1.005 . . . . 75.44 113.518 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 26' ' ' GLU . 22.5 mt -75.93 -51.22 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.033 0.933 . . . . 64.11 111.376 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -62.08 -48.24 81.07 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.111 -0.947 . . . . 53.41 112.646 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -27.03 68.59 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.426 0.898 . . . . 75.5 113.426 174.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.23 -29.23 51.04 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 118.69 -1.061 . . . . 20.32 112.395 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.37 -30.6 13.83 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.471 1.135 . . . . 72.43 112.732 175.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -72.9 -39.39 66.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.687 1.195 . . . . 75.45 113.335 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.6 mt -111.06 130.05 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.483 -0.932 . . . . 62.42 108.483 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HA ' HD23 ' A' ' 9' ' ' LEU . 12.1 mptt -88.02 134.13 33.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.928 1.291 . . . . 63.21 110.642 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.7 -168.15 26.38 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 109.683 -1.367 . . . . 74.13 109.683 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.2 t -134.97 153.96 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.885 1.274 . . . . 70.24 108.317 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.4 p -128.6 160.48 32.28 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.465 1.506 . . . . 70.22 110.622 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -133.75 148.84 51.44 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 107.452 -1.314 . . . . 72.33 107.452 169.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.422 HG12 ' CE2' ' A' ' 50' ' ' PHE . 7.8 mt -138.72 129.91 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 105.963 -1.866 . . . . 62.45 105.963 176.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.2 m -139.28 138.95 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 123.426 0.454 . . . . 74.23 110.029 175.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -109.94 117.17 33.09 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.083 1.753 . . . . 74.34 107.277 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -116.08 51.33 0.97 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.181 1.392 . . . . 73.54 109.162 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.95 -116.62 5.67 Favored Glycine 0 CA--C 1.534 1.227 0 N-CA-C 107.977 -2.049 . . . . 50.4 107.977 -171.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -72.59 -34.91 67.73 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.154 1.168 . . . . 73.31 114.154 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.44 161.75 29.51 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.856 0.723 . . . . 72.23 111.829 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -159.26 131.46 6.58 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 106.886 -1.524 . . . . 73.35 106.886 -173.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -121.07 149.2 43.08 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.978 1.311 . . . . 75.04 108.824 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.422 ' CE2' HG12 ' A' ' 41' ' ' ILE . 5.5 t80 -141.82 119.75 11.98 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.351 -1.352 . . . . 70.41 107.351 177.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 34.3 m -96.09 134.07 39.58 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.592 1.157 . . . . 45.21 108.909 172.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.58 107.0 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.939 -1.504 . . . . 74.15 106.939 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 m -99.33 100.63 11.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.717 1.207 . . . . 51.0 108.426 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.94 178.02 7.08 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.238 1.015 . . . . 75.3 111.325 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.47 29.55 2.57 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 125.216 1.388 . . . . 43.33 113.356 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -158.28 -33.48 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.35 1.575 . . . . 73.3 112.566 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.68 170.05 19.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.953 1.301 . . . . 75.41 110.37 -176.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.23 132.47 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 O-C-N 124.173 0.921 . . . . 63.15 109.181 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.4 mt -122.97 135.29 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.292 1.437 . . . . 74.53 107.926 172.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.6 143.34 47.71 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 124.175 0.922 . . . . 63.21 108.812 176.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -133.38 132.0 40.7 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.627 1.171 . . . . 63.35 109.734 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -113.02 143.57 44.08 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 125.427 1.704 . . . . 73.05 109.476 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -148.19 164.73 33.05 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.186 1.394 . . . . 75.23 108.659 173.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.7 m -113.51 131.28 56.12 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.434 -0.95 . . . . 72.31 108.434 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.0 t -62.76 119.37 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 125.011 1.324 . . . . 63.33 111.213 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.91 -10.47 73.85 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-O 117.906 -1.497 . . . . 75.31 113.668 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -107.52 139.46 42.01 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.64 1.72 . . . . 71.42 109.355 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.77 120.14 13.02 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 123.606 0.762 . . . . 72.15 111.736 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.5 m -138.92 140.58 38.37 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.263 1.425 . . . . 74.14 108.28 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -67.44 131.11 45.04 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.87 0.731 . . . . 74.33 111.214 168.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.479 HD12 ' CG2' ' A' ' 81' ' ' THR . 19.6 mt -120.77 109.31 15.01 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.543 1.537 . . . . 71.33 107.921 177.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -74.82 154.52 38.25 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.536 1.135 . . . . 63.54 111.178 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.9 m -110.59 169.56 8.67 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.882 1.673 . . . . 60.32 109.208 175.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -53.06 -25.68 13.49 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.769 1.628 . . . . 75.24 115.022 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.486 HG21 HD21 ' A' ' 24' ' ' LEU . 66.5 p -82.09 -18.74 41.97 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 128.548 2.739 . . . . 74.02 113.968 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.56 0.63 55.47 Favored Glycine 0 CA--C 1.543 1.786 0 CA-C-O 118.549 -1.139 . . . . 62.43 112.564 -174.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -75.63 105.06 6.46 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.525 1.53 . . . . 74.34 111.98 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -99.93 133.2 44.64 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.54 1.136 . . . . 71.12 111.079 176.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -147.03 131.47 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.455 1.502 . . . . 71.33 109.908 -172.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -79.47 129.61 34.63 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.577 1.551 . . . . 75.51 110.218 -172.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.479 ' CG2' HD12 ' A' ' 71' ' ' LEU . 14.6 t -162.69 159.24 24.11 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 124.25 0.969 . . . . 74.2 111.146 -173.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.9 m -104.15 146.31 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 125.287 1.435 . . . . 42.04 109.872 167.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.509 HG12 HD22 ' A' ' 91' ' ' LEU . 40.5 t -122.57 126.84 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 106.962 -1.496 . . . . 70.35 106.962 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -129.22 139.98 51.65 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.632 1.173 . . . . 65.02 111.522 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.7 tp -84.78 136.97 33.46 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.832 1.332 . . . . 64.15 109.567 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.95 16.12 5.26 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.198 0.999 . . . . 62.4 113.208 173.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.76 12.4 78.26 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.159 1.362 . . . . 63.34 113.081 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -143.91 57.29 1.34 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.862 1.265 . . . . 62.51 108.491 -171.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.276 0.8 OUTLIER 49.49 32.71 4.97 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.84 2.056 . . . . 73.45 115.327 169.369 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -142.48 127.57 18.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.478 1.911 . . . . 74.52 108.275 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.509 HD22 HG12 ' A' ' 83' ' ' VAL . 49.3 mt -107.17 134.24 50.58 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.593 1.157 . . . . 65.32 109.647 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.8 t -118.91 135.65 58.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.817 1.247 . . . . 61.13 109.181 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.5 t -155.92 142.4 18.57 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.211 1.004 . . . . 63.33 111.576 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.8 p -143.68 136.96 27.87 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.625 1.57 . . . . 75.11 110.121 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -102.78 -61.2 1.43 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.927 1.291 . . . . 65.02 109.613 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -140.88 -63.84 0.46 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 125.881 1.672 . . . . 65.23 109.15 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -140.78 10.63 2.22 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.673 1.589 . . . . 74.45 112.283 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.494 HG12 HD13 ' A' ' 115' ' ' LEU . 65.2 mt -111.53 108.79 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 125.477 1.511 . . . . 51.44 106.95 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -101.58 99.94 10.29 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.404 1.082 . . . . 74.33 110.306 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.63 127.5 35.92 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.091 1.356 . . . . 52.41 108.561 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.3 t -130.41 104.73 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.201 -1.407 . . . . 53.11 107.201 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.3 m -82.68 150.57 26.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.488 1.515 . . . . 54.15 109.842 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -147.09 139.93 25.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.979 1.311 . . . . 73.43 108.933 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.41 124.32 39.9 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.543 1.537 . . . . 75.03 107.418 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -127.55 84.76 2.28 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.555 1.942 . . . . 71.04 106.518 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.69 -114.89 7.19 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.266 1.412 . . . . 53.43 110.461 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -88.18 15.48 7.48 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.77 1.628 . . . . 71.13 114.087 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.8 mm -129.25 132.05 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.248 1.019 . . . . 60.11 108.815 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.435 HD11 ' CE1' ' A' ' 7' ' ' TYR . 46.1 mm -104.83 140.14 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.792 -1.188 . . . . 74.23 107.792 169.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.2 m -133.98 112.29 11.1 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.077 -1.453 . . . . 65.21 107.077 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -103.14 146.91 27.68 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.419 -0.586 . . . . 75.33 109.419 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.0 m -140.45 99.77 3.72 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.975 1.31 . . . . 75.43 109.265 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.6 mmm -92.19 150.59 20.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.103 1.761 . . . . 74.34 110.241 170.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.8 m -140.44 105.38 4.97 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.306 1.042 . . . . 60.32 108.898 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 HG12 ' A' ' 98' ' ' ILE . 12.6 tp -113.88 110.75 20.6 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.871 1.668 . . . . 71.2 108.583 177.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.31 -123.33 29.32 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 109.776 -1.33 . . . . 63.24 109.776 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -97.49 12.68 32.52 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.248 1.419 . . . . 71.45 113.18 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.4 mt -119.28 136.82 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.992 0.917 . . . . 75.42 109.865 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.5 t -119.72 96.71 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 124.33 1.019 . . . . 64.21 109.068 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -75.45 127.41 33.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.322 1.049 . . . . 74.24 111.475 172.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 157.21 29.58 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 123.921 0.763 . . . . 63.24 110.065 168.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -149.36 129.53 13.63 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.261 1.024 . . . . 62.53 109.099 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.63 137.36 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.93 1.292 . . . . 74.22 108.565 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.6 m -134.97 158.39 44.46 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.432 1.093 . . . . 75.33 110.136 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -123.09 134.9 54.22 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 125.345 1.458 . . . . 63.23 108.931 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -68.83 146.83 52.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.912 1.685 . . . . 72.42 112.745 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 105.653 -1.981 . . . . 72.13 105.653 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 109.527 -0.546 . . . . 72.34 109.527 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -78.35 56.38 1.72 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.056 1.743 . . . . 74.21 112.056 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -129.02 120.6 26.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.982 1.313 . . . . 75.25 109.515 -175.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.72 164.44 10.58 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 110.022 -1.231 . . . . 65.11 110.022 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.26 142.85 32.09 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.178 1.391 . . . . 74.12 110.213 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -136.53 150.46 48.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.426 1.09 . . . . 74.24 109.818 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -121.75 143.82 49.15 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.6 1.16 . . . . 63.35 108.839 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 36' ' ' LYS . 31.9 tp -55.17 137.91 45.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.477 1.511 . . . . 71.32 112.937 175.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -122.3 -50.88 1.99 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.44 1.496 . . . . 65.5 111.204 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.1 153.88 41.19 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 124.405 1.066 . . . . 73.05 111.719 -172.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -140.66 132.67 27.79 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.761 1.624 . . . . 74.35 108.997 -170.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -138.54 133.73 32.96 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.32 1.048 . . . . 71.15 109.255 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 54.72 27.73 9.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.097 1.759 . . . . 63.12 113.178 -173.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -62.55 -54.5 38.83 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-O 117.84 -1.076 . . . . 74.25 112.131 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -61.1 -47.0 88.32 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-O 118.072 -0.966 . . . . 60.04 113.257 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.54 -47.05 73.64 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.669 1.187 . . . . 53.45 113.667 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -69.83 -45.48 67.76 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.669 1.187 . . . . 70.13 113.419 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.7 mmt -62.83 -48.2 80.09 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 124.502 1.126 . . . . 61.43 112.717 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.483 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.6 mptm? -59.84 -31.15 69.48 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.468 0.914 . . . . 62.13 113.468 172.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.2 54.63 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.469 1.285 . . . . 71.32 114.469 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.3 pt -79.73 -7.87 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 113.344 0.868 . . . . 75.3 113.344 172.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.68 24.08 37.07 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.736 -1.035 . . . . 44.11 112.72 172.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.65 141.01 98.18 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.851 1.26 . . . . 72.05 110.264 172.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -66.04 143.01 70.49 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.434 2.089 . . . . 64.41 111.901 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.426 ' HA ' HD12 ' A' ' 29' ' ' ILE . 37.1 tt0 -57.44 -27.07 62.11 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.664 1.357 . . . . 74.34 114.664 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -64.51 -45.44 87.22 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 117.885 -1.055 . . . . 73.54 113.568 172.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.8 mt -64.76 -25.12 67.78 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.154 0.981 . . . . 75.44 113.291 173.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.483 HD13 ' HD2' ' A' ' 20' ' ' LYS . 64.7 mt -80.63 -50.86 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.298 1.039 . . . . 64.11 110.802 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -61.94 -42.76 99.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 117.816 -1.087 . . . . 53.41 113.007 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -27.18 62.6 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 118.236 -0.888 . . . . 75.5 112.728 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.67 -27.42 61.01 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.846 -0.975 . . . . 20.32 112.382 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.01 -26.05 14.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.846 1.258 . . . . 72.43 113.147 174.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -80.33 -44.45 19.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.041 0.936 . . . . 75.45 111.156 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.7 mt -102.67 127.64 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.351 1.06 . . . . 62.42 108.165 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HA ' HD23 ' A' ' 9' ' ' LEU . 4.3 tmmm? -76.96 118.16 19.27 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.896 1.278 . . . . 63.21 109.975 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.2 170.16 37.13 Favored Glycine 0 CA--C 1.531 1.091 0 O-C-N 124.247 0.967 . . . . 74.13 110.72 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.8 t -124.58 149.93 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.081 1.352 . . . . 70.24 108.819 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.0 p -126.41 165.95 18.11 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.73 1.612 . . . . 70.22 110.164 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -152.3 141.64 21.53 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.801 -1.185 . . . . 72.33 107.801 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.14 132.69 50.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.395 -1.706 . . . . 62.45 106.395 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.7 t -140.09 100.98 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.827 0.851 . . . . 74.23 108.96 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -87.29 141.58 28.54 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.494 1.118 . . . . 74.34 109.229 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -152.03 77.13 1.2 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.018 0.927 . . . . 73.54 109.002 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.37 -120.52 8.41 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 109.377 -1.489 . . . . 50.4 109.377 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -75.48 -32.17 60.47 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.717 1.207 . . . . 73.31 114.073 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.56 148.83 38.57 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 124.124 0.89 . . . . 72.23 111.861 175.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -138.26 133.08 32.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.95 1.7 . . . . 73.35 106.674 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -125.41 160.05 30.37 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.87 1.668 . . . . 75.04 110.37 173.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -155.97 145.94 21.35 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.559 -1.275 . . . . 70.41 107.559 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.6 m -129.05 117.86 21.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 124.235 0.959 . . . . 45.21 109.849 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.4 mt -90.56 139.49 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.045 1.338 . . . . 74.15 108.456 172.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.2 m -135.9 112.75 10.24 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.616 1.166 . . . . 51.0 108.079 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -120.15 74.76 1.06 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.465 1.106 . . . . 75.3 109.988 -174.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.82 -91.21 1.39 Allowed Glycine 0 CA--C 1.532 1.126 0 N-CA-C 108.847 -1.701 . . . . 43.33 108.847 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.8 m -105.67 -43.09 5.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.94 1.296 . . . . 73.3 112.08 -176.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -72.72 146.02 46.74 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.95 1.3 . . . . 75.41 112.215 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.2 t -133.92 130.31 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.644 1.177 . . . . 63.15 108.78 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.7 mt -130.71 111.62 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.743 1.217 . . . . 74.53 108.581 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.54 149.47 24.07 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.379 0.672 . . . . 63.21 110.975 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -139.31 153.67 47.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.084 1.753 . . . . 63.35 108.245 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -137.08 141.1 42.38 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 124.815 1.322 . . . . 73.05 109.072 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -145.74 168.01 21.76 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.443 1.097 . . . . 75.23 109.851 173.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.2 m -118.92 130.0 55.48 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.685 -1.228 . . . . 72.31 107.685 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.15 123.15 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.298 1.039 . . . . 63.33 110.782 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.31 2.07 77.58 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 118.267 -1.296 . . . . 75.31 113.396 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -115.31 152.16 33.27 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.571 1.548 . . . . 71.42 109.701 171.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -77.11 127.63 33.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.73 1.612 . . . . 72.15 110.61 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.7 m -146.59 149.47 33.61 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.153 1.381 . . . . 74.14 109.739 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -77.5 145.62 36.89 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 112.688 0.625 . . . . 74.33 112.688 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 mt -122.35 127.85 50.27 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.605 1.562 . . . . 71.33 108.291 173.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -95.29 142.66 27.44 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.43 1.092 . . . . 63.54 110.313 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 p -103.26 -177.57 3.41 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.385 1.474 . . . . 60.32 111.663 173.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.7 mtt -60.02 -38.43 82.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.74 1.616 . . . . 75.24 115.04 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.4 p -89.84 -1.63 58.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.454 1.502 . . . . 74.02 112.838 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.59 19.24 32.74 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 118.249 -1.306 . . . . 62.43 112.722 172.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -69.37 113.98 7.19 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.152 1.476 . . . . 74.34 109.963 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -104.24 125.44 50.51 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 124.153 0.908 . . . . 71.12 109.092 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -146.12 123.27 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 124.427 1.079 . . . . 71.33 110.983 -170.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -72.8 140.59 47.78 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 124.3 1.04 . . . . 75.51 112.351 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.8 t -171.09 163.02 7.26 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.493 1.517 . . . . 74.2 109.692 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.1 t -103.06 136.0 37.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.259 1.024 . . . . 42.04 108.461 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.9 t -103.52 127.8 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 107.996 -1.112 . . . . 70.35 107.996 171.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -125.51 151.67 46.01 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.264 1.425 . . . . 65.02 111.647 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 tp -101.33 137.02 40.23 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 124.757 1.286 . . . . 64.15 109.509 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -87.54 15.56 6.55 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.567 1.147 . . . . 62.4 113.258 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.96 13.83 80.62 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.95 1.262 . . . . 63.34 113.257 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -143.22 57.11 1.39 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.727 1.211 . . . . 62.51 108.561 -173.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.274 0.3 OUTLIER 44.15 37.0 1.67 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.198 2.199 . . . . 73.45 114.97 175.194 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -140.88 121.99 14.7 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 125.622 1.569 . . . . 74.52 109.02 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.3 mt -95.99 142.84 27.73 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 124.718 1.262 . . . . 65.32 109.721 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.9 t -132.56 137.92 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.471 1.508 . . . . 61.13 108.653 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 t -155.13 149.99 26.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.865 0.866 . . . . 63.33 110.734 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.0 p -143.56 130.74 20.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.942 1.297 . . . . 75.11 109.708 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -95.08 -60.2 1.73 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.312 1.045 . . . . 65.02 110.373 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -143.78 -75.57 0.25 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.682 1.593 . . . . 65.23 108.631 -173.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -116.95 -17.03 10.49 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.245 1.818 . . . . 74.45 111.232 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.5 ' CG1' HD13 ' A' ' 115' ' ' LEU . 21.5 mt -88.86 111.21 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.935 1.294 . . . . 51.44 108.455 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.0 tmmt? -101.27 115.41 30.43 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 124.389 1.075 . . . . 74.33 108.974 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.4 m -117.03 124.36 49.12 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 124.846 1.341 . . . . 52.41 109.073 -169.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.8 t -131.89 117.14 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.528 1.131 . . . . 53.11 109.407 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.1 m -102.92 155.13 18.56 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.769 1.228 . . . . 54.15 109.643 173.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -139.15 144.89 38.81 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.639 1.976 . . . . 73.43 109.661 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 tp -124.85 118.06 25.5 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.863 2.065 . . . . 75.03 106.994 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -122.0 69.2 0.94 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.041 1.337 . . . . 71.04 108.136 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.11 -110.96 3.63 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 110.065 -1.214 . . . . 53.43 110.065 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -79.51 -6.58 57.27 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 117.254 -1.355 . . . . 71.13 113.461 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.2 mm -112.65 136.94 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 119.91 1.232 . . . . 60.11 109.385 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.9 mm -115.54 142.69 27.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.041 1.337 . . . . 74.23 108.151 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.0 m -133.43 124.83 27.79 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.371 1.045 . . . . 65.21 108.235 172.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -108.46 134.95 50.54 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.555 1.142 . . . . 75.33 107.946 170.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 62.6 m -136.41 117.79 14.68 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.303 1.441 . . . . 75.43 108.255 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 33.1 mtm -123.17 142.45 50.89 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.09 0.956 . . . . 74.34 109.715 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.9 m -125.54 113.44 17.44 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.332 1.453 . . . . 60.32 108.662 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.5 HD13 ' CG1' ' A' ' 98' ' ' ILE . 11.6 tp -121.18 107.5 12.65 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.361 1.464 . . . . 71.2 108.048 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.37 -111.67 4.21 Favored Glycine 0 CA--C 1.533 1.199 0 O-C-N 124.837 1.336 . . . . 63.24 110.442 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -99.6 1.36 43.62 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.733 2.013 . . . . 71.45 113.665 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 91.4 mt -120.68 139.51 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.677 1.191 . . . . 75.42 109.967 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.2 t -125.19 101.08 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 124.187 0.929 . . . . 64.21 109.772 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -68.55 138.45 55.14 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.307 1.443 . . . . 74.24 112.099 169.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.5 mppt? -136.37 157.33 47.06 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 124.486 1.116 . . . . 63.24 110.778 167.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.03 141.84 12.88 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.846 1.258 . . . . 62.53 108.996 -177.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.21 139.7 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.702 1.201 . . . . 74.22 108.368 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 45.0 m -133.05 160.56 36.81 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.479 1.512 . . . . 75.33 109.312 173.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.64 144.91 39.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.63 1.172 . . . . 63.23 110.695 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -63.03 145.34 55.65 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.79 2.036 . . . . 72.42 113.7 -171.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.8 mt . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 103.886 -2.635 . . . . 72.13 103.886 -175.126 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.4 p . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 109.658 -0.497 . . . . 72.34 109.658 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -63.3 -30.82 71.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.265 1.426 . . . . 74.21 114.271 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.1 p -52.72 121.62 7.54 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.063 2.145 . . . . 75.25 113.933 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.49 166.23 14.85 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 109.522 -1.431 . . . . 65.11 109.522 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.16 144.51 37.14 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.378 1.071 . . . . 74.12 108.65 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -137.48 155.82 48.86 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.855 1.262 . . . . 74.24 110.437 -172.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -129.0 146.17 51.05 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.473 1.109 . . . . 63.35 109.581 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.82 129.6 41.16 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.7 1.2 . . . . 71.32 111.517 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 65.6 mm-40 -111.36 -56.59 2.36 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.035 1.334 . . . . 65.5 110.743 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.37 155.47 45.91 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 124.615 1.197 . . . . 73.05 112.056 -170.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -142.38 122.62 13.86 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.087 1.755 . . . . 74.35 107.797 -168.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -129.09 140.94 51.37 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.524 0.73 . . . . 71.15 109.668 170.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 56.17 33.48 22.14 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.632 1.973 . . . . 63.12 112.46 -171.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.0 -62.37 1.6 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.103 -0.951 . . . . 74.25 111.676 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.99 -34.04 75.44 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 113.671 0.989 . . . . 60.04 113.671 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.66 -52.7 64.38 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.079 0.951 . . . . 53.45 112.652 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -67.34 -49.53 63.67 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.656 1.182 . . . . 70.13 113.165 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.1 mmt -67.1 -36.94 83.05 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.745 1.278 . . . . 61.43 113.139 -173.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -77.95 -25.52 48.28 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 118.047 -0.978 . . . . 62.13 112.534 173.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.37 -35.96 63.54 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 113.739 1.015 . . . . 71.32 113.739 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.6 pt -77.44 -10.27 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 O-C-N 123.917 0.76 . . . . 75.3 112.966 170.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.72 29.43 23.86 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.382 -1.232 . . . . 44.11 113.073 167.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.6 mt -65.39 152.17 92.67 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 119.125 1.463 . . . . 72.05 111.718 172.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -64.61 140.69 69.72 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.244 1.963 . . . . 64.41 111.269 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.59 -21.63 53.79 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.686 1.365 . . . . 74.34 114.686 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -59.54 -52.21 66.53 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 117.586 -1.197 . . . . 73.54 113.328 166.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.6 mt -61.12 -30.36 70.32 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.943 1.09 . . . . 75.44 113.943 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.13 -54.2 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 O-C-N 124.17 0.919 . . . . 64.11 111.707 171.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -66.92 -27.55 67.58 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.961 1.467 . . . . 53.41 114.961 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.17 -21.25 31.37 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.759 1.224 . . . . 75.5 112.257 171.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.44 -15.7 52.25 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 118.564 -1.131 . . . . 20.32 112.275 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.12 -31.8 15.37 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.739 1.269 . . . . 72.43 113.079 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -83.48 -45.55 13.49 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.954 0.797 . . . . 75.45 111.032 177.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.4 mm -89.71 125.4 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.06 0.944 . . . . 62.42 109.402 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -85.42 146.46 26.96 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.531 1.144 . . . . 63.21 110.248 166.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -101.84 -168.85 27.38 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 109.753 -1.339 . . . . 74.13 109.753 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.4 t -129.86 158.47 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 126.693 1.997 . . . . 70.24 108.583 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.0 t -137.4 161.04 37.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.071 1.349 . . . . 70.22 110.125 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -143.35 147.81 35.26 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 123.76 0.824 . . . . 72.33 109.287 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.7 mt -132.03 126.01 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.461 -1.681 . . . . 62.45 106.461 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.9 t -136.87 92.2 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.197 -1.038 . . . . 74.23 108.197 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -79.98 138.68 37.12 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.128 0.971 . . . . 74.34 109.577 171.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -148.6 74.79 1.29 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.094 0.958 . . . . 73.54 109.298 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.43 -125.02 11.37 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.277 -1.529 . . . . 50.4 109.277 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mmpp? -70.26 -32.36 70.16 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.894 1.277 . . . . 73.31 114.377 173.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.0 157.22 31.33 Favored 'General case' 0 C--N 1.345 0.399 0 O-C-N 124.046 0.841 . . . . 72.23 111.893 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -157.05 127.33 6.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.039 -1.467 . . . . 73.35 107.039 -173.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -115.75 151.55 34.93 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.873 1.669 . . . . 75.04 109.886 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -147.44 119.81 8.42 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.057 -1.09 . . . . 70.41 108.057 -176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.1 m -102.07 129.97 48.53 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 124.49 1.119 . . . . 45.21 108.576 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.0 mt -113.63 120.16 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 106.839 -1.541 . . . . 74.15 106.839 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.5 m -113.88 104.07 11.81 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.644 1.215 . . . . 51.0 107.799 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.2 -162.29 0.11 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.813 1.645 . . . . 75.3 111.933 172.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.94 -27.03 69.65 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-O 118.788 -1.006 . . . . 43.33 113.738 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.0 p -163.75 25.37 0.08 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.429 1.492 . . . . 73.3 112.648 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -139.47 142.58 37.35 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.408 1.083 . . . . 75.41 109.967 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.29 128.89 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 124.293 0.996 . . . . 63.15 108.823 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.8 mt -130.95 123.11 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.766 1.626 . . . . 74.53 107.467 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.43 138.81 49.55 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.125 0.97 . . . . 63.21 109.034 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -134.48 145.19 48.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.037 1.335 . . . . 63.35 108.658 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -125.05 145.98 49.66 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 124.817 1.323 . . . . 73.05 109.195 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -149.21 161.02 42.84 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.65 1.18 . . . . 75.23 109.88 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.3 m -108.86 130.0 55.41 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.347 1.03 . . . . 72.31 108.467 172.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 80.3 t -66.78 115.27 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.763 1.225 . . . . 63.33 110.578 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.25 -9.56 50.02 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-O 117.971 -1.46 . . . . 75.31 112.963 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -114.52 149.13 36.9 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.422 1.611 . . . . 71.42 109.916 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -71.41 133.37 45.88 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.93 0.769 . . . . 72.15 110.725 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.5 m -139.02 168.16 20.45 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.717 1.607 . . . . 74.14 108.936 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -110.89 133.26 53.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.867 0.867 . . . . 74.33 109.901 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -122.02 138.48 54.42 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.443 1.497 . . . . 71.33 109.292 -171.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -109.75 141.86 41.78 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.327 1.451 . . . . 63.54 111.912 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 m -99.63 167.06 10.81 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.91 1.684 . . . . 60.32 111.61 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 65.3 mtm -57.56 -26.75 61.9 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.947 1.699 . . . . 75.24 114.986 170.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.1 t -83.62 -10.83 57.97 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.645 1.178 . . . . 74.02 113.557 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.84 4.46 67.32 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 118.457 -1.19 . . . . 62.43 113.296 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -71.06 136.48 48.3 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.277 1.538 . . . . 74.34 109.648 172.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -120.66 135.38 55.13 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.295 0.997 . . . . 71.12 108.609 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.14 132.1 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.591 1.156 . . . . 71.33 110.562 -171.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -74.42 141.2 45.06 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 124.283 0.989 . . . . 75.51 111.85 173.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.5 t -164.94 154.05 12.73 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.586 1.555 . . . . 74.2 110.003 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.73 133.61 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 107.865 -1.161 . . . . 42.04 107.865 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -112.17 129.04 68.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 108.311 -0.996 . . . . 70.35 108.311 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -141.11 147.39 38.42 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.054 1.342 . . . . 65.02 111.712 -173.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 tp -75.54 138.63 41.64 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.349 1.059 . . . . 64.15 111.492 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -89.45 6.35 41.17 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.889 1.275 . . . . 62.4 112.415 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.74 16.55 77.96 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.798 1.19 . . . . 63.34 112.948 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -150.22 48.25 0.9 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.249 1.42 . . . . 62.51 108.86 -172.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.302 0.0 OUTLIER 53.13 33.51 15.28 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.642 1.577 . . . . 73.45 114.079 178.059 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -130.5 141.56 50.49 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 125.787 1.635 . . . . 74.52 108.748 -171.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.1 mt -117.66 113.27 21.65 Favored 'General case' 0 C--N 1.343 0.312 0 O-C-N 124.539 1.149 . . . . 65.32 109.414 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.0 t -95.01 136.93 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.877 1.671 . . . . 61.13 109.137 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.13 147.32 22.38 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.54 1.536 . . . . 63.33 110.62 -174.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.6 p -150.67 132.78 15.3 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.392 1.477 . . . . 75.11 109.725 -175.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -98.15 -70.15 0.73 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.09 1.356 . . . . 65.02 108.895 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -135.3 -57.17 0.8 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.702 1.601 . . . . 65.23 108.887 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -149.09 10.29 0.79 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.415 1.486 . . . . 74.45 112.564 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.472 HG13 HD13 ' A' ' 115' ' ' LEU . 4.3 mp -108.48 104.8 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.549 -1.278 . . . . 51.44 107.549 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -86.88 106.64 17.9 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 124.121 0.888 . . . . 74.33 109.253 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 55.7 p -111.45 123.55 50.45 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.757 1.285 . . . . 52.41 111.141 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.5 t -126.1 105.32 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 126.037 1.735 . . . . 53.11 107.495 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.6 m -82.13 152.42 26.53 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.012 1.325 . . . . 54.15 109.769 172.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -142.28 139.06 31.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.856 1.662 . . . . 73.43 108.953 174.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.1 tp -117.71 126.73 53.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.917 2.087 . . . . 75.03 106.734 173.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -133.97 81.19 1.9 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.474 1.91 . . . . 71.04 106.285 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.13 -116.62 9.08 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 110.202 -1.159 . . . . 53.43 110.202 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -88.52 17.74 5.14 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.205 1.802 . . . . 71.13 114.221 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.4 mm -129.99 132.79 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.178 0.991 . . . . 60.11 108.932 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 49.8 mm -111.36 136.2 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 125.09 1.356 . . . . 74.23 107.849 171.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.8 m -127.34 122.88 34.93 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.151 -1.425 . . . . 65.21 107.151 173.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -113.75 134.04 55.0 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.274 -1.009 . . . . 75.33 108.274 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.2 m -133.69 108.12 8.34 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 124.539 1.15 . . . . 75.43 108.533 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.1 mtp -108.27 146.52 32.75 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.541 1.937 . . . . 74.34 109.246 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.4 m -137.59 94.38 2.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.293 1.037 . . . . 60.32 109.587 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.472 HD13 HG13 ' A' ' 98' ' ' ILE . 8.2 tp -98.77 109.1 21.91 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.32 1.448 . . . . 71.2 108.846 173.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.45 -111.1 3.73 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 124.807 1.317 . . . . 63.24 110.817 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -101.53 1.37 37.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.722 2.009 . . . . 71.45 113.648 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 89.5 mt -120.85 143.78 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.123 1.369 . . . . 75.42 110.143 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.7 t -123.01 91.3 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 O-C-N 124.23 0.956 . . . . 64.21 110.24 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -68.47 127.14 31.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.334 1.054 . . . . 74.24 112.1 173.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -125.2 146.38 49.54 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.738 1.215 . . . . 63.24 110.465 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -142.94 132.54 23.75 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.896 1.278 . . . . 62.53 108.326 -174.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.69 133.26 67.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.556 -1.276 . . . . 74.22 107.556 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.1 m -134.55 150.18 50.72 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 124.626 1.204 . . . . 75.33 110.025 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -120.01 141.42 49.73 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.547 1.539 . . . . 63.23 109.727 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -67.74 141.18 56.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.264 1.826 . . . . 72.42 112.103 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.4 mt . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 106.295 -1.742 . . . . 72.13 106.295 -173.351 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 . . . . . 0 N--CA 1.502 2.128 0 N-CA-C 102.544 -3.132 . . . . 74.42 102.544 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 2.3 m170 50.91 95.7 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 127.345 2.258 . . . . 63.42 113.969 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -123.32 119.85 31.33 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.068 0.947 . . . . 55.23 109.415 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -155.4 158.3 38.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.861 1.664 . . . . 74.33 110.067 175.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -166.4 124.54 1.43 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.584 1.554 . . . . 71.43 108.646 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -176.82 154.63 1.18 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.632 1.573 . . . . 75.21 110.423 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 84.9 t -77.68 -61.09 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 124.828 1.251 . . . . 73.0 111.148 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -92.29 177.55 6.11 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.378 1.471 . . . . 33.23 110.965 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -111.9 157.09 21.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.996 0.919 . . . . 64.11 111.827 175.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.0 m -99.78 110.59 22.97 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.702 1.601 . . . . 72.34 108.781 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -70.02 -25.33 63.53 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.988 1.107 . . . . 74.21 113.988 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.2 t -52.77 115.08 1.64 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.058 2.143 . . . . 75.25 113.147 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.09 164.96 16.05 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 110.557 -1.017 . . . . 65.11 110.557 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.423 ' HB3' HD12 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -109.66 144.86 37.41 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.851 1.661 . . . . 74.12 110.399 175.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.494 ' CZ ' HD11 ' A' ' 109' ' ' ILE . 37.0 m-85 -140.81 141.15 34.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.998 1.319 . . . . 74.24 109.645 -173.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -107.93 148.04 30.2 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.538 1.135 . . . . 63.35 109.899 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.64 127.47 31.82 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.469 1.508 . . . . 71.32 111.207 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -109.4 -57.19 2.2 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.821 1.248 . . . . 65.5 110.973 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.5 p -152.86 172.16 17.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.563 1.145 . . . . 73.05 111.2 -174.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -168.27 148.59 4.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.876 1.271 . . . . 74.35 111.0 -165.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -140.04 143.23 36.27 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.873 1.269 . . . . 71.15 108.797 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 57.59 26.02 12.32 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.482 1.913 . . . . 63.12 113.616 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -61.5 -55.66 28.58 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-O 118.232 -0.889 . . . . 74.25 113.185 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -62.41 -43.48 98.72 Favored 'General case' 0 C--N 1.347 0.472 0 O-C-N 124.308 1.005 . . . . 60.04 112.919 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.92 -45.47 82.68 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.711 1.204 . . . . 53.45 113.566 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -68.08 -47.17 69.01 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.958 1.303 . . . . 70.13 113.187 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.5 mmt -65.9 -44.61 84.73 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.565 1.166 . . . . 61.43 113.049 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.505 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.3 mptm? -60.71 -32.43 71.68 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.932 0.893 . . . . 62.13 113.032 171.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.56 -37.69 59.77 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.396 1.258 . . . . 71.32 114.396 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.1 pt -79.11 -5.14 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 113.427 0.899 . . . . 75.3 113.427 172.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.98 27.81 25.1 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 118.666 -1.074 . . . . 44.11 112.893 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.66 146.73 98.61 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 118.822 1.311 . . . . 72.05 111.122 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -68.31 140.83 49.75 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.05 1.834 . . . . 64.41 110.799 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.08 -21.88 64.09 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.63 1.344 . . . . 74.34 114.63 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.62 -49.94 74.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.351 1.06 . . . . 73.54 113.349 169.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.6 mt -63.92 -23.74 67.46 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 124.65 1.18 . . . . 75.44 113.569 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.505 HD13 ' HD2' ' A' ' 20' ' ' LYS . 68.6 mt -83.15 -50.46 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.325 1.05 . . . . 64.11 110.602 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -60.94 -42.59 98.49 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 117.821 -1.085 . . . . 53.41 113.16 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -27.59 63.34 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 118.22 -0.895 . . . . 75.5 112.819 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.54 -30.04 57.06 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-O 119.077 -0.846 . . . . 20.32 112.552 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.79 -30.75 14.69 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.632 1.173 . . . . 72.43 112.789 173.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -72.78 -49.96 27.36 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.627 1.171 . . . . 75.45 111.52 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 mt -93.37 129.56 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.268 1.027 . . . . 62.42 108.347 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -80.44 110.17 15.63 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 124.135 0.897 . . . . 63.21 108.787 170.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.51 -172.97 41.75 Favored Glycine 0 CA--C 1.538 1.487 0 O-C-N 124.469 1.106 . . . . 74.13 110.429 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.5 t -129.82 153.79 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.709 1.204 . . . . 70.24 109.701 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.0 t -130.35 155.98 45.45 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.552 1.941 . . . . 70.22 109.164 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -141.02 143.67 34.56 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.752 1.221 . . . . 72.33 107.879 170.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.1 mt -132.07 130.36 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.08 -1.822 . . . . 62.45 106.08 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -134.74 135.5 53.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.15 -1.056 . . . . 74.23 108.15 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -126.92 130.82 50.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.819 1.248 . . . . 74.34 108.687 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -133.19 55.07 1.92 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.144 1.378 . . . . 73.54 109.289 -172.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.13 -115.96 5.69 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 108.718 -1.753 . . . . 50.4 108.718 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -70.69 -35.42 72.77 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.249 1.204 . . . . 73.31 114.249 173.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.63 156.09 37.11 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 124.021 0.825 . . . . 72.23 111.373 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -150.93 141.29 22.4 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.037 -1.468 . . . . 73.35 107.037 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -129.27 151.63 49.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.229 1.811 . . . . 75.04 109.153 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -148.79 126.23 11.61 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.686 -1.228 . . . . 70.41 107.686 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 m -109.18 126.61 53.45 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.688 1.243 . . . . 45.21 108.931 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.25 133.93 51.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.724 -1.584 . . . . 74.15 106.724 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.0 m -133.52 104.84 6.58 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 124.166 0.916 . . . . 51.0 109.394 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -107.38 77.49 1.15 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.918 0.887 . . . . 75.3 110.153 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.34 -49.41 4.23 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.513 1.53 . . . . 43.33 112.212 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.44 -39.65 0.09 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.171 0.986 . . . . 73.3 111.872 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -67.09 137.26 56.24 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.475 1.11 . . . . 75.41 111.684 172.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.6 t -125.31 130.47 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 O-C-N 124.612 1.195 . . . . 63.15 109.147 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.8 mt -119.34 128.67 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.871 1.269 . . . . 74.53 108.019 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -116.66 127.14 54.16 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 124.589 1.18 . . . . 63.21 108.693 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -121.94 145.04 48.5 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.413 1.485 . . . . 63.35 109.075 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -132.8 140.78 48.16 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 125.376 1.672 . . . . 73.05 108.995 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -149.46 166.93 27.64 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.033 1.333 . . . . 75.23 109.146 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.4 m -119.21 127.01 52.89 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.886 -1.153 . . . . 72.31 107.886 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.8 t -63.73 126.95 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.768 1.227 . . . . 63.33 111.324 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.14 -3.1 85.66 Favored Glycine 0 CA--C 1.542 1.764 0 CA-C-O 118.249 -1.306 . . . . 75.31 113.558 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -116.62 141.02 48.74 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.127 1.771 . . . . 71.42 109.859 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -66.45 118.57 10.28 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.04 1.336 . . . . 72.15 111.616 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 40.5 m -140.46 153.26 46.2 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.577 1.551 . . . . 74.14 109.153 -175.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -100.96 128.65 46.9 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.99 0.916 . . . . 74.33 109.77 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.3 mt -120.37 131.92 55.05 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.762 1.225 . . . . 71.33 110.467 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -90.43 130.92 36.45 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.277 1.831 . . . . 63.54 110.47 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.6 p -85.52 -179.93 7.01 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.572 1.149 . . . . 60.32 111.651 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.2 mtt -59.03 -30.83 68.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.18 1.548 . . . . 75.24 115.18 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.4 p -87.82 -7.51 57.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.368 1.467 . . . . 74.02 113.235 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.63 6.68 58.27 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 118.187 -1.34 . . . . 62.43 112.592 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -69.0 113.36 6.31 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 119.405 1.603 . . . . 74.34 110.791 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -94.44 124.95 38.78 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 124.612 1.195 . . . . 71.12 110.502 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.92 126.19 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.309 1.444 . . . . 71.33 110.361 -170.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -72.5 132.92 44.47 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.22 1.408 . . . . 75.51 111.885 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.3 t -161.93 170.02 20.13 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.267 1.427 . . . . 74.2 109.445 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.95 144.03 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 108.283 -1.006 . . . . 42.04 108.283 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.563 HG12 HD22 ' A' ' 91' ' ' LEU . 22.3 t -112.05 125.65 69.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 O-C-N 124.358 1.037 . . . . 70.35 108.252 177.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -112.91 141.78 46.35 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.805 1.642 . . . . 65.02 110.496 177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.0 tp -92.95 136.82 32.92 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.426 1.079 . . . . 64.15 109.189 168.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.18 12.63 11.19 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.261 1.024 . . . . 62.4 113.318 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.9 14.12 80.33 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 125.131 1.348 . . . . 63.34 113.115 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -140.41 52.07 1.65 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.718 1.207 . . . . 62.51 109.697 -171.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.276 0.0 OUTLIER 58.04 21.78 8.21 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.905 1.682 . . . . 73.45 114.818 173.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -135.05 120.9 19.66 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.502 1.521 . . . . 74.52 109.714 -164.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.563 HD22 HG12 ' A' ' 83' ' ' VAL . 56.2 mt -105.55 132.39 51.77 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.895 1.278 . . . . 65.32 109.945 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.1 t -119.61 136.52 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.008 1.323 . . . . 61.13 109.157 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.0 t -154.37 149.08 26.48 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.27 1.028 . . . . 63.33 110.846 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.2 p -146.33 132.08 18.97 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.724 1.209 . . . . 75.11 109.783 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -97.96 -63.39 1.13 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.975 1.31 . . . . 65.02 110.396 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -140.17 -73.49 0.36 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.189 1.796 . . . . 65.23 108.237 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -127.38 -1.77 6.26 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.255 1.822 . . . . 74.45 112.305 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.451 HG12 HD12 ' A' ' 115' ' ' LEU . 37.6 mt -97.4 110.9 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.839 1.656 . . . . 51.44 108.384 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -102.61 98.76 8.77 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.765 1.226 . . . . 74.33 110.195 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.5 t -82.92 131.27 35.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.327 1.451 . . . . 52.41 110.882 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.8 t -135.69 101.82 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 106.844 -1.539 . . . . 53.11 106.844 172.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.0 m -84.89 148.9 26.02 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.186 1.394 . . . . 54.15 109.766 173.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -147.71 130.76 16.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.042 1.337 . . . . 73.43 109.313 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 tt -113.93 130.55 56.5 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.232 -1.396 . . . . 75.03 107.232 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -132.62 82.71 2.02 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.431 1.892 . . . . 71.04 106.702 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.25 -111.78 4.44 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.745 1.164 . . . . 53.43 111.287 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -83.72 -4.72 58.85 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.329 1.452 . . . . 71.13 113.535 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.8 mm -110.94 138.46 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 119.499 1.045 . . . . 60.11 109.666 -176.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.494 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 36.6 mm -109.6 136.6 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.754 -1.202 . . . . 74.23 107.754 169.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.0 m -127.57 115.41 18.77 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 106.532 -1.655 . . . . 65.21 106.532 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -117.64 126.56 52.73 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.481 -0.933 . . . . 75.33 108.481 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 66.7 m -124.65 112.81 17.22 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 124.661 1.226 . . . . 75.43 108.386 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 95.1 mtp -105.86 149.86 26.14 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.873 1.269 . . . . 74.34 109.21 173.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.5 m -140.79 104.4 4.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.563 0.745 . . . . 60.32 109.21 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.451 HD12 HG12 ' A' ' 98' ' ' ILE . 7.0 tt -103.2 102.14 12.12 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.544 1.537 . . . . 71.2 107.55 175.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.27 -122.93 30.91 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 110.849 -0.9 . . . . 63.24 110.849 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -84.88 3.33 38.5 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.915 1.686 . . . . 71.45 115.173 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.8 mt -102.93 139.75 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.889 0.875 . . . . 75.42 108.995 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.38 96.85 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.205 1.002 . . . . 64.21 109.119 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -86.21 136.35 33.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.676 1.591 . . . . 74.24 112.48 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -119.65 150.19 40.74 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.049 1.34 . . . . 63.24 111.085 173.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 mmt-85 -141.98 136.1 29.98 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.503 1.921 . . . . 62.53 108.074 173.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.6 133.98 65.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.583 -1.266 . . . . 74.22 107.583 174.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.5 m -135.16 159.98 39.83 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.994 1.317 . . . . 75.33 109.648 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -137.79 143.3 41.0 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.489 1.116 . . . . 63.23 110.702 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.7 ttp85 -63.28 137.1 58.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.592 1.957 . . . . 72.42 113.768 -170.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.423 HD12 ' HB3' ' A' ' 6' ' ' LYS . 40.4 mt . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 106.039 -1.838 . . . . 72.13 106.039 -171.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 . . . . . 0 N--CA 1.5 2.033 0 N-CA-C 102.88 -3.007 . . . . 74.42 102.88 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -165.68 71.85 0.16 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.063 1.345 . . . . 63.42 108.001 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -142.98 158.98 43.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.05 1.34 . . . . 55.23 110.381 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -134.91 87.71 2.36 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.872 1.269 . . . . 74.33 108.854 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -160.47 158.38 29.24 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.782 1.633 . . . . 71.43 110.017 174.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -133.7 60.05 1.72 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.227 1.411 . . . . 75.21 109.552 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 28.3 m -134.75 166.53 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.598 1.559 . . . . 73.0 110.346 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -65.84 145.31 56.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.116 1.366 . . . . 33.23 112.811 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.5 mmm -77.04 147.4 36.75 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.452 1.101 . . . . 64.11 112.384 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.7 p -94.41 132.75 38.71 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.854 1.262 . . . . 72.34 110.042 171.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -80.39 -16.82 53.57 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.549 1.314 . . . . 74.21 114.549 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.8 p -66.93 132.76 48.62 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.759 1.224 . . . . 75.25 113.483 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.1 168.34 14.67 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.285 0.945 . . . . 65.11 110.778 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -99.89 147.07 25.94 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.274 1.43 . . . . 74.12 111.137 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.496 ' CE2' HD11 ' A' ' 109' ' ' ILE . 31.5 m-85 -138.41 155.08 48.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.593 1.557 . . . . 74.24 109.453 -176.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -127.77 145.39 50.93 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.505 -0.924 . . . . 63.35 108.505 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 tt -61.96 131.24 49.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.22 1.408 . . . . 71.32 110.432 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -109.7 -50.06 3.03 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.609 1.164 . . . . 65.5 110.919 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.2 158.15 35.68 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 124.387 1.054 . . . . 73.05 111.109 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -128.08 155.83 43.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.844 1.257 . . . . 74.35 108.683 170.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -135.69 131.33 35.53 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.264 1.426 . . . . 71.15 108.175 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 58.23 39.27 25.94 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.352 1.861 . . . . 63.12 112.142 -169.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -64.11 -63.57 1.12 Allowed 'General case' 0 C--N 1.346 0.454 0 C-N-CA 124.875 1.27 . . . . 74.25 112.296 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.47 -28.43 69.66 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.566 0.95 . . . . 60.04 113.566 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.88 -51.9 65.17 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.102 0.961 . . . . 53.45 112.346 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -70.59 -48.47 55.04 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.831 1.252 . . . . 70.13 113.8 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.9 mmt -67.99 -39.83 83.2 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 124.374 1.046 . . . . 61.43 113.155 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -73.87 -27.68 61.2 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 118.137 -0.935 . . . . 62.13 112.513 173.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.75 -33.82 66.61 Favored 'General case' 0 C--N 1.349 0.562 0 N-CA-C 113.945 1.091 . . . . 71.32 113.945 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.8 pt -80.3 -4.6 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 N-CA-C 113.239 0.829 . . . . 75.3 113.239 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.03 21.69 41.27 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 118.202 -1.332 . . . . 44.11 113.522 167.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.0 mt -63.88 143.78 98.1 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 119.42 1.61 . . . . 72.05 111.212 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.18 143.72 84.66 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.396 2.064 . . . . 64.41 111.56 172.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.06 -22.48 62.73 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.123 1.527 . . . . 74.34 115.123 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.17 -43.16 99.31 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.245 1.018 . . . . 73.54 113.138 169.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.9 mt -72.0 -24.57 61.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.529 1.132 . . . . 75.44 113.621 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.69 -55.39 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 123.58 0.752 . . . . 64.11 111.176 168.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -65.99 -26.5 67.58 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 115.019 1.489 . . . . 53.41 115.019 -174.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.69 -23.15 31.83 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 124.237 0.961 . . . . 75.5 112.454 171.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.68 -23.81 37.99 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-O 118.964 -0.909 . . . . 20.32 112.298 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.13 -35.17 25.8 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 117.54 -1.219 . . . . 72.43 113.609 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -83.08 -49.75 9.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.79 0.723 . . . . 75.45 111.39 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.41 123.62 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.131 0.973 . . . . 62.42 109.263 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.28 107.17 18.38 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.018 -1.104 . . . . 63.21 108.018 171.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.61 165.81 51.95 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 124.612 1.195 . . . . 74.13 111.507 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 78.6 t -102.05 155.37 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.339 1.056 . . . . 70.24 108.697 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 97.6 p -145.42 167.36 23.12 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.599 1.16 . . . . 70.22 109.916 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -161.58 142.26 10.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.466 1.106 . . . . 72.33 108.682 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -129.48 142.12 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.929 -1.508 . . . . 62.45 106.929 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.69 100.96 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.699 -1.223 . . . . 74.23 107.699 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -77.31 129.9 36.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.039 0.936 . . . . 74.34 109.825 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -128.31 51.52 1.98 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.438 1.495 . . . . 73.54 109.282 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.33 -118.44 6.74 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 108.871 -1.692 . . . . 50.4 108.871 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -65.99 -34.71 78.72 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.937 1.295 . . . . 73.31 113.95 172.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -75.73 157.96 32.89 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.073 0.858 . . . . 72.23 111.599 171.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -156.57 125.23 5.85 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.908 -1.515 . . . . 73.35 106.908 -172.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 139.82 46.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.847 1.259 . . . . 75.04 109.103 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.28 132.37 55.29 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.772 1.629 . . . . 70.41 107.535 172.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.92 109.16 10.68 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.689 1.196 . . . . 45.21 108.16 176.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.92 132.75 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.736 1.214 . . . . 74.15 108.185 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.1 m -114.76 111.46 21.29 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.307 1.004 . . . . 51.0 108.984 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.14 76.15 1.89 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.691 1.196 . . . . 75.3 109.432 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.68 -96.95 1.99 Allowed Glycine 0 CA--C 1.531 1.079 0 N-CA-C 108.776 -1.73 . . . . 43.33 108.776 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.3 m -101.88 -40.7 6.79 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.726 1.21 . . . . 73.3 112.574 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -73.02 153.58 40.83 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.079 0.952 . . . . 75.41 112.066 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.21 131.43 67.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 124.536 1.148 . . . . 63.15 109.553 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.2 mt -105.17 134.6 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 126.468 1.907 . . . . 74.53 107.957 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -125.82 124.78 41.7 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.488 1.115 . . . . 63.21 108.38 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -137.71 133.08 33.77 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.552 1.141 . . . . 63.35 108.976 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -116.48 147.67 41.52 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 124.601 1.188 . . . . 73.05 109.711 172.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -150.86 160.66 43.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.102 1.361 . . . . 75.23 110.091 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.2 m -103.47 135.66 44.66 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 124.237 0.961 . . . . 72.31 108.517 169.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.07 119.29 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.948 1.299 . . . . 63.33 111.2 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.92 -13.59 65.89 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 117.967 -1.463 . . . . 75.31 113.326 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -99.11 148.52 23.97 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.522 1.661 . . . . 71.42 110.369 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -69.75 114.44 7.95 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 124.082 0.864 . . . . 72.15 110.793 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.7 m -129.32 151.74 49.63 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.344 1.458 . . . . 74.14 107.689 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -100.96 119.97 39.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.035 0.934 . . . . 74.33 110.276 -174.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.99 134.27 52.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.097 1.359 . . . . 71.33 110.411 -172.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -90.45 147.92 23.1 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.474 1.51 . . . . 63.54 110.336 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.3 p -112.45 178.31 4.34 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.47 1.508 . . . . 60.32 110.231 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -59.99 -29.78 68.69 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.575 1.324 . . . . 75.24 114.575 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.3 p -81.95 -8.21 59.66 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.527 1.531 . . . . 74.02 113.035 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.99 8.12 72.96 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-O 118.363 -1.243 . . . . 62.43 112.581 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -69.97 114.08 7.79 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 119.072 1.436 . . . . 74.34 110.921 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -100.86 121.41 41.67 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 124.943 1.402 . . . . 71.12 109.496 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.42 133.02 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 124.625 1.203 . . . . 71.33 110.877 -172.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -78.21 141.12 38.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.198 1.399 . . . . 75.51 112.177 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.0 t -167.07 153.86 8.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.713 1.205 . . . . 74.2 110.394 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.5 m -90.15 142.42 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.418 1.087 . . . . 42.04 109.431 165.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.56 124.72 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.253 -1.388 . . . . 70.35 107.253 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -135.75 136.81 41.08 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.357 1.063 . . . . 65.02 110.273 -170.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.625 HD23 ' H ' ' A' ' 87' ' ' GLY . 2.7 tt -79.41 129.77 34.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.489 1.115 . . . . 64.15 110.167 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -73.94 -9.5 58.7 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.477 1.911 . . . . 62.4 114.165 -173.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.625 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 92.15 5.72 65.53 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.122 1.344 . . . . 63.34 112.189 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -147.6 57.05 1.11 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.77 1.285 . . . . 62.51 109.358 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 63.8 19.76 11.89 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.821 1.648 . . . . 73.45 114.101 171.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -128.76 142.68 50.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.706 1.602 . . . . 74.52 109.598 -166.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 74.1 mt -114.91 123.26 48.7 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.346 1.058 . . . . 65.32 109.204 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.7 t -104.65 140.14 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.364 1.466 . . . . 61.13 108.902 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 100' ' ' SER . 6.3 t -162.79 135.24 5.5 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.446 1.098 . . . . 63.33 110.084 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 78.5 p -131.36 122.3 26.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.523 1.129 . . . . 75.11 109.403 -176.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -81.9 -66.56 0.87 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.395 1.078 . . . . 65.02 111.221 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -144.14 -52.4 0.32 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.64 1.576 . . . . 65.23 109.491 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -142.8 3.22 1.42 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.577 1.551 . . . . 74.45 112.363 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.428 ' CG1' HD13 ' A' ' 115' ' ' LEU . 78.3 mt -99.73 110.91 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.702 1.601 . . . . 51.44 106.959 174.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -103.63 86.84 2.7 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.934 1.294 . . . . 74.33 109.575 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.432 ' HB2' HG23 ' A' ' 93' ' ' THR . 69.7 m -79.36 127.72 32.44 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.186 1.395 . . . . 52.41 110.764 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.4 t -135.74 102.1 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 108.063 -1.088 . . . . 53.11 108.063 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.7 m -85.89 157.38 20.19 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.461 1.504 . . . . 54.15 110.478 176.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -148.71 143.56 26.52 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.612 1.565 . . . . 73.43 110.987 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.5 tt -129.98 128.03 41.23 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.317 1.447 . . . . 75.03 108.999 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -137.52 77.45 1.64 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.071 1.748 . . . . 71.04 107.604 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.8 -123.9 22.89 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 110.096 -1.202 . . . . 53.43 110.096 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -75.65 -12.33 60.18 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.239 1.415 . . . . 71.13 114.153 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mm -102.95 137.63 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 119.287 0.949 . . . . 60.11 109.534 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.496 HD11 ' CE2' ' A' ' 7' ' ' TYR . 11.2 mm -125.9 140.62 48.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 108.105 -1.072 . . . . 74.23 108.105 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.6 m -135.94 160.73 37.69 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.462 1.505 . . . . 65.21 108.743 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -154.58 147.67 24.72 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.57 1.148 . . . . 75.33 108.618 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.5 m -131.82 108.07 9.18 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 125.115 1.509 . . . . 75.43 108.22 171.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 72.8 mtp -96.21 144.71 26.17 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.826 1.651 . . . . 74.34 108.747 168.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 65.2 m -133.88 108.05 8.2 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.44 -0.948 . . . . 60.32 108.44 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.428 HD13 ' CG1' ' A' ' 98' ' ' ILE . 17.3 tp -111.86 99.36 8.06 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.477 1.511 . . . . 71.2 107.712 175.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.81 -122.82 27.15 Favored Glycine 0 CA--C 1.535 1.281 0 O-C-N 124.726 1.266 . . . . 63.24 110.429 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.87 -17.69 55.19 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.522 1.929 . . . . 71.45 114.48 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 75.9 mt -102.16 140.62 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.604 1.162 . . . . 75.42 110.381 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.4 t -122.76 90.0 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.361 1.064 . . . . 64.21 109.551 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -71.76 124.79 25.55 Favored 'General case' 0 C--N 1.345 0.394 0 C-N-CA 124.451 1.101 . . . . 74.24 111.729 174.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -120.62 148.74 43.5 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.879 1.271 . . . . 63.24 109.344 176.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.72 120.7 7.68 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.482 -0.933 . . . . 62.53 108.482 -166.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -118.83 141.69 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.164 1.386 . . . . 74.22 109.4 -172.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.6 m -144.21 166.62 24.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.232 1.413 . . . . 75.33 111.985 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -139.48 138.9 36.79 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.868 1.267 . . . . 63.23 109.952 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -69.31 131.7 45.27 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.262 2.225 . . . . 72.42 112.563 -174.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.8 mt . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 105.522 -2.029 . . . . 72.13 105.522 -174.238 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 29.7 p80 . . . . . 0 N--CA 1.503 2.213 0 N-CA-C 105.588 -2.004 . . . . 74.42 105.588 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.81 151.64 31.78 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 124.509 1.124 . . . . 63.42 111.065 -178.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -69.3 161.08 30.04 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.949 1.7 . . . . 55.23 112.411 174.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -132.35 85.52 2.24 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.739 1.216 . . . . 74.33 108.82 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -98.01 -81.87 0.43 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.703 1.201 . . . . 71.43 108.764 172.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.9 169.63 12.34 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.596 1.159 . . . . 75.21 111.867 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.32 21.04 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 125.232 1.413 . . . . 73.0 111.976 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -164.02 166.84 21.11 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.948 1.299 . . . . 33.23 111.11 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mmm -131.27 169.01 16.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.043 1.737 . . . . 64.11 110.31 173.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t -136.71 144.33 43.82 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.915 1.286 . . . . 72.34 109.499 176.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -80.16 -27.27 39.01 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.192 1.182 . . . . 74.21 114.192 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.9 m -57.1 111.17 0.98 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.244 1.818 . . . . 75.25 113.376 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.39 160.72 10.81 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.667 -1.373 . . . . 65.11 109.667 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -98.13 146.86 25.15 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 124.551 1.14 . . . . 74.12 110.973 176.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -139.69 146.37 39.56 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.057 1.343 . . . . 74.24 109.519 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -111.29 148.93 31.86 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.48 1.512 . . . . 63.35 109.79 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.78 128.71 37.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.885 1.274 . . . . 71.32 111.128 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -111.15 -50.57 2.93 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.17 1.388 . . . . 65.5 111.501 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.46 167.52 30.19 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.452 1.101 . . . . 73.05 111.27 -173.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -167.51 125.06 1.21 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.652 1.181 . . . . 74.35 110.918 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -111.52 143.99 41.48 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.214 1.406 . . . . 71.15 109.435 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 57.46 38.71 28.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.594 1.958 . . . . 63.12 111.832 -170.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -65.25 -58.39 6.07 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.451 -0.785 . . . . 74.25 111.409 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -62.09 -40.35 95.55 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 113.401 0.889 . . . . 60.04 113.401 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.6 -46.07 91.63 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 124.169 0.988 . . . . 53.45 113.019 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -70.91 -47.78 57.24 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-O 117.633 -1.175 . . . . 70.13 112.898 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.2 mtt -64.27 -35.59 81.35 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 124.926 1.391 . . . . 61.43 113.911 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -71.18 -30.76 66.82 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 118.167 -0.921 . . . . 62.13 113.159 169.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.17 -37.31 61.32 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.357 1.243 . . . . 71.32 114.357 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.549 ' CD1' HD13 ' A' ' 24' ' ' LEU . 41.9 pt -74.18 -12.88 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.877 0.871 . . . . 75.3 113.18 170.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.46 22.54 34.11 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.349 -1.251 . . . . 44.11 112.726 173.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.597 HD11 HG21 ' A' ' 75' ' ' THR . 6.0 mp -72.25 141.2 83.24 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.262 1.531 . . . . 72.05 110.562 172.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.528 ' HD2' HD12 ' A' ' 28' ' ' LEU . 71.8 Cg_endo -65.78 152.37 81.77 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.59 2.193 . . . . 64.41 112.162 176.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -65.94 -20.48 66.23 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.35 1.241 . . . . 74.34 114.35 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.03 -46.12 82.63 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.309 1.044 . . . . 73.54 113.072 171.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 25' ' ' PRO . 74.8 mt -62.85 -30.11 71.25 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.553 1.141 . . . . 75.44 112.813 174.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.1 mt -71.37 -50.86 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.615 1.166 . . . . 64.11 111.781 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -58.72 -50.31 74.36 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 117.817 -1.087 . . . . 53.41 112.958 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -21.14 63.72 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.013 1.116 . . . . 75.5 114.013 174.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.38 -29.21 45.55 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 118.934 -0.926 . . . . 20.32 111.974 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 -29.26 14.05 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.763 1.225 . . . . 72.43 112.897 174.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -71.91 -35.61 69.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 118.022 -0.99 . . . . 75.45 113.432 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.3 mt -113.4 119.12 59.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.079 -1.082 . . . . 62.42 108.079 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -69.48 137.55 52.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.101 0.96 . . . . 63.21 111.55 171.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.16 -179.82 39.7 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 124.687 1.242 . . . . 74.13 110.474 172.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.6 t -130.9 150.23 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 126.047 1.739 . . . . 70.24 107.843 174.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 t -144.83 108.0 4.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.409 0.683 . . . . 70.22 109.965 -170.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -91.96 147.07 23.24 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.061 0.944 . . . . 72.33 110.853 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 mt -132.6 128.02 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 106.29 -1.744 . . . . 62.45 106.29 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.8 t -134.18 127.14 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.021 -1.103 . . . . 74.23 108.021 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -122.16 136.07 54.86 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.013 1.325 . . . . 74.34 108.045 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -148.46 76.65 1.37 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.901 0.881 . . . . 73.54 109.024 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.6 -120.36 8.97 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 108.983 -1.647 . . . . 50.4 108.983 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.4 mmtt -75.67 -32.16 60.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.863 1.265 . . . . 73.31 114.258 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.71 155.83 35.28 Favored 'General case' 0 C--N 1.346 0.421 0 O-C-N 123.918 0.762 . . . . 72.23 112.093 175.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -154.91 128.43 8.52 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 106.989 -1.486 . . . . 73.35 106.989 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -114.37 151.95 32.26 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.707 1.203 . . . . 75.04 109.549 170.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -145.27 128.29 16.52 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.943 -1.503 . . . . 70.41 106.943 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.3 m -116.04 117.77 31.02 Favored 'General case' 0 C--N 1.344 0.352 0 O-C-N 124.511 1.132 . . . . 45.21 109.4 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 mp -97.88 121.56 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.207 1.403 . . . . 74.15 107.485 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.8 m -113.56 109.38 18.54 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.801 -1.185 . . . . 51.0 107.801 173.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.54 -164.01 0.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.705 1.602 . . . . 75.3 111.551 173.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.69 -25.23 70.26 Favored Glycine 0 CA--C 1.542 1.721 0 CA-C-O 118.735 -1.036 . . . . 43.33 113.797 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.5 p -161.85 20.17 0.11 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.357 1.463 . . . . 73.3 113.032 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.68 146.98 52.31 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 125.071 1.349 . . . . 75.41 110.122 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.9 t -124.93 124.02 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.082 -1.081 . . . . 63.15 108.082 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -134.46 123.95 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.101 -1.444 . . . . 74.53 107.101 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.16 149.06 43.36 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.071 0.948 . . . . 63.21 111.064 175.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -133.04 152.59 51.95 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.925 1.69 . . . . 63.35 108.908 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -125.74 142.75 51.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 125.114 1.509 . . . . 73.05 109.034 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -146.5 167.11 24.49 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.901 1.281 . . . . 75.23 109.351 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.8 m -118.38 129.21 55.29 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.557 -1.275 . . . . 72.31 107.557 173.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.02 121.02 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.908 1.283 . . . . 63.33 110.922 -175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.9 -4.37 78.43 Favored Glycine 0 CA--C 1.542 1.75 0 CA-C-O 118.353 -1.248 . . . . 75.31 113.285 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -112.59 137.81 50.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.149 1.78 . . . . 71.42 108.651 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.81 125.96 28.27 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.803 0.689 . . . . 72.15 110.919 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.4 m -138.41 163.4 31.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.58 1.552 . . . . 74.14 108.942 -175.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -103.86 125.95 50.64 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.518 0.727 . . . . 74.33 110.023 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.497 HD12 HG21 ' A' ' 81' ' ' THR . 64.7 mt -108.09 127.7 54.03 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.658 1.183 . . . . 71.33 109.393 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -88.34 153.56 21.1 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.589 1.556 . . . . 63.54 110.898 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.2 p -111.14 173.79 6.17 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.645 1.578 . . . . 60.32 111.786 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -60.33 -31.2 70.08 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.512 1.301 . . . . 75.24 114.512 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.597 HG21 HD11 ' A' ' 24' ' ' LEU . 42.5 p -88.73 -7.33 56.46 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.71 1.204 . . . . 74.02 113.248 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.15 9.81 63.14 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.346 -1.252 . . . . 62.43 113.042 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -64.72 146.12 55.22 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 119.254 1.527 . . . . 74.34 110.46 167.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -129.02 124.98 36.32 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.254 -1.017 . . . . 71.12 108.254 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 m -141.51 128.09 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 124.47 1.106 . . . . 71.33 110.8 -171.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -77.32 139.84 39.87 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.384 1.474 . . . . 75.51 111.6 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.497 HG21 HD12 ' A' ' 71' ' ' LEU . 8.3 t -169.61 154.43 5.52 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 124.906 1.379 . . . . 74.2 109.719 -165.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 t -121.28 133.75 66.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.972 -1.121 . . . . 42.04 107.972 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.8 t -106.83 126.53 62.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 108.322 -0.992 . . . . 70.35 108.322 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.31 135.67 53.82 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.347 1.459 . . . . 65.02 110.093 174.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.54 121.06 31.4 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.5 1.125 . . . . 64.15 108.958 169.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.509 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 6.5 tt0 -81.87 -168.57 1.97 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.002 1.321 . . . . 62.4 111.217 174.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.509 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -93.41 11.08 72.25 Favored Glycine 0 CA--C 1.539 1.571 0 CA-C-O 117.71 -1.606 . . . . 63.34 113.353 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -140.48 44.93 1.85 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.725 1.763 . . . . 62.51 110.925 -173.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 65.3 21.36 11.99 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.052 1.341 . . . . 73.45 113.395 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -120.98 126.5 50.11 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.918 1.287 . . . . 74.52 110.674 -164.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.0 mt -101.53 109.28 21.06 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 124.671 1.232 . . . . 65.32 109.1 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 86.6 t -95.99 132.63 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.86 1.264 . . . . 61.13 108.759 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.6 t -154.55 148.78 25.97 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 124.07 0.856 . . . . 63.33 110.977 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.4 p -147.26 133.38 19.33 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.786 1.234 . . . . 75.11 110.0 -173.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -93.53 -77.17 0.46 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.598 1.559 . . . . 65.02 109.727 -176.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -128.5 -58.85 1.17 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.066 1.747 . . . . 65.23 108.843 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -144.52 8.42 1.34 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.005 1.722 . . . . 74.45 112.223 -175.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.521 HG13 HD13 ' A' ' 115' ' ' LEU . 4.5 mp -103.56 115.89 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.297 -1.371 . . . . 51.44 107.297 177.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -103.18 91.13 3.96 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 124.629 1.206 . . . . 74.33 108.962 -173.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.7 p -100.43 112.53 24.89 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.336 1.454 . . . . 52.41 111.927 -174.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.3 t -114.85 106.91 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.409 1.884 . . . . 53.11 107.794 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.5 m -84.32 151.51 24.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.716 1.206 . . . . 54.15 109.863 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -146.4 130.66 17.52 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.444 1.497 . . . . 73.43 109.164 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.3 tt -111.39 128.42 55.97 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.76 1.224 . . . . 75.03 108.079 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -130.26 82.32 2.06 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.348 1.859 . . . . 71.04 106.51 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.42 -117.42 10.62 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.495 -1.042 . . . . 53.43 110.495 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -85.78 9.59 16.1 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.014 1.726 . . . . 71.13 113.81 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.3 mm -122.61 134.23 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.53 1.132 . . . . 60.11 109.114 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.92 137.84 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.701 -1.222 . . . . 74.23 107.701 170.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.4 m -131.77 116.51 17.36 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.201 -1.407 . . . . 65.21 107.201 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.79 137.98 48.99 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.575 -0.898 . . . . 75.33 108.575 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 99.1 m -133.29 112.89 12.03 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 124.795 1.31 . . . . 75.43 108.247 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 33.1 mtp -111.04 146.87 35.96 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 126.0 1.72 . . . . 74.34 109.181 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.2 m -138.93 98.6 3.57 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 124.41 1.069 . . . . 60.32 109.258 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.521 HD13 HG13 ' A' ' 98' ' ' ILE . 9.2 tp -104.4 112.06 24.95 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.537 1.535 . . . . 71.2 108.354 174.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.43 -114.71 6.78 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 124.729 1.268 . . . . 63.24 110.871 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.54 8.0 44.85 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.452 1.901 . . . . 71.45 113.469 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.9 mp -124.16 143.17 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.689 1.195 . . . . 75.42 109.594 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.5 t -126.95 94.41 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.079 0.952 . . . . 64.21 110.297 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -75.83 132.61 40.48 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 123.677 0.791 . . . . 74.24 111.035 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -122.62 149.67 43.68 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 124.339 1.025 . . . . 63.24 109.499 173.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.13 133.64 23.43 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.043 1.337 . . . . 62.53 108.368 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -124.86 137.01 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.892 1.277 . . . . 74.22 108.053 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.1 m -137.98 156.86 47.4 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.691 1.196 . . . . 75.33 110.563 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -126.44 146.42 50.09 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.53 1.532 . . . . 63.23 109.744 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.3 tpp85 -56.92 142.15 42.52 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.459 2.303 . . . . 72.42 112.98 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 105.883 -1.895 . . . . 72.13 105.883 -175.814 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 33.6 m170 . . . . . 0 N--CA 1.501 2.078 0 N-CA-C 107.71 -1.218 . . . . 74.42 107.71 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 2.0 m80 66.18 -172.52 0.19 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.616 1.567 . . . . 63.42 112.913 -167.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -137.53 169.3 18.02 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.833 1.253 . . . . 55.23 109.724 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -146.42 174.28 11.52 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.507 1.523 . . . . 74.33 110.825 -175.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -106.5 76.52 1.14 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.061 0.944 . . . . 71.43 109.497 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.25 151.32 6.72 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.279 1.432 . . . . 75.21 109.671 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.64 -40.88 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 124.754 1.284 . . . . 73.0 111.647 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . 61.64 161.63 0.07 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.436 2.294 . . . . 33.23 113.789 -173.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.0 mmm -126.95 140.05 52.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.642 0.777 . . . . 64.11 109.982 -175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.9 p -137.85 94.91 2.95 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.958 1.303 . . . . 72.34 110.067 -170.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -63.74 -25.23 68.1 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.18 1.548 . . . . 74.21 115.18 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.5 p -57.65 119.58 6.85 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.244 1.817 . . . . 75.25 113.679 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.04 164.97 13.23 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 110.689 -0.964 . . . . 65.11 110.689 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.49 ' HB3' HD12 ' A' ' 127' ' ' ILE . 2.5 mtmt -95.14 147.87 22.98 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.639 1.576 . . . . 74.12 111.68 173.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -143.08 133.91 25.36 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.032 1.333 . . . . 74.24 109.798 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -102.16 150.54 23.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.786 1.234 . . . . 63.35 110.267 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.89 128.97 38.35 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.101 1.36 . . . . 71.32 111.096 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -113.54 -51.58 2.8 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 124.796 1.238 . . . . 65.5 111.64 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -152.92 168.27 26.37 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.489 1.118 . . . . 73.05 111.259 -170.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -165.39 145.35 6.8 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.787 1.235 . . . . 74.35 111.049 -170.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -139.84 146.82 39.84 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.947 1.299 . . . . 71.15 109.508 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 55.12 27.68 9.87 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.513 1.925 . . . . 63.12 113.035 -173.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -63.43 -60.32 3.52 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-O 118.078 -0.963 . . . . 74.25 111.58 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -60.34 -41.87 94.49 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 124.281 0.988 . . . . 60.04 113.041 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.75 -48.93 71.99 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.556 1.143 . . . . 53.45 113.397 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -66.68 -47.2 73.2 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.193 1.397 . . . . 70.13 113.072 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.8 mmt -68.64 -39.63 80.63 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.545 1.138 . . . . 61.43 113.105 -175.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.497 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.3 mptm? -66.34 -34.13 77.28 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.932 0.893 . . . . 62.13 112.637 169.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.7 -34.9 67.45 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 114.415 1.265 . . . . 71.32 114.415 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.0 pt -77.67 -9.79 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 113.143 0.794 . . . . 75.3 113.143 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.19 26.71 20.62 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.235 -1.314 . . . . 44.11 112.988 168.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 75' ' ' THR . 79.1 mt -69.3 151.78 96.8 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 119.351 1.575 . . . . 72.05 111.711 172.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -69.88 147.72 62.7 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.192 1.928 . . . . 64.41 111.538 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.404 ' HA ' HD12 ' A' ' 29' ' ' ILE . 63.0 tt0 -54.75 -30.91 57.67 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.025 1.33 . . . . 74.34 114.484 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -63.08 -45.57 91.5 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 117.877 -1.059 . . . . 73.54 113.702 175.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.0 mt -65.66 -26.88 67.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.186 0.994 . . . . 75.44 113.429 174.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.497 HD13 ' HD2' ' A' ' 20' ' ' LYS . 54.1 mt -78.79 -50.95 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.162 0.985 . . . . 64.11 110.677 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -62.48 -40.92 98.23 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 117.731 -1.128 . . . . 53.41 113.622 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -28.91 64.29 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.425 -0.797 . . . . 75.5 112.61 172.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.14 -31.53 57.39 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-O 118.957 -0.913 . . . . 20.32 112.617 -174.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -30.46 16.49 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.418 1.087 . . . . 72.43 112.945 173.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.79 -50.95 21.07 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.385 1.074 . . . . 75.45 111.063 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.1 mm -88.03 126.81 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 O-C-N 124.337 1.023 . . . . 62.42 109.196 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -82.61 135.19 35.12 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.265 0.978 . . . . 63.21 110.19 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.62 -171.16 34.49 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 109.829 -1.308 . . . . 74.13 109.829 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 76.0 t -135.3 161.94 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 126.342 1.857 . . . . 70.24 108.86 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.2 t -145.63 157.66 43.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.277 1.031 . . . . 70.22 110.125 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -137.74 131.4 31.23 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 108.422 -0.955 . . . . 72.33 108.422 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.3 mt -110.63 130.94 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 106.112 -1.811 . . . . 62.45 106.112 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.4 t -134.2 124.99 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.0 0.92 . . . . 74.23 108.569 -173.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -114.14 131.67 56.34 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.815 1.246 . . . . 74.34 108.994 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -133.55 52.86 2.05 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.243 1.417 . . . . 73.54 109.806 -174.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.65 -115.01 5.12 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 108.742 -1.743 . . . . 50.4 108.742 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -71.88 -38.1 70.07 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.961 1.097 . . . . 73.31 113.961 173.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.19 158.62 33.82 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 124.124 0.89 . . . . 72.23 111.864 172.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -158.63 135.5 9.68 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 106.217 -1.772 . . . . 73.35 106.217 -173.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -121.0 154.79 35.56 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.95 0.781 . . . . 75.04 110.089 171.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -137.38 125.26 22.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 124.532 1.145 . . . . 70.41 108.836 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.4 m -107.23 125.03 50.61 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.893 1.677 . . . . 45.21 108.166 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.8 mt -121.37 116.09 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.003 -1.11 . . . . 74.15 108.003 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -113.66 114.01 25.81 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 124.385 1.053 . . . . 51.0 110.073 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -146.93 145.73 29.89 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.834 0.853 . . . . 75.3 110.33 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.97 -90.9 0.59 Allowed Glycine 0 CA--C 1.532 1.102 0 N-CA-C 109.504 -1.438 . . . . 43.33 109.504 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.2 t -156.33 42.15 0.38 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.14 1.376 . . . . 73.3 110.155 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -154.23 159.77 41.49 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.273 1.029 . . . . 75.41 111.48 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.6 t -127.63 131.41 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 125.443 1.497 . . . . 63.15 109.222 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.2 mt -115.91 113.36 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.32 1.448 . . . . 74.53 108.363 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.22 119.91 40.47 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.198 -1.038 . . . . 63.21 108.198 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -114.13 166.01 12.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.413 1.085 . . . . 63.35 110.096 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -141.34 140.95 33.86 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.224 1.01 . . . . 73.05 109.732 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -151.19 152.6 33.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.99 1.316 . . . . 75.23 109.871 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.9 m -100.7 132.73 45.94 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.498 -0.927 . . . . 72.31 108.498 171.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.19 112.33 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.313 1.045 . . . . 63.33 110.654 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.83 -14.68 49.26 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.053 -1.415 . . . . 75.31 112.712 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -99.98 145.11 28.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.501 1.65 . . . . 71.42 110.461 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -66.99 127.53 32.93 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.129 1.371 . . . . 72.15 111.379 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.5 m -148.65 153.7 38.66 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.293 1.437 . . . . 74.14 109.332 -175.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -92.94 123.66 36.36 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.59 0.756 . . . . 74.33 110.649 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.5 138.5 40.79 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.279 1.432 . . . . 71.33 109.121 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -103.88 139.33 39.21 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.496 1.519 . . . . 63.54 109.68 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.4 m -88.25 163.93 15.87 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.399 1.48 . . . . 60.32 110.889 173.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 74.7 mtm -54.49 -29.16 49.34 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.729 1.381 . . . . 75.24 114.729 169.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.516 HG21 HD21 ' A' ' 24' ' ' LEU . 47.0 p -85.57 -10.89 55.28 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.916 2.086 . . . . 74.02 113.306 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.84 4.33 60.36 Favored Glycine 0 CA--C 1.538 1.524 0 CA-C-O 118.149 -1.362 . . . . 62.43 113.215 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -65.52 121.25 14.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.428 1.614 . . . . 74.34 110.442 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -108.21 129.3 55.2 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.06 0.85 . . . . 71.12 109.65 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.55 131.83 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.594 1.157 . . . . 71.33 111.124 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -75.09 125.94 29.99 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.356 1.462 . . . . 75.51 110.694 174.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.4 t -151.4 164.13 37.41 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.576 1.551 . . . . 74.2 109.642 -172.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.15 130.89 66.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.033 -1.099 . . . . 42.04 108.033 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.8 t -103.22 128.26 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 124.095 0.872 . . . . 70.35 109.313 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -114.55 171.4 7.65 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.968 2.107 . . . . 65.02 110.295 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.473 HD13 ' H ' ' A' ' 87' ' ' GLY . 1.7 tm? -131.52 124.17 29.55 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.134 -1.432 . . . . 64.15 107.134 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.71 13.89 3.52 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.466 1.284 . . . . 62.4 114.466 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.473 ' H ' HD13 ' A' ' 85' ' ' LEU . . . 74.71 13.79 81.88 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.371 1.462 . . . . 63.34 113.014 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -145.08 51.8 1.22 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.573 1.187 . . . . 62.51 109.978 -169.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.276 0.5 OUTLIER 51.65 30.85 7.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.437 1.895 . . . . 73.45 115.171 175.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -140.56 120.93 14.02 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.877 1.271 . . . . 74.52 108.822 -167.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.6 mt -91.92 118.68 30.98 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.148 0.979 . . . . 65.32 109.293 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 91.7 t -101.72 126.37 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.11 1.364 . . . . 61.13 108.819 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.5 m -141.22 149.88 41.96 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.143 0.977 . . . . 63.33 109.373 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.6 p -147.0 138.71 24.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.791 0.836 . . . . 75.11 109.922 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -98.08 -79.61 0.47 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.729 1.611 . . . . 65.02 108.892 -176.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -136.37 -44.7 0.62 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.923 1.289 . . . . 65.23 109.734 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -150.02 8.76 0.65 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.177 1.391 . . . . 74.45 112.64 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.466 HG13 HD13 ' A' ' 115' ' ' LEU . 4.4 mp -109.18 116.12 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.698 1.199 . . . . 51.44 107.769 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.2 tmtp? -98.2 87.81 4.02 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.056 1.342 . . . . 74.33 109.232 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.4 t -74.97 127.82 34.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.132 1.373 . . . . 52.41 111.743 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.6 t -138.24 95.98 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.698 1.599 . . . . 53.11 107.579 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 87.3 m -82.32 155.72 24.64 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.073 1.349 . . . . 54.15 110.285 173.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -145.37 141.64 28.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.422 1.489 . . . . 73.43 109.84 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 tp -119.46 124.14 45.76 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.945 2.098 . . . . 75.03 107.155 172.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -131.18 81.7 2.0 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 106.285 -1.746 . . . . 71.04 106.285 171.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.79 -116.82 9.69 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.946 1.26 . . . . 53.43 110.631 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -80.49 -0.98 39.77 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.977 1.311 . . . . 71.13 114.37 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.8 mm -115.55 131.91 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 119.466 1.03 . . . . 60.11 109.437 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.9 mm -108.84 138.23 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 125.095 1.358 . . . . 74.23 108.122 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.9 m -133.41 110.97 10.37 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 124.629 1.206 . . . . 65.21 107.751 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.9 135.67 45.82 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.912 -0.773 . . . . 75.33 108.912 175.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.4 m -131.76 117.65 18.87 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.845 1.258 . . . . 75.43 108.454 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -110.09 149.93 29.32 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.155 1.382 . . . . 74.34 109.456 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.9 m -133.34 98.93 4.37 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.194 0.934 . . . . 60.32 109.378 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.466 HD13 HG13 ' A' ' 98' ' ' ILE . 8.9 tp -102.01 109.79 21.6 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 125.175 1.39 . . . . 71.2 108.732 174.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.47 -114.86 6.94 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 124.864 1.353 . . . . 63.24 110.777 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.11 -0.74 53.17 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.583 1.953 . . . . 71.45 113.926 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.0 mt -118.06 143.5 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.813 1.245 . . . . 75.42 110.113 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.5 t -125.33 95.17 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.915 0.886 . . . . 64.21 110.053 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -70.86 137.68 49.6 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.833 1.653 . . . . 74.24 112.628 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -124.83 151.87 44.67 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.394 1.077 . . . . 63.24 111.253 170.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.8 mmt-85 -138.87 136.65 35.78 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.781 2.032 . . . . 62.53 108.111 172.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.35 133.72 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.522 -1.288 . . . . 74.22 107.522 173.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.4 m -137.34 156.76 47.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.866 1.266 . . . . 75.33 109.67 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -134.39 144.71 48.35 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.471 1.108 . . . . 63.23 110.657 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.8 ttp85 -64.11 143.61 57.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.352 1.861 . . . . 72.42 114.014 -170.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 6' ' ' LYS . 15.3 mt . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 105.462 -2.051 . . . . 72.13 105.462 -172.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 . . . . . 0 N--CA 1.501 2.085 0 N-CA-C 107.833 -1.173 . . . . 74.42 107.833 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 22.5 p80 56.13 29.58 14.89 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.146 2.178 . . . . 63.42 114.572 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -62.69 136.06 57.68 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.559 1.544 . . . . 55.23 112.21 -175.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 74.9 t60 64.22 74.18 0.41 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.903 2.081 . . . . 74.33 111.584 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -158.17 147.67 19.66 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.004 1.321 . . . . 71.43 109.716 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -69.72 125.65 27.35 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.686 1.194 . . . . 75.21 110.695 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 20.3 m -117.86 -32.76 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 124.793 1.308 . . . . 73.0 112.223 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . 57.86 -152.54 0.4 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.641 1.977 . . . . 33.23 113.238 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -137.14 142.69 42.23 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.719 1.208 . . . . 64.11 109.241 171.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 t -161.27 130.79 4.75 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.762 1.225 . . . . 72.34 108.653 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.434 ' HA ' HD22 ' A' ' 104' ' ' LEU . 27.5 m-85 -60.99 -34.55 74.97 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.469 1.507 . . . . 74.21 114.538 172.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 t -58.98 123.46 16.65 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.806 1.642 . . . . 75.25 113.295 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.66 164.79 13.25 Favored Glycine 0 CA--C 1.539 1.563 0 O-C-N 124.419 1.074 . . . . 65.11 110.529 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HB3' HD12 ' A' ' 127' ' ' ILE . 1.4 mmmt -98.97 148.3 24.13 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.031 1.732 . . . . 74.12 111.356 174.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -142.98 155.44 44.68 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.177 1.391 . . . . 74.24 109.528 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -127.14 144.04 51.12 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.527 -0.916 . . . . 63.35 108.527 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 36' ' ' LYS . 58.2 tp -56.66 134.83 54.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.696 1.198 . . . . 71.32 111.742 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -115.46 -51.42 2.69 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 124.798 1.311 . . . . 65.5 110.116 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 t -159.66 162.68 35.18 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 124.409 1.068 . . . . 73.05 110.185 -173.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -155.78 159.82 39.75 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.554 1.542 . . . . 74.35 111.349 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -137.84 142.18 40.77 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.138 1.375 . . . . 71.15 108.619 176.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 57.4 28.33 15.22 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.276 1.831 . . . . 63.12 113.167 -174.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.67 -57.92 9.32 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.058 0.943 . . . . 74.25 112.163 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -52.69 -50.01 64.15 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.313 1.845 . . . . 60.04 112.348 173.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.91 -47.11 86.19 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.14 1.376 . . . . 53.45 113.956 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -69.43 -46.29 67.13 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 124.787 1.235 . . . . 70.13 113.567 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.5 mmt -65.81 -37.93 87.59 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 124.729 1.268 . . . . 61.43 112.975 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.465 ' HD3' HD13 ' A' ' 29' ' ' ILE . 8.1 mmmm -71.94 -27.09 62.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.103 0.961 . . . . 62.13 112.482 171.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.03 -37.47 58.32 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.556 1.142 . . . . 71.32 113.721 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.9 pt -78.24 -8.27 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 113.391 0.886 . . . . 75.3 113.391 170.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.8 31.46 26.59 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.509 -1.162 . . . . 44.11 112.547 169.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.31 153.06 93.37 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 118.861 1.33 . . . . 72.05 111.704 173.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.7 142.22 69.45 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.18 1.92 . . . . 64.41 111.407 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -59.02 -24.84 63.16 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.514 1.301 . . . . 74.34 114.514 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -62.66 -47.23 84.59 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 117.266 -1.349 . . . . 73.54 113.55 171.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.2 mt -63.67 -28.04 69.63 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.306 1.042 . . . . 75.44 113.693 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.465 HD13 ' HD3' ' A' ' 20' ' ' LYS . 15.4 mt -76.95 -52.64 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.322 1.049 . . . . 64.11 111.394 176.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -62.7 -41.08 98.94 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 117.576 -1.202 . . . . 53.41 113.335 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -25.61 61.21 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 118.216 -0.897 . . . . 75.5 113.171 172.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.83 -32.28 50.48 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.148 -0.807 . . . . 20.32 111.978 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.0 -31.57 16.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.677 1.191 . . . . 72.43 113.066 173.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -72.27 -54.4 9.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.686 1.194 . . . . 75.45 110.854 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.9 mm -94.22 125.63 46.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 124.346 1.029 . . . . 62.42 108.636 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.498 ' HA ' HD23 ' A' ' 9' ' ' LEU . 13.7 mptt -73.79 104.75 4.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.452 1.101 . . . . 63.21 110.284 170.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.0 158.1 51.82 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 124.497 1.123 . . . . 74.13 110.592 176.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.3 t -100.91 152.19 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.119 0.968 . . . . 70.24 109.257 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.7 t -130.3 155.58 46.08 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.109 1.764 . . . . 70.22 108.563 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -158.05 143.25 16.7 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.493 -0.558 . . . . 72.33 109.493 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.407 HG12 ' CE1' ' A' ' 50' ' ' PHE . 11.3 mt -134.76 133.44 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 106.077 -1.823 . . . . 62.45 106.077 -173.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.2 t -140.34 98.92 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 107.81 -1.181 . . . . 74.23 107.81 -175.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -82.37 133.14 35.22 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.667 1.187 . . . . 74.34 109.928 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -133.81 54.32 1.96 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.941 1.297 . . . . 73.54 110.153 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.9 -111.92 3.61 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 109.156 -1.578 . . . . 50.4 109.156 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -77.34 -33.03 55.5 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.373 1.069 . . . . 73.31 113.813 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.56 154.7 34.26 Favored 'General case' 0 C--N 1.346 0.421 0 O-C-N 124.147 0.904 . . . . 72.23 111.267 172.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -144.99 135.16 23.98 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.49 -1.67 . . . . 73.35 106.49 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -123.27 152.66 41.13 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.229 1.411 . . . . 75.04 110.058 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.407 ' CE1' HG12 ' A' ' 41' ' ' ILE . 8.0 t80 -143.24 135.35 26.98 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.231 -1.396 . . . . 70.41 107.231 177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 m -123.1 107.26 11.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.529 1.131 . . . . 45.21 109.633 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.5 mt -95.31 136.38 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.609 1.164 . . . . 74.15 108.544 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.2 m -123.09 125.49 45.28 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.478 1.111 . . . . 51.0 108.763 172.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.74 70.73 0.72 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.292 1.037 . . . . 75.3 108.813 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.44 -37.86 1.83 Allowed Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.85 1.69 . . . . 43.33 113.894 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.0 p -157.05 -45.39 0.07 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.131 1.466 . . . . 73.3 112.137 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.99 139.28 48.53 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.27 1.028 . . . . 75.41 110.823 171.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.96 136.4 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 124.541 1.15 . . . . 63.15 109.315 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.6 mt -125.76 124.19 65.97 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 C-N-CA 124.669 1.188 . . . . 74.53 109.067 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -109.24 124.0 50.17 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 125.206 1.566 . . . . 63.21 107.749 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -122.09 144.82 48.69 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.976 1.31 . . . . 63.35 108.685 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -135.23 143.27 46.25 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 125.019 1.449 . . . . 73.05 109.407 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.76 162.74 40.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.509 1.123 . . . . 75.23 110.022 175.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.1 m -108.59 130.04 55.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.391 1.076 . . . . 72.31 108.35 172.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.9 116.82 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.239 1.016 . . . . 63.33 110.439 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.74 -8.16 39.53 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.006 -1.441 . . . . 75.31 112.413 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -121.32 154.01 36.97 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 119.155 1.478 . . . . 71.42 111.065 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.39 131.86 39.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.913 1.685 . . . . 72.15 110.422 174.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.8 m -143.32 156.69 44.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.442 1.497 . . . . 74.14 108.416 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -95.62 123.89 39.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.701 0.8 . . . . 74.33 110.289 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.01 135.27 51.12 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.193 1.797 . . . . 71.33 109.176 -174.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -100.26 145.22 28.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.355 1.462 . . . . 63.54 111.82 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.3 p -104.82 174.35 5.92 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.107 1.763 . . . . 60.32 112.069 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -54.8 -34.96 63.35 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.471 1.656 . . . . 75.24 115.471 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.5 p -91.47 -5.44 54.25 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.616 1.566 . . . . 74.02 112.983 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.27 13.35 54.48 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 118.337 -1.257 . . . . 62.43 112.954 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -65.38 130.02 41.81 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.188 1.494 . . . . 74.34 109.995 173.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.5 mtpt -114.57 120.27 39.63 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.488 -0.93 . . . . 71.12 108.488 -174.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 m -138.68 128.45 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.903 1.281 . . . . 71.33 111.226 -170.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.86 135.9 40.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.525 1.13 . . . . 75.51 112.296 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 t -161.49 151.9 17.59 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.295 1.438 . . . . 74.2 110.181 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.99 136.41 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.621 1.168 . . . . 42.04 107.958 170.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -106.77 132.24 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 108.249 -1.019 . . . . 70.35 108.249 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -132.04 147.73 52.46 Favored 'General case' 0 C--N 1.345 0.373 0 C-N-CA 124.94 1.296 . . . . 65.02 112.646 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.842 HD23 ' H ' ' A' ' 87' ' ' GLY . 3.3 tt -109.44 128.43 55.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.693 1.597 . . . . 64.15 109.094 -174.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.47 11.59 21.23 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.164 1.385 . . . . 62.4 114.134 -176.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.842 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 81.21 -1.52 84.81 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.833 1.682 . . . . 63.34 113.137 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -121.94 38.19 4.18 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.747 1.619 . . . . 62.51 111.63 -168.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.326 0.3 OUTLIER 52.38 41.23 30.57 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.572 1.949 . . . . 73.45 113.917 178.753 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -138.81 141.91 38.72 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.263 1.825 . . . . 74.52 108.353 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.2 mt -121.63 119.43 31.84 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 124.302 1.001 . . . . 65.32 110.245 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -102.36 133.81 44.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.271 1.428 . . . . 61.13 108.883 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 t -153.03 135.67 15.25 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.457 1.103 . . . . 63.33 110.576 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.9 p -137.86 126.49 23.66 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.005 1.322 . . . . 75.11 110.155 -172.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -92.27 -61.26 1.65 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.917 1.287 . . . . 65.02 110.145 -175.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -143.15 -70.12 0.33 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.263 1.425 . . . . 65.23 108.43 -174.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -123.77 -20.58 5.41 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.977 1.711 . . . . 74.45 111.186 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.57 HG13 HD13 ' A' ' 115' ' ' LEU . 4.3 mp -79.32 121.78 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.71 1.204 . . . . 51.44 109.275 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -112.28 93.31 4.38 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.108 1.363 . . . . 74.33 108.722 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.2 t -95.09 112.3 24.02 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.872 1.669 . . . . 52.41 110.205 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.4 t -113.82 116.33 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.143 1.377 . . . . 53.11 108.347 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.0 m -94.72 152.54 18.37 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.812 1.645 . . . . 54.15 109.92 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -145.17 140.9 28.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.799 1.64 . . . . 73.43 109.383 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 3' ' ' PHE . 13.6 tp -122.36 126.46 48.09 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.292 1.837 . . . . 75.03 107.05 173.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -133.49 87.18 2.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.552 1.941 . . . . 71.04 106.84 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.94 -114.79 6.88 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 110.58 -1.008 . . . . 53.43 110.58 175.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.56 3.69 49.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.424 1.49 . . . . 71.13 113.798 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.7 mm -116.27 131.68 68.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.282 0.946 . . . . 60.11 109.054 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 42.9 mm -106.38 136.12 42.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.264 0 N-CA-C 107.527 -1.286 . . . . 74.23 107.527 168.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.9 m -123.27 137.66 54.81 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.168 -1.419 . . . . 65.21 107.168 172.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.71 135.09 41.72 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.405 -0.961 . . . . 75.33 108.405 176.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 90.7 m -132.81 116.03 16.03 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.605 1.191 . . . . 75.43 108.547 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 94.0 mtp -107.62 142.37 37.67 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.431 1.492 . . . . 74.34 108.935 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.7 m -132.58 108.25 8.96 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.288 0.993 . . . . 60.32 108.639 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.57 HD13 HG13 ' A' ' 98' ' ' ILE . 12.8 tp -121.1 112.76 19.1 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.529 1.531 . . . . 71.2 108.117 177.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.3 -118.61 15.47 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 124.657 1.223 . . . . 63.24 110.129 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.47 3.92 50.64 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.502 1.521 . . . . 71.45 113.114 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mp -111.45 135.43 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.056 0.942 . . . . 75.42 109.273 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.14 96.08 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.035 0.934 . . . . 64.21 109.421 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -76.34 131.05 38.94 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.636 1.574 . . . . 74.24 112.193 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -113.67 152.52 30.33 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.601 1.161 . . . . 63.24 109.825 167.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -150.48 138.65 20.25 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.837 1.255 . . . . 62.53 109.038 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -130.22 137.05 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.82 1.248 . . . . 74.22 108.534 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 42.3 m -132.2 160.99 34.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.285 1.434 . . . . 75.33 110.273 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -136.2 144.46 44.94 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.799 1.24 . . . . 63.23 110.227 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -62.63 139.05 58.63 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 126.136 1.775 . . . . 72.42 113.765 -171.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 6' ' ' LYS . 23.1 mt . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 105.776 -1.935 . . . . 72.13 105.776 -174.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 69.7 m80 . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 103.842 -2.651 . . . . 74.42 103.842 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -146.32 137.25 24.31 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 125.334 1.454 . . . . 63.42 109.109 172.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -126.28 179.66 5.17 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.034 1.733 . . . . 55.23 109.316 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 64.65 77.42 0.31 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.278 1.831 . . . . 74.33 111.563 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -141.85 163.06 33.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.243 1.417 . . . . 71.43 110.51 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -134.98 52.73 2.03 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.906 1.282 . . . . 75.21 109.695 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 16.2 m -143.95 141.8 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.045 1.338 . . . . 73.0 109.679 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -84.3 157.27 21.58 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.825 1.25 . . . . 33.23 111.101 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.02 156.96 25.64 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.958 0.786 . . . . 64.11 111.531 171.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 t -161.57 145.61 12.86 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.066 1.347 . . . . 72.34 108.583 174.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -62.6 -27.7 69.37 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 115.355 1.613 . . . . 74.21 115.355 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.0 p -58.3 119.95 7.83 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.565 1.546 . . . . 75.25 113.974 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.08 160.32 9.48 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 110.121 -1.192 . . . . 65.11 110.121 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HB3' HD12 ' A' ' 127' ' ' ILE . 6.2 mtmt -92.39 149.25 21.52 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.82 1.248 . . . . 74.12 112.072 172.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -139.89 152.08 46.14 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.622 1.569 . . . . 74.24 109.353 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -125.1 148.13 48.69 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.264 1.425 . . . . 63.35 109.297 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.2 129.96 42.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.167 0.987 . . . . 71.32 111.722 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -114.24 -50.42 2.81 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.655 1.582 . . . . 65.5 111.23 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.8 t -152.7 170.58 19.9 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 124.259 0.974 . . . . 73.05 110.804 -171.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -167.83 149.94 5.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.148 1.379 . . . . 74.35 111.412 -166.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -142.47 140.69 31.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.203 1.401 . . . . 71.15 108.673 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 57.52 26.59 12.91 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.465 1.906 . . . . 63.12 113.952 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -62.48 -56.36 18.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.089 0.955 . . . . 74.25 112.263 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -49.91 -55.44 14.42 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.971 1.708 . . . . 60.04 111.996 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.1 -51.22 64.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.067 1.747 . . . . 53.45 114.351 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -67.39 -45.59 75.75 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.379 1.072 . . . . 70.13 113.377 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.4 mmt -68.35 -35.61 78.01 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 124.76 1.287 . . . . 61.43 112.666 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.7 mptm? -64.27 -36.0 82.67 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.809 0.843 . . . . 62.13 113.138 167.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.52 -35.82 60.65 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 114.679 1.363 . . . . 71.32 114.679 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.46 ' CD1' HD13 ' A' ' 24' ' ' LEU . 42.5 pt -76.28 -10.56 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.679 0.792 . . . . 75.3 113.108 170.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.4 27.07 26.15 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 118.41 -1.216 . . . . 44.11 112.862 170.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.525 HD11 ' CG2' ' A' ' 75' ' ' THR . 4.5 mp -67.58 147.26 98.74 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 119.112 1.456 . . . . 72.05 111.159 173.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -66.77 145.97 76.93 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.162 1.908 . . . . 64.41 111.433 172.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.463 ' HA ' HD12 ' A' ' 29' ' ' ILE . 42.5 tt0 -55.78 -29.2 59.25 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.47 1.285 . . . . 74.34 114.47 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -63.56 -45.42 90.57 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 117.772 -1.109 . . . . 73.54 113.827 174.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.2 mt -64.6 -27.41 68.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.227 1.011 . . . . 75.44 113.339 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.516 HD13 ' HD2' ' A' ' 20' ' ' LYS . 42.8 mt -77.93 -54.98 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.221 1.008 . . . . 64.11 110.09 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -58.9 -40.79 85.54 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.951 1.093 . . . . 53.41 113.951 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -29.44 62.7 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 118.431 -0.795 . . . . 75.5 112.732 173.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.69 -21.43 71.95 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-O 118.715 -1.047 . . . . 20.32 112.787 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -102.02 -24.98 13.91 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 124.661 1.184 . . . . 72.43 113.14 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -68.94 -52.6 27.54 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.941 1.296 . . . . 75.45 110.687 172.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.1 mm -96.39 137.06 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.755 1.222 . . . . 62.42 109.431 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -90.87 126.77 36.14 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.723 1.209 . . . . 63.21 110.042 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.37 175.97 46.36 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 124.475 1.109 . . . . 74.13 110.707 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.26 151.3 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.546 1.538 . . . . 70.24 108.213 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.3 t -148.82 105.53 3.57 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.852 0.861 . . . . 70.22 109.771 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -81.19 143.5 32.3 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 125.081 1.352 . . . . 72.33 110.801 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.41 HG12 ' CE1' ' A' ' 50' ' ' PHE . 13.8 mt -127.0 132.02 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 107.178 -1.415 . . . . 62.45 107.178 174.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.4 m -139.34 143.32 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.126 0.57 . . . . 74.23 109.931 172.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -121.73 128.24 51.57 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.219 1.808 . . . . 74.34 106.913 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -139.89 77.81 1.63 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.032 0.933 . . . . 73.54 108.891 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.18 -121.54 10.39 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 108.741 -1.744 . . . . 50.4 108.741 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -79.37 -26.66 41.98 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.387 1.254 . . . . 73.31 114.387 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.9 154.38 28.38 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 123.876 0.87 . . . . 72.23 111.442 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -146.02 134.11 21.55 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.834 -1.543 . . . . 73.35 106.834 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -123.01 159.14 29.0 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.302 1.041 . . . . 75.04 110.122 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.41 ' CE1' HG12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -151.47 123.12 7.95 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.076 1.35 . . . . 70.41 108.687 -174.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -119.81 107.13 12.8 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.271 1.029 . . . . 45.21 108.994 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.17 117.34 54.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.322 1.049 . . . . 74.15 108.708 -173.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.4 m -99.0 133.01 43.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.973 1.309 . . . . 51.0 109.089 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.25 81.17 1.87 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.645 1.178 . . . . 75.3 109.035 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.08 -79.36 1.92 Allowed Glycine 0 CA--C 1.531 1.045 0 N-CA-C 109.412 -1.475 . . . . 43.33 109.412 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 t -136.3 -30.04 0.95 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.847 1.259 . . . . 73.3 112.06 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -73.12 139.41 46.41 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 123.656 0.782 . . . . 75.41 110.837 170.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.01 117.64 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.002 -1.11 . . . . 63.15 108.002 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.0 mt -107.15 124.41 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.582 -1.266 . . . . 74.53 107.582 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -108.4 128.85 55.13 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 124.696 1.248 . . . . 63.21 108.703 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -132.58 154.12 50.34 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.144 1.378 . . . . 63.35 108.787 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.84 148.98 25.92 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 124.421 1.076 . . . . 73.05 109.969 -173.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -156.96 154.07 29.08 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 124.668 1.23 . . . . 75.23 110.267 -175.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -96.24 129.96 43.44 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.631 1.207 . . . . 72.31 108.307 170.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.87 125.39 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.37 1.068 . . . . 63.33 110.515 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.69 -35.02 5.2 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 118.381 -1.233 . . . . 75.31 111.553 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -97.4 143.18 28.39 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 118.861 1.33 . . . . 71.42 111.762 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.72 126.55 30.07 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.71 1.604 . . . . 72.15 111.067 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.4 m -141.79 153.29 44.44 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.853 1.261 . . . . 74.14 108.78 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.48 120.15 37.34 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.826 1.25 . . . . 74.33 108.761 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.43 HD23 HG22 ' A' ' 81' ' ' THR . 2.9 mm? -111.37 116.15 30.48 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 124.415 1.086 . . . . 71.33 109.031 -176.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -76.04 152.21 36.95 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 124.548 1.155 . . . . 63.54 111.084 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.1 p -114.94 179.67 3.88 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.795 1.638 . . . . 60.32 109.929 173.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 43.7 mtm -56.26 -29.23 60.83 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.811 1.782 . . . . 75.24 115.811 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.525 ' CG2' HD11 ' A' ' 24' ' ' LEU . 63.2 p -86.24 -13.03 48.03 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.507 1.523 . . . . 74.02 113.325 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.53 -1.9 60.42 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 118.287 -1.285 . . . . 62.43 112.074 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -67.68 115.06 6.83 Favored 'General case' 0 C--N 1.349 0.547 0 CA-C-N 119.294 1.547 . . . . 74.34 110.984 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -111.8 136.0 51.66 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 124.791 1.307 . . . . 71.12 109.361 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.96 128.64 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.827 1.251 . . . . 71.33 110.316 -169.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.54 128.83 38.05 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 124.44 1.088 . . . . 75.51 111.939 174.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.43 HG22 HD23 ' A' ' 71' ' ' LEU . 12.1 t -158.05 157.62 33.24 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.076 1.35 . . . . 74.2 109.433 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.1 m -101.2 151.93 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.875 1.27 . . . . 42.04 109.663 169.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.52 127.0 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.763 -1.199 . . . . 70.35 107.763 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -117.51 172.38 7.37 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.814 1.646 . . . . 65.02 109.67 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 87' ' ' GLY . 5.3 tt -130.11 129.06 43.06 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.611 1.164 . . . . 64.15 108.624 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -86.16 15.53 5.09 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.196 1.398 . . . . 62.4 114.602 -174.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.576 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 72.76 12.05 78.08 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 125.291 1.424 . . . . 63.34 113.161 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -143.36 51.88 1.36 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.648 1.179 . . . . 62.51 109.019 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.296 0.3 OUTLIER 48.72 38.29 11.34 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.892 2.077 . . . . 73.45 114.437 171.445 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -143.51 133.49 24.15 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 125.55 1.54 . . . . 74.52 108.431 -170.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.1 mt -103.91 124.27 48.67 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 124.525 1.141 . . . . 65.32 109.742 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.9 t -106.91 133.34 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.407 1.483 . . . . 61.13 108.617 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.7 t -164.98 140.8 5.52 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.201 1.0 . . . . 63.33 110.476 -168.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.5 m -146.72 128.97 15.72 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.666 0.604 . . . . 75.11 110.542 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -86.89 -154.75 0.24 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.773 1.629 . . . . 65.02 110.675 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.45 -34.1 74.86 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.639 1.576 . . . . 65.23 113.952 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -162.47 12.2 0.07 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.343 1.457 . . . . 74.45 112.47 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.432 HG12 HD13 ' A' ' 115' ' ' LEU . 21.9 mt -116.22 117.07 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.263 -1.384 . . . . 51.44 107.263 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -85.17 146.94 26.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.543 1.137 . . . . 74.33 108.687 169.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.7 m -150.43 125.99 10.23 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 123.857 0.723 . . . . 52.41 110.321 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.08 110.44 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.801 -1.185 . . . . 53.11 107.801 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.7 m -92.32 152.37 19.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.424 1.09 . . . . 54.15 109.511 172.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -143.74 138.38 28.77 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.979 1.712 . . . . 73.43 109.927 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.4 tp -118.58 125.14 49.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.84 2.056 . . . . 75.03 106.762 172.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -129.87 78.81 1.87 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.658 1.983 . . . . 71.04 106.293 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.99 -111.78 4.27 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.588 1.09 . . . . 53.43 110.58 176.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.74 -17.23 56.16 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.888 1.275 . . . . 71.13 113.536 175.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.8 mm -102.39 132.41 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 119.027 0.83 . . . . 60.11 110.161 -174.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.2 mm -108.53 140.39 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.022 1.329 . . . . 74.23 108.4 170.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.7 m -133.02 141.77 48.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.778 1.231 . . . . 65.21 107.719 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -132.95 142.0 48.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.565 1.146 . . . . 75.33 107.911 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.2 m -135.08 105.6 6.41 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 124.91 1.381 . . . . 75.43 108.206 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.6 mtp -98.58 148.28 23.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.901 1.68 . . . . 74.34 108.963 173.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.6 m -138.7 109.55 6.71 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.135 0.974 . . . . 60.32 108.83 173.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.432 HD13 HG12 ' A' ' 98' ' ' ILE . 12.7 tp -114.37 109.4 18.28 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.545 1.538 . . . . 71.2 108.14 176.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.47 -112.33 4.89 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 124.822 1.326 . . . . 63.24 110.465 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.83 2.37 41.01 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.74 2.016 . . . . 71.45 113.706 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.1 mt -122.5 142.83 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.709 1.204 . . . . 75.42 110.346 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.6 t -123.85 90.99 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.559 1.144 . . . . 64.21 110.164 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -73.57 128.92 36.83 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.4 1.08 . . . . 74.24 112.111 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -123.99 152.4 42.59 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.285 1.034 . . . . 63.24 110.716 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -140.61 144.3 35.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.965 1.306 . . . . 62.53 109.002 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -135.1 126.89 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.464 1.106 . . . . 74.22 108.109 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.8 m -129.87 159.43 36.63 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.74 1.216 . . . . 75.33 110.102 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -135.73 146.28 47.53 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.484 1.114 . . . . 63.23 110.626 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.3 ttp85 -62.79 139.52 58.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.242 2.217 . . . . 72.42 114.067 -172.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 6' ' ' LYS . 5.0 mt . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 105.792 -1.929 . . . . 72.13 105.792 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 . . . . . 0 N--CA 1.502 2.145 0 N-CA-C 108.11 -1.07 . . . . 74.42 108.11 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.45 149.28 33.39 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 125.336 1.454 . . . . 63.42 109.655 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 62.76 89.16 0.09 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.33 2.252 . . . . 55.23 112.52 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -154.21 42.32 0.51 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.972 0.909 . . . . 74.33 111.824 -171.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -133.34 152.23 51.91 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.65 1.18 . . . . 71.43 111.009 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -166.58 157.97 12.94 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.886 1.674 . . . . 75.21 109.575 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 26.2 m -100.25 140.81 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.157 0.983 . . . . 73.0 109.913 172.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -171.35 147.76 2.5 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.761 1.624 . . . . 33.23 108.909 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.3 mmm -118.55 117.23 28.43 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 124.384 1.052 . . . . 64.11 108.556 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.9 p -140.79 116.47 10.25 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.955 1.302 . . . . 72.34 108.946 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -60.24 -33.23 72.0 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.874 1.435 . . . . 74.21 114.874 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.2 p -57.61 133.3 55.17 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.168 1.787 . . . . 75.25 114.564 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.54 165.25 10.23 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.742 1.163 . . . . 65.11 110.217 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.486 ' HB3' HD12 ' A' ' 127' ' ' ILE . 8.3 mtmt -92.97 145.23 24.53 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 124.694 1.198 . . . . 74.12 112.004 173.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -135.94 147.67 48.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.508 1.523 . . . . 74.24 109.506 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -116.69 148.73 40.78 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.303 1.441 . . . . 63.35 109.454 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.481 HD13 ' HG3' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -72.84 121.88 20.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.71 1.204 . . . . 71.32 111.716 -175.109 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -96.31 -56.47 2.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.72 1.208 . . . . 65.5 111.85 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.5 t -161.77 159.05 26.64 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.15 0.98 . . . . 73.05 110.448 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -135.4 147.19 48.93 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.251 1.42 . . . . 74.35 108.698 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -123.32 138.05 54.7 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.1 1.36 . . . . 71.15 108.476 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 56.37 32.79 21.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.262 1.825 . . . . 63.12 112.616 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -61.74 -60.72 3.23 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.324 1.05 . . . . 74.25 110.594 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.47 -39.05 89.48 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 124.478 1.111 . . . . 60.04 113.559 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.68 -48.26 81.69 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.45 1.1 . . . . 53.45 112.965 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -68.32 -45.43 72.97 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.948 1.299 . . . . 70.13 113.072 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.9 mmt -69.19 -37.38 78.12 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.32 1.048 . . . . 61.43 113.118 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.542 ' HD2' HD13 ' A' ' 29' ' ' ILE . 6.3 mptt -67.01 -35.42 79.91 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.904 0.882 . . . . 62.13 112.754 169.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.56 -34.18 69.75 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.386 1.254 . . . . 71.32 114.386 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.9 pt -79.06 -9.72 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 113.204 0.816 . . . . 75.3 113.204 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.89 22.64 22.77 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 118.099 -1.389 . . . . 44.11 113.52 167.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.68 151.5 97.21 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 119.629 1.715 . . . . 72.05 111.866 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.26 147.51 59.81 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.291 1.994 . . . . 64.41 111.789 172.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.401 ' HA ' HD12 ' A' ' 29' ' ' ILE . 44.1 tt0 -57.11 -29.64 63.69 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.028 1.492 . . . . 74.34 115.028 -177.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -62.27 -44.67 96.01 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.383 0.882 . . . . 73.54 113.383 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -65.8 -27.6 68.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.549 1.539 . . . . 75.44 112.763 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.542 HD13 ' HD2' ' A' ' 20' ' ' LYS . 68.5 mt -79.95 -47.5 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.64 1.176 . . . . 64.11 111.085 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -65.23 -40.56 94.22 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-O 117.76 -1.114 . . . . 53.41 113.395 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.62 -25.38 61.28 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 118.262 -0.875 . . . . 75.5 112.854 172.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.57 -37.45 46.28 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 123.894 0.759 . . . . 20.32 111.953 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -28.47 21.79 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.517 1.127 . . . . 72.43 113.203 175.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.86 -57.63 3.93 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.59 1.156 . . . . 75.45 111.059 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.8 mm -81.86 119.11 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 124.328 1.017 . . . . 62.42 109.195 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.481 ' HG3' HD13 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -83.2 132.95 35.04 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 124.529 1.143 . . . . 63.21 111.054 177.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -97.75 -179.62 33.29 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 124.917 1.385 . . . . 74.13 110.996 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.4 t -129.44 147.35 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.393 1.877 . . . . 70.24 107.881 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.4 t -145.69 107.69 4.34 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.356 0.662 . . . . 70.22 110.022 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -85.22 148.72 25.94 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.573 1.149 . . . . 72.33 110.723 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.6 mt -126.84 133.67 67.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 124.943 1.402 . . . . 62.45 107.356 175.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.5 t -140.57 97.85 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.661 -0.866 . . . . 74.23 108.661 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -80.56 140.62 35.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.289 0.636 . . . . 74.34 109.519 168.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -146.74 71.63 1.24 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.067 0.947 . . . . 73.54 109.198 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.56 -127.0 11.5 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 109.311 -1.516 . . . . 50.4 109.311 -177.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -65.49 -35.52 81.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.239 1.416 . . . . 73.31 113.843 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -76.42 156.31 33.26 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 124.166 0.986 . . . . 72.23 112.14 174.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -151.98 126.41 9.38 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.711 -1.218 . . . . 73.35 107.711 -172.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -112.11 154.82 24.86 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.842 2.057 . . . . 75.04 109.926 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.95 143.15 25.04 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.535 1.534 . . . . 70.41 108.196 175.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.4 m -135.99 98.07 3.79 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.33 1.052 . . . . 45.21 108.564 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.1 mt -93.39 114.79 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.907 1.283 . . . . 74.15 109.368 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.0 m -104.92 118.1 35.69 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.831 1.653 . . . . 51.0 108.602 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -169.48 155.96 6.45 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.94 0.896 . . . . 75.3 111.462 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.39 -82.81 1.45 Allowed Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.071 -1.212 . . . . 43.33 110.071 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.9 p -157.0 12.4 0.24 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.584 1.554 . . . . 73.3 112.727 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.35 179.74 8.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.147 0.979 . . . . 75.41 111.577 -172.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.9 t -130.41 126.04 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.555 1.142 . . . . 63.15 108.723 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.3 mt -108.56 128.7 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.821 1.249 . . . . 74.53 108.827 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -114.5 133.61 55.64 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 124.859 1.35 . . . . 63.21 108.661 176.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -133.23 144.63 49.9 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.14 1.376 . . . . 63.35 108.694 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -132.28 145.13 51.08 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 124.882 1.364 . . . . 73.05 109.778 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -157.17 151.07 24.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.568 1.547 . . . . 75.23 108.204 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.4 m -93.69 140.53 29.53 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.708 0.803 . . . . 72.31 108.928 167.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.06 107.1 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.986 0.914 . . . . 63.33 110.064 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.06 -4.42 30.24 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 117.533 -1.704 . . . . 75.31 113.17 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -98.25 147.69 24.38 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.903 1.851 . . . . 71.42 109.409 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -84.87 125.68 32.83 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.749 1.22 . . . . 72.15 109.616 172.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.1 m -146.24 151.72 38.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.924 1.29 . . . . 74.14 109.61 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.55 116.59 28.57 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.905 1.282 . . . . 74.33 109.071 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.417 HD12 ' CG2' ' A' ' 81' ' ' THR . 83.0 mt -108.72 116.12 31.37 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.559 1.144 . . . . 71.33 109.848 -170.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -79.22 131.82 36.31 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.662 1.226 . . . . 63.54 111.484 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.8 p -90.82 169.67 10.75 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.572 1.549 . . . . 60.32 110.99 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.3 mtm -57.24 -27.47 62.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.929 1.692 . . . . 75.24 115.18 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 p -82.68 -14.55 54.43 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.246 1.818 . . . . 74.02 113.072 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.02 -4.55 59.0 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.289 1.423 . . . . 62.43 112.341 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -69.85 135.48 49.65 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 119.099 1.449 . . . . 74.34 110.439 173.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -138.41 136.5 36.34 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.969 0.793 . . . . 71.12 109.693 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.0 m -149.1 138.66 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.231 1.412 . . . . 71.33 110.089 -170.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 136.19 46.61 Favored 'General case' 0 C--N 1.346 0.416 0 O-C-N 124.213 0.946 . . . . 75.51 112.081 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.417 ' CG2' HD12 ' A' ' 71' ' ' LEU . 6.4 t -164.8 149.49 9.4 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.552 1.541 . . . . 74.2 109.384 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.3 t -99.32 138.48 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.516 1.126 . . . . 42.04 108.582 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 52.7 t -108.73 125.32 65.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 124.451 1.095 . . . . 70.35 108.254 172.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -120.15 157.16 29.6 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.892 1.677 . . . . 65.02 110.978 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.742 HD23 ' H ' ' A' ' 87' ' ' GLY . 6.7 tt -124.63 125.59 44.38 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.937 1.295 . . . . 64.15 108.137 -175.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.01 13.08 5.34 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.307 1.443 . . . . 62.4 114.87 -173.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.742 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 75.13 8.25 83.0 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 125.247 1.403 . . . . 63.34 113.031 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -142.28 61.77 1.44 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.978 1.311 . . . . 62.51 108.858 -171.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 48.02 35.24 4.88 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.155 2.182 . . . . 73.45 115.929 167.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -143.8 139.8 29.53 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.664 1.586 . . . . 74.52 108.691 -172.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.5 mt -113.56 122.63 47.82 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 124.362 1.039 . . . . 65.32 109.684 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.4 t -105.63 134.93 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.472 1.509 . . . . 61.13 108.92 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 t -163.38 144.98 9.57 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.237 1.415 . . . . 63.33 109.969 -171.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 83.9 m -147.86 129.35 14.92 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.809 0.844 . . . . 75.11 110.105 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -69.37 -75.12 0.12 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.831 1.252 . . . . 65.02 111.261 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -138.32 -41.07 0.51 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.328 1.851 . . . . 65.23 110.447 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -154.92 21.16 0.44 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.25 1.42 . . . . 74.45 111.825 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.478 HG13 HD13 ' A' ' 115' ' ' LEU . 5.1 mp -120.89 91.05 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.069 1.347 . . . . 51.44 107.697 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -70.06 109.49 4.59 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.051 0.94 . . . . 74.33 111.313 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.6 m -116.88 114.45 23.9 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 124.872 1.358 . . . . 52.41 109.332 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.1 t -117.46 110.16 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.962 1.305 . . . . 53.11 107.898 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.2 m -86.17 153.14 22.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.369 1.468 . . . . 54.15 109.688 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -148.11 138.88 23.07 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.816 1.246 . . . . 73.43 109.802 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.0 tp -116.28 126.57 53.74 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.824 2.05 . . . . 75.03 107.704 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -126.46 70.42 1.25 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.001 1.721 . . . . 71.04 106.766 170.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.41 -110.14 3.31 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.913 1.244 . . . . 53.43 110.417 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.03 4.51 14.24 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.476 1.511 . . . . 71.13 113.903 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.8 mm -123.92 140.5 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.118 0.967 . . . . 60.11 109.165 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.7 mm -120.3 137.27 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 125.123 1.369 . . . . 74.23 107.966 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.7 m -134.65 115.61 14.01 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 124.671 1.232 . . . . 65.21 107.84 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -106.08 139.64 40.3 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.436 -0.95 . . . . 75.33 108.436 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.7 m -131.28 120.69 23.54 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.873 1.358 . . . . 75.43 108.358 174.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.4 mtm -112.72 150.19 31.89 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.884 1.674 . . . . 74.34 109.594 173.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.1 m -138.87 96.3 3.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.556 1.142 . . . . 60.32 108.862 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.478 HD13 HG13 ' A' ' 98' ' ' ILE . 9.2 tp -104.73 111.01 23.57 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.443 1.497 . . . . 71.2 108.883 175.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.34 -112.87 5.36 Favored Glycine 0 CA--C 1.533 1.193 0 O-C-N 124.574 1.171 . . . . 63.24 110.413 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -110.9 18.74 19.23 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.91 1.684 . . . . 71.45 111.29 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.4 mt -129.4 136.88 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.015 1.326 . . . . 75.42 109.026 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.6 t -121.99 95.69 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 124.237 0.961 . . . . 64.21 109.565 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -75.05 128.24 35.09 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.814 1.245 . . . . 74.24 112.317 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.04 153.34 34.88 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 124.094 0.871 . . . . 63.24 110.835 169.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -135.29 139.06 44.07 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 126.362 1.865 . . . . 62.53 108.199 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.32 133.71 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 O-C-N 124.802 1.314 . . . . 74.22 107.622 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.9 m -137.37 158.51 44.24 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.122 1.369 . . . . 75.33 110.116 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -139.11 142.77 38.08 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.583 1.153 . . . . 63.23 110.755 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -68.06 136.82 54.38 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.969 2.108 . . . . 72.42 113.005 -168.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 6' ' ' LYS . 17.5 mt . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 105.494 -2.039 . . . . 72.13 105.494 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 74.2 m80 . . . . . 0 N--CA 1.501 2.082 0 N-CA-C 103.149 -2.908 . . . . 74.42 103.149 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 49.5 m80 55.52 -157.29 0.24 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.707 2.003 . . . . 63.42 113.662 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -98.83 76.66 2.18 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.947 1.299 . . . . 55.23 109.25 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -89.41 93.03 9.37 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.908 0.883 . . . . 74.33 110.019 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -162.96 128.69 3.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.67 1.188 . . . . 71.43 108.565 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 6.9 m80 56.98 84.5 0.09 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.91 2.084 . . . . 75.21 113.023 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 26.9 m -105.06 19.64 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 125.114 1.365 . . . . 73.0 112.405 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -161.61 167.03 25.99 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.479 1.512 . . . . 33.23 110.622 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptm -67.8 161.74 25.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.575 1.55 . . . . 64.11 112.259 171.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.0 t -153.05 151.47 30.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.719 0.808 . . . . 72.34 110.078 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -68.18 -30.95 70.18 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 117.625 -1.179 . . . . 74.21 113.621 169.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.5 p -58.88 103.1 0.14 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.488 1.515 . . . . 75.25 112.968 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.75 174.11 37.77 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 108.958 -1.657 . . . . 65.11 108.958 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.53 146.11 48.36 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.686 -1.227 . . . . 74.12 107.686 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.435 ' CE1' HD11 ' A' ' 109' ' ' ILE . 8.1 m-85 -143.1 130.24 20.78 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.798 0.839 . . . . 74.24 110.397 -168.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.9 149.21 24.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.988 0.915 . . . . 63.35 110.532 174.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 36' ' ' LYS . 61.0 tp -68.64 132.31 46.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.6 0.76 . . . . 71.32 111.131 173.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -106.08 -53.53 2.62 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 124.67 1.231 . . . . 65.5 110.829 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.25 157.66 15.61 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 124.447 1.092 . . . . 73.05 110.382 -175.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.412 ' HG3' HD11 ' A' ' 9' ' ' LEU . 3.5 mp0 -135.98 137.69 41.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.562 1.145 . . . . 74.35 108.582 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -112.86 137.15 51.64 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.217 1.407 . . . . 71.15 108.406 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 57.39 30.19 18.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.124 1.77 . . . . 63.12 112.964 -171.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.21 -58.36 8.63 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 124.177 0.991 . . . . 74.25 112.111 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -52.59 -52.15 56.57 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.344 1.858 . . . . 60.04 112.42 173.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.96 -48.78 77.54 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.332 1.453 . . . . 53.45 114.037 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -67.72 -45.7 74.29 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.862 1.265 . . . . 70.13 113.593 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 7.3 mmt -65.38 -40.22 93.23 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 124.699 1.25 . . . . 61.43 112.829 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -67.84 -28.3 67.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.187 0.995 . . . . 62.13 113.052 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.63 -34.71 40.33 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 114.099 1.148 . . . . 71.32 114.099 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.0 pt -77.12 -6.82 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 113.065 0.765 . . . . 75.3 113.065 169.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.59 31.24 24.96 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.604 -1.109 . . . . 44.11 112.345 169.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.486 HD21 HG21 ' A' ' 75' ' ' THR . 0.1 OUTLIER -68.01 151.57 97.09 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 118.636 1.218 . . . . 72.05 111.774 177.64 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.51 139.48 59.03 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.01 1.807 . . . . 64.41 110.763 169.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.452 ' HA ' HD12 ' A' ' 29' ' ' ILE . 20.3 tt0 -63.45 -20.33 65.48 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.4 1.259 . . . . 74.34 114.4 -174.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.58 -45.71 91.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 117.881 -1.057 . . . . 73.54 113.435 168.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.8 mt -66.81 -26.96 67.19 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 124.212 1.005 . . . . 75.44 113.518 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 26' ' ' GLU . 22.5 mt -75.93 -51.22 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.033 0.933 . . . . 64.11 111.376 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -62.08 -48.24 81.07 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.111 -0.947 . . . . 53.41 112.646 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -27.03 68.59 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.426 0.898 . . . . 75.5 113.426 174.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.23 -29.23 51.04 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 118.69 -1.061 . . . . 20.32 112.395 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.37 -30.6 13.83 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.471 1.135 . . . . 72.43 112.732 175.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -72.9 -39.39 66.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.687 1.195 . . . . 75.45 113.335 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.6 mt -111.06 130.05 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.483 -0.932 . . . . 62.42 108.483 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HA ' HD23 ' A' ' 9' ' ' LEU . 12.1 mptt -88.02 134.13 33.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.928 1.291 . . . . 63.21 110.642 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.7 -168.15 26.38 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 109.683 -1.367 . . . . 74.13 109.683 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.2 t -134.97 153.96 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.885 1.274 . . . . 70.24 108.317 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.4 p -128.6 160.48 32.28 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.465 1.506 . . . . 70.22 110.622 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -133.75 148.84 51.44 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 107.452 -1.314 . . . . 72.33 107.452 169.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.422 HG12 ' CE2' ' A' ' 50' ' ' PHE . 7.8 mt -138.72 129.91 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 105.963 -1.866 . . . . 62.45 105.963 176.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.2 m -139.28 138.95 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 123.426 0.454 . . . . 74.23 110.029 175.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -109.94 117.17 33.09 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.083 1.753 . . . . 74.34 107.277 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -116.08 51.33 0.97 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.181 1.392 . . . . 73.54 109.162 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.95 -116.62 5.67 Favored Glycine 0 CA--C 1.534 1.227 0 N-CA-C 107.977 -2.049 . . . . 50.4 107.977 -171.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -72.59 -34.91 67.73 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.154 1.168 . . . . 73.31 114.154 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.44 161.75 29.51 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.856 0.723 . . . . 72.23 111.829 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -159.26 131.46 6.58 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 106.886 -1.524 . . . . 73.35 106.886 -173.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -121.07 149.2 43.08 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.978 1.311 . . . . 75.04 108.824 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.422 ' CE2' HG12 ' A' ' 41' ' ' ILE . 5.5 t80 -141.82 119.75 11.98 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.351 -1.352 . . . . 70.41 107.351 177.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 34.3 m -96.09 134.07 39.58 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.592 1.157 . . . . 45.21 108.909 172.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.58 107.0 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.939 -1.504 . . . . 74.15 106.939 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 m -99.33 100.63 11.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.717 1.207 . . . . 51.0 108.426 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.94 178.02 7.08 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.238 1.015 . . . . 75.3 111.325 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.47 29.55 2.57 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 125.216 1.388 . . . . 43.33 113.356 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -158.28 -33.48 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.35 1.575 . . . . 73.3 112.566 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.68 170.05 19.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.953 1.301 . . . . 75.41 110.37 -176.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.23 132.47 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 O-C-N 124.173 0.921 . . . . 63.15 109.181 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.4 mt -122.97 135.29 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.292 1.437 . . . . 74.53 107.926 172.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.6 143.34 47.71 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 124.175 0.922 . . . . 63.21 108.812 176.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -133.38 132.0 40.7 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.627 1.171 . . . . 63.35 109.734 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -113.02 143.57 44.08 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 125.427 1.704 . . . . 73.05 109.476 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -148.19 164.73 33.05 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.186 1.394 . . . . 75.23 108.659 173.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.7 m -113.51 131.28 56.12 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.434 -0.95 . . . . 72.31 108.434 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.0 t -62.76 119.37 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 125.011 1.324 . . . . 63.33 111.213 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.91 -10.47 73.85 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-O 117.906 -1.497 . . . . 75.31 113.668 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -107.52 139.46 42.01 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.64 1.72 . . . . 71.42 109.355 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.77 120.14 13.02 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 123.606 0.762 . . . . 72.15 111.736 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.5 m -138.92 140.58 38.37 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.263 1.425 . . . . 74.14 108.28 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -67.44 131.11 45.04 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.87 0.731 . . . . 74.33 111.214 168.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.479 HD12 ' CG2' ' A' ' 81' ' ' THR . 19.6 mt -120.77 109.31 15.01 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.543 1.537 . . . . 71.33 107.921 177.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -74.82 154.52 38.25 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.536 1.135 . . . . 63.54 111.178 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.9 m -110.59 169.56 8.67 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.882 1.673 . . . . 60.32 109.208 175.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -53.06 -25.68 13.49 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.769 1.628 . . . . 75.24 115.022 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.486 HG21 HD21 ' A' ' 24' ' ' LEU . 66.5 p -82.09 -18.74 41.97 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 128.548 2.739 . . . . 74.02 113.968 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.56 0.63 55.47 Favored Glycine 0 CA--C 1.543 1.786 0 CA-C-O 118.549 -1.139 . . . . 62.43 112.564 -174.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -75.63 105.06 6.46 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.525 1.53 . . . . 74.34 111.98 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -99.93 133.2 44.64 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.54 1.136 . . . . 71.12 111.079 176.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -147.03 131.47 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.455 1.502 . . . . 71.33 109.908 -172.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -79.47 129.61 34.63 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.577 1.551 . . . . 75.51 110.218 -172.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.479 ' CG2' HD12 ' A' ' 71' ' ' LEU . 14.6 t -162.69 159.24 24.11 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 124.25 0.969 . . . . 74.2 111.146 -173.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.9 m -104.15 146.31 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 125.287 1.435 . . . . 42.04 109.872 167.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.509 HG12 HD22 ' A' ' 91' ' ' LEU . 40.5 t -122.57 126.84 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 106.962 -1.496 . . . . 70.35 106.962 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -129.22 139.98 51.65 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.632 1.173 . . . . 65.02 111.522 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.7 tp -84.78 136.97 33.46 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.832 1.332 . . . . 64.15 109.567 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.95 16.12 5.26 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.198 0.999 . . . . 62.4 113.208 173.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.76 12.4 78.26 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.159 1.362 . . . . 63.34 113.081 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -143.91 57.29 1.34 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.862 1.265 . . . . 62.51 108.491 -171.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.276 0.8 OUTLIER 49.49 32.71 4.97 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.84 2.056 . . . . 73.45 115.327 169.369 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -142.48 127.57 18.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.478 1.911 . . . . 74.52 108.275 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.509 HD22 HG12 ' A' ' 83' ' ' VAL . 49.3 mt -107.17 134.24 50.58 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.593 1.157 . . . . 65.32 109.647 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.8 t -118.91 135.65 58.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.817 1.247 . . . . 61.13 109.181 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.5 t -155.92 142.4 18.57 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.211 1.004 . . . . 63.33 111.576 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.8 p -143.68 136.96 27.87 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.625 1.57 . . . . 75.11 110.121 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -102.78 -61.2 1.43 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.927 1.291 . . . . 65.02 109.613 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -140.88 -63.84 0.46 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 125.881 1.672 . . . . 65.23 109.15 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -140.78 10.63 2.22 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.673 1.589 . . . . 74.45 112.283 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.494 HG12 HD13 ' A' ' 115' ' ' LEU . 65.2 mt -111.53 108.79 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 125.477 1.511 . . . . 51.44 106.95 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -101.58 99.94 10.29 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.404 1.082 . . . . 74.33 110.306 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.63 127.5 35.92 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.091 1.356 . . . . 52.41 108.561 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.3 t -130.41 104.73 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.201 -1.407 . . . . 53.11 107.201 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.3 m -82.68 150.57 26.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.488 1.515 . . . . 54.15 109.842 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -147.09 139.93 25.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.979 1.311 . . . . 73.43 108.933 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.41 124.32 39.9 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.543 1.537 . . . . 75.03 107.418 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -127.55 84.76 2.28 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.555 1.942 . . . . 71.04 106.518 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.69 -114.89 7.19 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.266 1.412 . . . . 53.43 110.461 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -88.18 15.48 7.48 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.77 1.628 . . . . 71.13 114.087 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.8 mm -129.25 132.05 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.248 1.019 . . . . 60.11 108.815 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.435 HD11 ' CE1' ' A' ' 7' ' ' TYR . 46.1 mm -104.83 140.14 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.792 -1.188 . . . . 74.23 107.792 169.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.2 m -133.98 112.29 11.1 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.077 -1.453 . . . . 65.21 107.077 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -103.14 146.91 27.68 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.419 -0.586 . . . . 75.33 109.419 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.0 m -140.45 99.77 3.72 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.975 1.31 . . . . 75.43 109.265 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.6 mmm -92.19 150.59 20.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.103 1.761 . . . . 74.34 110.241 170.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.8 m -140.44 105.38 4.97 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.306 1.042 . . . . 60.32 108.898 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 HG12 ' A' ' 98' ' ' ILE . 12.6 tp -113.88 110.75 20.6 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.871 1.668 . . . . 71.2 108.583 177.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.31 -123.33 29.32 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 109.776 -1.33 . . . . 63.24 109.776 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -97.49 12.68 32.52 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.248 1.419 . . . . 71.45 113.18 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.4 mt -119.28 136.82 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.992 0.917 . . . . 75.42 109.865 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.5 t -119.72 96.71 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 124.33 1.019 . . . . 64.21 109.068 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -75.45 127.41 33.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.322 1.049 . . . . 74.24 111.475 172.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 157.21 29.58 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 123.921 0.763 . . . . 63.24 110.065 168.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -149.36 129.53 13.63 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.261 1.024 . . . . 62.53 109.099 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.63 137.36 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.93 1.292 . . . . 74.22 108.565 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.6 m -134.97 158.39 44.46 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.432 1.093 . . . . 75.33 110.136 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -123.09 134.9 54.22 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 125.345 1.458 . . . . 63.23 108.931 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -68.83 146.83 52.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.912 1.685 . . . . 72.42 112.745 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 105.653 -1.981 . . . . 72.13 105.653 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 19.6 p80 . . . . . 0 N--CA 1.501 2.086 0 N-CA-C 103.88 -2.637 . . . . 74.42 103.88 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -150.92 163.96 37.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.187 1.795 . . . . 63.42 109.998 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -132.46 -33.52 1.26 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.006 1.322 . . . . 55.23 111.679 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -67.28 170.28 7.45 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.226 1.411 . . . . 74.33 112.302 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 75.34 -61.21 0.48 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 127.658 2.383 . . . . 71.43 112.622 -172.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -66.4 145.87 55.2 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.714 1.206 . . . . 75.21 112.835 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.6 m -135.44 47.83 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 125.625 1.57 . . . . 73.0 110.372 -175.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -160.4 155.93 25.31 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 124.526 1.13 . . . . 33.23 111.345 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ppp? -92.98 166.54 12.32 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.456 1.502 . . . . 64.11 110.559 168.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -165.39 147.9 7.81 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.278 1.031 . . . . 72.34 109.527 173.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -78.35 56.38 1.72 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.056 1.743 . . . . 74.21 112.056 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -129.02 120.6 26.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.982 1.313 . . . . 75.25 109.515 -175.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.72 164.44 10.58 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 110.022 -1.231 . . . . 65.11 110.022 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.26 142.85 32.09 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.178 1.391 . . . . 74.12 110.213 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -136.53 150.46 48.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.426 1.09 . . . . 74.24 109.818 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -121.75 143.82 49.15 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.6 1.16 . . . . 63.35 108.839 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 36' ' ' LYS . 31.9 tp -55.17 137.91 45.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.477 1.511 . . . . 71.32 112.937 175.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -122.3 -50.88 1.99 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.44 1.496 . . . . 65.5 111.204 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.1 153.88 41.19 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 124.405 1.066 . . . . 73.05 111.719 -172.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -140.66 132.67 27.79 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.761 1.624 . . . . 74.35 108.997 -170.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -138.54 133.73 32.96 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.32 1.048 . . . . 71.15 109.255 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 54.72 27.73 9.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.097 1.759 . . . . 63.12 113.178 -173.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -62.55 -54.5 38.83 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-O 117.84 -1.076 . . . . 74.25 112.131 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -61.1 -47.0 88.32 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-O 118.072 -0.966 . . . . 60.04 113.257 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.54 -47.05 73.64 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.669 1.187 . . . . 53.45 113.667 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -69.83 -45.48 67.76 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.669 1.187 . . . . 70.13 113.419 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.7 mmt -62.83 -48.2 80.09 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 124.502 1.126 . . . . 61.43 112.717 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.483 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.6 mptm? -59.84 -31.15 69.48 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.468 0.914 . . . . 62.13 113.468 172.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.2 54.63 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.469 1.285 . . . . 71.32 114.469 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.3 pt -79.73 -7.87 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 113.344 0.868 . . . . 75.3 113.344 172.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.68 24.08 37.07 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.736 -1.035 . . . . 44.11 112.72 172.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.65 141.01 98.18 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.851 1.26 . . . . 72.05 110.264 172.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -66.04 143.01 70.49 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.434 2.089 . . . . 64.41 111.901 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.426 ' HA ' HD12 ' A' ' 29' ' ' ILE . 37.1 tt0 -57.44 -27.07 62.11 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.664 1.357 . . . . 74.34 114.664 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -64.51 -45.44 87.22 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 117.885 -1.055 . . . . 73.54 113.568 172.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.8 mt -64.76 -25.12 67.78 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.154 0.981 . . . . 75.44 113.291 173.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.483 HD13 ' HD2' ' A' ' 20' ' ' LYS . 64.7 mt -80.63 -50.86 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.298 1.039 . . . . 64.11 110.802 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -61.94 -42.76 99.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 117.816 -1.087 . . . . 53.41 113.007 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -27.18 62.6 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 118.236 -0.888 . . . . 75.5 112.728 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.67 -27.42 61.01 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.846 -0.975 . . . . 20.32 112.382 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.01 -26.05 14.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.846 1.258 . . . . 72.43 113.147 174.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -80.33 -44.45 19.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.041 0.936 . . . . 75.45 111.156 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.7 mt -102.67 127.64 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.351 1.06 . . . . 62.42 108.165 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HA ' HD23 ' A' ' 9' ' ' LEU . 4.3 tmmm? -76.96 118.16 19.27 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.896 1.278 . . . . 63.21 109.975 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.2 170.16 37.13 Favored Glycine 0 CA--C 1.531 1.091 0 O-C-N 124.247 0.967 . . . . 74.13 110.72 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.8 t -124.58 149.93 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.081 1.352 . . . . 70.24 108.819 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.0 p -126.41 165.95 18.11 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.73 1.612 . . . . 70.22 110.164 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -152.3 141.64 21.53 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.801 -1.185 . . . . 72.33 107.801 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.14 132.69 50.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.395 -1.706 . . . . 62.45 106.395 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.7 t -140.09 100.98 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.827 0.851 . . . . 74.23 108.96 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -87.29 141.58 28.54 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.494 1.118 . . . . 74.34 109.229 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -152.03 77.13 1.2 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.018 0.927 . . . . 73.54 109.002 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.37 -120.52 8.41 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 109.377 -1.489 . . . . 50.4 109.377 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -75.48 -32.17 60.47 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.717 1.207 . . . . 73.31 114.073 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.56 148.83 38.57 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 124.124 0.89 . . . . 72.23 111.861 175.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -138.26 133.08 32.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.95 1.7 . . . . 73.35 106.674 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -125.41 160.05 30.37 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.87 1.668 . . . . 75.04 110.37 173.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -155.97 145.94 21.35 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.559 -1.275 . . . . 70.41 107.559 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.6 m -129.05 117.86 21.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 124.235 0.959 . . . . 45.21 109.849 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.414 HG23 ' C23' ' A' ' 201' ' ' 2VN . 72.4 mt -90.56 139.49 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.045 1.338 . . . . 74.15 108.456 172.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.2 m -135.9 112.75 10.24 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.616 1.166 . . . . 51.0 108.079 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -120.15 74.76 1.06 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.465 1.106 . . . . 75.3 109.988 -174.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.82 -91.21 1.39 Allowed Glycine 0 CA--C 1.532 1.126 0 N-CA-C 108.847 -1.701 . . . . 43.33 108.847 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.8 m -105.67 -43.09 5.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.94 1.296 . . . . 73.3 112.08 -176.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -72.72 146.02 46.74 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.95 1.3 . . . . 75.41 112.215 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.2 t -133.92 130.31 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.644 1.177 . . . . 63.15 108.78 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.7 mt -130.71 111.62 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.743 1.217 . . . . 74.53 108.581 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.54 149.47 24.07 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.379 0.672 . . . . 63.21 110.975 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -139.31 153.67 47.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.084 1.753 . . . . 63.35 108.245 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -137.08 141.1 42.38 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 124.815 1.322 . . . . 73.05 109.072 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -145.74 168.01 21.76 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.443 1.097 . . . . 75.23 109.851 173.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.2 m -118.92 130.0 55.48 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.685 -1.228 . . . . 72.31 107.685 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.15 123.15 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.298 1.039 . . . . 63.33 110.782 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.31 2.07 77.58 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 118.267 -1.296 . . . . 75.31 113.396 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -115.31 152.16 33.27 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.571 1.548 . . . . 71.42 109.701 171.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -77.11 127.63 33.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.73 1.612 . . . . 72.15 110.61 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.7 m -146.59 149.47 33.61 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.153 1.381 . . . . 74.14 109.739 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -77.5 145.62 36.89 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 112.688 0.625 . . . . 74.33 112.688 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.488 HD22 ' C55' ' A' ' 201' ' ' 2VN . 15.3 mt -122.35 127.85 50.27 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.605 1.562 . . . . 71.33 108.291 173.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -95.29 142.66 27.44 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.43 1.092 . . . . 63.54 110.313 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 p -103.26 -177.57 3.41 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.385 1.474 . . . . 60.32 111.663 173.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.7 mtt -60.02 -38.43 82.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.74 1.616 . . . . 75.24 115.04 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.4 p -89.84 -1.63 58.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.454 1.502 . . . . 74.02 112.838 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.59 19.24 32.74 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 118.249 -1.306 . . . . 62.43 112.722 172.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -69.37 113.98 7.19 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.152 1.476 . . . . 74.34 109.963 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -104.24 125.44 50.51 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 124.153 0.908 . . . . 71.12 109.092 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -146.12 123.27 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 124.427 1.079 . . . . 71.33 110.983 -170.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -72.8 140.59 47.78 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 124.3 1.04 . . . . 75.51 112.351 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.8 t -171.09 163.02 7.26 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.493 1.517 . . . . 74.2 109.692 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.1 t -103.06 136.0 37.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.259 1.024 . . . . 42.04 108.461 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.9 t -103.52 127.8 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 107.996 -1.112 . . . . 70.35 107.996 171.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -125.51 151.67 46.01 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.264 1.425 . . . . 65.02 111.647 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 tp -101.33 137.02 40.23 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 124.757 1.286 . . . . 64.15 109.509 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -87.54 15.56 6.55 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.567 1.147 . . . . 62.4 113.258 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.96 13.83 80.62 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.95 1.262 . . . . 63.34 113.257 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -143.22 57.11 1.39 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.727 1.211 . . . . 62.51 108.561 -173.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.274 0.3 OUTLIER 44.15 37.0 1.67 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.198 2.199 . . . . 73.45 114.97 175.194 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -140.88 121.99 14.7 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 125.622 1.569 . . . . 74.52 109.02 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.3 mt -95.99 142.84 27.73 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 124.718 1.262 . . . . 65.32 109.721 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.9 t -132.56 137.92 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.471 1.508 . . . . 61.13 108.653 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 t -155.13 149.99 26.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.865 0.866 . . . . 63.33 110.734 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.0 p -143.56 130.74 20.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.942 1.297 . . . . 75.11 109.708 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -95.08 -60.2 1.73 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.312 1.045 . . . . 65.02 110.373 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -143.78 -75.57 0.25 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.682 1.593 . . . . 65.23 108.631 -173.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -116.95 -17.03 10.49 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.245 1.818 . . . . 74.45 111.232 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.5 ' CG1' HD13 ' A' ' 115' ' ' LEU . 21.5 mt -88.86 111.21 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.935 1.294 . . . . 51.44 108.455 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.0 tmmt? -101.27 115.41 30.43 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 124.389 1.075 . . . . 74.33 108.974 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.4 m -117.03 124.36 49.12 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 124.846 1.341 . . . . 52.41 109.073 -169.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.8 t -131.89 117.14 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.528 1.131 . . . . 53.11 109.407 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.1 m -102.92 155.13 18.56 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.769 1.228 . . . . 54.15 109.643 173.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -139.15 144.89 38.81 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.639 1.976 . . . . 73.43 109.661 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 tp -124.85 118.06 25.5 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.863 2.065 . . . . 75.03 106.994 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -122.0 69.2 0.94 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.041 1.337 . . . . 71.04 108.136 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.11 -110.96 3.63 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 110.065 -1.214 . . . . 53.43 110.065 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -79.51 -6.58 57.27 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 117.254 -1.355 . . . . 71.13 113.461 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.2 mm -112.65 136.94 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 119.91 1.232 . . . . 60.11 109.385 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.9 mm -115.54 142.69 27.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.041 1.337 . . . . 74.23 108.151 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.0 m -133.43 124.83 27.79 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.371 1.045 . . . . 65.21 108.235 172.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -108.46 134.95 50.54 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.555 1.142 . . . . 75.33 107.946 170.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 62.6 m -136.41 117.79 14.68 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.303 1.441 . . . . 75.43 108.255 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 33.1 mtm -123.17 142.45 50.89 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.09 0.956 . . . . 74.34 109.715 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.9 m -125.54 113.44 17.44 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.332 1.453 . . . . 60.32 108.662 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.5 HD13 ' CG1' ' A' ' 98' ' ' ILE . 11.6 tp -121.18 107.5 12.65 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.361 1.464 . . . . 71.2 108.048 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.37 -111.67 4.21 Favored Glycine 0 CA--C 1.533 1.199 0 O-C-N 124.837 1.336 . . . . 63.24 110.442 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -99.6 1.36 43.62 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.733 2.013 . . . . 71.45 113.665 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 91.4 mt -120.68 139.51 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.677 1.191 . . . . 75.42 109.967 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.2 t -125.19 101.08 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 124.187 0.929 . . . . 64.21 109.772 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -68.55 138.45 55.14 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.307 1.443 . . . . 74.24 112.099 169.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.5 mppt? -136.37 157.33 47.06 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 124.486 1.116 . . . . 63.24 110.778 167.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.03 141.84 12.88 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.846 1.258 . . . . 62.53 108.996 -177.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.21 139.7 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.702 1.201 . . . . 74.22 108.368 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 45.0 m -133.05 160.56 36.81 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.479 1.512 . . . . 75.33 109.312 173.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.64 144.91 39.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.63 1.172 . . . . 63.23 110.695 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -63.03 145.34 55.65 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.79 2.036 . . . . 72.42 113.7 -171.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.8 mt . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 103.886 -2.635 . . . . 72.13 103.886 -175.126 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' 2VN . . . . . 0.488 ' C55' HD22 ' A' ' 71' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 102.296 -3.224 . . . . 74.42 102.296 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -166.61 -45.38 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.334 1.054 . . . . 63.42 111.032 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -67.04 155.55 38.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.646 1.179 . . . . 55.23 112.444 175.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -130.25 -83.34 0.54 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.698 1.199 . . . . 74.33 109.385 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -165.38 161.54 18.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.316 1.446 . . . . 71.43 110.026 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -157.46 71.97 0.66 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 123.942 0.776 . . . . 75.21 110.005 174.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 92.3 t 69.29 -71.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 128.26 2.624 . . . . 73.0 112.085 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -85.29 179.46 7.2 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.915 1.686 . . . . 33.23 111.065 169.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -112.32 157.41 21.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.86 1.264 . . . . 64.11 111.518 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.4 p -118.12 108.83 15.67 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.326 1.85 . . . . 72.34 109.658 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -63.3 -30.82 71.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.265 1.426 . . . . 74.21 114.271 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.1 p -52.72 121.62 7.54 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.063 2.145 . . . . 75.25 113.933 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.49 166.23 14.85 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 109.522 -1.431 . . . . 65.11 109.522 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.16 144.51 37.14 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.378 1.071 . . . . 74.12 108.65 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -137.48 155.82 48.86 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.855 1.262 . . . . 74.24 110.437 -172.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -129.0 146.17 51.05 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.473 1.109 . . . . 63.35 109.581 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.82 129.6 41.16 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.7 1.2 . . . . 71.32 111.517 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 65.6 mm-40 -111.36 -56.59 2.36 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.035 1.334 . . . . 65.5 110.743 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.37 155.47 45.91 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 124.615 1.197 . . . . 73.05 112.056 -170.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -142.38 122.62 13.86 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.087 1.755 . . . . 74.35 107.797 -168.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -129.09 140.94 51.37 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.524 0.73 . . . . 71.15 109.668 170.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 56.17 33.48 22.14 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.632 1.973 . . . . 63.12 112.46 -171.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.0 -62.37 1.6 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.103 -0.951 . . . . 74.25 111.676 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.99 -34.04 75.44 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 113.671 0.989 . . . . 60.04 113.671 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.66 -52.7 64.38 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.079 0.951 . . . . 53.45 112.652 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -67.34 -49.53 63.67 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.656 1.182 . . . . 70.13 113.165 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.1 mmt -67.1 -36.94 83.05 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.745 1.278 . . . . 61.43 113.139 -173.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -77.95 -25.52 48.28 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 118.047 -0.978 . . . . 62.13 112.534 173.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.37 -35.96 63.54 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 113.739 1.015 . . . . 71.32 113.739 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.6 pt -77.44 -10.27 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 O-C-N 123.917 0.76 . . . . 75.3 112.966 170.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.72 29.43 23.86 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.382 -1.232 . . . . 44.11 113.073 167.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.6 mt -65.39 152.17 92.67 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 119.125 1.463 . . . . 72.05 111.718 172.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -64.61 140.69 69.72 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.244 1.963 . . . . 64.41 111.269 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.59 -21.63 53.79 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.686 1.365 . . . . 74.34 114.686 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -59.54 -52.21 66.53 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 117.586 -1.197 . . . . 73.54 113.328 166.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.6 mt -61.12 -30.36 70.32 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.943 1.09 . . . . 75.44 113.943 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.13 -54.2 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 O-C-N 124.17 0.919 . . . . 64.11 111.707 171.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -66.92 -27.55 67.58 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.961 1.467 . . . . 53.41 114.961 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.17 -21.25 31.37 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.759 1.224 . . . . 75.5 112.257 171.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.44 -15.7 52.25 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 118.564 -1.131 . . . . 20.32 112.275 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.12 -31.8 15.37 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.739 1.269 . . . . 72.43 113.079 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -83.48 -45.55 13.49 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.954 0.797 . . . . 75.45 111.032 177.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.4 mm -89.71 125.4 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.06 0.944 . . . . 62.42 109.402 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -85.42 146.46 26.96 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.531 1.144 . . . . 63.21 110.248 166.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -101.84 -168.85 27.38 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 109.753 -1.339 . . . . 74.13 109.753 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.4 t -129.86 158.47 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 126.693 1.997 . . . . 70.24 108.583 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.0 t -137.4 161.04 37.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.071 1.349 . . . . 70.22 110.125 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -143.35 147.81 35.26 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 123.76 0.824 . . . . 72.33 109.287 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.7 mt -132.03 126.01 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.461 -1.681 . . . . 62.45 106.461 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.9 t -136.87 92.2 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.197 -1.038 . . . . 74.23 108.197 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -79.98 138.68 37.12 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.128 0.971 . . . . 74.34 109.577 171.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -148.6 74.79 1.29 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.094 0.958 . . . . 73.54 109.298 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.43 -125.02 11.37 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.277 -1.529 . . . . 50.4 109.277 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mmpp? -70.26 -32.36 70.16 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.894 1.277 . . . . 73.31 114.377 173.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.0 157.22 31.33 Favored 'General case' 0 C--N 1.345 0.399 0 O-C-N 124.046 0.841 . . . . 72.23 111.893 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -157.05 127.33 6.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.039 -1.467 . . . . 73.35 107.039 -173.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -115.75 151.55 34.93 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.873 1.669 . . . . 75.04 109.886 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -147.44 119.81 8.42 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.057 -1.09 . . . . 70.41 108.057 -176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.1 m -102.07 129.97 48.53 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 124.49 1.119 . . . . 45.21 108.576 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.0 mt -113.63 120.16 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 106.839 -1.541 . . . . 74.15 106.839 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.5 m -113.88 104.07 11.81 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.644 1.215 . . . . 51.0 107.799 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.2 -162.29 0.11 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.813 1.645 . . . . 75.3 111.933 172.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.94 -27.03 69.65 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-O 118.788 -1.006 . . . . 43.33 113.738 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.0 p -163.75 25.37 0.08 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.429 1.492 . . . . 73.3 112.648 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -139.47 142.58 37.35 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.408 1.083 . . . . 75.41 109.967 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.29 128.89 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 124.293 0.996 . . . . 63.15 108.823 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.8 mt -130.95 123.11 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.766 1.626 . . . . 74.53 107.467 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.43 138.81 49.55 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.125 0.97 . . . . 63.21 109.034 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -134.48 145.19 48.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.037 1.335 . . . . 63.35 108.658 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -125.05 145.98 49.66 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 124.817 1.323 . . . . 73.05 109.195 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -149.21 161.02 42.84 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.65 1.18 . . . . 75.23 109.88 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.3 m -108.86 130.0 55.41 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.347 1.03 . . . . 72.31 108.467 172.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 80.3 t -66.78 115.27 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.763 1.225 . . . . 63.33 110.578 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.25 -9.56 50.02 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-O 117.971 -1.46 . . . . 75.31 112.963 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -114.52 149.13 36.9 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.422 1.611 . . . . 71.42 109.916 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -71.41 133.37 45.88 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.93 0.769 . . . . 72.15 110.725 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.5 m -139.02 168.16 20.45 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.717 1.607 . . . . 74.14 108.936 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -110.89 133.26 53.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.867 0.867 . . . . 74.33 109.901 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -122.02 138.48 54.42 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.443 1.497 . . . . 71.33 109.292 -171.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -109.75 141.86 41.78 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.327 1.451 . . . . 63.54 111.912 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 m -99.63 167.06 10.81 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.91 1.684 . . . . 60.32 111.61 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 65.3 mtm -57.56 -26.75 61.9 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.947 1.699 . . . . 75.24 114.986 170.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.1 t -83.62 -10.83 57.97 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.645 1.178 . . . . 74.02 113.557 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.84 4.46 67.32 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 118.457 -1.19 . . . . 62.43 113.296 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -71.06 136.48 48.3 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.277 1.538 . . . . 74.34 109.648 172.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -120.66 135.38 55.13 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.295 0.997 . . . . 71.12 108.609 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.14 132.1 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.591 1.156 . . . . 71.33 110.562 -171.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -74.42 141.2 45.06 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 124.283 0.989 . . . . 75.51 111.85 173.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.5 t -164.94 154.05 12.73 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.586 1.555 . . . . 74.2 110.003 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.73 133.61 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 107.865 -1.161 . . . . 42.04 107.865 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -112.17 129.04 68.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 108.311 -0.996 . . . . 70.35 108.311 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -141.11 147.39 38.42 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.054 1.342 . . . . 65.02 111.712 -173.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 tp -75.54 138.63 41.64 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.349 1.059 . . . . 64.15 111.492 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -89.45 6.35 41.17 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.889 1.275 . . . . 62.4 112.415 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.74 16.55 77.96 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.798 1.19 . . . . 63.34 112.948 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -150.22 48.25 0.9 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.249 1.42 . . . . 62.51 108.86 -172.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.302 0.0 OUTLIER 53.13 33.51 15.28 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.642 1.577 . . . . 73.45 114.079 178.059 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -130.5 141.56 50.49 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 125.787 1.635 . . . . 74.52 108.748 -171.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.1 mt -117.66 113.27 21.65 Favored 'General case' 0 C--N 1.343 0.312 0 O-C-N 124.539 1.149 . . . . 65.32 109.414 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.0 t -95.01 136.93 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.877 1.671 . . . . 61.13 109.137 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.13 147.32 22.38 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.54 1.536 . . . . 63.33 110.62 -174.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.6 p -150.67 132.78 15.3 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.392 1.477 . . . . 75.11 109.725 -175.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -98.15 -70.15 0.73 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.09 1.356 . . . . 65.02 108.895 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -135.3 -57.17 0.8 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.702 1.601 . . . . 65.23 108.887 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -149.09 10.29 0.79 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.415 1.486 . . . . 74.45 112.564 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.472 HG13 HD13 ' A' ' 115' ' ' LEU . 4.3 mp -108.48 104.8 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.549 -1.278 . . . . 51.44 107.549 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -86.88 106.64 17.9 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 124.121 0.888 . . . . 74.33 109.253 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 55.7 p -111.45 123.55 50.45 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.757 1.285 . . . . 52.41 111.141 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.5 t -126.1 105.32 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 126.037 1.735 . . . . 53.11 107.495 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.6 m -82.13 152.42 26.53 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.012 1.325 . . . . 54.15 109.769 172.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -142.28 139.06 31.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.856 1.662 . . . . 73.43 108.953 174.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.1 tp -117.71 126.73 53.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.917 2.087 . . . . 75.03 106.734 173.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -133.97 81.19 1.9 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.474 1.91 . . . . 71.04 106.285 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.13 -116.62 9.08 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 110.202 -1.159 . . . . 53.43 110.202 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -88.52 17.74 5.14 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.205 1.802 . . . . 71.13 114.221 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.4 mm -129.99 132.79 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.178 0.991 . . . . 60.11 108.932 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 49.8 mm -111.36 136.2 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 125.09 1.356 . . . . 74.23 107.849 171.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.8 m -127.34 122.88 34.93 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.151 -1.425 . . . . 65.21 107.151 173.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -113.75 134.04 55.0 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.274 -1.009 . . . . 75.33 108.274 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.2 m -133.69 108.12 8.34 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 124.539 1.15 . . . . 75.43 108.533 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.1 mtp -108.27 146.52 32.75 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.541 1.937 . . . . 74.34 109.246 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.4 m -137.59 94.38 2.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.293 1.037 . . . . 60.32 109.587 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.472 HD13 HG13 ' A' ' 98' ' ' ILE . 8.2 tp -98.77 109.1 21.91 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.32 1.448 . . . . 71.2 108.846 173.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.45 -111.1 3.73 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 124.807 1.317 . . . . 63.24 110.817 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -101.53 1.37 37.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.722 2.009 . . . . 71.45 113.648 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 89.5 mt -120.85 143.78 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.123 1.369 . . . . 75.42 110.143 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.7 t -123.01 91.3 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 O-C-N 124.23 0.956 . . . . 64.21 110.24 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -68.47 127.14 31.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.334 1.054 . . . . 74.24 112.1 173.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -125.2 146.38 49.54 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.738 1.215 . . . . 63.24 110.465 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -142.94 132.54 23.75 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.896 1.278 . . . . 62.53 108.326 -174.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.69 133.26 67.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.556 -1.276 . . . . 74.22 107.556 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.1 m -134.55 150.18 50.72 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 124.626 1.204 . . . . 75.33 110.025 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -120.01 141.42 49.73 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.547 1.539 . . . . 63.23 109.727 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -67.74 141.18 56.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.264 1.826 . . . . 72.42 112.103 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.4 mt . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 106.295 -1.742 . . . . 72.13 106.295 -173.351 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 108.781 -0.822 . . . . 72.34 108.781 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -70.02 -25.33 63.53 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.988 1.107 . . . . 74.21 113.988 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.2 t -52.77 115.08 1.64 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.058 2.143 . . . . 75.25 113.147 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.09 164.96 16.05 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 110.557 -1.017 . . . . 65.11 110.557 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.423 ' HB3' HD12 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -109.66 144.86 37.41 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.851 1.661 . . . . 74.12 110.399 175.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.494 ' CZ ' HD11 ' A' ' 109' ' ' ILE . 37.0 m-85 -140.81 141.15 34.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.998 1.319 . . . . 74.24 109.645 -173.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -107.93 148.04 30.2 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.538 1.135 . . . . 63.35 109.899 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.64 127.47 31.82 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.469 1.508 . . . . 71.32 111.207 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -109.4 -57.19 2.2 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.821 1.248 . . . . 65.5 110.973 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.5 p -152.86 172.16 17.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.563 1.145 . . . . 73.05 111.2 -174.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -168.27 148.59 4.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.876 1.271 . . . . 74.35 111.0 -165.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -140.04 143.23 36.27 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.873 1.269 . . . . 71.15 108.797 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 57.59 26.02 12.32 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.482 1.913 . . . . 63.12 113.616 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -61.5 -55.66 28.58 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-O 118.232 -0.889 . . . . 74.25 113.185 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -62.41 -43.48 98.72 Favored 'General case' 0 C--N 1.347 0.472 0 O-C-N 124.308 1.005 . . . . 60.04 112.919 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.92 -45.47 82.68 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.711 1.204 . . . . 53.45 113.566 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -68.08 -47.17 69.01 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.958 1.303 . . . . 70.13 113.187 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.5 mmt -65.9 -44.61 84.73 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.565 1.166 . . . . 61.43 113.049 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.505 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.3 mptm? -60.71 -32.43 71.68 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.932 0.893 . . . . 62.13 113.032 171.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.56 -37.69 59.77 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.396 1.258 . . . . 71.32 114.396 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.1 pt -79.11 -5.14 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 113.427 0.899 . . . . 75.3 113.427 172.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.98 27.81 25.1 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 118.666 -1.074 . . . . 44.11 112.893 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.66 146.73 98.61 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 118.822 1.311 . . . . 72.05 111.122 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -68.31 140.83 49.75 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.05 1.834 . . . . 64.41 110.799 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.08 -21.88 64.09 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.63 1.344 . . . . 74.34 114.63 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.62 -49.94 74.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.351 1.06 . . . . 73.54 113.349 169.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.6 mt -63.92 -23.74 67.46 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 124.65 1.18 . . . . 75.44 113.569 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.505 HD13 ' HD2' ' A' ' 20' ' ' LYS . 68.6 mt -83.15 -50.46 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.325 1.05 . . . . 64.11 110.602 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -60.94 -42.59 98.49 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 117.821 -1.085 . . . . 53.41 113.16 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -27.59 63.34 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 118.22 -0.895 . . . . 75.5 112.819 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.54 -30.04 57.06 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-O 119.077 -0.846 . . . . 20.32 112.552 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.79 -30.75 14.69 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.632 1.173 . . . . 72.43 112.789 173.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -72.78 -49.96 27.36 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.627 1.171 . . . . 75.45 111.52 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 mt -93.37 129.56 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.268 1.027 . . . . 62.42 108.347 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -80.44 110.17 15.63 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 124.135 0.897 . . . . 63.21 108.787 170.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.51 -172.97 41.75 Favored Glycine 0 CA--C 1.538 1.487 0 O-C-N 124.469 1.106 . . . . 74.13 110.429 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.5 t -129.82 153.79 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.709 1.204 . . . . 70.24 109.701 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.0 t -130.35 155.98 45.45 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.552 1.941 . . . . 70.22 109.164 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -141.02 143.67 34.56 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.752 1.221 . . . . 72.33 107.879 170.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.1 mt -132.07 130.36 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.08 -1.822 . . . . 62.45 106.08 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -134.74 135.5 53.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.15 -1.056 . . . . 74.23 108.15 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -126.92 130.82 50.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.819 1.248 . . . . 74.34 108.687 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -133.19 55.07 1.92 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.144 1.378 . . . . 73.54 109.289 -172.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.13 -115.96 5.69 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 108.718 -1.753 . . . . 50.4 108.718 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -70.69 -35.42 72.77 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.249 1.204 . . . . 73.31 114.249 173.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.63 156.09 37.11 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 124.021 0.825 . . . . 72.23 111.373 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -150.93 141.29 22.4 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.037 -1.468 . . . . 73.35 107.037 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -129.27 151.63 49.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.229 1.811 . . . . 75.04 109.153 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -148.79 126.23 11.61 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.686 -1.228 . . . . 70.41 107.686 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 m -109.18 126.61 53.45 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.688 1.243 . . . . 45.21 108.931 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.25 133.93 51.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.724 -1.584 . . . . 74.15 106.724 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.0 m -133.52 104.84 6.58 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 124.166 0.916 . . . . 51.0 109.394 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -107.38 77.49 1.15 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.918 0.887 . . . . 75.3 110.153 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.34 -49.41 4.23 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.513 1.53 . . . . 43.33 112.212 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.44 -39.65 0.09 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.171 0.986 . . . . 73.3 111.872 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -67.09 137.26 56.24 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.475 1.11 . . . . 75.41 111.684 172.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.6 t -125.31 130.47 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 O-C-N 124.612 1.195 . . . . 63.15 109.147 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.8 mt -119.34 128.67 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.871 1.269 . . . . 74.53 108.019 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -116.66 127.14 54.16 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 124.589 1.18 . . . . 63.21 108.693 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -121.94 145.04 48.5 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.413 1.485 . . . . 63.35 109.075 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -132.8 140.78 48.16 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 125.376 1.672 . . . . 73.05 108.995 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -149.46 166.93 27.64 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.033 1.333 . . . . 75.23 109.146 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.4 m -119.21 127.01 52.89 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.886 -1.153 . . . . 72.31 107.886 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.8 t -63.73 126.95 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.768 1.227 . . . . 63.33 111.324 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.14 -3.1 85.66 Favored Glycine 0 CA--C 1.542 1.764 0 CA-C-O 118.249 -1.306 . . . . 75.31 113.558 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -116.62 141.02 48.74 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.127 1.771 . . . . 71.42 109.859 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -66.45 118.57 10.28 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.04 1.336 . . . . 72.15 111.616 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 40.5 m -140.46 153.26 46.2 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.577 1.551 . . . . 74.14 109.153 -175.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -100.96 128.65 46.9 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.99 0.916 . . . . 74.33 109.77 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.3 mt -120.37 131.92 55.05 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.762 1.225 . . . . 71.33 110.467 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -90.43 130.92 36.45 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.277 1.831 . . . . 63.54 110.47 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.6 p -85.52 -179.93 7.01 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.572 1.149 . . . . 60.32 111.651 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.2 mtt -59.03 -30.83 68.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.18 1.548 . . . . 75.24 115.18 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.4 p -87.82 -7.51 57.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.368 1.467 . . . . 74.02 113.235 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.63 6.68 58.27 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 118.187 -1.34 . . . . 62.43 112.592 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -69.0 113.36 6.31 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 119.405 1.603 . . . . 74.34 110.791 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -94.44 124.95 38.78 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 124.612 1.195 . . . . 71.12 110.502 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.92 126.19 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.309 1.444 . . . . 71.33 110.361 -170.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -72.5 132.92 44.47 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.22 1.408 . . . . 75.51 111.885 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.3 t -161.93 170.02 20.13 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.267 1.427 . . . . 74.2 109.445 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.449 ' CG1' HE22 ' A' ' 84' ' ' GLN . 2.6 t -124.95 144.03 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 108.283 -1.006 . . . . 42.04 108.283 171.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.563 HG12 HD22 ' A' ' 91' ' ' LEU . 22.3 t -112.05 125.65 69.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 O-C-N 124.358 1.037 . . . . 70.35 108.252 177.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.449 HE22 ' CG1' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -112.91 141.78 46.35 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.805 1.642 . . . . 65.02 110.496 177.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.0 tp -92.95 136.82 32.92 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.426 1.079 . . . . 64.15 109.189 168.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.18 12.63 11.19 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.261 1.024 . . . . 62.4 113.318 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.9 14.12 80.33 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 125.131 1.348 . . . . 63.34 113.115 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -140.41 52.07 1.65 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.718 1.207 . . . . 62.51 109.697 -171.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.276 0.0 OUTLIER 58.04 21.78 8.21 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.905 1.682 . . . . 73.45 114.818 173.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -135.05 120.9 19.66 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.502 1.521 . . . . 74.52 109.714 -164.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.563 HD22 HG12 ' A' ' 83' ' ' VAL . 56.2 mt -105.55 132.39 51.77 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.895 1.278 . . . . 65.32 109.945 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.1 t -119.61 136.52 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.008 1.323 . . . . 61.13 109.157 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.0 t -154.37 149.08 26.48 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.27 1.028 . . . . 63.33 110.846 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.2 p -146.33 132.08 18.97 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.724 1.209 . . . . 75.11 109.783 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -97.96 -63.39 1.13 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.975 1.31 . . . . 65.02 110.396 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -140.17 -73.49 0.36 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.189 1.796 . . . . 65.23 108.237 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -127.38 -1.77 6.26 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.255 1.822 . . . . 74.45 112.305 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.451 HG12 HD12 ' A' ' 115' ' ' LEU . 37.6 mt -97.4 110.9 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.839 1.656 . . . . 51.44 108.384 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -102.61 98.76 8.77 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.765 1.226 . . . . 74.33 110.195 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.5 t -82.92 131.27 35.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.327 1.451 . . . . 52.41 110.882 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.8 t -135.69 101.82 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 106.844 -1.539 . . . . 53.11 106.844 172.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.0 m -84.89 148.9 26.02 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.186 1.394 . . . . 54.15 109.766 173.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -147.71 130.76 16.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.042 1.337 . . . . 73.43 109.313 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 tt -113.93 130.55 56.5 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.232 -1.396 . . . . 75.03 107.232 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -132.62 82.71 2.02 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.431 1.892 . . . . 71.04 106.702 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.25 -111.78 4.44 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.745 1.164 . . . . 53.43 111.287 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -83.72 -4.72 58.85 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.329 1.452 . . . . 71.13 113.535 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.8 mm -110.94 138.46 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 119.499 1.045 . . . . 60.11 109.666 -176.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.494 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 36.6 mm -109.6 136.6 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.754 -1.202 . . . . 74.23 107.754 169.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.0 m -127.57 115.41 18.77 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 106.532 -1.655 . . . . 65.21 106.532 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -117.64 126.56 52.73 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.481 -0.933 . . . . 75.33 108.481 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 66.7 m -124.65 112.81 17.22 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 124.661 1.226 . . . . 75.43 108.386 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 95.1 mtp -105.86 149.86 26.14 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.873 1.269 . . . . 74.34 109.21 173.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.5 m -140.79 104.4 4.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.563 0.745 . . . . 60.32 109.21 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.451 HD12 HG12 ' A' ' 98' ' ' ILE . 7.0 tt -103.2 102.14 12.12 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.544 1.537 . . . . 71.2 107.55 175.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.27 -122.93 30.91 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 110.849 -0.9 . . . . 63.24 110.849 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -84.88 3.33 38.5 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.915 1.686 . . . . 71.45 115.173 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.8 mt -102.93 139.75 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.889 0.875 . . . . 75.42 108.995 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.38 96.85 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.205 1.002 . . . . 64.21 109.119 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -86.21 136.35 33.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.676 1.591 . . . . 74.24 112.48 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -119.65 150.19 40.74 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.049 1.34 . . . . 63.24 111.085 173.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 mmt-85 -141.98 136.1 29.98 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.503 1.921 . . . . 62.53 108.074 173.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.6 133.98 65.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.583 -1.266 . . . . 74.22 107.583 174.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.5 m -135.16 159.98 39.83 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.994 1.317 . . . . 75.33 109.648 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -137.79 143.3 41.0 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.489 1.116 . . . . 63.23 110.702 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.7 ttp85 -63.28 137.1 58.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.592 1.957 . . . . 72.42 113.768 -170.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.423 HD12 ' HB3' ' A' ' 6' ' ' LYS . 40.4 mt . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 106.039 -1.838 . . . . 72.13 106.039 -171.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 110.042 -0.355 . . . . 72.34 110.042 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -80.39 -16.82 53.57 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.549 1.314 . . . . 74.21 114.549 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.8 p -66.93 132.76 48.62 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.759 1.224 . . . . 75.25 113.483 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.1 168.34 14.67 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.285 0.945 . . . . 65.11 110.778 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -99.89 147.07 25.94 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.274 1.43 . . . . 74.12 111.137 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.496 ' CE2' HD11 ' A' ' 109' ' ' ILE . 31.5 m-85 -138.41 155.08 48.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.593 1.557 . . . . 74.24 109.453 -176.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -127.77 145.39 50.93 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.505 -0.924 . . . . 63.35 108.505 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 tt -61.96 131.24 49.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.22 1.408 . . . . 71.32 110.432 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -109.7 -50.06 3.03 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.609 1.164 . . . . 65.5 110.919 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.2 158.15 35.68 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 124.387 1.054 . . . . 73.05 111.109 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -128.08 155.83 43.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.844 1.257 . . . . 74.35 108.683 170.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -135.69 131.33 35.53 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.264 1.426 . . . . 71.15 108.175 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 58.23 39.27 25.94 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.352 1.861 . . . . 63.12 112.142 -169.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -64.11 -63.57 1.12 Allowed 'General case' 0 C--N 1.346 0.454 0 C-N-CA 124.875 1.27 . . . . 74.25 112.296 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.47 -28.43 69.66 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.566 0.95 . . . . 60.04 113.566 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.88 -51.9 65.17 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.102 0.961 . . . . 53.45 112.346 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -70.59 -48.47 55.04 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.831 1.252 . . . . 70.13 113.8 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.9 mmt -67.99 -39.83 83.2 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 124.374 1.046 . . . . 61.43 113.155 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -73.87 -27.68 61.2 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 118.137 -0.935 . . . . 62.13 112.513 173.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.75 -33.82 66.61 Favored 'General case' 0 C--N 1.349 0.562 0 N-CA-C 113.945 1.091 . . . . 71.32 113.945 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.8 pt -80.3 -4.6 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 N-CA-C 113.239 0.829 . . . . 75.3 113.239 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.03 21.69 41.27 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 118.202 -1.332 . . . . 44.11 113.522 167.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.0 mt -63.88 143.78 98.1 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 119.42 1.61 . . . . 72.05 111.212 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.18 143.72 84.66 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.396 2.064 . . . . 64.41 111.56 172.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.06 -22.48 62.73 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.123 1.527 . . . . 74.34 115.123 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.17 -43.16 99.31 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.245 1.018 . . . . 73.54 113.138 169.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.9 mt -72.0 -24.57 61.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.529 1.132 . . . . 75.44 113.621 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.69 -55.39 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 123.58 0.752 . . . . 64.11 111.176 168.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -65.99 -26.5 67.58 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 115.019 1.489 . . . . 53.41 115.019 -174.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.69 -23.15 31.83 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 124.237 0.961 . . . . 75.5 112.454 171.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.68 -23.81 37.99 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-O 118.964 -0.909 . . . . 20.32 112.298 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.13 -35.17 25.8 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 117.54 -1.219 . . . . 72.43 113.609 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -83.08 -49.75 9.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.79 0.723 . . . . 75.45 111.39 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.41 123.62 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.131 0.973 . . . . 62.42 109.263 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.28 107.17 18.38 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.018 -1.104 . . . . 63.21 108.018 171.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.61 165.81 51.95 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 124.612 1.195 . . . . 74.13 111.507 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 78.6 t -102.05 155.37 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.339 1.056 . . . . 70.24 108.697 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 97.6 p -145.42 167.36 23.12 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.599 1.16 . . . . 70.22 109.916 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -161.58 142.26 10.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.466 1.106 . . . . 72.33 108.682 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -129.48 142.12 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.929 -1.508 . . . . 62.45 106.929 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.69 100.96 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.699 -1.223 . . . . 74.23 107.699 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -77.31 129.9 36.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.039 0.936 . . . . 74.34 109.825 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -128.31 51.52 1.98 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.438 1.495 . . . . 73.54 109.282 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.33 -118.44 6.74 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 108.871 -1.692 . . . . 50.4 108.871 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -65.99 -34.71 78.72 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.937 1.295 . . . . 73.31 113.95 172.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -75.73 157.96 32.89 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.073 0.858 . . . . 72.23 111.599 171.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -156.57 125.23 5.85 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.908 -1.515 . . . . 73.35 106.908 -172.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 139.82 46.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.847 1.259 . . . . 75.04 109.103 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.28 132.37 55.29 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.772 1.629 . . . . 70.41 107.535 172.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.92 109.16 10.68 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.689 1.196 . . . . 45.21 108.16 176.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.92 132.75 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.736 1.214 . . . . 74.15 108.185 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.1 m -114.76 111.46 21.29 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.307 1.004 . . . . 51.0 108.984 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.14 76.15 1.89 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.691 1.196 . . . . 75.3 109.432 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.68 -96.95 1.99 Allowed Glycine 0 CA--C 1.531 1.079 0 N-CA-C 108.776 -1.73 . . . . 43.33 108.776 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.3 m -101.88 -40.7 6.79 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.726 1.21 . . . . 73.3 112.574 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -73.02 153.58 40.83 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.079 0.952 . . . . 75.41 112.066 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.21 131.43 67.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 124.536 1.148 . . . . 63.15 109.553 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.2 mt -105.17 134.6 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 126.468 1.907 . . . . 74.53 107.957 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -125.82 124.78 41.7 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.488 1.115 . . . . 63.21 108.38 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -137.71 133.08 33.77 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.552 1.141 . . . . 63.35 108.976 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -116.48 147.67 41.52 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 124.601 1.188 . . . . 73.05 109.711 172.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -150.86 160.66 43.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.102 1.361 . . . . 75.23 110.091 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.2 m -103.47 135.66 44.66 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 124.237 0.961 . . . . 72.31 108.517 169.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.07 119.29 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.948 1.299 . . . . 63.33 111.2 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.92 -13.59 65.89 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 117.967 -1.463 . . . . 75.31 113.326 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -99.11 148.52 23.97 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.522 1.661 . . . . 71.42 110.369 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -69.75 114.44 7.95 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 124.082 0.864 . . . . 72.15 110.793 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.7 m -129.32 151.74 49.63 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.344 1.458 . . . . 74.14 107.689 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -100.96 119.97 39.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.035 0.934 . . . . 74.33 110.276 -174.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.99 134.27 52.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.097 1.359 . . . . 71.33 110.411 -172.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -90.45 147.92 23.1 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.474 1.51 . . . . 63.54 110.336 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.3 p -112.45 178.31 4.34 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.47 1.508 . . . . 60.32 110.231 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -59.99 -29.78 68.69 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.575 1.324 . . . . 75.24 114.575 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.3 p -81.95 -8.21 59.66 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.527 1.531 . . . . 74.02 113.035 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.99 8.12 72.96 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-O 118.363 -1.243 . . . . 62.43 112.581 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -69.97 114.08 7.79 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 119.072 1.436 . . . . 74.34 110.921 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -100.86 121.41 41.67 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 124.943 1.402 . . . . 71.12 109.496 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.42 133.02 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 124.625 1.203 . . . . 71.33 110.877 -172.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -78.21 141.12 38.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.198 1.399 . . . . 75.51 112.177 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.0 t -167.07 153.86 8.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.713 1.205 . . . . 74.2 110.394 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.5 m -90.15 142.42 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.418 1.087 . . . . 42.04 109.431 165.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.56 124.72 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.253 -1.388 . . . . 70.35 107.253 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -135.75 136.81 41.08 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.357 1.063 . . . . 65.02 110.273 -170.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.625 HD23 ' H ' ' A' ' 87' ' ' GLY . 2.7 tt -79.41 129.77 34.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.489 1.115 . . . . 64.15 110.167 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -73.94 -9.5 58.7 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.477 1.911 . . . . 62.4 114.165 -173.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.625 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 92.15 5.72 65.53 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.122 1.344 . . . . 63.34 112.189 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -147.6 57.05 1.11 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.77 1.285 . . . . 62.51 109.358 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 63.8 19.76 11.89 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.821 1.648 . . . . 73.45 114.101 171.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -128.76 142.68 50.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.706 1.602 . . . . 74.52 109.598 -166.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 74.1 mt -114.91 123.26 48.7 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.346 1.058 . . . . 65.32 109.204 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.7 t -104.65 140.14 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.364 1.466 . . . . 61.13 108.902 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 100' ' ' SER . 6.3 t -162.79 135.24 5.5 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.446 1.098 . . . . 63.33 110.084 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 78.5 p -131.36 122.3 26.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.523 1.129 . . . . 75.11 109.403 -176.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -81.9 -66.56 0.87 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.395 1.078 . . . . 65.02 111.221 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -144.14 -52.4 0.32 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.64 1.576 . . . . 65.23 109.491 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -142.8 3.22 1.42 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.577 1.551 . . . . 74.45 112.363 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.428 ' CG1' HD13 ' A' ' 115' ' ' LEU . 78.3 mt -99.73 110.91 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.702 1.601 . . . . 51.44 106.959 174.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -103.63 86.84 2.7 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.934 1.294 . . . . 74.33 109.575 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.432 ' HB2' HG23 ' A' ' 93' ' ' THR . 69.7 m -79.36 127.72 32.44 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.186 1.395 . . . . 52.41 110.764 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.4 t -135.74 102.1 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 108.063 -1.088 . . . . 53.11 108.063 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.7 m -85.89 157.38 20.19 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.461 1.504 . . . . 54.15 110.478 176.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -148.71 143.56 26.52 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.612 1.565 . . . . 73.43 110.987 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.5 tt -129.98 128.03 41.23 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.317 1.447 . . . . 75.03 108.999 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -137.52 77.45 1.64 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.071 1.748 . . . . 71.04 107.604 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.8 -123.9 22.89 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 110.096 -1.202 . . . . 53.43 110.096 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -75.65 -12.33 60.18 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.239 1.415 . . . . 71.13 114.153 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mm -102.95 137.63 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 119.287 0.949 . . . . 60.11 109.534 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.496 HD11 ' CE2' ' A' ' 7' ' ' TYR . 11.2 mm -125.9 140.62 48.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 108.105 -1.072 . . . . 74.23 108.105 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.6 m -135.94 160.73 37.69 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.462 1.505 . . . . 65.21 108.743 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -154.58 147.67 24.72 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.57 1.148 . . . . 75.33 108.618 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.5 m -131.82 108.07 9.18 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 125.115 1.509 . . . . 75.43 108.22 171.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 72.8 mtp -96.21 144.71 26.17 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.826 1.651 . . . . 74.34 108.747 168.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 65.2 m -133.88 108.05 8.2 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.44 -0.948 . . . . 60.32 108.44 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.428 HD13 ' CG1' ' A' ' 98' ' ' ILE . 17.3 tp -111.86 99.36 8.06 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.477 1.511 . . . . 71.2 107.712 175.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.81 -122.82 27.15 Favored Glycine 0 CA--C 1.535 1.281 0 O-C-N 124.726 1.266 . . . . 63.24 110.429 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.87 -17.69 55.19 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.522 1.929 . . . . 71.45 114.48 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 75.9 mt -102.16 140.62 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.604 1.162 . . . . 75.42 110.381 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.4 t -122.76 90.0 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.361 1.064 . . . . 64.21 109.551 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -71.76 124.79 25.55 Favored 'General case' 0 C--N 1.345 0.394 0 C-N-CA 124.451 1.101 . . . . 74.24 111.729 174.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -120.62 148.74 43.5 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.879 1.271 . . . . 63.24 109.344 176.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.72 120.7 7.68 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.482 -0.933 . . . . 62.53 108.482 -166.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -118.83 141.69 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.164 1.386 . . . . 74.22 109.4 -172.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.6 m -144.21 166.62 24.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.232 1.413 . . . . 75.33 111.985 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -139.48 138.9 36.79 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.868 1.267 . . . . 63.23 109.952 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -69.31 131.7 45.27 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.262 2.225 . . . . 72.42 112.563 -174.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.8 mt . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 105.522 -2.029 . . . . 72.13 105.522 -174.238 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 CA--C 1.535 0.391 0 N-CA-C 109.499 -0.556 . . . . 72.34 109.499 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -80.16 -27.27 39.01 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.192 1.182 . . . . 74.21 114.192 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.9 m -57.1 111.17 0.98 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.244 1.818 . . . . 75.25 113.376 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.39 160.72 10.81 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.667 -1.373 . . . . 65.11 109.667 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -98.13 146.86 25.15 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 124.551 1.14 . . . . 74.12 110.973 176.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -139.69 146.37 39.56 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.057 1.343 . . . . 74.24 109.519 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -111.29 148.93 31.86 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.48 1.512 . . . . 63.35 109.79 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.78 128.71 37.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.885 1.274 . . . . 71.32 111.128 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -111.15 -50.57 2.93 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.17 1.388 . . . . 65.5 111.501 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.46 167.52 30.19 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.452 1.101 . . . . 73.05 111.27 -173.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -167.51 125.06 1.21 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.652 1.181 . . . . 74.35 110.918 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -111.52 143.99 41.48 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.214 1.406 . . . . 71.15 109.435 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 57.46 38.71 28.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.594 1.958 . . . . 63.12 111.832 -170.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -65.25 -58.39 6.07 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.451 -0.785 . . . . 74.25 111.409 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -62.09 -40.35 95.55 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 113.401 0.889 . . . . 60.04 113.401 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.6 -46.07 91.63 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 124.169 0.988 . . . . 53.45 113.019 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -70.91 -47.78 57.24 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-O 117.633 -1.175 . . . . 70.13 112.898 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.2 mtt -64.27 -35.59 81.35 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 124.926 1.391 . . . . 61.43 113.911 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -71.18 -30.76 66.82 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 118.167 -0.921 . . . . 62.13 113.159 169.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.17 -37.31 61.32 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.357 1.243 . . . . 71.32 114.357 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.549 ' CD1' HD13 ' A' ' 24' ' ' LEU . 41.9 pt -74.18 -12.88 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.877 0.871 . . . . 75.3 113.18 170.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.46 22.54 34.11 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.349 -1.251 . . . . 44.11 112.726 173.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.597 HD11 HG21 ' A' ' 75' ' ' THR . 6.0 mp -72.25 141.2 83.24 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.262 1.531 . . . . 72.05 110.562 172.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.528 ' HD2' HD12 ' A' ' 28' ' ' LEU . 71.8 Cg_endo -65.78 152.37 81.77 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.59 2.193 . . . . 64.41 112.162 176.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -65.94 -20.48 66.23 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.35 1.241 . . . . 74.34 114.35 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.03 -46.12 82.63 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.309 1.044 . . . . 73.54 113.072 171.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 25' ' ' PRO . 74.8 mt -62.85 -30.11 71.25 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.553 1.141 . . . . 75.44 112.813 174.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.1 mt -71.37 -50.86 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.615 1.166 . . . . 64.11 111.781 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -58.72 -50.31 74.36 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 117.817 -1.087 . . . . 53.41 112.958 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -21.14 63.72 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.013 1.116 . . . . 75.5 114.013 174.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.38 -29.21 45.55 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 118.934 -0.926 . . . . 20.32 111.974 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 -29.26 14.05 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.763 1.225 . . . . 72.43 112.897 174.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -71.91 -35.61 69.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 118.022 -0.99 . . . . 75.45 113.432 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.3 mt -113.4 119.12 59.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.079 -1.082 . . . . 62.42 108.079 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -69.48 137.55 52.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.101 0.96 . . . . 63.21 111.55 171.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.16 -179.82 39.7 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 124.687 1.242 . . . . 74.13 110.474 172.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.6 t -130.9 150.23 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 126.047 1.739 . . . . 70.24 107.843 174.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 t -144.83 108.0 4.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.409 0.683 . . . . 70.22 109.965 -170.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -91.96 147.07 23.24 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.061 0.944 . . . . 72.33 110.853 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 mt -132.6 128.02 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 106.29 -1.744 . . . . 62.45 106.29 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.8 t -134.18 127.14 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.021 -1.103 . . . . 74.23 108.021 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -122.16 136.07 54.86 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.013 1.325 . . . . 74.34 108.045 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -148.46 76.65 1.37 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.901 0.881 . . . . 73.54 109.024 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.6 -120.36 8.97 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 108.983 -1.647 . . . . 50.4 108.983 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.4 mmtt -75.67 -32.16 60.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.863 1.265 . . . . 73.31 114.258 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.71 155.83 35.28 Favored 'General case' 0 C--N 1.346 0.421 0 O-C-N 123.918 0.762 . . . . 72.23 112.093 175.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -154.91 128.43 8.52 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 106.989 -1.486 . . . . 73.35 106.989 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -114.37 151.95 32.26 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.707 1.203 . . . . 75.04 109.549 170.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -145.27 128.29 16.52 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.943 -1.503 . . . . 70.41 106.943 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.3 m -116.04 117.77 31.02 Favored 'General case' 0 C--N 1.344 0.352 0 O-C-N 124.511 1.132 . . . . 45.21 109.4 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 mp -97.88 121.56 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.207 1.403 . . . . 74.15 107.485 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.8 m -113.56 109.38 18.54 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.801 -1.185 . . . . 51.0 107.801 173.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.54 -164.01 0.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.705 1.602 . . . . 75.3 111.551 173.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.69 -25.23 70.26 Favored Glycine 0 CA--C 1.542 1.721 0 CA-C-O 118.735 -1.036 . . . . 43.33 113.797 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.5 p -161.85 20.17 0.11 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.357 1.463 . . . . 73.3 113.032 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.68 146.98 52.31 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 125.071 1.349 . . . . 75.41 110.122 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.9 t -124.93 124.02 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.082 -1.081 . . . . 63.15 108.082 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -134.46 123.95 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.101 -1.444 . . . . 74.53 107.101 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.16 149.06 43.36 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.071 0.948 . . . . 63.21 111.064 175.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -133.04 152.59 51.95 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.925 1.69 . . . . 63.35 108.908 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -125.74 142.75 51.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 125.114 1.509 . . . . 73.05 109.034 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -146.5 167.11 24.49 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.901 1.281 . . . . 75.23 109.351 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.8 m -118.38 129.21 55.29 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.557 -1.275 . . . . 72.31 107.557 173.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.02 121.02 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.908 1.283 . . . . 63.33 110.922 -175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.9 -4.37 78.43 Favored Glycine 0 CA--C 1.542 1.75 0 CA-C-O 118.353 -1.248 . . . . 75.31 113.285 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -112.59 137.81 50.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.149 1.78 . . . . 71.42 108.651 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.81 125.96 28.27 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.803 0.689 . . . . 72.15 110.919 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.4 m -138.41 163.4 31.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.58 1.552 . . . . 74.14 108.942 -175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -103.86 125.95 50.64 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.518 0.727 . . . . 74.33 110.023 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.497 HD12 HG21 ' A' ' 81' ' ' THR . 64.7 mt -108.09 127.7 54.03 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.658 1.183 . . . . 71.33 109.393 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -88.34 153.56 21.1 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.589 1.556 . . . . 63.54 110.898 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.2 p -111.14 173.79 6.17 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.645 1.578 . . . . 60.32 111.786 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -60.33 -31.2 70.08 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.512 1.301 . . . . 75.24 114.512 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.597 HG21 HD11 ' A' ' 24' ' ' LEU . 42.5 p -88.73 -7.33 56.46 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.71 1.204 . . . . 74.02 113.248 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.15 9.81 63.14 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.346 -1.252 . . . . 62.43 113.042 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -64.72 146.12 55.22 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 119.254 1.527 . . . . 74.34 110.46 167.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -129.02 124.98 36.32 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.254 -1.017 . . . . 71.12 108.254 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 m -141.51 128.09 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 124.47 1.106 . . . . 71.33 110.8 -171.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -77.32 139.84 39.87 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.384 1.474 . . . . 75.51 111.6 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.497 HG21 HD12 ' A' ' 71' ' ' LEU . 8.3 t -169.61 154.43 5.52 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 124.906 1.379 . . . . 74.2 109.719 -165.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 t -121.28 133.75 66.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.972 -1.121 . . . . 42.04 107.972 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.8 t -106.83 126.53 62.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 108.322 -0.992 . . . . 70.35 108.322 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.31 135.67 53.82 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.347 1.459 . . . . 65.02 110.093 174.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.54 121.06 31.4 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.5 1.125 . . . . 64.15 108.958 169.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.509 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 6.5 tt0 -81.87 -168.57 1.97 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.002 1.321 . . . . 62.4 111.217 174.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.509 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -93.41 11.08 72.25 Favored Glycine 0 CA--C 1.539 1.571 0 CA-C-O 117.71 -1.606 . . . . 63.34 113.353 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -140.48 44.93 1.85 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.725 1.763 . . . . 62.51 110.925 -173.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 65.3 21.36 11.99 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.052 1.341 . . . . 73.45 113.395 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -120.98 126.5 50.11 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.918 1.287 . . . . 74.52 110.674 -164.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.0 mt -101.53 109.28 21.06 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 124.671 1.232 . . . . 65.32 109.1 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 86.6 t -95.99 132.63 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.86 1.264 . . . . 61.13 108.759 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.6 t -154.55 148.78 25.97 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 124.07 0.856 . . . . 63.33 110.977 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.4 p -147.26 133.38 19.33 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.786 1.234 . . . . 75.11 110.0 -173.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -93.53 -77.17 0.46 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.598 1.559 . . . . 65.02 109.727 -176.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -128.5 -58.85 1.17 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.066 1.747 . . . . 65.23 108.843 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -144.52 8.42 1.34 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.005 1.722 . . . . 74.45 112.223 -175.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.521 HG13 HD13 ' A' ' 115' ' ' LEU . 4.5 mp -103.56 115.89 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.297 -1.371 . . . . 51.44 107.297 177.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -103.18 91.13 3.96 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 124.629 1.206 . . . . 74.33 108.962 -173.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.7 p -100.43 112.53 24.89 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.336 1.454 . . . . 52.41 111.927 -174.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.3 t -114.85 106.91 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.409 1.884 . . . . 53.11 107.794 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.5 m -84.32 151.51 24.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.716 1.206 . . . . 54.15 109.863 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -146.4 130.66 17.52 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.444 1.497 . . . . 73.43 109.164 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.3 tt -111.39 128.42 55.97 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.76 1.224 . . . . 75.03 108.079 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -130.26 82.32 2.06 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.348 1.859 . . . . 71.04 106.51 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.42 -117.42 10.62 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.495 -1.042 . . . . 53.43 110.495 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -85.78 9.59 16.1 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.014 1.726 . . . . 71.13 113.81 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.3 mm -122.61 134.23 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.53 1.132 . . . . 60.11 109.114 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.92 137.84 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.701 -1.222 . . . . 74.23 107.701 170.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.4 m -131.77 116.51 17.36 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.201 -1.407 . . . . 65.21 107.201 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.79 137.98 48.99 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.575 -0.898 . . . . 75.33 108.575 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 99.1 m -133.29 112.89 12.03 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 124.795 1.31 . . . . 75.43 108.247 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 33.1 mtp -111.04 146.87 35.96 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 126.0 1.72 . . . . 74.34 109.181 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.2 m -138.93 98.6 3.57 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 124.41 1.069 . . . . 60.32 109.258 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.521 HD13 HG13 ' A' ' 98' ' ' ILE . 9.2 tp -104.4 112.06 24.95 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.537 1.535 . . . . 71.2 108.354 174.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.43 -114.71 6.78 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 124.729 1.268 . . . . 63.24 110.871 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.54 8.0 44.85 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.452 1.901 . . . . 71.45 113.469 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.9 mp -124.16 143.17 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.689 1.195 . . . . 75.42 109.594 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.5 t -126.95 94.41 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.079 0.952 . . . . 64.21 110.297 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -75.83 132.61 40.48 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 123.677 0.791 . . . . 74.24 111.035 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -122.62 149.67 43.68 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 124.339 1.025 . . . . 63.24 109.499 173.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.13 133.64 23.43 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.043 1.337 . . . . 62.53 108.368 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -124.86 137.01 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.892 1.277 . . . . 74.22 108.053 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.1 m -137.98 156.86 47.4 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.691 1.196 . . . . 75.33 110.563 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -126.44 146.42 50.09 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.53 1.532 . . . . 63.23 109.744 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.3 tpp85 -56.92 142.15 42.52 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.459 2.303 . . . . 72.42 112.98 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 105.883 -1.895 . . . . 72.13 105.883 -175.814 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.9 p . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 110.067 -0.346 . . . . 72.34 110.067 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -63.74 -25.23 68.1 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.18 1.548 . . . . 74.21 115.18 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.5 p -57.65 119.58 6.85 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.244 1.817 . . . . 75.25 113.679 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.04 164.97 13.23 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 110.689 -0.964 . . . . 65.11 110.689 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.49 ' HB3' HD12 ' A' ' 127' ' ' ILE . 2.5 mtmt -95.14 147.87 22.98 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.639 1.576 . . . . 74.12 111.68 173.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -143.08 133.91 25.36 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.032 1.333 . . . . 74.24 109.798 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -102.16 150.54 23.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.786 1.234 . . . . 63.35 110.267 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.89 128.97 38.35 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.101 1.36 . . . . 71.32 111.096 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -113.54 -51.58 2.8 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 124.796 1.238 . . . . 65.5 111.64 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -152.92 168.27 26.37 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.489 1.118 . . . . 73.05 111.259 -170.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -165.39 145.35 6.8 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.787 1.235 . . . . 74.35 111.049 -170.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -139.84 146.82 39.84 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.947 1.299 . . . . 71.15 109.508 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 55.12 27.68 9.87 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.513 1.925 . . . . 63.12 113.035 -173.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -63.43 -60.32 3.52 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-O 118.078 -0.963 . . . . 74.25 111.58 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -60.34 -41.87 94.49 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 124.281 0.988 . . . . 60.04 113.041 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.75 -48.93 71.99 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.556 1.143 . . . . 53.45 113.397 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -66.68 -47.2 73.2 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.193 1.397 . . . . 70.13 113.072 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.8 mmt -68.64 -39.63 80.63 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.545 1.138 . . . . 61.43 113.105 -175.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.497 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.3 mptm? -66.34 -34.13 77.28 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.932 0.893 . . . . 62.13 112.637 169.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.7 -34.9 67.45 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 114.415 1.265 . . . . 71.32 114.415 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.0 pt -77.67 -9.79 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 113.143 0.794 . . . . 75.3 113.143 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.19 26.71 20.62 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.235 -1.314 . . . . 44.11 112.988 168.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 75' ' ' THR . 79.1 mt -69.3 151.78 96.8 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 119.351 1.575 . . . . 72.05 111.711 172.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -69.88 147.72 62.7 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.192 1.928 . . . . 64.41 111.538 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.404 ' HA ' HD12 ' A' ' 29' ' ' ILE . 63.0 tt0 -54.75 -30.91 57.67 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.025 1.33 . . . . 74.34 114.484 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -63.08 -45.57 91.5 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 117.877 -1.059 . . . . 73.54 113.702 175.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.0 mt -65.66 -26.88 67.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.186 0.994 . . . . 75.44 113.429 174.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.497 HD13 ' HD2' ' A' ' 20' ' ' LYS . 54.1 mt -78.79 -50.95 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.162 0.985 . . . . 64.11 110.677 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -62.48 -40.92 98.23 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 117.731 -1.128 . . . . 53.41 113.622 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -28.91 64.29 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.425 -0.797 . . . . 75.5 112.61 172.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.14 -31.53 57.39 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-O 118.957 -0.913 . . . . 20.32 112.617 -174.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -30.46 16.49 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.418 1.087 . . . . 72.43 112.945 173.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.79 -50.95 21.07 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.385 1.074 . . . . 75.45 111.063 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.1 mm -88.03 126.81 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 O-C-N 124.337 1.023 . . . . 62.42 109.196 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -82.61 135.19 35.12 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.265 0.978 . . . . 63.21 110.19 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.62 -171.16 34.49 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 109.829 -1.308 . . . . 74.13 109.829 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 76.0 t -135.3 161.94 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 126.342 1.857 . . . . 70.24 108.86 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.2 t -145.63 157.66 43.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.277 1.031 . . . . 70.22 110.125 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -137.74 131.4 31.23 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 108.422 -0.955 . . . . 72.33 108.422 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.3 mt -110.63 130.94 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 106.112 -1.811 . . . . 62.45 106.112 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.4 t -134.2 124.99 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.0 0.92 . . . . 74.23 108.569 -173.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -114.14 131.67 56.34 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.815 1.246 . . . . 74.34 108.994 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -133.55 52.86 2.05 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.243 1.417 . . . . 73.54 109.806 -174.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.65 -115.01 5.12 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 108.742 -1.743 . . . . 50.4 108.742 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -71.88 -38.1 70.07 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.961 1.097 . . . . 73.31 113.961 173.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.19 158.62 33.82 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 124.124 0.89 . . . . 72.23 111.864 172.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -158.63 135.5 9.68 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 106.217 -1.772 . . . . 73.35 106.217 -173.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -121.0 154.79 35.56 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.95 0.781 . . . . 75.04 110.089 171.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -137.38 125.26 22.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 124.532 1.145 . . . . 70.41 108.836 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.4 m -107.23 125.03 50.61 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.893 1.677 . . . . 45.21 108.166 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.8 mt -121.37 116.09 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.003 -1.11 . . . . 74.15 108.003 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -113.66 114.01 25.81 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 124.385 1.053 . . . . 51.0 110.073 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -146.93 145.73 29.89 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.834 0.853 . . . . 75.3 110.33 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.97 -90.9 0.59 Allowed Glycine 0 CA--C 1.532 1.102 0 N-CA-C 109.504 -1.438 . . . . 43.33 109.504 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.2 t -156.33 42.15 0.38 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.14 1.376 . . . . 73.3 110.155 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -154.23 159.77 41.49 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.273 1.029 . . . . 75.41 111.48 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.6 t -127.63 131.41 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 125.443 1.497 . . . . 63.15 109.222 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.2 mt -115.91 113.36 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.32 1.448 . . . . 74.53 108.363 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.22 119.91 40.47 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.198 -1.038 . . . . 63.21 108.198 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -114.13 166.01 12.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.413 1.085 . . . . 63.35 110.096 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -141.34 140.95 33.86 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.224 1.01 . . . . 73.05 109.732 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -151.19 152.6 33.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.99 1.316 . . . . 75.23 109.871 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.9 m -100.7 132.73 45.94 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.498 -0.927 . . . . 72.31 108.498 171.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.19 112.33 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.313 1.045 . . . . 63.33 110.654 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.83 -14.68 49.26 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.053 -1.415 . . . . 75.31 112.712 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -99.98 145.11 28.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.501 1.65 . . . . 71.42 110.461 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -66.99 127.53 32.93 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.129 1.371 . . . . 72.15 111.379 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.5 m -148.65 153.7 38.66 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.293 1.437 . . . . 74.14 109.332 -175.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -92.94 123.66 36.36 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.59 0.756 . . . . 74.33 110.649 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.5 138.5 40.79 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.279 1.432 . . . . 71.33 109.121 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -103.88 139.33 39.21 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.496 1.519 . . . . 63.54 109.68 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.4 m -88.25 163.93 15.87 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.399 1.48 . . . . 60.32 110.889 173.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 74.7 mtm -54.49 -29.16 49.34 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.729 1.381 . . . . 75.24 114.729 169.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.516 HG21 HD21 ' A' ' 24' ' ' LEU . 47.0 p -85.57 -10.89 55.28 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.916 2.086 . . . . 74.02 113.306 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.84 4.33 60.36 Favored Glycine 0 CA--C 1.538 1.524 0 CA-C-O 118.149 -1.362 . . . . 62.43 113.215 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -65.52 121.25 14.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.428 1.614 . . . . 74.34 110.442 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -108.21 129.3 55.2 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.06 0.85 . . . . 71.12 109.65 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.55 131.83 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.594 1.157 . . . . 71.33 111.124 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -75.09 125.94 29.99 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.356 1.462 . . . . 75.51 110.694 174.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.4 t -151.4 164.13 37.41 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.576 1.551 . . . . 74.2 109.642 -172.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.15 130.89 66.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.033 -1.099 . . . . 42.04 108.033 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.8 t -103.22 128.26 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 124.095 0.872 . . . . 70.35 109.313 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -114.55 171.4 7.65 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.968 2.107 . . . . 65.02 110.295 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.473 HD13 ' H ' ' A' ' 87' ' ' GLY . 1.7 tm? -131.52 124.17 29.55 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.134 -1.432 . . . . 64.15 107.134 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.71 13.89 3.52 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.466 1.284 . . . . 62.4 114.466 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.473 ' H ' HD13 ' A' ' 85' ' ' LEU . . . 74.71 13.79 81.88 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.371 1.462 . . . . 63.34 113.014 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -145.08 51.8 1.22 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.573 1.187 . . . . 62.51 109.978 -169.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.276 0.5 OUTLIER 51.65 30.85 7.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.437 1.895 . . . . 73.45 115.171 175.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -140.56 120.93 14.02 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.877 1.271 . . . . 74.52 108.822 -167.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.6 mt -91.92 118.68 30.98 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.148 0.979 . . . . 65.32 109.293 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 91.7 t -101.72 126.37 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.11 1.364 . . . . 61.13 108.819 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.5 m -141.22 149.88 41.96 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.143 0.977 . . . . 63.33 109.373 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.6 p -147.0 138.71 24.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.791 0.836 . . . . 75.11 109.922 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -98.08 -79.61 0.47 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.729 1.611 . . . . 65.02 108.892 -176.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -136.37 -44.7 0.62 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.923 1.289 . . . . 65.23 109.734 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -150.02 8.76 0.65 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.177 1.391 . . . . 74.45 112.64 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.466 HG13 HD13 ' A' ' 115' ' ' LEU . 4.4 mp -109.18 116.12 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.698 1.199 . . . . 51.44 107.769 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.2 tmtp? -98.2 87.81 4.02 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.056 1.342 . . . . 74.33 109.232 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.4 t -74.97 127.82 34.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.132 1.373 . . . . 52.41 111.743 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.6 t -138.24 95.98 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.698 1.599 . . . . 53.11 107.579 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 87.3 m -82.32 155.72 24.64 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.073 1.349 . . . . 54.15 110.285 173.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -145.37 141.64 28.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.422 1.489 . . . . 73.43 109.84 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 tp -119.46 124.14 45.76 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.945 2.098 . . . . 75.03 107.155 172.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -131.18 81.7 2.0 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 106.285 -1.746 . . . . 71.04 106.285 171.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.79 -116.82 9.69 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.946 1.26 . . . . 53.43 110.631 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -80.49 -0.98 39.77 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.977 1.311 . . . . 71.13 114.37 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.8 mm -115.55 131.91 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 119.466 1.03 . . . . 60.11 109.437 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.9 mm -108.84 138.23 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 125.095 1.358 . . . . 74.23 108.122 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.9 m -133.41 110.97 10.37 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 124.629 1.206 . . . . 65.21 107.751 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.9 135.67 45.82 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.912 -0.773 . . . . 75.33 108.912 175.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.4 m -131.76 117.65 18.87 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.845 1.258 . . . . 75.43 108.454 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -110.09 149.93 29.32 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.155 1.382 . . . . 74.34 109.456 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.9 m -133.34 98.93 4.37 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.194 0.934 . . . . 60.32 109.378 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.466 HD13 HG13 ' A' ' 98' ' ' ILE . 8.9 tp -102.01 109.79 21.6 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 125.175 1.39 . . . . 71.2 108.732 174.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.47 -114.86 6.94 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 124.864 1.353 . . . . 63.24 110.777 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.11 -0.74 53.17 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.583 1.953 . . . . 71.45 113.926 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.0 mt -118.06 143.5 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.813 1.245 . . . . 75.42 110.113 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.5 t -125.33 95.17 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.915 0.886 . . . . 64.21 110.053 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -70.86 137.68 49.6 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.833 1.653 . . . . 74.24 112.628 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -124.83 151.87 44.67 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.394 1.077 . . . . 63.24 111.253 170.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.8 mmt-85 -138.87 136.65 35.78 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.781 2.032 . . . . 62.53 108.111 172.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.35 133.72 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.522 -1.288 . . . . 74.22 107.522 173.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.4 m -137.34 156.76 47.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.866 1.266 . . . . 75.33 109.67 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -134.39 144.71 48.35 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.471 1.108 . . . . 63.23 110.657 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.8 ttp85 -64.11 143.61 57.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.352 1.861 . . . . 72.42 114.014 -170.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 6' ' ' LYS . 15.3 mt . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 105.462 -2.051 . . . . 72.13 105.462 -172.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 t . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 108.653 -0.869 . . . . 72.34 108.653 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.434 ' HA ' HD22 ' A' ' 104' ' ' LEU . 27.5 m-85 -60.99 -34.55 74.97 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.469 1.507 . . . . 74.21 114.538 172.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 t -58.98 123.46 16.65 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.806 1.642 . . . . 75.25 113.295 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.66 164.79 13.25 Favored Glycine 0 CA--C 1.539 1.563 0 O-C-N 124.419 1.074 . . . . 65.11 110.529 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HB3' HD12 ' A' ' 127' ' ' ILE . 1.4 mmmt -98.97 148.3 24.13 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.031 1.732 . . . . 74.12 111.356 174.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -142.98 155.44 44.68 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.177 1.391 . . . . 74.24 109.528 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -127.14 144.04 51.12 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.527 -0.916 . . . . 63.35 108.527 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 36' ' ' LYS . 58.2 tp -56.66 134.83 54.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.696 1.198 . . . . 71.32 111.742 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -115.46 -51.42 2.69 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 124.798 1.311 . . . . 65.5 110.116 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 t -159.66 162.68 35.18 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 124.409 1.068 . . . . 73.05 110.185 -173.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -155.78 159.82 39.75 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.554 1.542 . . . . 74.35 111.349 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -137.84 142.18 40.77 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.138 1.375 . . . . 71.15 108.619 176.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 57.4 28.33 15.22 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.276 1.831 . . . . 63.12 113.167 -174.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.67 -57.92 9.32 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.058 0.943 . . . . 74.25 112.163 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -52.69 -50.01 64.15 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.313 1.845 . . . . 60.04 112.348 173.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.91 -47.11 86.19 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.14 1.376 . . . . 53.45 113.956 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -69.43 -46.29 67.13 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 124.787 1.235 . . . . 70.13 113.567 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.5 mmt -65.81 -37.93 87.59 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 124.729 1.268 . . . . 61.43 112.975 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.465 ' HD3' HD13 ' A' ' 29' ' ' ILE . 8.1 mmmm -71.94 -27.09 62.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.103 0.961 . . . . 62.13 112.482 171.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.03 -37.47 58.32 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.556 1.142 . . . . 71.32 113.721 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.9 pt -78.24 -8.27 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 113.391 0.886 . . . . 75.3 113.391 170.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.8 31.46 26.59 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.509 -1.162 . . . . 44.11 112.547 169.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.31 153.06 93.37 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 118.861 1.33 . . . . 72.05 111.704 173.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.7 142.22 69.45 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.18 1.92 . . . . 64.41 111.407 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -59.02 -24.84 63.16 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.514 1.301 . . . . 74.34 114.514 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -62.66 -47.23 84.59 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 117.266 -1.349 . . . . 73.54 113.55 171.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.2 mt -63.67 -28.04 69.63 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.306 1.042 . . . . 75.44 113.693 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.465 HD13 ' HD3' ' A' ' 20' ' ' LYS . 15.4 mt -76.95 -52.64 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.322 1.049 . . . . 64.11 111.394 176.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -62.7 -41.08 98.94 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 117.576 -1.202 . . . . 53.41 113.335 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -25.61 61.21 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 118.216 -0.897 . . . . 75.5 113.171 172.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.83 -32.28 50.48 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.148 -0.807 . . . . 20.32 111.978 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.0 -31.57 16.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.677 1.191 . . . . 72.43 113.066 173.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -72.27 -54.4 9.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.686 1.194 . . . . 75.45 110.854 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.9 mm -94.22 125.63 46.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 124.346 1.029 . . . . 62.42 108.636 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.498 ' HA ' HD23 ' A' ' 9' ' ' LEU . 13.7 mptt -73.79 104.75 4.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.452 1.101 . . . . 63.21 110.284 170.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.0 158.1 51.82 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 124.497 1.123 . . . . 74.13 110.592 176.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.3 t -100.91 152.19 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.119 0.968 . . . . 70.24 109.257 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.7 t -130.3 155.58 46.08 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.109 1.764 . . . . 70.22 108.563 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -158.05 143.25 16.7 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.493 -0.558 . . . . 72.33 109.493 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.407 HG12 ' CE1' ' A' ' 50' ' ' PHE . 11.3 mt -134.76 133.44 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 106.077 -1.823 . . . . 62.45 106.077 -173.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.2 t -140.34 98.92 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 107.81 -1.181 . . . . 74.23 107.81 -175.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -82.37 133.14 35.22 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.667 1.187 . . . . 74.34 109.928 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -133.81 54.32 1.96 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.941 1.297 . . . . 73.54 110.153 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.9 -111.92 3.61 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 109.156 -1.578 . . . . 50.4 109.156 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -77.34 -33.03 55.5 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.373 1.069 . . . . 73.31 113.813 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.56 154.7 34.26 Favored 'General case' 0 C--N 1.346 0.421 0 O-C-N 124.147 0.904 . . . . 72.23 111.267 172.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -144.99 135.16 23.98 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.49 -1.67 . . . . 73.35 106.49 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -123.27 152.66 41.13 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.229 1.411 . . . . 75.04 110.058 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.407 ' CE1' HG12 ' A' ' 41' ' ' ILE . 8.0 t80 -143.24 135.35 26.98 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.231 -1.396 . . . . 70.41 107.231 177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 m -123.1 107.26 11.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.529 1.131 . . . . 45.21 109.633 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.5 mt -95.31 136.38 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.609 1.164 . . . . 74.15 108.544 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.2 m -123.09 125.49 45.28 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.478 1.111 . . . . 51.0 108.763 172.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.74 70.73 0.72 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.292 1.037 . . . . 75.3 108.813 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.44 -37.86 1.83 Allowed Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.85 1.69 . . . . 43.33 113.894 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.0 p -157.05 -45.39 0.07 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.131 1.466 . . . . 73.3 112.137 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.99 139.28 48.53 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.27 1.028 . . . . 75.41 110.823 171.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.96 136.4 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 124.541 1.15 . . . . 63.15 109.315 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.6 mt -125.76 124.19 65.97 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 C-N-CA 124.669 1.188 . . . . 74.53 109.067 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -109.24 124.0 50.17 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 125.206 1.566 . . . . 63.21 107.749 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -122.09 144.82 48.69 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.976 1.31 . . . . 63.35 108.685 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -135.23 143.27 46.25 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 125.019 1.449 . . . . 73.05 109.407 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.76 162.74 40.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.509 1.123 . . . . 75.23 110.022 175.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.1 m -108.59 130.04 55.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.391 1.076 . . . . 72.31 108.35 172.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.9 116.82 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.239 1.016 . . . . 63.33 110.439 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.74 -8.16 39.53 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.006 -1.441 . . . . 75.31 112.413 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -121.32 154.01 36.97 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 119.155 1.478 . . . . 71.42 111.065 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.39 131.86 39.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.913 1.685 . . . . 72.15 110.422 174.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.8 m -143.32 156.69 44.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.442 1.497 . . . . 74.14 108.416 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -95.62 123.89 39.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.701 0.8 . . . . 74.33 110.289 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.01 135.27 51.12 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.193 1.797 . . . . 71.33 109.176 -174.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -100.26 145.22 28.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.355 1.462 . . . . 63.54 111.82 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.3 p -104.82 174.35 5.92 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.107 1.763 . . . . 60.32 112.069 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -54.8 -34.96 63.35 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.471 1.656 . . . . 75.24 115.471 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.5 p -91.47 -5.44 54.25 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.616 1.566 . . . . 74.02 112.983 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.27 13.35 54.48 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 118.337 -1.257 . . . . 62.43 112.954 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -65.38 130.02 41.81 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.188 1.494 . . . . 74.34 109.995 173.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.5 mtpt -114.57 120.27 39.63 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.488 -0.93 . . . . 71.12 108.488 -174.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 m -138.68 128.45 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.903 1.281 . . . . 71.33 111.226 -170.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.86 135.9 40.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.525 1.13 . . . . 75.51 112.296 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 t -161.49 151.9 17.59 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.295 1.438 . . . . 74.2 110.181 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.99 136.41 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.621 1.168 . . . . 42.04 107.958 170.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -106.77 132.24 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 108.249 -1.019 . . . . 70.35 108.249 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -132.04 147.73 52.46 Favored 'General case' 0 C--N 1.345 0.373 0 C-N-CA 124.94 1.296 . . . . 65.02 112.646 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.842 HD23 ' H ' ' A' ' 87' ' ' GLY . 3.3 tt -109.44 128.43 55.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.693 1.597 . . . . 64.15 109.094 -174.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.47 11.59 21.23 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.164 1.385 . . . . 62.4 114.134 -176.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.842 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 81.21 -1.52 84.81 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.833 1.682 . . . . 63.34 113.137 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -121.94 38.19 4.18 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.747 1.619 . . . . 62.51 111.63 -168.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.326 0.3 OUTLIER 52.38 41.23 30.57 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.572 1.949 . . . . 73.45 113.917 178.753 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -138.81 141.91 38.72 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.263 1.825 . . . . 74.52 108.353 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.2 mt -121.63 119.43 31.84 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 124.302 1.001 . . . . 65.32 110.245 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -102.36 133.81 44.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.271 1.428 . . . . 61.13 108.883 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 t -153.03 135.67 15.25 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.457 1.103 . . . . 63.33 110.576 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.9 p -137.86 126.49 23.66 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.005 1.322 . . . . 75.11 110.155 -172.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -92.27 -61.26 1.65 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.917 1.287 . . . . 65.02 110.145 -175.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -143.15 -70.12 0.33 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.263 1.425 . . . . 65.23 108.43 -174.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -123.77 -20.58 5.41 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.977 1.711 . . . . 74.45 111.186 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.57 HG13 HD13 ' A' ' 115' ' ' LEU . 4.3 mp -79.32 121.78 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.71 1.204 . . . . 51.44 109.275 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -112.28 93.31 4.38 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.108 1.363 . . . . 74.33 108.722 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.2 t -95.09 112.3 24.02 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.872 1.669 . . . . 52.41 110.205 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.4 t -113.82 116.33 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.143 1.377 . . . . 53.11 108.347 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.0 m -94.72 152.54 18.37 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.812 1.645 . . . . 54.15 109.92 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -145.17 140.9 28.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.799 1.64 . . . . 73.43 109.383 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 3' ' ' PHE . 13.6 tp -122.36 126.46 48.09 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.292 1.837 . . . . 75.03 107.05 173.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -133.49 87.18 2.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.552 1.941 . . . . 71.04 106.84 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.94 -114.79 6.88 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 110.58 -1.008 . . . . 53.43 110.58 175.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.56 3.69 49.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.424 1.49 . . . . 71.13 113.798 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.7 mm -116.27 131.68 68.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.282 0.946 . . . . 60.11 109.054 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 42.9 mm -106.38 136.12 42.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.264 0 N-CA-C 107.527 -1.286 . . . . 74.23 107.527 168.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.9 m -123.27 137.66 54.81 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.168 -1.419 . . . . 65.21 107.168 172.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -134.71 135.09 41.72 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.405 -0.961 . . . . 75.33 108.405 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 90.7 m -132.81 116.03 16.03 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.605 1.191 . . . . 75.43 108.547 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 94.0 mtp -107.62 142.37 37.67 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.431 1.492 . . . . 74.34 108.935 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.7 m -132.58 108.25 8.96 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.288 0.993 . . . . 60.32 108.639 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.57 HD13 HG13 ' A' ' 98' ' ' ILE . 12.8 tp -121.1 112.76 19.1 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.529 1.531 . . . . 71.2 108.117 177.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.3 -118.61 15.47 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 124.657 1.223 . . . . 63.24 110.129 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.47 3.92 50.64 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.502 1.521 . . . . 71.45 113.114 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mp -111.45 135.43 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.056 0.942 . . . . 75.42 109.273 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.14 96.08 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.035 0.934 . . . . 64.21 109.421 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -76.34 131.05 38.94 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.636 1.574 . . . . 74.24 112.193 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -113.67 152.52 30.33 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.601 1.161 . . . . 63.24 109.825 167.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -150.48 138.65 20.25 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.837 1.255 . . . . 62.53 109.038 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -130.22 137.05 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.82 1.248 . . . . 74.22 108.534 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 42.3 m -132.2 160.99 34.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.285 1.434 . . . . 75.33 110.273 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -136.2 144.46 44.94 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.799 1.24 . . . . 63.23 110.227 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -62.63 139.05 58.63 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 126.136 1.775 . . . . 72.42 113.765 -171.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 6' ' ' LYS . 23.1 mt . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 105.776 -1.935 . . . . 72.13 105.776 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 108.583 -0.895 . . . . 72.34 108.583 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -62.6 -27.7 69.37 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 115.355 1.613 . . . . 74.21 115.355 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.0 p -58.3 119.95 7.83 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.565 1.546 . . . . 75.25 113.974 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.08 160.32 9.48 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 110.121 -1.192 . . . . 65.11 110.121 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HB3' HD12 ' A' ' 127' ' ' ILE . 6.2 mtmt -92.39 149.25 21.52 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.82 1.248 . . . . 74.12 112.072 172.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -139.89 152.08 46.14 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.622 1.569 . . . . 74.24 109.353 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -125.1 148.13 48.69 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.264 1.425 . . . . 63.35 109.297 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.2 129.96 42.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.167 0.987 . . . . 71.32 111.722 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -114.24 -50.42 2.81 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.655 1.582 . . . . 65.5 111.23 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.8 t -152.7 170.58 19.9 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 124.259 0.974 . . . . 73.05 110.804 -171.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -167.83 149.94 5.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.148 1.379 . . . . 74.35 111.412 -166.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -142.47 140.69 31.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.203 1.401 . . . . 71.15 108.673 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 57.52 26.59 12.91 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.465 1.906 . . . . 63.12 113.952 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -62.48 -56.36 18.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.089 0.955 . . . . 74.25 112.263 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -49.91 -55.44 14.42 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.971 1.708 . . . . 60.04 111.996 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.1 -51.22 64.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.067 1.747 . . . . 53.45 114.351 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -67.39 -45.59 75.75 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.379 1.072 . . . . 70.13 113.377 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.4 mmt -68.35 -35.61 78.01 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 124.76 1.287 . . . . 61.43 112.666 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.516 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.7 mptm? -64.27 -36.0 82.67 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.809 0.843 . . . . 62.13 113.138 167.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.52 -35.82 60.65 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 114.679 1.363 . . . . 71.32 114.679 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.46 ' CD1' HD13 ' A' ' 24' ' ' LEU . 42.5 pt -76.28 -10.56 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.679 0.792 . . . . 75.3 113.108 170.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.4 27.07 26.15 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 118.41 -1.216 . . . . 44.11 112.862 170.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.525 HD11 ' CG2' ' A' ' 75' ' ' THR . 4.5 mp -67.58 147.26 98.74 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 119.112 1.456 . . . . 72.05 111.159 173.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -66.77 145.97 76.93 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.162 1.908 . . . . 64.41 111.433 172.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.463 ' HA ' HD12 ' A' ' 29' ' ' ILE . 42.5 tt0 -55.78 -29.2 59.25 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.47 1.285 . . . . 74.34 114.47 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -63.56 -45.42 90.57 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 117.772 -1.109 . . . . 73.54 113.827 174.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.2 mt -64.6 -27.41 68.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.227 1.011 . . . . 75.44 113.339 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.516 HD13 ' HD2' ' A' ' 20' ' ' LYS . 42.8 mt -77.93 -54.98 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.221 1.008 . . . . 64.11 110.09 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -58.9 -40.79 85.54 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.951 1.093 . . . . 53.41 113.951 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -29.44 62.7 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 118.431 -0.795 . . . . 75.5 112.732 173.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.69 -21.43 71.95 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-O 118.715 -1.047 . . . . 20.32 112.787 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -102.02 -24.98 13.91 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 124.661 1.184 . . . . 72.43 113.14 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -68.94 -52.6 27.54 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.941 1.296 . . . . 75.45 110.687 172.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.1 mm -96.39 137.06 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.755 1.222 . . . . 62.42 109.431 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -90.87 126.77 36.14 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.723 1.209 . . . . 63.21 110.042 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.37 175.97 46.36 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 124.475 1.109 . . . . 74.13 110.707 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.26 151.3 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.546 1.538 . . . . 70.24 108.213 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.3 t -148.82 105.53 3.57 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.852 0.861 . . . . 70.22 109.771 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -81.19 143.5 32.3 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 125.081 1.352 . . . . 72.33 110.801 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.41 HG12 ' CE1' ' A' ' 50' ' ' PHE . 13.8 mt -127.0 132.02 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 107.178 -1.415 . . . . 62.45 107.178 174.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.4 m -139.34 143.32 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.126 0.57 . . . . 74.23 109.931 172.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -121.73 128.24 51.57 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.219 1.808 . . . . 74.34 106.913 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -139.89 77.81 1.63 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.032 0.933 . . . . 73.54 108.891 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.18 -121.54 10.39 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 108.741 -1.744 . . . . 50.4 108.741 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -79.37 -26.66 41.98 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.387 1.254 . . . . 73.31 114.387 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.9 154.38 28.38 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 123.876 0.87 . . . . 72.23 111.442 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -146.02 134.11 21.55 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.834 -1.543 . . . . 73.35 106.834 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -123.01 159.14 29.0 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.302 1.041 . . . . 75.04 110.122 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.41 ' CE1' HG12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -151.47 123.12 7.95 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.076 1.35 . . . . 70.41 108.687 -174.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -119.81 107.13 12.8 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.271 1.029 . . . . 45.21 108.994 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.17 117.34 54.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.322 1.049 . . . . 74.15 108.708 -173.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.4 m -99.0 133.01 43.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.973 1.309 . . . . 51.0 109.089 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.25 81.17 1.87 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.645 1.178 . . . . 75.3 109.035 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.08 -79.36 1.92 Allowed Glycine 0 CA--C 1.531 1.045 0 N-CA-C 109.412 -1.475 . . . . 43.33 109.412 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 t -136.3 -30.04 0.95 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.847 1.259 . . . . 73.3 112.06 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -73.12 139.41 46.41 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 123.656 0.782 . . . . 75.41 110.837 170.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.01 117.64 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.002 -1.11 . . . . 63.15 108.002 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.0 mt -107.15 124.41 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.582 -1.266 . . . . 74.53 107.582 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -108.4 128.85 55.13 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 124.696 1.248 . . . . 63.21 108.703 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -132.58 154.12 50.34 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.144 1.378 . . . . 63.35 108.787 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.84 148.98 25.92 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 124.421 1.076 . . . . 73.05 109.969 -173.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -156.96 154.07 29.08 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 124.668 1.23 . . . . 75.23 110.267 -175.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -96.24 129.96 43.44 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.631 1.207 . . . . 72.31 108.307 170.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.87 125.39 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.37 1.068 . . . . 63.33 110.515 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.69 -35.02 5.2 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 118.381 -1.233 . . . . 75.31 111.553 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -97.4 143.18 28.39 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 118.861 1.33 . . . . 71.42 111.762 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.72 126.55 30.07 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.71 1.604 . . . . 72.15 111.067 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.4 m -141.79 153.29 44.44 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.853 1.261 . . . . 74.14 108.78 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.48 120.15 37.34 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.826 1.25 . . . . 74.33 108.761 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.43 HD23 HG22 ' A' ' 81' ' ' THR . 2.9 mm? -111.37 116.15 30.48 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 124.415 1.086 . . . . 71.33 109.031 -176.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -76.04 152.21 36.95 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 124.548 1.155 . . . . 63.54 111.084 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.1 p -114.94 179.67 3.88 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.795 1.638 . . . . 60.32 109.929 173.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 43.7 mtm -56.26 -29.23 60.83 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.811 1.782 . . . . 75.24 115.811 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.525 ' CG2' HD11 ' A' ' 24' ' ' LEU . 63.2 p -86.24 -13.03 48.03 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.507 1.523 . . . . 74.02 113.325 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.53 -1.9 60.42 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 118.287 -1.285 . . . . 62.43 112.074 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -67.68 115.06 6.83 Favored 'General case' 0 C--N 1.349 0.547 0 CA-C-N 119.294 1.547 . . . . 74.34 110.984 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -111.8 136.0 51.66 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 124.791 1.307 . . . . 71.12 109.361 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.96 128.64 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.827 1.251 . . . . 71.33 110.316 -169.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.54 128.83 38.05 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 124.44 1.088 . . . . 75.51 111.939 174.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.43 HG22 HD23 ' A' ' 71' ' ' LEU . 12.1 t -158.05 157.62 33.24 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.076 1.35 . . . . 74.2 109.433 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.1 m -101.2 151.93 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.875 1.27 . . . . 42.04 109.663 169.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.52 127.0 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.763 -1.199 . . . . 70.35 107.763 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -117.51 172.38 7.37 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.814 1.646 . . . . 65.02 109.67 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 87' ' ' GLY . 5.3 tt -130.11 129.06 43.06 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.611 1.164 . . . . 64.15 108.624 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -86.16 15.53 5.09 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.196 1.398 . . . . 62.4 114.602 -174.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.576 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 72.76 12.05 78.08 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 125.291 1.424 . . . . 63.34 113.161 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -143.36 51.88 1.36 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.648 1.179 . . . . 62.51 109.019 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.296 0.3 OUTLIER 48.72 38.29 11.34 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.892 2.077 . . . . 73.45 114.437 171.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -143.51 133.49 24.15 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 125.55 1.54 . . . . 74.52 108.431 -170.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.1 mt -103.91 124.27 48.67 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 124.525 1.141 . . . . 65.32 109.742 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.9 t -106.91 133.34 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.407 1.483 . . . . 61.13 108.617 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.7 t -164.98 140.8 5.52 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.201 1.0 . . . . 63.33 110.476 -168.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.5 m -146.72 128.97 15.72 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.666 0.604 . . . . 75.11 110.542 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -86.89 -154.75 0.24 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.773 1.629 . . . . 65.02 110.675 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.45 -34.1 74.86 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.639 1.576 . . . . 65.23 113.952 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -162.47 12.2 0.07 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.343 1.457 . . . . 74.45 112.47 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.432 HG12 HD13 ' A' ' 115' ' ' LEU . 21.9 mt -116.22 117.07 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.263 -1.384 . . . . 51.44 107.263 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -85.17 146.94 26.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.543 1.137 . . . . 74.33 108.687 169.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.7 m -150.43 125.99 10.23 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 123.857 0.723 . . . . 52.41 110.321 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.08 110.44 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.801 -1.185 . . . . 53.11 107.801 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.7 m -92.32 152.37 19.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.424 1.09 . . . . 54.15 109.511 172.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -143.74 138.38 28.77 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.979 1.712 . . . . 73.43 109.927 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.4 tp -118.58 125.14 49.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.84 2.056 . . . . 75.03 106.762 172.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -129.87 78.81 1.87 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.658 1.983 . . . . 71.04 106.293 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.99 -111.78 4.27 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.588 1.09 . . . . 53.43 110.58 176.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.74 -17.23 56.16 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.888 1.275 . . . . 71.13 113.536 175.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.8 mm -102.39 132.41 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 119.027 0.83 . . . . 60.11 110.161 -174.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.2 mm -108.53 140.39 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.022 1.329 . . . . 74.23 108.4 170.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.7 m -133.02 141.77 48.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.778 1.231 . . . . 65.21 107.719 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -132.95 142.0 48.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.565 1.146 . . . . 75.33 107.911 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.2 m -135.08 105.6 6.41 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 124.91 1.381 . . . . 75.43 108.206 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.6 mtp -98.58 148.28 23.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.901 1.68 . . . . 74.34 108.963 173.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.6 m -138.7 109.55 6.71 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.135 0.974 . . . . 60.32 108.83 173.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.432 HD13 HG12 ' A' ' 98' ' ' ILE . 12.7 tp -114.37 109.4 18.28 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.545 1.538 . . . . 71.2 108.14 176.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.47 -112.33 4.89 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 124.822 1.326 . . . . 63.24 110.465 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.83 2.37 41.01 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.74 2.016 . . . . 71.45 113.706 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.1 mt -122.5 142.83 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.709 1.204 . . . . 75.42 110.346 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.6 t -123.85 90.99 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.559 1.144 . . . . 64.21 110.164 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -73.57 128.92 36.83 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.4 1.08 . . . . 74.24 112.111 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -123.99 152.4 42.59 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.285 1.034 . . . . 63.24 110.716 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -140.61 144.3 35.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.965 1.306 . . . . 62.53 109.002 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -135.1 126.89 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.464 1.106 . . . . 74.22 108.109 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.8 m -129.87 159.43 36.63 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.74 1.216 . . . . 75.33 110.102 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -135.73 146.28 47.53 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.484 1.114 . . . . 63.23 110.626 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.3 ttp85 -62.79 139.52 58.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.242 2.217 . . . . 72.42 114.067 -172.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 6' ' ' LYS . 5.0 mt . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 105.792 -1.929 . . . . 72.13 105.792 -175.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.9 p . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 108.946 -0.761 . . . . 72.34 108.946 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -60.24 -33.23 72.0 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.874 1.435 . . . . 74.21 114.874 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.2 p -57.61 133.3 55.17 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.168 1.787 . . . . 75.25 114.564 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.54 165.25 10.23 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.742 1.163 . . . . 65.11 110.217 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.486 ' HB3' HD12 ' A' ' 127' ' ' ILE . 8.3 mtmt -92.97 145.23 24.53 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 124.694 1.198 . . . . 74.12 112.004 173.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -135.94 147.67 48.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.508 1.523 . . . . 74.24 109.506 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -116.69 148.73 40.78 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.303 1.441 . . . . 63.35 109.454 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.481 HD13 ' HG3' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -72.84 121.88 20.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.71 1.204 . . . . 71.32 111.716 -175.109 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -96.31 -56.47 2.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.72 1.208 . . . . 65.5 111.85 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.5 t -161.77 159.05 26.64 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.15 0.98 . . . . 73.05 110.448 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -135.4 147.19 48.93 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.251 1.42 . . . . 74.35 108.698 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -123.32 138.05 54.7 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.1 1.36 . . . . 71.15 108.476 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 56.37 32.79 21.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.262 1.825 . . . . 63.12 112.616 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -61.74 -60.72 3.23 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.324 1.05 . . . . 74.25 110.594 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.47 -39.05 89.48 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 124.478 1.111 . . . . 60.04 113.559 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.68 -48.26 81.69 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.45 1.1 . . . . 53.45 112.965 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -68.32 -45.43 72.97 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.948 1.299 . . . . 70.13 113.072 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.9 mmt -69.19 -37.38 78.12 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.32 1.048 . . . . 61.43 113.118 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.542 ' HD2' HD13 ' A' ' 29' ' ' ILE . 6.3 mptt -67.01 -35.42 79.91 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.904 0.882 . . . . 62.13 112.754 169.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.56 -34.18 69.75 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.386 1.254 . . . . 71.32 114.386 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.9 pt -79.06 -9.72 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 113.204 0.816 . . . . 75.3 113.204 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.89 22.64 22.77 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 118.099 -1.389 . . . . 44.11 113.52 167.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.68 151.5 97.21 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 119.629 1.715 . . . . 72.05 111.866 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.26 147.51 59.81 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.291 1.994 . . . . 64.41 111.789 172.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.401 ' HA ' HD12 ' A' ' 29' ' ' ILE . 44.1 tt0 -57.11 -29.64 63.69 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.028 1.492 . . . . 74.34 115.028 -177.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -62.27 -44.67 96.01 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.383 0.882 . . . . 73.54 113.383 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -65.8 -27.6 68.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.549 1.539 . . . . 75.44 112.763 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.542 HD13 ' HD2' ' A' ' 20' ' ' LYS . 68.5 mt -79.95 -47.5 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.64 1.176 . . . . 64.11 111.085 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -65.23 -40.56 94.22 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-O 117.76 -1.114 . . . . 53.41 113.395 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.62 -25.38 61.28 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 118.262 -0.875 . . . . 75.5 112.854 172.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.57 -37.45 46.28 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 123.894 0.759 . . . . 20.32 111.953 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -28.47 21.79 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.517 1.127 . . . . 72.43 113.203 175.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.86 -57.63 3.93 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.59 1.156 . . . . 75.45 111.059 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.8 mm -81.86 119.11 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 124.328 1.017 . . . . 62.42 109.195 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.481 ' HG3' HD13 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -83.2 132.95 35.04 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 124.529 1.143 . . . . 63.21 111.054 177.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -97.75 -179.62 33.29 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 124.917 1.385 . . . . 74.13 110.996 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.4 t -129.44 147.35 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.393 1.877 . . . . 70.24 107.881 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.4 t -145.69 107.69 4.34 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.356 0.662 . . . . 70.22 110.022 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -85.22 148.72 25.94 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.573 1.149 . . . . 72.33 110.723 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.6 mt -126.84 133.67 67.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 124.943 1.402 . . . . 62.45 107.356 175.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.5 t -140.57 97.85 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.661 -0.866 . . . . 74.23 108.661 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -80.56 140.62 35.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.289 0.636 . . . . 74.34 109.519 168.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -146.74 71.63 1.24 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.067 0.947 . . . . 73.54 109.198 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.56 -127.0 11.5 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 109.311 -1.516 . . . . 50.4 109.311 -177.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -65.49 -35.52 81.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.239 1.416 . . . . 73.31 113.843 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -76.42 156.31 33.26 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 124.166 0.986 . . . . 72.23 112.14 174.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -151.98 126.41 9.38 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.711 -1.218 . . . . 73.35 107.711 -172.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -112.11 154.82 24.86 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.842 2.057 . . . . 75.04 109.926 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.95 143.15 25.04 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.535 1.534 . . . . 70.41 108.196 175.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.4 m -135.99 98.07 3.79 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.33 1.052 . . . . 45.21 108.564 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.1 mt -93.39 114.79 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.907 1.283 . . . . 74.15 109.368 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.0 m -104.92 118.1 35.69 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.831 1.653 . . . . 51.0 108.602 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -169.48 155.96 6.45 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.94 0.896 . . . . 75.3 111.462 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.39 -82.81 1.45 Allowed Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.071 -1.212 . . . . 43.33 110.071 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.9 p -157.0 12.4 0.24 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.584 1.554 . . . . 73.3 112.727 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.35 179.74 8.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.147 0.979 . . . . 75.41 111.577 -172.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.9 t -130.41 126.04 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.555 1.142 . . . . 63.15 108.723 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.3 mt -108.56 128.7 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.821 1.249 . . . . 74.53 108.827 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -114.5 133.61 55.64 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 124.859 1.35 . . . . 63.21 108.661 176.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -133.23 144.63 49.9 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.14 1.376 . . . . 63.35 108.694 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -132.28 145.13 51.08 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 124.882 1.364 . . . . 73.05 109.778 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -157.17 151.07 24.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.568 1.547 . . . . 75.23 108.204 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.4 m -93.69 140.53 29.53 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.708 0.803 . . . . 72.31 108.928 167.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.06 107.1 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.986 0.914 . . . . 63.33 110.064 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.06 -4.42 30.24 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 117.533 -1.704 . . . . 75.31 113.17 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -98.25 147.69 24.38 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.903 1.851 . . . . 71.42 109.409 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -84.87 125.68 32.83 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.749 1.22 . . . . 72.15 109.616 172.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.1 m -146.24 151.72 38.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.924 1.29 . . . . 74.14 109.61 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.55 116.59 28.57 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.905 1.282 . . . . 74.33 109.071 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.417 HD12 ' CG2' ' A' ' 81' ' ' THR . 83.0 mt -108.72 116.12 31.37 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.559 1.144 . . . . 71.33 109.848 -170.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -79.22 131.82 36.31 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.662 1.226 . . . . 63.54 111.484 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.8 p -90.82 169.67 10.75 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.572 1.549 . . . . 60.32 110.99 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.3 mtm -57.24 -27.47 62.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.929 1.692 . . . . 75.24 115.18 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 p -82.68 -14.55 54.43 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.246 1.818 . . . . 74.02 113.072 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.02 -4.55 59.0 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.289 1.423 . . . . 62.43 112.341 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -69.85 135.48 49.65 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 119.099 1.449 . . . . 74.34 110.439 173.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -138.41 136.5 36.34 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.969 0.793 . . . . 71.12 109.693 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.0 m -149.1 138.66 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.231 1.412 . . . . 71.33 110.089 -170.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 136.19 46.61 Favored 'General case' 0 C--N 1.346 0.416 0 O-C-N 124.213 0.946 . . . . 75.51 112.081 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.417 ' CG2' HD12 ' A' ' 71' ' ' LEU . 6.4 t -164.8 149.49 9.4 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.552 1.541 . . . . 74.2 109.384 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.3 t -99.32 138.48 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.516 1.126 . . . . 42.04 108.582 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 52.7 t -108.73 125.32 65.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 124.451 1.095 . . . . 70.35 108.254 172.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -120.15 157.16 29.6 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.892 1.677 . . . . 65.02 110.978 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.742 HD23 ' H ' ' A' ' 87' ' ' GLY . 6.7 tt -124.63 125.59 44.38 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.937 1.295 . . . . 64.15 108.137 -175.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.01 13.08 5.34 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.307 1.443 . . . . 62.4 114.87 -173.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.742 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 75.13 8.25 83.0 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 125.247 1.403 . . . . 63.34 113.031 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -142.28 61.77 1.44 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.978 1.311 . . . . 62.51 108.858 -171.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 48.02 35.24 4.88 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.155 2.182 . . . . 73.45 115.929 167.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -143.8 139.8 29.53 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.664 1.586 . . . . 74.52 108.691 -172.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.5 mt -113.56 122.63 47.82 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 124.362 1.039 . . . . 65.32 109.684 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.4 t -105.63 134.93 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.472 1.509 . . . . 61.13 108.92 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 t -163.38 144.98 9.57 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.237 1.415 . . . . 63.33 109.969 -171.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 83.9 m -147.86 129.35 14.92 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.809 0.844 . . . . 75.11 110.105 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -69.37 -75.12 0.12 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.831 1.252 . . . . 65.02 111.261 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -138.32 -41.07 0.51 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.328 1.851 . . . . 65.23 110.447 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -154.92 21.16 0.44 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.25 1.42 . . . . 74.45 111.825 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.478 HG13 HD13 ' A' ' 115' ' ' LEU . 5.1 mp -120.89 91.05 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.069 1.347 . . . . 51.44 107.697 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -70.06 109.49 4.59 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.051 0.94 . . . . 74.33 111.313 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.6 m -116.88 114.45 23.9 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 124.872 1.358 . . . . 52.41 109.332 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.1 t -117.46 110.16 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.962 1.305 . . . . 53.11 107.898 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.2 m -86.17 153.14 22.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.369 1.468 . . . . 54.15 109.688 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -148.11 138.88 23.07 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.816 1.246 . . . . 73.43 109.802 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.0 tp -116.28 126.57 53.74 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.824 2.05 . . . . 75.03 107.704 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -126.46 70.42 1.25 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.001 1.721 . . . . 71.04 106.766 170.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.41 -110.14 3.31 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.913 1.244 . . . . 53.43 110.417 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.03 4.51 14.24 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.476 1.511 . . . . 71.13 113.903 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.8 mm -123.92 140.5 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.118 0.967 . . . . 60.11 109.165 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.7 mm -120.3 137.27 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 125.123 1.369 . . . . 74.23 107.966 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.7 m -134.65 115.61 14.01 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 124.671 1.232 . . . . 65.21 107.84 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -106.08 139.64 40.3 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.436 -0.95 . . . . 75.33 108.436 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.7 m -131.28 120.69 23.54 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.873 1.358 . . . . 75.43 108.358 174.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.4 mtm -112.72 150.19 31.89 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.884 1.674 . . . . 74.34 109.594 173.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.1 m -138.87 96.3 3.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.556 1.142 . . . . 60.32 108.862 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.478 HD13 HG13 ' A' ' 98' ' ' ILE . 9.2 tp -104.73 111.01 23.57 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.443 1.497 . . . . 71.2 108.883 175.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.34 -112.87 5.36 Favored Glycine 0 CA--C 1.533 1.193 0 O-C-N 124.574 1.171 . . . . 63.24 110.413 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -110.9 18.74 19.23 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.91 1.684 . . . . 71.45 111.29 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.4 mt -129.4 136.88 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.015 1.326 . . . . 75.42 109.026 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.6 t -121.99 95.69 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 124.237 0.961 . . . . 64.21 109.565 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -75.05 128.24 35.09 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.814 1.245 . . . . 74.24 112.317 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.04 153.34 34.88 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 124.094 0.871 . . . . 63.24 110.835 169.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -135.29 139.06 44.07 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 126.362 1.865 . . . . 62.53 108.199 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.32 133.71 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 O-C-N 124.802 1.314 . . . . 74.22 107.622 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.9 m -137.37 158.51 44.24 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.122 1.369 . . . . 75.33 110.116 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -139.11 142.77 38.08 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.583 1.153 . . . . 63.23 110.755 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -68.06 136.82 54.38 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.969 2.108 . . . . 72.42 113.005 -168.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 6' ' ' LYS . 17.5 mt . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 105.494 -2.039 . . . . 72.13 105.494 -174.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 CA--C 1.533 0.323 0 N-CA-C 110.078 -0.341 . . . . 72.34 110.078 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -68.18 -30.95 70.18 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 117.625 -1.179 . . . . 74.21 113.621 169.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.5 p -58.88 103.1 0.14 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.488 1.515 . . . . 75.25 112.968 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.75 174.11 37.77 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 108.958 -1.657 . . . . 65.11 108.958 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.53 146.11 48.36 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.686 -1.227 . . . . 74.12 107.686 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.435 ' CE1' HD11 ' A' ' 109' ' ' ILE . 8.1 m-85 -143.1 130.24 20.78 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.798 0.839 . . . . 74.24 110.397 -168.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -87.9 149.21 24.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.988 0.915 . . . . 63.35 110.532 174.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 36' ' ' LYS . 61.0 tp -68.64 132.31 46.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.6 0.76 . . . . 71.32 111.131 173.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -106.08 -53.53 2.62 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 124.67 1.231 . . . . 65.5 110.829 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.25 157.66 15.61 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 124.447 1.092 . . . . 73.05 110.382 -175.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.412 ' HG3' HD11 ' A' ' 9' ' ' LEU . 3.5 mp0 -135.98 137.69 41.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.562 1.145 . . . . 74.35 108.582 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -112.86 137.15 51.64 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.217 1.407 . . . . 71.15 108.406 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 57.39 30.19 18.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.124 1.77 . . . . 63.12 112.964 -171.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.21 -58.36 8.63 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 124.177 0.991 . . . . 74.25 112.111 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -52.59 -52.15 56.57 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.344 1.858 . . . . 60.04 112.42 173.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.96 -48.78 77.54 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.332 1.453 . . . . 53.45 114.037 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -67.72 -45.7 74.29 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.862 1.265 . . . . 70.13 113.593 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 7.3 mmt -65.38 -40.22 93.23 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 124.699 1.25 . . . . 61.43 112.829 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -67.84 -28.3 67.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.187 0.995 . . . . 62.13 113.052 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.63 -34.71 40.33 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 114.099 1.148 . . . . 71.32 114.099 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.0 pt -77.12 -6.82 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 113.065 0.765 . . . . 75.3 113.065 169.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.59 31.24 24.96 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.604 -1.109 . . . . 44.11 112.345 169.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.486 HD21 HG21 ' A' ' 75' ' ' THR . 0.1 OUTLIER -68.01 151.57 97.09 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 118.636 1.218 . . . . 72.05 111.774 177.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.51 139.48 59.03 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.01 1.807 . . . . 64.41 110.763 169.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.452 ' HA ' HD12 ' A' ' 29' ' ' ILE . 20.3 tt0 -63.45 -20.33 65.48 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.4 1.259 . . . . 74.34 114.4 -174.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.58 -45.71 91.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 117.881 -1.057 . . . . 73.54 113.435 168.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.8 mt -66.81 -26.96 67.19 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 124.212 1.005 . . . . 75.44 113.518 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 26' ' ' GLU . 22.5 mt -75.93 -51.22 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.033 0.933 . . . . 64.11 111.376 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -62.08 -48.24 81.07 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.111 -0.947 . . . . 53.41 112.646 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -27.03 68.59 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.426 0.898 . . . . 75.5 113.426 174.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.23 -29.23 51.04 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 118.69 -1.061 . . . . 20.32 112.395 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.37 -30.6 13.83 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.471 1.135 . . . . 72.43 112.732 175.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -72.9 -39.39 66.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.687 1.195 . . . . 75.45 113.335 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.6 mt -111.06 130.05 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.483 -0.932 . . . . 62.42 108.483 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HA ' HD23 ' A' ' 9' ' ' LEU . 12.1 mptt -88.02 134.13 33.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.928 1.291 . . . . 63.21 110.642 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.7 -168.15 26.38 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 109.683 -1.367 . . . . 74.13 109.683 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.2 t -134.97 153.96 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.885 1.274 . . . . 70.24 108.317 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.4 p -128.6 160.48 32.28 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.465 1.506 . . . . 70.22 110.622 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -133.75 148.84 51.44 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 107.452 -1.314 . . . . 72.33 107.452 169.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.422 HG12 ' CE2' ' A' ' 50' ' ' PHE . 7.8 mt -138.72 129.91 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 105.963 -1.866 . . . . 62.45 105.963 176.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.2 m -139.28 138.95 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 123.426 0.454 . . . . 74.23 110.029 175.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -109.94 117.17 33.09 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.083 1.753 . . . . 74.34 107.277 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -116.08 51.33 0.97 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.181 1.392 . . . . 73.54 109.162 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.95 -116.62 5.67 Favored Glycine 0 CA--C 1.534 1.227 0 N-CA-C 107.977 -2.049 . . . . 50.4 107.977 -171.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -72.59 -34.91 67.73 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.154 1.168 . . . . 73.31 114.154 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.44 161.75 29.51 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.856 0.723 . . . . 72.23 111.829 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -159.26 131.46 6.58 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 106.886 -1.524 . . . . 73.35 106.886 -173.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -121.07 149.2 43.08 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.978 1.311 . . . . 75.04 108.824 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.422 ' CE2' HG12 ' A' ' 41' ' ' ILE . 5.5 t80 -141.82 119.75 11.98 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.351 -1.352 . . . . 70.41 107.351 177.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 34.3 m -96.09 134.07 39.58 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.592 1.157 . . . . 45.21 108.909 172.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.58 107.0 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.939 -1.504 . . . . 74.15 106.939 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 m -99.33 100.63 11.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.717 1.207 . . . . 51.0 108.426 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.94 178.02 7.08 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.238 1.015 . . . . 75.3 111.325 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.47 29.55 2.57 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 125.216 1.388 . . . . 43.33 113.356 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -158.28 -33.48 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.35 1.575 . . . . 73.3 112.566 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.68 170.05 19.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.953 1.301 . . . . 75.41 110.37 -176.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.487 HG12 HE21 ' A' ' 60' ' ' GLN . 21.9 t -119.23 132.47 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 O-C-N 124.173 0.921 . . . . 63.15 109.181 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.4 mt -122.97 135.29 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.292 1.437 . . . . 74.53 107.926 172.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.487 HE21 HG12 ' A' ' 58' ' ' VAL . 3.4 mp0 -119.6 143.34 47.71 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 124.175 0.922 . . . . 63.21 108.812 176.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -133.38 132.0 40.7 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.627 1.171 . . . . 63.35 109.734 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -113.02 143.57 44.08 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 125.427 1.704 . . . . 73.05 109.476 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -148.19 164.73 33.05 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.186 1.394 . . . . 75.23 108.659 173.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.7 m -113.51 131.28 56.12 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.434 -0.95 . . . . 72.31 108.434 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.0 t -62.76 119.37 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 125.011 1.324 . . . . 63.33 111.213 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.438 ' HA2' HE21 ' A' ' 84' ' ' GLN . . . 92.91 -10.47 73.85 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-O 117.906 -1.497 . . . . 75.31 113.668 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -107.52 139.46 42.01 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.64 1.72 . . . . 71.42 109.355 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.77 120.14 13.02 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 123.606 0.762 . . . . 72.15 111.736 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.5 m -138.92 140.58 38.37 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.263 1.425 . . . . 74.14 108.28 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -67.44 131.11 45.04 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.87 0.731 . . . . 74.33 111.214 168.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.479 HD12 ' CG2' ' A' ' 81' ' ' THR . 19.6 mt -120.77 109.31 15.01 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.543 1.537 . . . . 71.33 107.921 177.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -74.82 154.52 38.25 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.536 1.135 . . . . 63.54 111.178 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.9 m -110.59 169.56 8.67 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.882 1.673 . . . . 60.32 109.208 175.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -53.06 -25.68 13.49 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.769 1.628 . . . . 75.24 115.022 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.486 HG21 HD21 ' A' ' 24' ' ' LEU . 66.5 p -82.09 -18.74 41.97 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 128.548 2.739 . . . . 74.02 113.968 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.56 0.63 55.47 Favored Glycine 0 CA--C 1.543 1.786 0 CA-C-O 118.549 -1.139 . . . . 62.43 112.564 -174.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -75.63 105.06 6.46 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.525 1.53 . . . . 74.34 111.98 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -99.93 133.2 44.64 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.54 1.136 . . . . 71.12 111.079 176.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -147.03 131.47 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.455 1.502 . . . . 71.33 109.908 -172.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -79.47 129.61 34.63 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.577 1.551 . . . . 75.51 110.218 -172.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.479 ' CG2' HD12 ' A' ' 71' ' ' LEU . 14.6 t -162.69 159.24 24.11 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 124.25 0.969 . . . . 74.2 111.146 -173.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.9 m -104.15 146.31 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 125.287 1.435 . . . . 42.04 109.872 167.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.509 HG12 HD22 ' A' ' 91' ' ' LEU . 40.5 t -122.57 126.84 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 106.962 -1.496 . . . . 70.35 106.962 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.438 HE21 ' HA2' ' A' ' 66' ' ' GLY . 2.4 mt-30 -129.22 139.98 51.65 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.632 1.173 . . . . 65.02 111.522 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.7 tp -84.78 136.97 33.46 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.832 1.332 . . . . 64.15 109.567 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.95 16.12 5.26 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.198 0.999 . . . . 62.4 113.208 173.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.76 12.4 78.26 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.159 1.362 . . . . 63.34 113.081 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -143.91 57.29 1.34 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.862 1.265 . . . . 62.51 108.491 -171.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.276 0.8 OUTLIER 49.49 32.71 4.97 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.84 2.056 . . . . 73.45 115.327 169.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -142.48 127.57 18.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.478 1.911 . . . . 74.52 108.275 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.509 HD22 HG12 ' A' ' 83' ' ' VAL . 49.3 mt -107.17 134.24 50.58 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.593 1.157 . . . . 65.32 109.647 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.8 t -118.91 135.65 58.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.817 1.247 . . . . 61.13 109.181 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.5 t -155.92 142.4 18.57 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.211 1.004 . . . . 63.33 111.576 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.8 p -143.68 136.96 27.87 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.625 1.57 . . . . 75.11 110.121 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -102.78 -61.2 1.43 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.927 1.291 . . . . 65.02 109.613 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -140.88 -63.84 0.46 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 125.881 1.672 . . . . 65.23 109.15 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -140.78 10.63 2.22 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.673 1.589 . . . . 74.45 112.283 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.494 HG12 HD13 ' A' ' 115' ' ' LEU . 65.2 mt -111.53 108.79 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 125.477 1.511 . . . . 51.44 106.95 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -101.58 99.94 10.29 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.404 1.082 . . . . 74.33 110.306 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.63 127.5 35.92 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.091 1.356 . . . . 52.41 108.561 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.3 t -130.41 104.73 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.201 -1.407 . . . . 53.11 107.201 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.3 m -82.68 150.57 26.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.488 1.515 . . . . 54.15 109.842 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -147.09 139.93 25.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.979 1.311 . . . . 73.43 108.933 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.41 124.32 39.9 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.543 1.537 . . . . 75.03 107.418 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -127.55 84.76 2.28 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.555 1.942 . . . . 71.04 106.518 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.69 -114.89 7.19 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.266 1.412 . . . . 53.43 110.461 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -88.18 15.48 7.48 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.77 1.628 . . . . 71.13 114.087 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.8 mm -129.25 132.05 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.248 1.019 . . . . 60.11 108.815 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.435 HD11 ' CE1' ' A' ' 7' ' ' TYR . 46.1 mm -104.83 140.14 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.792 -1.188 . . . . 74.23 107.792 169.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.2 m -133.98 112.29 11.1 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.077 -1.453 . . . . 65.21 107.077 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -103.14 146.91 27.68 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.419 -0.586 . . . . 75.33 109.419 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.0 m -140.45 99.77 3.72 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.975 1.31 . . . . 75.43 109.265 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.6 mmm -92.19 150.59 20.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.103 1.761 . . . . 74.34 110.241 170.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.8 m -140.44 105.38 4.97 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.306 1.042 . . . . 60.32 108.898 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 HG12 ' A' ' 98' ' ' ILE . 12.6 tp -113.88 110.75 20.6 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.871 1.668 . . . . 71.2 108.583 177.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.31 -123.33 29.32 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 109.776 -1.33 . . . . 63.24 109.776 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -97.49 12.68 32.52 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.248 1.419 . . . . 71.45 113.18 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.4 mt -119.28 136.82 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.992 0.917 . . . . 75.42 109.865 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.5 t -119.72 96.71 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 124.33 1.019 . . . . 64.21 109.068 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -75.45 127.41 33.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.322 1.049 . . . . 74.24 111.475 172.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 157.21 29.58 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 123.921 0.763 . . . . 63.24 110.065 168.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -149.36 129.53 13.63 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.261 1.024 . . . . 62.53 109.099 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.63 137.36 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.93 1.292 . . . . 74.22 108.565 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.6 m -134.97 158.39 44.46 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.432 1.093 . . . . 75.33 110.136 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -123.09 134.9 54.22 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 125.345 1.458 . . . . 63.23 108.931 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -68.83 146.83 52.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.912 1.685 . . . . 72.42 112.745 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 105.653 -1.981 . . . . 72.13 105.653 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 109.527 -0.546 . . . . 72.34 109.527 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -78.35 56.38 1.72 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.056 1.743 . . . . 74.21 112.056 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -129.02 120.6 26.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.982 1.313 . . . . 75.25 109.515 -175.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.72 164.44 10.58 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 110.022 -1.231 . . . . 65.11 110.022 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.26 142.85 32.09 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.178 1.391 . . . . 74.12 110.213 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -136.53 150.46 48.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.426 1.09 . . . . 74.24 109.818 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -121.75 143.82 49.15 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.6 1.16 . . . . 63.35 108.839 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 36' ' ' LYS . 31.9 tp -55.17 137.91 45.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.477 1.511 . . . . 71.32 112.937 175.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -122.3 -50.88 1.99 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.44 1.496 . . . . 65.5 111.204 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.1 153.88 41.19 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 124.405 1.066 . . . . 73.05 111.719 -172.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -140.66 132.67 27.79 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.761 1.624 . . . . 74.35 108.997 -170.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -138.54 133.73 32.96 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.32 1.048 . . . . 71.15 109.255 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 54.72 27.73 9.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.097 1.759 . . . . 63.12 113.178 -173.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -62.55 -54.5 38.83 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-O 117.84 -1.076 . . . . 74.25 112.131 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -61.1 -47.0 88.32 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-O 118.072 -0.966 . . . . 60.04 113.257 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.54 -47.05 73.64 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.669 1.187 . . . . 53.45 113.667 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -69.83 -45.48 67.76 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.669 1.187 . . . . 70.13 113.419 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.7 mmt -62.83 -48.2 80.09 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 124.502 1.126 . . . . 61.43 112.717 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.483 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.6 mptm? -59.84 -31.15 69.48 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.468 0.914 . . . . 62.13 113.468 172.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.2 54.63 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.469 1.285 . . . . 71.32 114.469 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.3 pt -79.73 -7.87 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 113.344 0.868 . . . . 75.3 113.344 172.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.68 24.08 37.07 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.736 -1.035 . . . . 44.11 112.72 172.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.65 141.01 98.18 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.851 1.26 . . . . 72.05 110.264 172.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -66.04 143.01 70.49 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.434 2.089 . . . . 64.41 111.901 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.426 ' HA ' HD12 ' A' ' 29' ' ' ILE . 37.1 tt0 -57.44 -27.07 62.11 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.664 1.357 . . . . 74.34 114.664 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -64.51 -45.44 87.22 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 117.885 -1.055 . . . . 73.54 113.568 172.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.8 mt -64.76 -25.12 67.78 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.154 0.981 . . . . 75.44 113.291 173.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.483 HD13 ' HD2' ' A' ' 20' ' ' LYS . 64.7 mt -80.63 -50.86 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.298 1.039 . . . . 64.11 110.802 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -61.94 -42.76 99.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 117.816 -1.087 . . . . 53.41 113.007 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -27.18 62.6 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 118.236 -0.888 . . . . 75.5 112.728 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.67 -27.42 61.01 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.846 -0.975 . . . . 20.32 112.382 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.01 -26.05 14.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.846 1.258 . . . . 72.43 113.147 174.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -80.33 -44.45 19.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.041 0.936 . . . . 75.45 111.156 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.7 mt -102.67 127.64 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.351 1.06 . . . . 62.42 108.165 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HA ' HD23 ' A' ' 9' ' ' LEU . 4.3 tmmm? -76.96 118.16 19.27 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.896 1.278 . . . . 63.21 109.975 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.2 170.16 37.13 Favored Glycine 0 CA--C 1.531 1.091 0 O-C-N 124.247 0.967 . . . . 74.13 110.72 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.8 t -124.58 149.93 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.081 1.352 . . . . 70.24 108.819 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.0 p -126.41 165.95 18.11 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.73 1.612 . . . . 70.22 110.164 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -152.3 141.64 21.53 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.801 -1.185 . . . . 72.33 107.801 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.14 132.69 50.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.395 -1.706 . . . . 62.45 106.395 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.7 t -140.09 100.98 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.827 0.851 . . . . 74.23 108.96 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -87.29 141.58 28.54 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.494 1.118 . . . . 74.34 109.229 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -152.03 77.13 1.2 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.018 0.927 . . . . 73.54 109.002 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.37 -120.52 8.41 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 109.377 -1.489 . . . . 50.4 109.377 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -75.48 -32.17 60.47 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.717 1.207 . . . . 73.31 114.073 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.56 148.83 38.57 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 124.124 0.89 . . . . 72.23 111.861 175.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -138.26 133.08 32.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.95 1.7 . . . . 73.35 106.674 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -125.41 160.05 30.37 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.87 1.668 . . . . 75.04 110.37 173.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -155.97 145.94 21.35 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.559 -1.275 . . . . 70.41 107.559 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.6 m -129.05 117.86 21.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 124.235 0.959 . . . . 45.21 109.849 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.4 mt -90.56 139.49 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.045 1.338 . . . . 74.15 108.456 172.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.2 m -135.9 112.75 10.24 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.616 1.166 . . . . 51.0 108.079 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -120.15 74.76 1.06 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.465 1.106 . . . . 75.3 109.988 -174.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.82 -91.21 1.39 Allowed Glycine 0 CA--C 1.532 1.126 0 N-CA-C 108.847 -1.701 . . . . 43.33 108.847 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.8 m -105.67 -43.09 5.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.94 1.296 . . . . 73.3 112.08 -176.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -72.72 146.02 46.74 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.95 1.3 . . . . 75.41 112.215 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.2 t -133.92 130.31 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.644 1.177 . . . . 63.15 108.78 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.7 mt -130.71 111.62 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.743 1.217 . . . . 74.53 108.581 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.54 149.47 24.07 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.379 0.672 . . . . 63.21 110.975 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -139.31 153.67 47.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.084 1.753 . . . . 63.35 108.245 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -137.08 141.1 42.38 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 124.815 1.322 . . . . 73.05 109.072 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -145.74 168.01 21.76 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.443 1.097 . . . . 75.23 109.851 173.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.2 m -118.92 130.0 55.48 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.685 -1.228 . . . . 72.31 107.685 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.15 123.15 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.298 1.039 . . . . 63.33 110.782 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.431 ' HA2' HE21 ' A' ' 84' ' ' GLN . . . 89.31 2.07 77.58 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 118.267 -1.296 . . . . 75.31 113.396 -177.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -115.31 152.16 33.27 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.571 1.548 . . . . 71.42 109.701 171.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -77.11 127.63 33.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.73 1.612 . . . . 72.15 110.61 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.7 m -146.59 149.47 33.61 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.153 1.381 . . . . 74.14 109.739 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -77.5 145.62 36.89 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 112.688 0.625 . . . . 74.33 112.688 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 mt -122.35 127.85 50.27 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.605 1.562 . . . . 71.33 108.291 173.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -95.29 142.66 27.44 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.43 1.092 . . . . 63.54 110.313 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 p -103.26 -177.57 3.41 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.385 1.474 . . . . 60.32 111.663 173.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.7 mtt -60.02 -38.43 82.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.74 1.616 . . . . 75.24 115.04 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.4 p -89.84 -1.63 58.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.454 1.502 . . . . 74.02 112.838 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.59 19.24 32.74 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 118.249 -1.306 . . . . 62.43 112.722 172.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -69.37 113.98 7.19 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.152 1.476 . . . . 74.34 109.963 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -104.24 125.44 50.51 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 124.153 0.908 . . . . 71.12 109.092 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -146.12 123.27 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 124.427 1.079 . . . . 71.33 110.983 -170.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -72.8 140.59 47.78 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 124.3 1.04 . . . . 75.51 112.351 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.8 t -171.09 163.02 7.26 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.493 1.517 . . . . 74.2 109.692 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.1 t -103.06 136.0 37.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.259 1.024 . . . . 42.04 108.461 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.9 t -103.52 127.8 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 107.996 -1.112 . . . . 70.35 107.996 171.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.431 HE21 ' HA2' ' A' ' 66' ' ' GLY . 22.8 mm-40 -125.51 151.67 46.01 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.264 1.425 . . . . 65.02 111.647 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 tp -101.33 137.02 40.23 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 124.757 1.286 . . . . 64.15 109.509 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -87.54 15.56 6.55 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.567 1.147 . . . . 62.4 113.258 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.96 13.83 80.62 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.95 1.262 . . . . 63.34 113.257 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -143.22 57.11 1.39 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.727 1.211 . . . . 62.51 108.561 -173.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.274 0.3 OUTLIER 44.15 37.0 1.67 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.198 2.199 . . . . 73.45 114.97 175.194 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -140.88 121.99 14.7 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 125.622 1.569 . . . . 74.52 109.02 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.3 mt -95.99 142.84 27.73 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 124.718 1.262 . . . . 65.32 109.721 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.9 t -132.56 137.92 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.471 1.508 . . . . 61.13 108.653 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 t -155.13 149.99 26.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.865 0.866 . . . . 63.33 110.734 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.0 p -143.56 130.74 20.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.942 1.297 . . . . 75.11 109.708 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -95.08 -60.2 1.73 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.312 1.045 . . . . 65.02 110.373 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -143.78 -75.57 0.25 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.682 1.593 . . . . 65.23 108.631 -173.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -116.95 -17.03 10.49 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.245 1.818 . . . . 74.45 111.232 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.5 ' CG1' HD13 ' A' ' 115' ' ' LEU . 21.5 mt -88.86 111.21 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.935 1.294 . . . . 51.44 108.455 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.0 tmmt? -101.27 115.41 30.43 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 124.389 1.075 . . . . 74.33 108.974 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.4 m -117.03 124.36 49.12 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 124.846 1.341 . . . . 52.41 109.073 -169.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.8 t -131.89 117.14 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.528 1.131 . . . . 53.11 109.407 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.1 m -102.92 155.13 18.56 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.769 1.228 . . . . 54.15 109.643 173.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -139.15 144.89 38.81 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.639 1.976 . . . . 73.43 109.661 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 tp -124.85 118.06 25.5 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.863 2.065 . . . . 75.03 106.994 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -122.0 69.2 0.94 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.041 1.337 . . . . 71.04 108.136 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.11 -110.96 3.63 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 110.065 -1.214 . . . . 53.43 110.065 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -79.51 -6.58 57.27 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 117.254 -1.355 . . . . 71.13 113.461 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.2 mm -112.65 136.94 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 119.91 1.232 . . . . 60.11 109.385 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.9 mm -115.54 142.69 27.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.041 1.337 . . . . 74.23 108.151 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.0 m -133.43 124.83 27.79 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.371 1.045 . . . . 65.21 108.235 172.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -108.46 134.95 50.54 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.555 1.142 . . . . 75.33 107.946 170.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 62.6 m -136.41 117.79 14.68 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.303 1.441 . . . . 75.43 108.255 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 33.1 mtm -123.17 142.45 50.89 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.09 0.956 . . . . 74.34 109.715 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.9 m -125.54 113.44 17.44 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.332 1.453 . . . . 60.32 108.662 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.5 HD13 ' CG1' ' A' ' 98' ' ' ILE . 11.6 tp -121.18 107.5 12.65 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.361 1.464 . . . . 71.2 108.048 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.37 -111.67 4.21 Favored Glycine 0 CA--C 1.533 1.199 0 O-C-N 124.837 1.336 . . . . 63.24 110.442 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -99.6 1.36 43.62 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.733 2.013 . . . . 71.45 113.665 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 91.4 mt -120.68 139.51 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.677 1.191 . . . . 75.42 109.967 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.2 t -125.19 101.08 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 124.187 0.929 . . . . 64.21 109.772 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -68.55 138.45 55.14 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.307 1.443 . . . . 74.24 112.099 169.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.5 mppt? -136.37 157.33 47.06 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 124.486 1.116 . . . . 63.24 110.778 167.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.03 141.84 12.88 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.846 1.258 . . . . 62.53 108.996 -177.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.21 139.7 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.702 1.201 . . . . 74.22 108.368 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 45.0 m -133.05 160.56 36.81 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.479 1.512 . . . . 75.33 109.312 173.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.64 144.91 39.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.63 1.172 . . . . 63.23 110.695 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -63.03 145.34 55.65 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.79 2.036 . . . . 72.42 113.7 -171.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.8 mt . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 103.886 -2.635 . . . . 72.13 103.886 -175.126 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.4 p . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 109.658 -0.497 . . . . 72.34 109.658 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -63.3 -30.82 71.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.265 1.426 . . . . 74.21 114.271 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.1 p -52.72 121.62 7.54 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.063 2.145 . . . . 75.25 113.933 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.49 166.23 14.85 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 109.522 -1.431 . . . . 65.11 109.522 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.16 144.51 37.14 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.378 1.071 . . . . 74.12 108.65 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -137.48 155.82 48.86 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.855 1.262 . . . . 74.24 110.437 -172.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -129.0 146.17 51.05 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.473 1.109 . . . . 63.35 109.581 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.82 129.6 41.16 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.7 1.2 . . . . 71.32 111.517 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 65.6 mm-40 -111.36 -56.59 2.36 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.035 1.334 . . . . 65.5 110.743 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.37 155.47 45.91 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 124.615 1.197 . . . . 73.05 112.056 -170.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -142.38 122.62 13.86 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.087 1.755 . . . . 74.35 107.797 -168.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -129.09 140.94 51.37 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.524 0.73 . . . . 71.15 109.668 170.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 56.17 33.48 22.14 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.632 1.973 . . . . 63.12 112.46 -171.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.0 -62.37 1.6 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.103 -0.951 . . . . 74.25 111.676 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.99 -34.04 75.44 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 113.671 0.989 . . . . 60.04 113.671 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.66 -52.7 64.38 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.079 0.951 . . . . 53.45 112.652 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -67.34 -49.53 63.67 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.656 1.182 . . . . 70.13 113.165 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.1 mmt -67.1 -36.94 83.05 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.745 1.278 . . . . 61.43 113.139 -173.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -77.95 -25.52 48.28 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 118.047 -0.978 . . . . 62.13 112.534 173.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.37 -35.96 63.54 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 113.739 1.015 . . . . 71.32 113.739 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.6 pt -77.44 -10.27 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 O-C-N 123.917 0.76 . . . . 75.3 112.966 170.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.72 29.43 23.86 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.382 -1.232 . . . . 44.11 113.073 167.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.6 mt -65.39 152.17 92.67 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 119.125 1.463 . . . . 72.05 111.718 172.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -64.61 140.69 69.72 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.244 1.963 . . . . 64.41 111.269 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.59 -21.63 53.79 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.686 1.365 . . . . 74.34 114.686 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -59.54 -52.21 66.53 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 117.586 -1.197 . . . . 73.54 113.328 166.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.6 mt -61.12 -30.36 70.32 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.943 1.09 . . . . 75.44 113.943 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.13 -54.2 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 O-C-N 124.17 0.919 . . . . 64.11 111.707 171.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -66.92 -27.55 67.58 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.961 1.467 . . . . 53.41 114.961 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.17 -21.25 31.37 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.759 1.224 . . . . 75.5 112.257 171.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.44 -15.7 52.25 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 118.564 -1.131 . . . . 20.32 112.275 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.12 -31.8 15.37 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.739 1.269 . . . . 72.43 113.079 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -83.48 -45.55 13.49 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.954 0.797 . . . . 75.45 111.032 177.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.4 mm -89.71 125.4 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.06 0.944 . . . . 62.42 109.402 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -85.42 146.46 26.96 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.531 1.144 . . . . 63.21 110.248 166.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -101.84 -168.85 27.38 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 109.753 -1.339 . . . . 74.13 109.753 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.4 t -129.86 158.47 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 126.693 1.997 . . . . 70.24 108.583 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.0 t -137.4 161.04 37.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.071 1.349 . . . . 70.22 110.125 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -143.35 147.81 35.26 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 123.76 0.824 . . . . 72.33 109.287 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.7 mt -132.03 126.01 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.461 -1.681 . . . . 62.45 106.461 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.9 t -136.87 92.2 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.197 -1.038 . . . . 74.23 108.197 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -79.98 138.68 37.12 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.128 0.971 . . . . 74.34 109.577 171.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -148.6 74.79 1.29 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.094 0.958 . . . . 73.54 109.298 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.43 -125.02 11.37 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.277 -1.529 . . . . 50.4 109.277 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mmpp? -70.26 -32.36 70.16 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.894 1.277 . . . . 73.31 114.377 173.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.0 157.22 31.33 Favored 'General case' 0 C--N 1.345 0.399 0 O-C-N 124.046 0.841 . . . . 72.23 111.893 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -157.05 127.33 6.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.039 -1.467 . . . . 73.35 107.039 -173.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -115.75 151.55 34.93 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.873 1.669 . . . . 75.04 109.886 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -147.44 119.81 8.42 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.057 -1.09 . . . . 70.41 108.057 -176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.1 m -102.07 129.97 48.53 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 124.49 1.119 . . . . 45.21 108.576 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.0 mt -113.63 120.16 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 106.839 -1.541 . . . . 74.15 106.839 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.5 m -113.88 104.07 11.81 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.644 1.215 . . . . 51.0 107.799 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.2 -162.29 0.11 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.813 1.645 . . . . 75.3 111.933 172.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.94 -27.03 69.65 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-O 118.788 -1.006 . . . . 43.33 113.738 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.0 p -163.75 25.37 0.08 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.429 1.492 . . . . 73.3 112.648 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -139.47 142.58 37.35 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.408 1.083 . . . . 75.41 109.967 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.29 128.89 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 124.293 0.996 . . . . 63.15 108.823 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.8 mt -130.95 123.11 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.766 1.626 . . . . 74.53 107.467 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.43 138.81 49.55 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.125 0.97 . . . . 63.21 109.034 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -134.48 145.19 48.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.037 1.335 . . . . 63.35 108.658 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -125.05 145.98 49.66 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 124.817 1.323 . . . . 73.05 109.195 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -149.21 161.02 42.84 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.65 1.18 . . . . 75.23 109.88 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.3 m -108.86 130.0 55.41 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.347 1.03 . . . . 72.31 108.467 172.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 80.3 t -66.78 115.27 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.763 1.225 . . . . 63.33 110.578 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.25 -9.56 50.02 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-O 117.971 -1.46 . . . . 75.31 112.963 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -114.52 149.13 36.9 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.422 1.611 . . . . 71.42 109.916 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -71.41 133.37 45.88 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.93 0.769 . . . . 72.15 110.725 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.5 m -139.02 168.16 20.45 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.717 1.607 . . . . 74.14 108.936 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -110.89 133.26 53.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.867 0.867 . . . . 74.33 109.901 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -122.02 138.48 54.42 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.443 1.497 . . . . 71.33 109.292 -171.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -109.75 141.86 41.78 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.327 1.451 . . . . 63.54 111.912 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 m -99.63 167.06 10.81 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.91 1.684 . . . . 60.32 111.61 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 65.3 mtm -57.56 -26.75 61.9 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.947 1.699 . . . . 75.24 114.986 170.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.1 t -83.62 -10.83 57.97 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.645 1.178 . . . . 74.02 113.557 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.84 4.46 67.32 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 118.457 -1.19 . . . . 62.43 113.296 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -71.06 136.48 48.3 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.277 1.538 . . . . 74.34 109.648 172.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -120.66 135.38 55.13 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.295 0.997 . . . . 71.12 108.609 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.14 132.1 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.591 1.156 . . . . 71.33 110.562 -171.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -74.42 141.2 45.06 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 124.283 0.989 . . . . 75.51 111.85 173.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.5 t -164.94 154.05 12.73 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.586 1.555 . . . . 74.2 110.003 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.73 133.61 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 107.865 -1.161 . . . . 42.04 107.865 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -112.17 129.04 68.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 108.311 -0.996 . . . . 70.35 108.311 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -141.11 147.39 38.42 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.054 1.342 . . . . 65.02 111.712 -173.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 tp -75.54 138.63 41.64 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.349 1.059 . . . . 64.15 111.492 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -89.45 6.35 41.17 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.889 1.275 . . . . 62.4 112.415 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.74 16.55 77.96 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.798 1.19 . . . . 63.34 112.948 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -150.22 48.25 0.9 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.249 1.42 . . . . 62.51 108.86 -172.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.302 0.0 OUTLIER 53.13 33.51 15.28 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.642 1.577 . . . . 73.45 114.079 178.059 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -130.5 141.56 50.49 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 125.787 1.635 . . . . 74.52 108.748 -171.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.1 mt -117.66 113.27 21.65 Favored 'General case' 0 C--N 1.343 0.312 0 O-C-N 124.539 1.149 . . . . 65.32 109.414 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.0 t -95.01 136.93 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.877 1.671 . . . . 61.13 109.137 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.13 147.32 22.38 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.54 1.536 . . . . 63.33 110.62 -174.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.6 p -150.67 132.78 15.3 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.392 1.477 . . . . 75.11 109.725 -175.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -98.15 -70.15 0.73 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.09 1.356 . . . . 65.02 108.895 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -135.3 -57.17 0.8 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.702 1.601 . . . . 65.23 108.887 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -149.09 10.29 0.79 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.415 1.486 . . . . 74.45 112.564 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.472 HG13 HD13 ' A' ' 115' ' ' LEU . 4.3 mp -108.48 104.8 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.549 -1.278 . . . . 51.44 107.549 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -86.88 106.64 17.9 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 124.121 0.888 . . . . 74.33 109.253 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 55.7 p -111.45 123.55 50.45 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.757 1.285 . . . . 52.41 111.141 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.5 t -126.1 105.32 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 126.037 1.735 . . . . 53.11 107.495 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.6 m -82.13 152.42 26.53 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.012 1.325 . . . . 54.15 109.769 172.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -142.28 139.06 31.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.856 1.662 . . . . 73.43 108.953 174.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.1 tp -117.71 126.73 53.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.917 2.087 . . . . 75.03 106.734 173.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -133.97 81.19 1.9 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.474 1.91 . . . . 71.04 106.285 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.13 -116.62 9.08 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 110.202 -1.159 . . . . 53.43 110.202 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -88.52 17.74 5.14 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.205 1.802 . . . . 71.13 114.221 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.4 mm -129.99 132.79 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.178 0.991 . . . . 60.11 108.932 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 49.8 mm -111.36 136.2 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 125.09 1.356 . . . . 74.23 107.849 171.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.8 m -127.34 122.88 34.93 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.151 -1.425 . . . . 65.21 107.151 173.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -113.75 134.04 55.0 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.274 -1.009 . . . . 75.33 108.274 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.2 m -133.69 108.12 8.34 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 124.539 1.15 . . . . 75.43 108.533 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.1 mtp -108.27 146.52 32.75 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.541 1.937 . . . . 74.34 109.246 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.4 m -137.59 94.38 2.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.293 1.037 . . . . 60.32 109.587 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.472 HD13 HG13 ' A' ' 98' ' ' ILE . 8.2 tp -98.77 109.1 21.91 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.32 1.448 . . . . 71.2 108.846 173.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.45 -111.1 3.73 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 124.807 1.317 . . . . 63.24 110.817 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -101.53 1.37 37.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.722 2.009 . . . . 71.45 113.648 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 89.5 mt -120.85 143.78 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.123 1.369 . . . . 75.42 110.143 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.7 t -123.01 91.3 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 O-C-N 124.23 0.956 . . . . 64.21 110.24 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -68.47 127.14 31.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.334 1.054 . . . . 74.24 112.1 173.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -125.2 146.38 49.54 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.738 1.215 . . . . 63.24 110.465 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -142.94 132.54 23.75 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.896 1.278 . . . . 62.53 108.326 -174.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.69 133.26 67.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.556 -1.276 . . . . 74.22 107.556 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.1 m -134.55 150.18 50.72 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 124.626 1.204 . . . . 75.33 110.025 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -120.01 141.42 49.73 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.547 1.539 . . . . 63.23 109.727 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -67.74 141.18 56.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.264 1.826 . . . . 72.42 112.103 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.4 mt . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 106.295 -1.742 . . . . 72.13 106.295 -173.351 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 . . . . . 0 N--CA 1.502 2.128 0 N-CA-C 102.544 -3.132 . . . . 74.42 102.544 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 2.3 m170 50.91 95.7 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 127.345 2.258 . . . . 63.42 113.969 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -123.32 119.85 31.33 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.068 0.947 . . . . 55.23 109.415 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -155.4 158.3 38.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.861 1.664 . . . . 74.33 110.067 175.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -166.4 124.54 1.43 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.584 1.554 . . . . 71.43 108.646 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -176.82 154.63 1.18 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.632 1.573 . . . . 75.21 110.423 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 84.9 t -77.68 -61.09 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 124.828 1.251 . . . . 73.0 111.148 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -92.29 177.55 6.11 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.378 1.471 . . . . 33.23 110.965 175.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -111.9 157.09 21.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.996 0.919 . . . . 64.11 111.827 175.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.0 m -99.78 110.59 22.97 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.702 1.601 . . . . 72.34 108.781 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -70.02 -25.33 63.53 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.988 1.107 . . . . 74.21 113.988 171.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.2 t -52.77 115.08 1.64 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 127.058 2.143 . . . . 75.25 113.147 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.09 164.96 16.05 Favored Glycine 0 CA--C 1.537 1.416 0 N-CA-C 110.557 -1.017 . . . . 65.11 110.557 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.423 ' HB3' HD12 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -109.66 144.86 37.41 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.851 1.661 . . . . 74.12 110.399 175.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.494 ' CZ ' HD11 ' A' ' 109' ' ' ILE . 37.0 m-85 -140.81 141.15 34.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.998 1.319 . . . . 74.24 109.645 -173.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -107.93 148.04 30.2 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.538 1.135 . . . . 63.35 109.899 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.64 127.47 31.82 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.469 1.508 . . . . 71.32 111.207 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -109.4 -57.19 2.2 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.821 1.248 . . . . 65.5 110.973 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 81.5 p -152.86 172.16 17.18 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.563 1.145 . . . . 73.05 111.2 -174.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -168.27 148.59 4.8 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.876 1.271 . . . . 74.35 111.0 -165.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -140.04 143.23 36.27 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.873 1.269 . . . . 71.15 108.797 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 57.59 26.02 12.32 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.482 1.913 . . . . 63.12 113.616 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -61.5 -55.66 28.58 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-O 118.232 -0.889 . . . . 74.25 113.185 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -62.41 -43.48 98.72 Favored 'General case' 0 C--N 1.347 0.472 0 O-C-N 124.308 1.005 . . . . 60.04 112.919 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.92 -45.47 82.68 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.711 1.204 . . . . 53.45 113.566 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -68.08 -47.17 69.01 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.958 1.303 . . . . 70.13 113.187 175.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.5 mmt -65.9 -44.61 84.73 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.565 1.166 . . . . 61.43 113.049 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.505 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.3 mptm? -60.71 -32.43 71.68 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.932 0.893 . . . . 62.13 113.032 171.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.56 -37.69 59.77 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.396 1.258 . . . . 71.32 114.396 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.1 pt -79.11 -5.14 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 113.427 0.899 . . . . 75.3 113.427 172.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.98 27.81 25.1 Favored Glycine 0 CA--C 1.534 1.219 0 CA-C-O 118.666 -1.074 . . . . 44.11 112.893 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.66 146.73 98.61 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 118.822 1.311 . . . . 72.05 111.122 175.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -68.31 140.83 49.75 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.05 1.834 . . . . 64.41 110.799 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -61.08 -21.88 64.09 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.63 1.344 . . . . 74.34 114.63 -175.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -61.62 -49.94 74.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.351 1.06 . . . . 73.54 113.349 169.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 57.6 mt -63.92 -23.74 67.46 Favored 'General case' 0 C--N 1.351 0.631 0 C-N-CA 124.65 1.18 . . . . 75.44 113.569 175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.505 HD13 ' HD2' ' A' ' 20' ' ' LYS . 68.6 mt -83.15 -50.46 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.325 1.05 . . . . 64.11 110.602 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 -60.94 -42.59 98.49 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 117.821 -1.085 . . . . 53.41 113.16 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.48 -27.59 63.34 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 118.22 -0.895 . . . . 75.5 112.819 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.54 -30.04 57.06 Favored Glycine 0 CA--C 1.537 1.415 0 CA-C-O 119.077 -0.846 . . . . 20.32 112.552 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.79 -30.75 14.69 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.632 1.173 . . . . 72.43 112.789 173.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -72.78 -49.96 27.36 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.627 1.171 . . . . 75.45 111.52 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.1 mt -93.37 129.56 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 124.268 1.027 . . . . 62.42 108.347 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -80.44 110.17 15.63 Favored 'General case' 0 C--N 1.342 0.282 0 O-C-N 124.135 0.897 . . . . 63.21 108.787 170.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.51 -172.97 41.75 Favored Glycine 0 CA--C 1.538 1.487 0 O-C-N 124.469 1.106 . . . . 74.13 110.429 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.5 t -129.82 153.79 39.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.709 1.204 . . . . 70.24 109.701 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.0 t -130.35 155.98 45.45 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.552 1.941 . . . . 70.22 109.164 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -141.02 143.67 34.56 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.752 1.221 . . . . 72.33 107.879 170.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.1 mt -132.07 130.36 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.08 -1.822 . . . . 62.45 106.08 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -134.74 135.5 53.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 108.15 -1.056 . . . . 74.23 108.15 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -126.92 130.82 50.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.819 1.248 . . . . 74.34 108.687 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -133.19 55.07 1.92 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.144 1.378 . . . . 73.54 109.289 -172.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.13 -115.96 5.69 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 108.718 -1.753 . . . . 50.4 108.718 -175.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -70.69 -35.42 72.77 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 114.249 1.204 . . . . 73.31 114.249 173.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.63 156.09 37.11 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 124.021 0.825 . . . . 72.23 111.373 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -150.93 141.29 22.4 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.037 -1.468 . . . . 73.35 107.037 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -129.27 151.63 49.72 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.229 1.811 . . . . 75.04 109.153 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -148.79 126.23 11.61 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.686 -1.228 . . . . 70.41 107.686 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 m -109.18 126.61 53.45 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 124.688 1.243 . . . . 45.21 108.931 175.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.25 133.93 51.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 N-CA-C 106.724 -1.584 . . . . 74.15 106.724 174.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.0 m -133.52 104.84 6.58 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 124.166 0.916 . . . . 51.0 109.394 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -107.38 77.49 1.15 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.918 0.887 . . . . 75.3 110.153 -177.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.34 -49.41 4.23 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.513 1.53 . . . . 43.33 112.212 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.44 -39.65 0.09 Allowed 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.171 0.986 . . . . 73.3 111.872 -176.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.2 ptmt -67.09 137.26 56.24 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 124.475 1.11 . . . . 75.41 111.684 172.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 44.6 t -125.31 130.47 72.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 O-C-N 124.612 1.195 . . . . 63.15 109.147 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.8 mt -119.34 128.67 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.871 1.269 . . . . 74.53 108.019 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -116.66 127.14 54.16 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 124.589 1.18 . . . . 63.21 108.693 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -121.94 145.04 48.5 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.413 1.485 . . . . 63.35 109.075 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -132.8 140.78 48.16 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 125.376 1.672 . . . . 73.05 108.995 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -149.46 166.93 27.64 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 125.033 1.333 . . . . 75.23 109.146 175.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 91.4 m -119.21 127.01 52.89 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 107.886 -1.153 . . . . 72.31 107.886 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 73.8 t -63.73 126.95 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 124.768 1.227 . . . . 63.33 111.324 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.14 -3.1 85.66 Favored Glycine 0 CA--C 1.542 1.764 0 CA-C-O 118.249 -1.306 . . . . 75.31 113.558 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -116.62 141.02 48.74 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.127 1.771 . . . . 71.42 109.859 176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -66.45 118.57 10.28 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.04 1.336 . . . . 72.15 111.616 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 40.5 m -140.46 153.26 46.2 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.577 1.551 . . . . 74.14 109.153 -175.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -100.96 128.65 46.9 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.99 0.916 . . . . 74.33 109.77 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.3 mt -120.37 131.92 55.05 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.762 1.225 . . . . 71.33 110.467 -172.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -90.43 130.92 36.45 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.277 1.831 . . . . 63.54 110.47 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 21.6 p -85.52 -179.93 7.01 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.572 1.149 . . . . 60.32 111.651 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.2 mtt -59.03 -30.83 68.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 115.18 1.548 . . . . 75.24 115.18 176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.4 p -87.82 -7.51 57.16 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.368 1.467 . . . . 74.02 113.235 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.63 6.68 58.27 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 118.187 -1.34 . . . . 62.43 112.592 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -69.0 113.36 6.31 Favored 'General case' 0 C--N 1.348 0.514 0 CA-C-N 119.405 1.603 . . . . 74.34 110.791 177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -94.44 124.95 38.78 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 124.612 1.195 . . . . 71.12 110.502 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -142.92 126.19 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.309 1.444 . . . . 71.33 110.361 -170.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -72.5 132.92 44.47 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.22 1.408 . . . . 75.51 111.885 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.3 t -161.93 170.02 20.13 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.267 1.427 . . . . 74.2 109.445 -176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.449 ' CG1' HE22 ' A' ' 84' ' ' GLN . 2.6 t -124.95 144.03 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 N-CA-C 108.283 -1.006 . . . . 42.04 108.283 171.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.563 HG12 HD22 ' A' ' 91' ' ' LEU . 22.3 t -112.05 125.65 69.37 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 O-C-N 124.358 1.037 . . . . 70.35 108.252 177.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.449 HE22 ' CG1' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -112.91 141.78 46.35 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.805 1.642 . . . . 65.02 110.496 177.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.0 tp -92.95 136.82 32.92 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.426 1.079 . . . . 64.15 109.189 168.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.18 12.63 11.19 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.261 1.024 . . . . 62.4 113.318 172.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.9 14.12 80.33 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 125.131 1.348 . . . . 63.34 113.115 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -140.41 52.07 1.65 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.718 1.207 . . . . 62.51 109.697 -171.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.276 0.0 OUTLIER 58.04 21.78 8.21 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.905 1.682 . . . . 73.45 114.818 173.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -135.05 120.9 19.66 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.502 1.521 . . . . 74.52 109.714 -164.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.563 HD22 HG12 ' A' ' 83' ' ' VAL . 56.2 mt -105.55 132.39 51.77 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.895 1.278 . . . . 65.32 109.945 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.1 t -119.61 136.52 56.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 125.008 1.323 . . . . 61.13 109.157 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.0 t -154.37 149.08 26.48 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.27 1.028 . . . . 63.33 110.846 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 15.2 p -146.33 132.08 18.97 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.724 1.209 . . . . 75.11 109.783 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -97.96 -63.39 1.13 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.975 1.31 . . . . 65.02 110.396 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -140.17 -73.49 0.36 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.189 1.796 . . . . 65.23 108.237 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -127.38 -1.77 6.26 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.255 1.822 . . . . 74.45 112.305 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.451 HG12 HD12 ' A' ' 115' ' ' LEU . 37.6 mt -97.4 110.9 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 125.839 1.656 . . . . 51.44 108.384 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -102.61 98.76 8.77 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.765 1.226 . . . . 74.33 110.195 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.5 t -82.92 131.27 35.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.327 1.451 . . . . 52.41 110.882 176.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.8 t -135.69 101.82 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 106.844 -1.539 . . . . 53.11 106.844 172.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.0 m -84.89 148.9 26.02 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.186 1.394 . . . . 54.15 109.766 173.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -147.71 130.76 16.31 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.042 1.337 . . . . 73.43 109.313 176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 tt -113.93 130.55 56.5 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.232 -1.396 . . . . 75.03 107.232 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -132.62 82.71 2.02 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.431 1.892 . . . . 71.04 106.702 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.25 -111.78 4.44 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.745 1.164 . . . . 53.43 111.287 177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -83.72 -4.72 58.85 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.329 1.452 . . . . 71.13 113.535 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.8 mm -110.94 138.46 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 119.499 1.045 . . . . 60.11 109.666 -176.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.494 HD11 ' CZ ' ' A' ' 7' ' ' TYR . 36.6 mm -109.6 136.6 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.754 -1.202 . . . . 74.23 107.754 169.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.0 m -127.57 115.41 18.77 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 106.532 -1.655 . . . . 65.21 106.532 175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -117.64 126.56 52.73 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.481 -0.933 . . . . 75.33 108.481 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 66.7 m -124.65 112.81 17.22 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 124.661 1.226 . . . . 75.43 108.386 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 95.1 mtp -105.86 149.86 26.14 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.873 1.269 . . . . 74.34 109.21 173.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 71.5 m -140.79 104.4 4.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.563 0.745 . . . . 60.32 109.21 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.451 HD12 HG12 ' A' ' 98' ' ' ILE . 7.0 tt -103.2 102.14 12.12 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 125.544 1.537 . . . . 71.2 107.55 175.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.27 -122.93 30.91 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 110.849 -0.9 . . . . 63.24 110.849 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -84.88 3.33 38.5 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.915 1.686 . . . . 71.45 115.173 174.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.8 mt -102.93 139.75 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.889 0.875 . . . . 75.42 108.995 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.7 t -130.38 96.85 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 124.205 1.002 . . . . 64.21 109.119 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -86.21 136.35 33.22 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.676 1.591 . . . . 74.24 112.48 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -119.65 150.19 40.74 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.049 1.34 . . . . 63.24 111.085 173.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 mmt-85 -141.98 136.1 29.98 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 126.503 1.921 . . . . 62.53 108.074 173.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.6 133.98 65.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 107.583 -1.266 . . . . 74.22 107.583 174.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.5 m -135.16 159.98 39.83 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.994 1.317 . . . . 75.33 109.648 176.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -137.79 143.3 41.0 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.489 1.116 . . . . 63.23 110.702 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.7 ttp85 -63.28 137.1 58.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.592 1.957 . . . . 72.42 113.768 -170.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.423 HD12 ' HB3' ' A' ' 6' ' ' LYS . 40.4 mt . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 106.039 -1.838 . . . . 72.13 106.039 -171.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 . . . . . 0 N--CA 1.5 2.033 0 N-CA-C 102.88 -3.007 . . . . 74.42 102.88 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -165.68 71.85 0.16 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.063 1.345 . . . . 63.42 108.001 178.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -142.98 158.98 43.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.05 1.34 . . . . 55.23 110.381 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -134.91 87.71 2.36 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.872 1.269 . . . . 74.33 108.854 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -160.47 158.38 29.24 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.782 1.633 . . . . 71.43 110.017 174.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 30.2 p-80 -133.7 60.05 1.72 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.227 1.411 . . . . 75.21 109.552 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 28.3 m -134.75 166.53 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 125.598 1.559 . . . . 73.0 110.346 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -65.84 145.31 56.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.116 1.366 . . . . 33.23 112.811 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.5 mmm -77.04 147.4 36.75 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.452 1.101 . . . . 64.11 112.384 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.7 p -94.41 132.75 38.71 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.854 1.262 . . . . 72.34 110.042 171.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -80.39 -16.82 53.57 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.549 1.314 . . . . 74.21 114.549 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 90.8 p -66.93 132.76 48.62 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.759 1.224 . . . . 75.25 113.483 -177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.1 168.34 14.67 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.285 0.945 . . . . 65.11 110.778 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt -99.89 147.07 25.94 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.274 1.43 . . . . 74.12 111.137 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.496 ' CE2' HD11 ' A' ' 109' ' ' ILE . 31.5 m-85 -138.41 155.08 48.83 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.593 1.557 . . . . 74.24 109.453 -176.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -127.77 145.39 50.93 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.505 -0.924 . . . . 63.35 108.505 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.3 tt -61.96 131.24 49.01 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.22 1.408 . . . . 71.32 110.432 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -109.7 -50.06 3.03 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.609 1.164 . . . . 65.5 110.919 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -157.2 158.15 35.68 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 124.387 1.054 . . . . 73.05 111.109 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -128.08 155.83 43.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.844 1.257 . . . . 74.35 108.683 170.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -135.69 131.33 35.53 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.264 1.426 . . . . 71.15 108.175 175.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 58.23 39.27 25.94 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.352 1.861 . . . . 63.12 112.142 -169.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -64.11 -63.57 1.12 Allowed 'General case' 0 C--N 1.346 0.454 0 C-N-CA 124.875 1.27 . . . . 74.25 112.296 177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.47 -28.43 69.66 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.566 0.95 . . . . 60.04 113.566 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.88 -51.9 65.17 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.102 0.961 . . . . 53.45 112.346 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -70.59 -48.47 55.04 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.831 1.252 . . . . 70.13 113.8 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.9 mmt -67.99 -39.83 83.2 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 124.374 1.046 . . . . 61.43 113.155 -173.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.6 mmmm -73.87 -27.68 61.2 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 118.137 -0.935 . . . . 62.13 112.513 173.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.75 -33.82 66.61 Favored 'General case' 0 C--N 1.349 0.562 0 N-CA-C 113.945 1.091 . . . . 71.32 113.945 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.8 pt -80.3 -4.6 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.898 0 N-CA-C 113.239 0.829 . . . . 75.3 113.239 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.03 21.69 41.27 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-O 118.202 -1.332 . . . . 44.11 113.522 167.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 24.0 mt -63.88 143.78 98.1 Favored Pre-proline 0 CA--C 1.548 0.874 0 CA-C-N 119.42 1.61 . . . . 72.05 111.212 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.18 143.72 84.66 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.396 2.064 . . . . 64.41 111.56 172.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -60.06 -22.48 62.73 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 115.123 1.527 . . . . 74.34 115.123 -173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -61.17 -43.16 99.31 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.245 1.018 . . . . 73.54 113.138 169.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 65.9 mt -72.0 -24.57 61.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.529 1.132 . . . . 75.44 113.621 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.1 mp -72.69 -55.39 13.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 123.58 0.752 . . . . 64.11 111.176 168.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -65.99 -26.5 67.58 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 115.019 1.489 . . . . 53.41 115.019 -174.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.69 -23.15 31.83 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 124.237 0.961 . . . . 75.5 112.454 171.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.68 -23.81 37.99 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-O 118.964 -0.909 . . . . 20.32 112.298 -175.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.13 -35.17 25.8 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 117.54 -1.219 . . . . 72.43 113.609 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -83.08 -49.75 9.21 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.79 0.723 . . . . 75.45 111.39 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 60.8 mt -76.41 123.62 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.131 0.973 . . . . 62.42 109.263 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.28 107.17 18.38 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.018 -1.104 . . . . 63.21 108.018 171.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -70.61 165.81 51.95 Favored Glycine 0 CA--C 1.536 1.406 0 O-C-N 124.612 1.195 . . . . 74.13 111.507 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 78.6 t -102.05 155.37 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 124.339 1.056 . . . . 70.24 108.697 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 97.6 p -145.42 167.36 23.12 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.599 1.16 . . . . 70.22 109.916 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -161.58 142.26 10.88 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.466 1.106 . . . . 72.33 108.682 -172.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 72.7 mt -129.48 142.12 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 106.929 -1.508 . . . . 62.45 106.929 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.1 t -136.69 100.96 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 107.699 -1.223 . . . . 74.23 107.699 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -77.31 129.9 36.46 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.039 0.936 . . . . 74.34 109.825 174.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -128.31 51.52 1.98 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.438 1.495 . . . . 73.54 109.282 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.33 -118.44 6.74 Favored Glycine 0 CA--C 1.534 1.24 0 N-CA-C 108.871 -1.692 . . . . 50.4 108.871 -175.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -65.99 -34.71 78.72 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.937 1.295 . . . . 73.31 113.95 172.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -75.73 157.96 32.89 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.073 0.858 . . . . 72.23 111.599 171.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -156.57 125.23 5.85 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.908 -1.515 . . . . 73.35 106.908 -172.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.02 139.82 46.07 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.847 1.259 . . . . 75.04 109.103 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.28 132.37 55.29 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.772 1.629 . . . . 70.41 107.535 172.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -129.92 109.16 10.68 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.689 1.196 . . . . 45.21 108.16 176.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mp -108.92 132.75 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 124.736 1.214 . . . . 74.15 108.185 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.1 m -114.76 111.46 21.29 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 124.307 1.004 . . . . 51.0 108.984 172.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -100.14 76.15 1.89 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.691 1.196 . . . . 75.3 109.432 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.68 -96.95 1.99 Allowed Glycine 0 CA--C 1.531 1.079 0 N-CA-C 108.776 -1.73 . . . . 43.33 108.776 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.3 m -101.88 -40.7 6.79 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.726 1.21 . . . . 73.3 112.574 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -73.02 153.58 40.83 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.079 0.952 . . . . 75.41 112.066 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.8 t -129.21 131.43 67.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 O-C-N 124.536 1.148 . . . . 63.15 109.553 177.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.2 mt -105.17 134.6 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 126.468 1.907 . . . . 74.53 107.957 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -125.82 124.78 41.7 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.488 1.115 . . . . 63.21 108.38 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -137.71 133.08 33.77 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.552 1.141 . . . . 63.35 108.976 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -116.48 147.67 41.52 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 124.601 1.188 . . . . 73.05 109.711 172.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -150.86 160.66 43.74 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.102 1.361 . . . . 75.23 110.091 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.2 m -103.47 135.66 44.66 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 124.237 0.961 . . . . 72.31 108.517 169.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.5 t -66.07 119.29 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.948 1.299 . . . . 63.33 111.2 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.92 -13.59 65.89 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-O 117.967 -1.463 . . . . 75.31 113.326 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -99.11 148.52 23.97 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.522 1.661 . . . . 71.42 110.369 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -69.75 114.44 7.95 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 124.082 0.864 . . . . 72.15 110.793 172.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.7 m -129.32 151.74 49.63 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.344 1.458 . . . . 74.14 107.689 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -100.96 119.97 39.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.035 0.934 . . . . 74.33 110.276 -174.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.99 134.27 52.29 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.097 1.359 . . . . 71.33 110.411 -172.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -90.45 147.92 23.1 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.474 1.51 . . . . 63.54 110.336 175.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 22.3 p -112.45 178.31 4.34 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.47 1.508 . . . . 60.32 110.231 170.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -59.99 -29.78 68.69 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.575 1.324 . . . . 75.24 114.575 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.3 p -81.95 -8.21 59.66 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.527 1.531 . . . . 74.02 113.035 175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.99 8.12 72.96 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-O 118.363 -1.243 . . . . 62.43 112.581 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -69.97 114.08 7.79 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 119.072 1.436 . . . . 74.34 110.921 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.3 mtpt -100.86 121.41 41.67 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 124.943 1.402 . . . . 71.12 109.496 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.2 m -145.42 133.02 15.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 124.625 1.203 . . . . 71.33 110.877 -172.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -78.21 141.12 38.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.198 1.399 . . . . 75.51 112.177 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.0 t -167.07 153.86 8.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.713 1.205 . . . . 74.2 110.394 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.5 m -90.15 142.42 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 124.418 1.087 . . . . 42.04 109.431 165.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.7 t -119.56 124.72 73.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 107.253 -1.388 . . . . 70.35 107.253 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -135.75 136.81 41.08 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.357 1.063 . . . . 65.02 110.273 -170.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.625 HD23 ' H ' ' A' ' 87' ' ' GLY . 2.7 tt -79.41 129.77 34.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.489 1.115 . . . . 64.15 110.167 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -73.94 -9.5 58.7 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.477 1.911 . . . . 62.4 114.165 -173.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.625 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 92.15 5.72 65.53 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 125.122 1.344 . . . . 63.34 112.189 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -147.6 57.05 1.11 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.77 1.285 . . . . 62.51 109.358 -176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 63.8 19.76 11.89 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.821 1.648 . . . . 73.45 114.101 171.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -128.76 142.68 50.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.706 1.602 . . . . 74.52 109.598 -166.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 74.1 mt -114.91 123.26 48.7 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.346 1.058 . . . . 65.32 109.204 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.7 t -104.65 140.14 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.364 1.466 . . . . 61.13 108.902 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 100' ' ' SER . 6.3 t -162.79 135.24 5.5 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.446 1.098 . . . . 63.33 110.084 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 78.5 p -131.36 122.3 26.12 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.523 1.129 . . . . 75.11 109.403 -176.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -81.9 -66.56 0.87 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.395 1.078 . . . . 65.02 111.221 -177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -144.14 -52.4 0.32 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.64 1.576 . . . . 65.23 109.491 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -142.8 3.22 1.42 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.577 1.551 . . . . 74.45 112.363 -179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.428 ' CG1' HD13 ' A' ' 115' ' ' LEU . 78.3 mt -99.73 110.91 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.702 1.601 . . . . 51.44 106.959 174.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt -103.63 86.84 2.7 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.934 1.294 . . . . 74.33 109.575 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.432 ' HB2' HG23 ' A' ' 93' ' ' THR . 69.7 m -79.36 127.72 32.44 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.186 1.395 . . . . 52.41 110.764 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.4 t -135.74 102.1 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 108.063 -1.088 . . . . 53.11 108.063 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.7 m -85.89 157.38 20.19 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.461 1.504 . . . . 54.15 110.478 176.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -148.71 143.56 26.52 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.612 1.565 . . . . 73.43 110.987 -176.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.5 tt -129.98 128.03 41.23 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.317 1.447 . . . . 75.03 108.999 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -137.52 77.45 1.64 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.071 1.748 . . . . 71.04 107.604 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.8 -123.9 22.89 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 110.096 -1.202 . . . . 53.43 110.096 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -75.65 -12.33 60.18 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.239 1.415 . . . . 71.13 114.153 177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.8 mm -102.95 137.63 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 119.287 0.949 . . . . 60.11 109.534 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.496 HD11 ' CE2' ' A' ' 7' ' ' TYR . 11.2 mm -125.9 140.62 48.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 108.105 -1.072 . . . . 74.23 108.105 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 28.6 m -135.94 160.73 37.69 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.462 1.505 . . . . 65.21 108.743 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -154.58 147.67 24.72 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.57 1.148 . . . . 75.33 108.618 175.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 98.5 m -131.82 108.07 9.18 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 125.115 1.509 . . . . 75.43 108.22 171.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 72.8 mtp -96.21 144.71 26.17 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.826 1.651 . . . . 74.34 108.747 168.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 65.2 m -133.88 108.05 8.2 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 108.44 -0.948 . . . . 60.32 108.44 176.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.428 HD13 ' CG1' ' A' ' 98' ' ' ILE . 17.3 tp -111.86 99.36 8.06 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.477 1.511 . . . . 71.2 107.712 175.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.81 -122.82 27.15 Favored Glycine 0 CA--C 1.535 1.281 0 O-C-N 124.726 1.266 . . . . 63.24 110.429 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.87 -17.69 55.19 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.522 1.929 . . . . 71.45 114.48 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 75.9 mt -102.16 140.62 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.604 1.162 . . . . 75.42 110.381 -176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.4 t -122.76 90.0 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 124.361 1.064 . . . . 64.21 109.551 -177.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -71.76 124.79 25.55 Favored 'General case' 0 C--N 1.345 0.394 0 C-N-CA 124.451 1.101 . . . . 74.24 111.729 174.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -120.62 148.74 43.5 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.879 1.271 . . . . 63.24 109.344 176.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.72 120.7 7.68 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.482 -0.933 . . . . 62.53 108.482 -166.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.2 mp -118.83 141.69 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 125.164 1.386 . . . . 74.22 109.4 -172.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.6 m -144.21 166.62 24.52 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.232 1.413 . . . . 75.33 111.985 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -139.48 138.9 36.79 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.868 1.267 . . . . 63.23 109.952 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -69.31 131.7 45.27 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.262 2.225 . . . . 72.42 112.563 -174.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 50.8 mt . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 105.522 -2.029 . . . . 72.13 105.522 -174.238 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 29.7 p80 . . . . . 0 N--CA 1.503 2.213 0 N-CA-C 105.588 -2.004 . . . . 74.42 105.588 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -113.81 151.64 31.78 Favored 'General case' 0 C--N 1.35 0.627 0 C-N-CA 124.509 1.124 . . . . 63.42 111.065 -178.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -69.3 161.08 30.04 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.949 1.7 . . . . 55.23 112.411 174.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -132.35 85.52 2.24 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.739 1.216 . . . . 74.33 108.82 175.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 28.1 m170 -98.01 -81.87 0.43 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.703 1.201 . . . . 71.43 108.764 172.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.9 169.63 12.34 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.596 1.159 . . . . 75.21 111.867 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.32 21.04 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 125.232 1.413 . . . . 73.0 111.976 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -164.02 166.84 21.11 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.948 1.299 . . . . 33.23 111.11 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mmm -131.27 169.01 16.56 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.043 1.737 . . . . 64.11 110.31 173.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t -136.71 144.33 43.82 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.915 1.286 . . . . 72.34 109.499 176.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -80.16 -27.27 39.01 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 114.192 1.182 . . . . 74.21 114.192 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.9 m -57.1 111.17 0.98 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.244 1.818 . . . . 75.25 113.376 -174.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 160.39 160.72 10.81 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.667 -1.373 . . . . 65.11 109.667 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -98.13 146.86 25.15 Favored 'General case' 0 C--N 1.345 0.409 0 C-N-CA 124.551 1.14 . . . . 74.12 110.973 176.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -139.69 146.37 39.56 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.057 1.343 . . . . 74.24 109.519 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -111.29 148.93 31.86 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.48 1.512 . . . . 63.35 109.79 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 tt -61.78 128.71 37.52 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.885 1.274 . . . . 71.32 111.128 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.1 mm-40 -111.15 -50.57 2.93 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.17 1.388 . . . . 65.5 111.501 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.46 167.52 30.19 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.452 1.101 . . . . 73.05 111.27 -173.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -167.51 125.06 1.21 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.652 1.181 . . . . 74.35 110.918 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -111.52 143.99 41.48 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.214 1.406 . . . . 71.15 109.435 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 57.46 38.71 28.27 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.594 1.958 . . . . 63.12 111.832 -170.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -65.25 -58.39 6.07 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.451 -0.785 . . . . 74.25 111.409 176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -62.09 -40.35 95.55 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 113.401 0.889 . . . . 60.04 113.401 174.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.6 -46.07 91.63 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 124.169 0.988 . . . . 53.45 113.019 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -70.91 -47.78 57.24 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-O 117.633 -1.175 . . . . 70.13 112.898 176.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 1.2 mtt -64.27 -35.59 81.35 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 124.926 1.391 . . . . 61.43 113.911 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -71.18 -30.76 66.82 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 118.167 -0.921 . . . . 62.13 113.159 169.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.17 -37.31 61.32 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.357 1.243 . . . . 71.32 114.357 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.549 ' CD1' HD13 ' A' ' 24' ' ' LEU . 41.9 pt -74.18 -12.88 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 123.877 0.871 . . . . 75.3 113.18 170.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.46 22.54 34.11 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.349 -1.251 . . . . 44.11 112.726 173.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.597 HD11 HG21 ' A' ' 75' ' ' THR . 6.0 mp -72.25 141.2 83.24 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.262 1.531 . . . . 72.05 110.562 172.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.528 ' HD2' HD12 ' A' ' 28' ' ' LEU . 71.8 Cg_endo -65.78 152.37 81.77 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.59 2.193 . . . . 64.41 112.162 176.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -65.94 -20.48 66.23 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 114.35 1.241 . . . . 74.34 114.35 -174.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.03 -46.12 82.63 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.309 1.044 . . . . 73.54 113.072 171.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 25' ' ' PRO . 74.8 mt -62.85 -30.11 71.25 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.553 1.141 . . . . 75.44 112.813 174.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.1 mt -71.37 -50.86 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.615 1.166 . . . . 64.11 111.781 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -58.72 -50.31 74.36 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-O 117.817 -1.087 . . . . 53.41 112.958 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.48 -21.14 63.72 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.013 1.116 . . . . 75.5 114.013 174.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.38 -29.21 45.55 Favored Glycine 0 CA--C 1.536 1.385 0 CA-C-O 118.934 -0.926 . . . . 20.32 111.974 -177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.39 -29.26 14.05 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.763 1.225 . . . . 72.43 112.897 174.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -71.91 -35.61 69.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 118.022 -0.99 . . . . 75.45 113.432 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.3 mt -113.4 119.12 59.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 108.079 -1.082 . . . . 62.42 108.079 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -69.48 137.55 52.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.101 0.96 . . . . 63.21 111.55 171.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -93.16 -179.82 39.7 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 124.687 1.242 . . . . 74.13 110.474 172.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.6 t -130.9 150.23 34.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 126.047 1.739 . . . . 70.24 107.843 174.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 t -144.83 108.0 4.56 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.409 0.683 . . . . 70.22 109.965 -170.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -91.96 147.07 23.24 Favored 'General case' 0 C--N 1.343 0.293 0 C-N-CA 124.061 0.944 . . . . 72.33 110.853 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 mt -132.6 128.02 57.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 106.29 -1.744 . . . . 62.45 106.29 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 78.8 t -134.18 127.14 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 108.021 -1.103 . . . . 74.23 108.021 -177.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -122.16 136.07 54.86 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.013 1.325 . . . . 74.34 108.045 177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -148.46 76.65 1.37 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.901 0.881 . . . . 73.54 109.024 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.6 -120.36 8.97 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 108.983 -1.647 . . . . 50.4 108.983 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.4 mmtt -75.67 -32.16 60.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.863 1.265 . . . . 73.31 114.258 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.71 155.83 35.28 Favored 'General case' 0 C--N 1.346 0.421 0 O-C-N 123.918 0.762 . . . . 72.23 112.093 175.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -154.91 128.43 8.52 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 106.989 -1.486 . . . . 73.35 106.989 -174.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -114.37 151.95 32.26 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.707 1.203 . . . . 75.04 109.549 170.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -145.27 128.29 16.52 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.943 -1.503 . . . . 70.41 106.943 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.3 m -116.04 117.77 31.02 Favored 'General case' 0 C--N 1.344 0.352 0 O-C-N 124.511 1.132 . . . . 45.21 109.4 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 mp -97.88 121.56 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 125.207 1.403 . . . . 74.15 107.485 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.8 m -113.56 109.38 18.54 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 107.801 -1.185 . . . . 51.0 107.801 173.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.54 -164.01 0.45 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.705 1.602 . . . . 75.3 111.551 173.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.69 -25.23 70.26 Favored Glycine 0 CA--C 1.542 1.721 0 CA-C-O 118.735 -1.036 . . . . 43.33 113.797 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.5 p -161.85 20.17 0.11 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.357 1.463 . . . . 73.3 113.032 177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.68 146.98 52.31 Favored 'General case' 0 C--N 1.345 0.387 0 C-N-CA 125.071 1.349 . . . . 75.41 110.122 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.9 t -124.93 124.02 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.082 -1.081 . . . . 63.15 108.082 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.4 mt -134.46 123.95 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.101 -1.444 . . . . 74.53 107.101 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.16 149.06 43.36 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.071 0.948 . . . . 63.21 111.064 175.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -133.04 152.59 51.95 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.925 1.69 . . . . 63.35 108.908 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -125.74 142.75 51.36 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 125.114 1.509 . . . . 73.05 109.034 173.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -146.5 167.11 24.49 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.901 1.281 . . . . 75.23 109.351 174.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.8 m -118.38 129.21 55.29 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 107.557 -1.275 . . . . 72.31 107.557 173.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.02 121.02 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 124.908 1.283 . . . . 63.33 110.922 -175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.9 -4.37 78.43 Favored Glycine 0 CA--C 1.542 1.75 0 CA-C-O 118.353 -1.248 . . . . 75.31 113.285 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -112.59 137.81 50.3 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.149 1.78 . . . . 71.42 108.651 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -70.81 125.96 28.27 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.803 0.689 . . . . 72.15 110.919 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.4 m -138.41 163.4 31.99 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.58 1.552 . . . . 74.14 108.942 -175.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -103.86 125.95 50.64 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.518 0.727 . . . . 74.33 110.023 -177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.497 HD12 HG21 ' A' ' 81' ' ' THR . 64.7 mt -108.09 127.7 54.03 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.658 1.183 . . . . 71.33 109.393 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 62.0 tt0 -88.34 153.56 21.1 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.589 1.556 . . . . 63.54 110.898 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.2 p -111.14 173.79 6.17 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.645 1.578 . . . . 60.32 111.786 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -60.33 -31.2 70.08 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.512 1.301 . . . . 75.24 114.512 174.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.597 HG21 HD11 ' A' ' 24' ' ' LEU . 42.5 p -88.73 -7.33 56.46 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.71 1.204 . . . . 74.02 113.248 176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.15 9.81 63.14 Favored Glycine 0 CA--C 1.536 1.382 0 CA-C-O 118.346 -1.252 . . . . 62.43 113.042 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -64.72 146.12 55.22 Favored 'General case' 0 C--N 1.349 0.581 0 CA-C-N 119.254 1.527 . . . . 74.34 110.46 167.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -129.02 124.98 36.32 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 108.254 -1.017 . . . . 71.12 108.254 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.6 m -141.51 128.09 20.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 124.47 1.106 . . . . 71.33 110.8 -171.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -77.32 139.84 39.87 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.384 1.474 . . . . 75.51 111.6 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.497 HG21 HD12 ' A' ' 71' ' ' LEU . 8.3 t -169.61 154.43 5.52 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 124.906 1.379 . . . . 74.2 109.719 -165.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 t -121.28 133.75 66.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.972 -1.121 . . . . 42.04 107.972 176.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.8 t -106.83 126.53 62.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 108.322 -0.992 . . . . 70.35 108.322 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.31 135.67 53.82 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.347 1.459 . . . . 65.02 110.093 174.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.54 121.06 31.4 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 124.5 1.125 . . . . 64.15 108.958 169.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.509 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 6.5 tt0 -81.87 -168.57 1.97 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.002 1.321 . . . . 62.4 111.217 174.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.509 ' H ' ' HG2' ' A' ' 86' ' ' GLU . . . -93.41 11.08 72.25 Favored Glycine 0 CA--C 1.539 1.571 0 CA-C-O 117.71 -1.606 . . . . 63.34 113.353 -177.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -140.48 44.93 1.85 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.725 1.763 . . . . 62.51 110.925 -173.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 65.3 21.36 11.99 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.052 1.341 . . . . 73.45 113.395 172.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -120.98 126.5 50.11 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.918 1.287 . . . . 74.52 110.674 -164.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.0 mt -101.53 109.28 21.06 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 124.671 1.232 . . . . 65.32 109.1 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 86.6 t -95.99 132.63 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.86 1.264 . . . . 61.13 108.759 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.6 t -154.55 148.78 25.97 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 124.07 0.856 . . . . 63.33 110.977 -177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 20.4 p -147.26 133.38 19.33 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.786 1.234 . . . . 75.11 110.0 -173.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -93.53 -77.17 0.46 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.598 1.559 . . . . 65.02 109.727 -176.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -128.5 -58.85 1.17 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.066 1.747 . . . . 65.23 108.843 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -144.52 8.42 1.34 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.005 1.722 . . . . 74.45 112.223 -175.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.521 HG13 HD13 ' A' ' 115' ' ' LEU . 4.5 mp -103.56 115.89 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 107.297 -1.371 . . . . 51.44 107.297 177.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -103.18 91.13 3.96 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 124.629 1.206 . . . . 74.33 108.962 -173.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.7 p -100.43 112.53 24.89 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.336 1.454 . . . . 52.41 111.927 -174.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 87.3 t -114.85 106.91 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 126.409 1.884 . . . . 53.11 107.794 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.5 m -84.32 151.51 24.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.716 1.206 . . . . 54.15 109.863 173.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -146.4 130.66 17.52 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.444 1.497 . . . . 73.43 109.164 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.3 tt -111.39 128.42 55.97 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.76 1.224 . . . . 75.03 108.079 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -130.26 82.32 2.06 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.348 1.859 . . . . 71.04 106.51 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 64.42 -117.42 10.62 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.495 -1.042 . . . . 53.43 110.495 178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -85.78 9.59 16.1 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.014 1.726 . . . . 71.13 113.81 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.3 mm -122.61 134.23 66.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 124.53 1.132 . . . . 60.11 109.114 178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 43.2 mm -107.92 137.84 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.701 -1.222 . . . . 74.23 107.701 170.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 63.4 m -131.77 116.51 17.36 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 107.201 -1.407 . . . . 65.21 107.201 175.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.79 137.98 48.99 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 108.575 -0.898 . . . . 75.33 108.575 175.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 99.1 m -133.29 112.89 12.03 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 124.795 1.31 . . . . 75.43 108.247 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 33.1 mtp -111.04 146.87 35.96 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 126.0 1.72 . . . . 74.34 109.181 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 95.2 m -138.93 98.6 3.57 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 124.41 1.069 . . . . 60.32 109.258 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.521 HD13 HG13 ' A' ' 98' ' ' ILE . 9.2 tp -104.4 112.06 24.95 Favored 'General case' 0 C--N 1.343 0.304 0 C-N-CA 125.537 1.535 . . . . 71.2 108.354 174.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.43 -114.71 6.78 Favored Glycine 0 CA--C 1.534 1.264 0 O-C-N 124.729 1.268 . . . . 63.24 110.871 175.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.54 8.0 44.85 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.452 1.901 . . . . 71.45 113.469 -178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.9 mp -124.16 143.17 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.689 1.195 . . . . 75.42 109.594 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 91.5 t -126.95 94.41 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.079 0.952 . . . . 64.21 110.297 -177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -75.83 132.61 40.48 Favored 'General case' 0 C--N 1.346 0.449 0 C-N-CA 123.677 0.791 . . . . 74.24 111.035 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -122.62 149.67 43.68 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 124.339 1.025 . . . . 63.24 109.499 173.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.13 133.64 23.43 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.043 1.337 . . . . 62.53 108.368 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.4 mp -124.86 137.01 58.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 124.892 1.277 . . . . 74.22 108.053 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.1 m -137.98 156.86 47.4 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.691 1.196 . . . . 75.33 110.563 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -126.44 146.42 50.09 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.53 1.532 . . . . 63.23 109.744 176.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.3 tpp85 -56.92 142.15 42.52 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.459 2.303 . . . . 72.42 112.98 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.0 mt . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 105.883 -1.895 . . . . 72.13 105.883 -175.814 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 33.6 m170 . . . . . 0 N--CA 1.501 2.078 0 N-CA-C 107.71 -1.218 . . . . 74.42 107.71 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 2.0 m80 66.18 -172.52 0.19 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.616 1.567 . . . . 63.42 112.913 -167.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -137.53 169.3 18.02 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.833 1.253 . . . . 55.23 109.724 174.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -146.42 174.28 11.52 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.507 1.523 . . . . 74.33 110.825 -175.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 8.9 t-160 -106.5 76.52 1.14 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.061 0.944 . . . . 71.43 109.497 176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.25 151.32 6.72 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.279 1.432 . . . . 75.21 109.671 176.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 23.2 m -110.64 -40.88 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 124.754 1.284 . . . . 73.0 111.647 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . 61.64 161.63 0.07 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.436 2.294 . . . . 33.23 113.789 -173.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.0 mmm -126.95 140.05 52.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.642 0.777 . . . . 64.11 109.982 -175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.9 p -137.85 94.91 2.95 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.958 1.303 . . . . 72.34 110.067 -170.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -63.74 -25.23 68.1 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.18 1.548 . . . . 74.21 115.18 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.5 p -57.65 119.58 6.85 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.244 1.817 . . . . 75.25 113.679 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.04 164.97 13.23 Favored Glycine 0 CA--C 1.539 1.54 0 N-CA-C 110.689 -0.964 . . . . 65.11 110.689 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.49 ' HB3' HD12 ' A' ' 127' ' ' ILE . 2.5 mtmt -95.14 147.87 22.98 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.639 1.576 . . . . 74.12 111.68 173.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -143.08 133.91 25.36 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.032 1.333 . . . . 74.24 109.798 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -102.16 150.54 23.17 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.786 1.234 . . . . 63.35 110.267 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.4 tt -62.89 128.97 38.35 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.101 1.36 . . . . 71.32 111.096 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -113.54 -51.58 2.8 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 124.796 1.238 . . . . 65.5 111.64 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 m -152.92 168.27 26.37 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 124.489 1.118 . . . . 73.05 111.259 -170.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -165.39 145.35 6.8 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.787 1.235 . . . . 74.35 111.049 -170.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -139.84 146.82 39.84 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.947 1.299 . . . . 71.15 109.508 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.5 m-20 55.12 27.68 9.87 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.513 1.925 . . . . 63.12 113.035 -173.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -63.43 -60.32 3.52 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-O 118.078 -0.963 . . . . 74.25 111.58 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -60.34 -41.87 94.49 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 124.281 0.988 . . . . 60.04 113.041 176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.75 -48.93 71.99 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.556 1.143 . . . . 53.45 113.397 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -66.68 -47.2 73.2 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.193 1.397 . . . . 70.13 113.072 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.8 mmt -68.64 -39.63 80.63 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.545 1.138 . . . . 61.43 113.105 -175.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.497 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.3 mptm? -66.34 -34.13 77.28 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.932 0.893 . . . . 62.13 112.637 169.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.7 -34.9 67.45 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 114.415 1.265 . . . . 71.32 114.415 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.0 pt -77.67 -9.79 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 113.143 0.794 . . . . 75.3 113.143 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 91.19 26.71 20.62 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 118.235 -1.314 . . . . 44.11 112.988 168.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 75' ' ' THR . 79.1 mt -69.3 151.78 96.8 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 119.351 1.575 . . . . 72.05 111.711 172.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -69.88 147.72 62.7 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.192 1.928 . . . . 64.41 111.538 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.404 ' HA ' HD12 ' A' ' 29' ' ' ILE . 63.0 tt0 -54.75 -30.91 57.67 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.025 1.33 . . . . 74.34 114.484 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -63.08 -45.57 91.5 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 117.877 -1.059 . . . . 73.54 113.702 175.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 50.0 mt -65.66 -26.88 67.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.186 0.994 . . . . 75.44 113.429 174.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.497 HD13 ' HD2' ' A' ' 20' ' ' LYS . 54.1 mt -78.79 -50.95 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.162 0.985 . . . . 64.11 110.677 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -62.48 -40.92 98.23 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 117.731 -1.128 . . . . 53.41 113.622 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.45 -28.91 64.29 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 118.425 -0.797 . . . . 75.5 112.61 172.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.14 -31.53 57.39 Favored Glycine 0 CA--C 1.538 1.507 0 CA-C-O 118.957 -0.913 . . . . 20.32 112.617 -174.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.41 -30.46 16.49 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.418 1.087 . . . . 72.43 112.945 173.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -72.79 -50.95 21.07 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.385 1.074 . . . . 75.45 111.063 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.1 mm -88.03 126.81 41.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 O-C-N 124.337 1.023 . . . . 62.42 109.196 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -82.61 135.19 35.12 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.265 0.978 . . . . 63.21 110.19 170.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.62 -171.16 34.49 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 109.829 -1.308 . . . . 74.13 109.829 171.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 76.0 t -135.3 161.94 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 126.342 1.857 . . . . 70.24 108.86 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.2 t -145.63 157.66 43.94 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.277 1.031 . . . . 70.22 110.125 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -137.74 131.4 31.23 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 108.422 -0.955 . . . . 72.33 108.422 171.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 63.3 mt -110.63 130.94 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 106.112 -1.811 . . . . 62.45 106.112 177.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.4 t -134.2 124.99 47.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 124.0 0.92 . . . . 74.23 108.569 -173.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -114.14 131.67 56.34 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.815 1.246 . . . . 74.34 108.994 178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -133.55 52.86 2.05 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.243 1.417 . . . . 73.54 109.806 -174.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.65 -115.01 5.12 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 108.742 -1.743 . . . . 50.4 108.742 -175.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -71.88 -38.1 70.07 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.961 1.097 . . . . 73.31 113.961 173.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -74.19 158.62 33.82 Favored 'General case' 0 C--N 1.346 0.42 0 O-C-N 124.124 0.89 . . . . 72.23 111.864 172.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -158.63 135.5 9.68 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 106.217 -1.772 . . . . 73.35 106.217 -173.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.7 mtmt -121.0 154.79 35.56 Favored 'General case' 0 C--O 1.233 0.228 0 O-C-N 123.95 0.781 . . . . 75.04 110.089 171.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -137.38 125.26 22.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 124.532 1.145 . . . . 70.41 108.836 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.4 m -107.23 125.03 50.61 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.893 1.677 . . . . 45.21 108.166 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 87.8 mt -121.37 116.09 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 N-CA-C 108.003 -1.11 . . . . 74.15 108.003 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 84.8 m -113.66 114.01 25.81 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 124.385 1.053 . . . . 51.0 110.073 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -146.93 145.73 29.89 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.834 0.853 . . . . 75.3 110.33 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.97 -90.9 0.59 Allowed Glycine 0 CA--C 1.532 1.102 0 N-CA-C 109.504 -1.438 . . . . 43.33 109.504 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.2 t -156.33 42.15 0.38 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.14 1.376 . . . . 73.3 110.155 175.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -154.23 159.77 41.49 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.273 1.029 . . . . 75.41 111.48 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.6 t -127.63 131.41 70.07 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 125.443 1.497 . . . . 63.15 109.222 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.2 mt -115.91 113.36 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.32 1.448 . . . . 74.53 108.363 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.22 119.91 40.47 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.198 -1.038 . . . . 63.21 108.198 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -114.13 166.01 12.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.413 1.085 . . . . 63.35 110.096 173.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -141.34 140.95 33.86 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.224 1.01 . . . . 73.05 109.732 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -151.19 152.6 33.54 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.99 1.316 . . . . 75.23 109.871 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 16.9 m -100.7 132.73 45.94 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.498 -0.927 . . . . 72.31 108.498 171.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.2 t -67.19 112.33 2.48 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.313 1.045 . . . . 63.33 110.654 -176.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.83 -14.68 49.26 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.053 -1.415 . . . . 75.31 112.712 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -99.98 145.11 28.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.501 1.65 . . . . 71.42 110.461 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -66.99 127.53 32.93 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.129 1.371 . . . . 72.15 111.379 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.5 m -148.65 153.7 38.66 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.293 1.437 . . . . 74.14 109.332 -175.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -92.94 123.66 36.36 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.59 0.756 . . . . 74.33 110.649 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.5 138.5 40.79 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.279 1.432 . . . . 71.33 109.121 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -103.88 139.33 39.21 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.496 1.519 . . . . 63.54 109.68 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.4 m -88.25 163.93 15.87 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.399 1.48 . . . . 60.32 110.889 173.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 74.7 mtm -54.49 -29.16 49.34 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.729 1.381 . . . . 75.24 114.729 169.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.516 HG21 HD21 ' A' ' 24' ' ' LEU . 47.0 p -85.57 -10.89 55.28 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.916 2.086 . . . . 74.02 113.306 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 95.84 4.33 60.36 Favored Glycine 0 CA--C 1.538 1.524 0 CA-C-O 118.149 -1.362 . . . . 62.43 113.215 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -65.52 121.25 14.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 119.428 1.614 . . . . 74.34 110.442 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -108.21 129.3 55.2 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.06 0.85 . . . . 71.12 109.65 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 m -148.55 131.83 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.594 1.157 . . . . 71.33 111.124 -173.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -75.09 125.94 29.99 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.356 1.462 . . . . 75.51 110.694 174.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.4 t -151.4 164.13 37.41 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.576 1.551 . . . . 74.2 109.642 -172.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -130.15 130.89 66.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 108.033 -1.099 . . . . 42.04 108.033 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 81.8 t -103.22 128.26 56.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 O-C-N 124.095 0.872 . . . . 70.35 109.313 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -114.55 171.4 7.65 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.968 2.107 . . . . 65.02 110.295 175.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.473 HD13 ' H ' ' A' ' 87' ' ' GLY . 1.7 tm? -131.52 124.17 29.55 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.134 -1.432 . . . . 64.15 107.134 175.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -82.71 13.89 3.52 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 114.466 1.284 . . . . 62.4 114.466 -175.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.473 ' H ' HD13 ' A' ' 85' ' ' LEU . . . 74.71 13.79 81.88 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.371 1.462 . . . . 63.34 113.014 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -145.08 51.8 1.22 Allowed 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.573 1.187 . . . . 62.51 109.978 -169.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.276 0.5 OUTLIER 51.65 30.85 7.09 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.437 1.895 . . . . 73.45 115.171 175.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -140.56 120.93 14.02 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.877 1.271 . . . . 74.52 108.822 -167.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.6 mt -91.92 118.68 30.98 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.148 0.979 . . . . 65.32 109.293 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 91.7 t -101.72 126.37 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 125.11 1.364 . . . . 61.13 108.819 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.5 m -141.22 149.88 41.96 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.143 0.977 . . . . 63.33 109.373 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 16.6 p -147.0 138.71 24.3 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.791 0.836 . . . . 75.11 109.922 175.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -98.08 -79.61 0.47 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.729 1.611 . . . . 65.02 108.892 -176.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -136.37 -44.7 0.62 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.923 1.289 . . . . 65.23 109.734 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -150.02 8.76 0.65 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.177 1.391 . . . . 74.45 112.64 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.466 HG13 HD13 ' A' ' 115' ' ' LEU . 4.4 mp -109.18 116.12 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.698 1.199 . . . . 51.44 107.769 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.2 tmtp? -98.2 87.81 4.02 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.056 1.342 . . . . 74.33 109.232 -171.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.4 t -74.97 127.82 34.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.132 1.373 . . . . 52.41 111.743 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 90.6 t -138.24 95.98 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.698 1.599 . . . . 53.11 107.579 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 87.3 m -82.32 155.72 24.64 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.073 1.349 . . . . 54.15 110.285 173.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -145.37 141.64 28.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.422 1.489 . . . . 73.43 109.84 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.1 tp -119.46 124.14 45.76 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.945 2.098 . . . . 75.03 107.155 172.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -131.18 81.7 2.0 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 106.285 -1.746 . . . . 71.04 106.285 171.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 63.79 -116.82 9.69 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 124.946 1.26 . . . . 53.43 110.631 177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -80.49 -0.98 39.77 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.977 1.311 . . . . 71.13 114.37 177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.8 mm -115.55 131.91 66.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 119.466 1.03 . . . . 60.11 109.437 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 51.9 mm -108.84 138.23 36.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 125.095 1.358 . . . . 74.23 108.122 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 66.9 m -133.41 110.97 10.37 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 124.629 1.206 . . . . 65.21 107.751 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.9 135.67 45.82 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.912 -0.773 . . . . 75.33 108.912 175.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.4 m -131.76 117.65 18.87 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.845 1.258 . . . . 75.43 108.454 175.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -110.09 149.93 29.32 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.155 1.382 . . . . 74.34 109.456 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.9 m -133.34 98.93 4.37 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 124.194 0.934 . . . . 60.32 109.378 177.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.466 HD13 HG13 ' A' ' 98' ' ' ILE . 8.9 tp -102.01 109.79 21.6 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 125.175 1.39 . . . . 71.2 108.732 174.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.47 -114.86 6.94 Favored Glycine 0 CA--C 1.534 1.252 0 O-C-N 124.864 1.353 . . . . 63.24 110.777 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.11 -0.74 53.17 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 126.583 1.953 . . . . 71.45 113.926 -177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.0 mt -118.06 143.5 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.813 1.245 . . . . 75.42 110.113 -176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 44.5 t -125.33 95.17 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 123.915 0.886 . . . . 64.21 110.053 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -70.86 137.68 49.6 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.833 1.653 . . . . 74.24 112.628 174.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -124.83 151.87 44.67 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.394 1.077 . . . . 63.24 111.253 170.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 6.8 mmt-85 -138.87 136.65 35.78 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.781 2.032 . . . . 62.53 108.111 172.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.35 133.72 68.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 107.522 -1.288 . . . . 74.22 107.522 173.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.4 m -137.34 156.76 47.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.866 1.266 . . . . 75.33 109.67 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -134.39 144.71 48.35 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.471 1.108 . . . . 63.23 110.657 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 32.8 ttp85 -64.11 143.61 57.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.352 1.861 . . . . 72.42 114.014 -170.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 6' ' ' LYS . 15.3 mt . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 105.462 -2.051 . . . . 72.13 105.462 -172.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 . . . . . 0 N--CA 1.501 2.085 0 N-CA-C 107.833 -1.173 . . . . 74.42 107.833 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 22.5 p80 56.13 29.58 14.89 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 127.146 2.178 . . . . 63.42 114.572 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -62.69 136.06 57.68 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.559 1.544 . . . . 55.23 112.21 -175.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 74.9 t60 64.22 74.18 0.41 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.903 2.081 . . . . 74.33 111.584 -176.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -158.17 147.67 19.66 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.004 1.321 . . . . 71.43 109.716 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -69.72 125.65 27.35 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.686 1.194 . . . . 75.21 110.695 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 20.3 m -117.86 -32.76 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 O-C-N 124.793 1.308 . . . . 73.0 112.223 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . 57.86 -152.54 0.4 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.641 1.977 . . . . 33.23 113.238 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -137.14 142.69 42.23 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.719 1.208 . . . . 64.11 109.241 171.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 t -161.27 130.79 4.75 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.762 1.225 . . . . 72.34 108.653 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.434 ' HA ' HD22 ' A' ' 104' ' ' LEU . 27.5 m-85 -60.99 -34.55 74.97 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.469 1.507 . . . . 74.21 114.538 172.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 t -58.98 123.46 16.65 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.806 1.642 . . . . 75.25 113.295 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.66 164.79 13.25 Favored Glycine 0 CA--C 1.539 1.563 0 O-C-N 124.419 1.074 . . . . 65.11 110.529 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HB3' HD12 ' A' ' 127' ' ' ILE . 1.4 mmmt -98.97 148.3 24.13 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.031 1.732 . . . . 74.12 111.356 174.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -142.98 155.44 44.68 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.177 1.391 . . . . 74.24 109.528 -177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -127.14 144.04 51.12 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.527 -0.916 . . . . 63.35 108.527 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 36' ' ' LYS . 58.2 tp -56.66 134.83 54.92 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.696 1.198 . . . . 71.32 111.742 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -115.46 -51.42 2.69 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 124.798 1.311 . . . . 65.5 110.116 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.9 t -159.66 162.68 35.18 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 124.409 1.068 . . . . 73.05 110.185 -173.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -155.78 159.82 39.75 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.554 1.542 . . . . 74.35 111.349 177.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -137.84 142.18 40.77 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.138 1.375 . . . . 71.15 108.619 176.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 57.4 28.33 15.22 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.276 1.831 . . . . 63.12 113.167 -174.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.67 -57.92 9.32 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.058 0.943 . . . . 74.25 112.163 176.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -52.69 -50.01 64.15 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.313 1.845 . . . . 60.04 112.348 173.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.91 -47.11 86.19 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.14 1.376 . . . . 53.45 113.956 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -69.43 -46.29 67.13 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 124.787 1.235 . . . . 70.13 113.567 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.5 mmt -65.81 -37.93 87.59 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 124.729 1.268 . . . . 61.43 112.975 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.465 ' HD3' HD13 ' A' ' 29' ' ' ILE . 8.1 mmmm -71.94 -27.09 62.57 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.103 0.961 . . . . 62.13 112.482 171.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.03 -37.47 58.32 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.556 1.142 . . . . 71.32 113.721 176.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.9 pt -78.24 -8.27 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 N-CA-C 113.391 0.886 . . . . 75.3 113.391 170.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.8 31.46 26.59 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.509 -1.162 . . . . 44.11 112.547 169.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.31 153.06 93.37 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 118.861 1.33 . . . . 72.05 111.704 173.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -65.7 142.22 69.45 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 122.18 1.92 . . . . 64.41 111.407 170.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -59.02 -24.84 63.16 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.514 1.301 . . . . 74.34 114.514 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -62.66 -47.23 84.59 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 117.266 -1.349 . . . . 73.54 113.55 171.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 36.2 mt -63.67 -28.04 69.63 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.306 1.042 . . . . 75.44 113.693 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.465 HD13 ' HD3' ' A' ' 20' ' ' LYS . 15.4 mt -76.95 -52.64 16.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.322 1.049 . . . . 64.11 111.394 176.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -62.7 -41.08 98.94 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 117.576 -1.202 . . . . 53.41 113.335 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.81 -25.61 61.21 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 118.216 -0.897 . . . . 75.5 113.171 172.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.83 -32.28 50.48 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-O 119.148 -0.807 . . . . 20.32 111.978 -175.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.0 -31.57 16.27 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.677 1.191 . . . . 72.43 113.066 173.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -72.27 -54.4 9.67 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.686 1.194 . . . . 75.45 110.854 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 21.9 mm -94.22 125.63 46.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 O-C-N 124.346 1.029 . . . . 62.42 108.636 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.498 ' HA ' HD23 ' A' ' 9' ' ' LEU . 13.7 mptt -73.79 104.75 4.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.452 1.101 . . . . 63.21 110.284 170.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.0 158.1 51.82 Favored Glycine 0 CA--C 1.533 1.17 0 O-C-N 124.497 1.123 . . . . 74.13 110.592 176.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.3 t -100.91 152.19 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 124.119 0.968 . . . . 70.24 109.257 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.7 t -130.3 155.58 46.08 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.109 1.764 . . . . 70.22 108.563 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -158.05 143.25 16.7 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.493 -0.558 . . . . 72.33 109.493 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.407 HG12 ' CE1' ' A' ' 50' ' ' PHE . 11.3 mt -134.76 133.44 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 106.077 -1.823 . . . . 62.45 106.077 -173.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 92.2 t -140.34 98.92 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 107.81 -1.181 . . . . 74.23 107.81 -175.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -82.37 133.14 35.22 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.667 1.187 . . . . 74.34 109.928 177.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -133.81 54.32 1.96 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.941 1.297 . . . . 73.54 110.153 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.9 -111.92 3.61 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 109.156 -1.578 . . . . 50.4 109.156 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.1 mmtm -77.34 -33.03 55.5 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.373 1.069 . . . . 73.31 113.813 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -76.56 154.7 34.26 Favored 'General case' 0 C--N 1.346 0.421 0 O-C-N 124.147 0.904 . . . . 72.23 111.267 172.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -144.99 135.16 23.98 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.49 -1.67 . . . . 73.35 106.49 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -123.27 152.66 41.13 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.229 1.411 . . . . 75.04 110.058 171.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.407 ' CE1' HG12 ' A' ' 41' ' ' ILE . 8.0 t80 -143.24 135.35 26.98 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.231 -1.396 . . . . 70.41 107.231 177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.3 m -123.1 107.26 11.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.529 1.131 . . . . 45.21 109.633 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 93.5 mt -95.31 136.38 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 124.609 1.164 . . . . 74.15 108.544 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.2 m -123.09 125.49 45.28 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.478 1.111 . . . . 51.0 108.763 172.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.74 70.73 0.72 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.292 1.037 . . . . 75.3 108.813 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.44 -37.86 1.83 Allowed Glycine 0 CA--C 1.54 1.617 0 C-N-CA 125.85 1.69 . . . . 43.33 113.894 175.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.0 p -157.05 -45.39 0.07 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 119.131 1.466 . . . . 73.3 112.137 -175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.99 139.28 48.53 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.27 1.028 . . . . 75.41 110.823 171.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.96 136.4 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 O-C-N 124.541 1.15 . . . . 63.15 109.315 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 52.6 mt -125.76 124.19 65.97 Favored 'Isoleucine or valine' 0 C--N 1.344 0.339 0 C-N-CA 124.669 1.188 . . . . 74.53 109.067 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -109.24 124.0 50.17 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 125.206 1.566 . . . . 63.21 107.749 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 -122.09 144.82 48.69 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 124.976 1.31 . . . . 63.35 108.685 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -135.23 143.27 46.25 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 125.019 1.449 . . . . 73.05 109.407 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -152.76 162.74 40.87 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.509 1.123 . . . . 75.23 110.022 175.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.1 m -108.59 130.04 55.31 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.391 1.076 . . . . 72.31 108.35 172.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.9 116.82 6.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.239 1.016 . . . . 63.33 110.439 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.74 -8.16 39.53 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 118.006 -1.441 . . . . 75.31 112.413 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -121.32 154.01 36.97 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 119.155 1.478 . . . . 71.42 111.065 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.39 131.86 39.37 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.913 1.685 . . . . 72.15 110.422 174.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.8 m -143.32 156.69 44.77 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.442 1.497 . . . . 74.14 108.416 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -95.62 123.89 39.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.701 0.8 . . . . 74.33 110.289 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.01 135.27 51.12 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.193 1.797 . . . . 71.33 109.176 -174.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -100.26 145.22 28.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.355 1.462 . . . . 63.54 111.82 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.3 p -104.82 174.35 5.92 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.107 1.763 . . . . 60.32 112.069 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -54.8 -34.96 63.35 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 115.471 1.656 . . . . 75.24 115.471 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 33.5 p -91.47 -5.44 54.25 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.616 1.566 . . . . 74.02 112.983 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.27 13.35 54.48 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-O 118.337 -1.257 . . . . 62.43 112.954 173.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 -65.38 130.02 41.81 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.188 1.494 . . . . 74.34 109.995 173.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.5 mtpt -114.57 120.27 39.63 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.488 -0.93 . . . . 71.12 108.488 -174.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.7 m -138.68 128.45 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 124.903 1.281 . . . . 71.33 111.226 -170.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -75.86 135.9 40.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.525 1.13 . . . . 75.51 112.296 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 t -161.49 151.9 17.59 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.295 1.438 . . . . 74.2 110.181 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.99 136.41 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.621 1.168 . . . . 42.04 107.958 170.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.4 t -106.77 132.24 54.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 108.249 -1.019 . . . . 70.35 108.249 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -132.04 147.73 52.46 Favored 'General case' 0 C--N 1.345 0.373 0 C-N-CA 124.94 1.296 . . . . 65.02 112.646 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.842 HD23 ' H ' ' A' ' 87' ' ' GLY . 3.3 tt -109.44 128.43 55.14 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.693 1.597 . . . . 64.15 109.094 -174.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.47 11.59 21.23 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.164 1.385 . . . . 62.4 114.134 -176.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.842 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 81.21 -1.52 84.81 Favored Glycine 0 CA--C 1.539 1.59 0 C-N-CA 125.833 1.682 . . . . 63.34 113.137 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -121.94 38.19 4.18 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.747 1.619 . . . . 62.51 111.63 -168.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.326 0.3 OUTLIER 52.38 41.23 30.57 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.572 1.949 . . . . 73.45 113.917 178.753 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -138.81 141.91 38.72 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.263 1.825 . . . . 74.52 108.353 -175.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.2 mt -121.63 119.43 31.84 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 124.302 1.001 . . . . 65.32 110.245 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.8 t -102.36 133.81 44.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.271 1.428 . . . . 61.13 108.883 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 t -153.03 135.67 15.25 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.457 1.103 . . . . 63.33 110.576 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.9 p -137.86 126.49 23.66 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.005 1.322 . . . . 75.11 110.155 -172.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -92.27 -61.26 1.65 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.917 1.287 . . . . 65.02 110.145 -175.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -143.15 -70.12 0.33 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.263 1.425 . . . . 65.23 108.43 -174.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -123.77 -20.58 5.41 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.977 1.711 . . . . 74.45 111.186 178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.57 HG13 HD13 ' A' ' 115' ' ' LEU . 4.3 mp -79.32 121.78 33.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.71 1.204 . . . . 51.44 109.275 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -112.28 93.31 4.38 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.108 1.363 . . . . 74.33 108.722 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.2 t -95.09 112.3 24.02 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.872 1.669 . . . . 52.41 110.205 -174.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.4 t -113.82 116.33 52.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.143 1.377 . . . . 53.11 108.347 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.0 m -94.72 152.54 18.37 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.812 1.645 . . . . 54.15 109.92 176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 59.5 tt0 -145.17 140.9 28.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.799 1.64 . . . . 73.43 109.383 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 3' ' ' PHE . 13.6 tp -122.36 126.46 48.09 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.292 1.837 . . . . 75.03 107.05 173.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -133.49 87.18 2.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.552 1.941 . . . . 71.04 106.84 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.94 -114.79 6.88 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 110.58 -1.008 . . . . 53.43 110.58 175.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -88.56 3.69 49.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.424 1.49 . . . . 71.13 113.798 176.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.7 mm -116.27 131.68 68.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 119.282 0.946 . . . . 60.11 109.054 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 42.9 mm -106.38 136.12 42.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.264 0 N-CA-C 107.527 -1.286 . . . . 74.23 107.527 168.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.9 m -123.27 137.66 54.81 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 107.168 -1.419 . . . . 65.21 107.168 172.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -134.71 135.09 41.72 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.405 -0.961 . . . . 75.33 108.405 176.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 90.7 m -132.81 116.03 16.03 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.605 1.191 . . . . 75.43 108.547 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 94.0 mtp -107.62 142.37 37.67 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.431 1.492 . . . . 74.34 108.935 176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 62.7 m -132.58 108.25 8.96 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.288 0.993 . . . . 60.32 108.639 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.57 HD13 HG13 ' A' ' 98' ' ' ILE . 12.8 tp -121.1 112.76 19.1 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.529 1.531 . . . . 71.2 108.117 177.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.3 -118.61 15.47 Favored Glycine 0 CA--C 1.534 1.243 0 O-C-N 124.657 1.223 . . . . 63.24 110.129 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.47 3.92 50.64 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.502 1.521 . . . . 71.45 113.114 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.5 mp -111.45 135.43 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.056 0.942 . . . . 75.42 109.273 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.0 t -126.14 96.08 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 C-N-CA 124.035 0.934 . . . . 64.21 109.421 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -76.34 131.05 38.94 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.636 1.574 . . . . 74.24 112.193 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -113.67 152.52 30.33 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 124.601 1.161 . . . . 63.24 109.825 167.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 64.6 ttt-85 -150.48 138.65 20.25 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.837 1.255 . . . . 62.53 109.038 175.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -130.22 137.05 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 124.82 1.248 . . . . 74.22 108.534 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 42.3 m -132.2 160.99 34.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.285 1.434 . . . . 75.33 110.273 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -136.2 144.46 44.94 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.799 1.24 . . . . 63.23 110.227 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.7 ttp85 -62.63 139.05 58.63 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 126.136 1.775 . . . . 72.42 113.765 -171.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.408 HD12 ' HB3' ' A' ' 6' ' ' LYS . 23.1 mt . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 105.776 -1.935 . . . . 72.13 105.776 -174.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 69.7 m80 . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 103.842 -2.651 . . . . 74.42 103.842 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -146.32 137.25 24.31 Favored 'General case' 0 C--N 1.345 0.402 0 C-N-CA 125.334 1.454 . . . . 63.42 109.109 172.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -126.28 179.66 5.17 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.034 1.733 . . . . 55.23 109.316 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 64.65 77.42 0.31 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.278 1.831 . . . . 74.33 111.563 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -141.85 163.06 33.91 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.243 1.417 . . . . 71.43 110.51 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -134.98 52.73 2.03 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.906 1.282 . . . . 75.21 109.695 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 16.2 m -143.95 141.8 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.045 1.338 . . . . 73.0 109.679 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -84.3 157.27 21.58 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.825 1.25 . . . . 33.23 111.101 174.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -81.02 156.96 25.64 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 123.958 0.786 . . . . 64.11 111.531 171.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 t -161.57 145.61 12.86 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.066 1.347 . . . . 72.34 108.583 174.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -62.6 -27.7 69.37 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 115.355 1.613 . . . . 74.21 115.355 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.0 p -58.3 119.95 7.83 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.565 1.546 . . . . 75.25 113.974 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.08 160.32 9.48 Favored Glycine 0 CA--C 1.537 1.44 0 N-CA-C 110.121 -1.192 . . . . 65.11 110.121 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HB3' HD12 ' A' ' 127' ' ' ILE . 6.2 mtmt -92.39 149.25 21.52 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.82 1.248 . . . . 74.12 112.072 172.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -139.89 152.08 46.14 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.622 1.569 . . . . 74.24 109.353 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -125.1 148.13 48.69 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.264 1.425 . . . . 63.35 109.297 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.2 129.96 42.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.167 0.987 . . . . 71.32 111.722 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -114.24 -50.42 2.81 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.655 1.582 . . . . 65.5 111.23 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.8 t -152.7 170.58 19.9 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 124.259 0.974 . . . . 73.05 110.804 -171.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -167.83 149.94 5.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.148 1.379 . . . . 74.35 111.412 -166.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -142.47 140.69 31.99 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.203 1.401 . . . . 71.15 108.673 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.3 m-20 57.52 26.59 12.91 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.465 1.906 . . . . 63.12 113.952 -177.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -62.48 -56.36 18.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.089 0.955 . . . . 74.25 112.263 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -49.91 -55.44 14.42 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.971 1.708 . . . . 60.04 111.996 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.1 -51.22 64.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.067 1.747 . . . . 53.45 114.351 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -67.39 -45.59 75.75 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.379 1.072 . . . . 70.13 113.377 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 12.4 mmt -68.35 -35.61 78.01 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 124.76 1.287 . . . . 61.43 112.666 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.516 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.7 mptm? -64.27 -36.0 82.67 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.809 0.843 . . . . 62.13 113.138 167.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.52 -35.82 60.65 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 114.679 1.363 . . . . 71.32 114.679 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.46 ' CD1' HD13 ' A' ' 24' ' ' LEU . 42.5 pt -76.28 -10.56 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.679 0.792 . . . . 75.3 113.108 170.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.4 27.07 26.15 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-O 118.41 -1.216 . . . . 44.11 112.862 170.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.525 HD11 ' CG2' ' A' ' 75' ' ' THR . 4.5 mp -67.58 147.26 98.74 Favored Pre-proline 0 CA--C 1.544 0.714 0 CA-C-N 119.112 1.456 . . . . 72.05 111.159 173.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -66.77 145.97 76.93 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.162 1.908 . . . . 64.41 111.433 172.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.463 ' HA ' HD12 ' A' ' 29' ' ' ILE . 42.5 tt0 -55.78 -29.2 59.25 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.47 1.285 . . . . 74.34 114.47 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -63.56 -45.42 90.57 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 117.772 -1.109 . . . . 73.54 113.827 174.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.2 mt -64.6 -27.41 68.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.227 1.011 . . . . 75.44 113.339 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.516 HD13 ' HD2' ' A' ' 20' ' ' LYS . 42.8 mt -77.93 -54.98 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.221 1.008 . . . . 64.11 110.09 177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -58.9 -40.79 85.54 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.951 1.093 . . . . 53.41 113.951 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.31 -29.44 62.7 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 118.431 -0.795 . . . . 75.5 112.732 173.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -77.69 -21.43 71.95 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-O 118.715 -1.047 . . . . 20.32 112.787 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -102.02 -24.98 13.91 Favored 'General case' 0 C--N 1.347 0.478 0 C-N-CA 124.661 1.184 . . . . 72.43 113.14 172.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -68.94 -52.6 27.54 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.941 1.296 . . . . 75.45 110.687 172.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.1 mm -96.39 137.06 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.755 1.222 . . . . 62.42 109.431 -177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -90.87 126.77 36.14 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.723 1.209 . . . . 63.21 110.042 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.37 175.97 46.36 Favored Glycine 0 CA--C 1.533 1.198 0 O-C-N 124.475 1.109 . . . . 74.13 110.707 175.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.26 151.3 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.546 1.538 . . . . 70.24 108.213 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.3 t -148.82 105.53 3.57 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.852 0.861 . . . . 70.22 109.771 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -81.19 143.5 32.3 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 125.081 1.352 . . . . 72.33 110.801 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.41 HG12 ' CE1' ' A' ' 50' ' ' PHE . 13.8 mt -127.0 132.02 70.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 107.178 -1.415 . . . . 62.45 107.178 174.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.4 m -139.34 143.32 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.126 0.57 . . . . 74.23 109.931 172.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -121.73 128.24 51.57 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.219 1.808 . . . . 74.34 106.913 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -139.89 77.81 1.63 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.032 0.933 . . . . 73.54 108.891 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.18 -121.54 10.39 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 108.741 -1.744 . . . . 50.4 108.741 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -79.37 -26.66 41.98 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.387 1.254 . . . . 73.31 114.387 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.9 154.38 28.38 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 123.876 0.87 . . . . 72.23 111.442 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -146.02 134.11 21.55 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.834 -1.543 . . . . 73.35 106.834 -175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -123.01 159.14 29.0 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.302 1.041 . . . . 75.04 110.122 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.41 ' CE1' HG12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -151.47 123.12 7.95 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.076 1.35 . . . . 70.41 108.687 -174.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -119.81 107.13 12.8 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.271 1.029 . . . . 45.21 108.994 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 mp -109.17 117.34 54.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.322 1.049 . . . . 74.15 108.708 -173.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 86.4 m -99.0 133.01 43.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.973 1.309 . . . . 51.0 109.089 173.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -136.25 81.17 1.87 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.645 1.178 . . . . 75.3 109.035 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.08 -79.36 1.92 Allowed Glycine 0 CA--C 1.531 1.045 0 N-CA-C 109.412 -1.475 . . . . 43.33 109.412 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 t -136.3 -30.04 0.95 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.847 1.259 . . . . 73.3 112.06 -178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -73.12 139.41 46.41 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 123.656 0.782 . . . . 75.41 110.837 170.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.4 t -130.01 117.64 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.002 -1.11 . . . . 63.15 108.002 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 92.0 mt -107.15 124.41 62.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 107.582 -1.266 . . . . 74.53 107.582 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -108.4 128.85 55.13 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 124.696 1.248 . . . . 63.21 108.703 176.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -132.58 154.12 50.34 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.144 1.378 . . . . 63.35 108.787 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -154.84 148.98 25.92 Favored 'General case' 0 C--O 1.232 0.167 0 O-C-N 124.421 1.076 . . . . 73.05 109.969 -173.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -156.96 154.07 29.08 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 124.668 1.23 . . . . 75.23 110.267 -175.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.0 m -96.24 129.96 43.44 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.631 1.207 . . . . 72.31 108.307 170.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.87 125.39 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.37 1.068 . . . . 63.33 110.515 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 101.69 -35.02 5.2 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-O 118.381 -1.233 . . . . 75.31 111.553 -175.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -97.4 143.18 28.39 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 118.861 1.33 . . . . 71.42 111.762 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.72 126.55 30.07 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.71 1.604 . . . . 72.15 111.067 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.4 m -141.79 153.29 44.44 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.853 1.261 . . . . 74.14 108.78 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.48 120.15 37.34 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.826 1.25 . . . . 74.33 108.761 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.43 HD23 HG22 ' A' ' 81' ' ' THR . 2.9 mm? -111.37 116.15 30.48 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 124.415 1.086 . . . . 71.33 109.031 -176.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -76.04 152.21 36.95 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 124.548 1.155 . . . . 63.54 111.084 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.1 p -114.94 179.67 3.88 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.795 1.638 . . . . 60.32 109.929 173.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 43.7 mtm -56.26 -29.23 60.83 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 115.811 1.782 . . . . 75.24 115.811 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.525 ' CG2' HD11 ' A' ' 24' ' ' LEU . 63.2 p -86.24 -13.03 48.03 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.507 1.523 . . . . 74.02 113.325 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 97.53 -1.9 60.42 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 118.287 -1.285 . . . . 62.43 112.074 -176.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -67.68 115.06 6.83 Favored 'General case' 0 C--N 1.349 0.547 0 CA-C-N 119.294 1.547 . . . . 74.34 110.984 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -111.8 136.0 51.66 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 124.791 1.307 . . . . 71.12 109.361 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.96 128.64 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 124.827 1.251 . . . . 71.33 110.316 -169.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.54 128.83 38.05 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 124.44 1.088 . . . . 75.51 111.939 174.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.43 HG22 HD23 ' A' ' 71' ' ' LEU . 12.1 t -158.05 157.62 33.24 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.076 1.35 . . . . 74.2 109.433 172.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.1 m -101.2 151.93 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.875 1.27 . . . . 42.04 109.663 169.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.52 127.0 66.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 107.763 -1.199 . . . . 70.35 107.763 177.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 57.5 mm-40 -117.51 172.38 7.37 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.814 1.646 . . . . 65.02 109.67 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 87' ' ' GLY . 5.3 tt -130.11 129.06 43.06 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.611 1.164 . . . . 64.15 108.624 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -86.16 15.53 5.09 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.196 1.398 . . . . 62.4 114.602 -174.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.576 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 72.76 12.05 78.08 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 125.291 1.424 . . . . 63.34 113.161 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -143.36 51.88 1.36 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.648 1.179 . . . . 62.51 109.019 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.296 0.3 OUTLIER 48.72 38.29 11.34 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 126.892 2.077 . . . . 73.45 114.437 171.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -143.51 133.49 24.15 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 125.55 1.54 . . . . 74.52 108.431 -170.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.1 mt -103.91 124.27 48.67 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 124.525 1.141 . . . . 65.32 109.742 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.9 t -106.91 133.34 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.407 1.483 . . . . 61.13 108.617 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.7 t -164.98 140.8 5.52 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.201 1.0 . . . . 63.33 110.476 -168.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.5 m -146.72 128.97 15.72 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 123.666 0.604 . . . . 75.11 110.542 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -86.89 -154.75 0.24 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.773 1.629 . . . . 65.02 110.675 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -61.45 -34.1 74.86 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.639 1.576 . . . . 65.23 113.952 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -162.47 12.2 0.07 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.343 1.457 . . . . 74.45 112.47 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.432 HG12 HD13 ' A' ' 115' ' ' LEU . 21.9 mt -116.22 117.07 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.263 -1.384 . . . . 51.44 107.263 178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -85.17 146.94 26.86 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.543 1.137 . . . . 74.33 108.687 169.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.7 m -150.43 125.99 10.23 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 123.857 0.723 . . . . 52.41 110.321 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.08 110.44 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 107.801 -1.185 . . . . 53.11 107.801 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.7 m -92.32 152.37 19.81 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.424 1.09 . . . . 54.15 109.511 172.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -143.74 138.38 28.77 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.979 1.712 . . . . 73.43 109.927 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.4 tp -118.58 125.14 49.16 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.84 2.056 . . . . 75.03 106.762 172.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -129.87 78.81 1.87 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.658 1.983 . . . . 71.04 106.293 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.99 -111.78 4.27 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.588 1.09 . . . . 53.43 110.58 176.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.74 -17.23 56.16 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.888 1.275 . . . . 71.13 113.536 175.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.8 mm -102.39 132.41 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 119.027 0.83 . . . . 60.11 110.161 -174.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 46.2 mm -108.53 140.39 27.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 125.022 1.329 . . . . 74.23 108.4 170.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 53.7 m -133.02 141.77 48.44 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.778 1.231 . . . . 65.21 107.719 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -132.95 142.0 48.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.565 1.146 . . . . 75.33 107.911 175.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.2 m -135.08 105.6 6.41 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 124.91 1.381 . . . . 75.43 108.206 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 48.6 mtp -98.58 148.28 23.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.901 1.68 . . . . 74.34 108.963 173.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.6 m -138.7 109.55 6.71 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.135 0.974 . . . . 60.32 108.83 173.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.432 HD13 HG12 ' A' ' 98' ' ' ILE . 12.7 tp -114.37 109.4 18.28 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.545 1.538 . . . . 71.2 108.14 176.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.47 -112.33 4.89 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 124.822 1.326 . . . . 63.24 110.465 178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.83 2.37 41.01 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.74 2.016 . . . . 71.45 113.706 -176.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.1 mt -122.5 142.83 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.709 1.204 . . . . 75.42 110.346 -177.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.6 t -123.85 90.99 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.559 1.144 . . . . 64.21 110.164 -175.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -73.57 128.92 36.83 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.4 1.08 . . . . 74.24 112.111 173.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -123.99 152.4 42.59 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.285 1.034 . . . . 63.24 110.716 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -140.61 144.3 35.71 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.965 1.306 . . . . 62.53 109.002 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -135.1 126.89 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.464 1.106 . . . . 74.22 108.109 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.8 m -129.87 159.43 36.63 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.74 1.216 . . . . 75.33 110.102 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 tmmm? -135.73 146.28 47.53 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.484 1.114 . . . . 63.23 110.626 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.3 ttp85 -62.79 139.52 58.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.242 2.217 . . . . 72.42 114.067 -172.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 6' ' ' LYS . 5.0 mt . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 105.792 -1.929 . . . . 72.13 105.792 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 44.5 p-80 . . . . . 0 N--CA 1.502 2.145 0 N-CA-C 108.11 -1.07 . . . . 74.42 108.11 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -146.45 149.28 33.39 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 125.336 1.454 . . . . 63.42 109.655 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 62.76 89.16 0.09 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.33 2.252 . . . . 55.23 112.52 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -154.21 42.32 0.51 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.972 0.909 . . . . 74.33 111.824 -171.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -133.34 152.23 51.91 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.65 1.18 . . . . 71.43 111.009 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -166.58 157.97 12.94 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.886 1.674 . . . . 75.21 109.575 -177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 26.2 m -100.25 140.81 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.157 0.983 . . . . 73.0 109.913 172.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -171.35 147.76 2.5 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.761 1.624 . . . . 33.23 108.909 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.3 mmm -118.55 117.23 28.43 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 124.384 1.052 . . . . 64.11 108.556 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.9 p -140.79 116.47 10.25 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.955 1.302 . . . . 72.34 108.946 -176.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -60.24 -33.23 72.0 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.874 1.435 . . . . 74.21 114.874 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.2 p -57.61 133.3 55.17 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.168 1.787 . . . . 75.25 114.564 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 140.54 165.25 10.23 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.742 1.163 . . . . 65.11 110.217 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.486 ' HB3' HD12 ' A' ' 127' ' ' ILE . 8.3 mtmt -92.97 145.23 24.53 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 124.694 1.198 . . . . 74.12 112.004 173.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -135.94 147.67 48.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.508 1.523 . . . . 74.24 109.506 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -116.69 148.73 40.78 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.303 1.441 . . . . 63.35 109.454 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.481 HD13 ' HG3' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -72.84 121.88 20.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.71 1.204 . . . . 71.32 111.716 -175.109 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -96.31 -56.47 2.61 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.72 1.208 . . . . 65.5 111.85 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 28.5 t -161.77 159.05 26.64 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.15 0.98 . . . . 73.05 110.448 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -135.4 147.19 48.93 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.251 1.42 . . . . 74.35 108.698 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -123.32 138.05 54.7 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.1 1.36 . . . . 71.15 108.476 172.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 56.37 32.79 21.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.262 1.825 . . . . 63.12 112.616 -173.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -61.74 -60.72 3.23 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 124.324 1.05 . . . . 74.25 110.594 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -61.47 -39.05 89.48 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 124.478 1.111 . . . . 60.04 113.559 178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.68 -48.26 81.69 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.45 1.1 . . . . 53.45 112.965 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -68.32 -45.43 72.97 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.948 1.299 . . . . 70.13 113.072 176.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 4.9 mmt -69.19 -37.38 78.12 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.32 1.048 . . . . 61.43 113.118 -176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.542 ' HD2' HD13 ' A' ' 29' ' ' ILE . 6.3 mptt -67.01 -35.42 79.91 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.904 0.882 . . . . 62.13 112.754 169.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.56 -34.18 69.75 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.386 1.254 . . . . 71.32 114.386 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.9 pt -79.06 -9.72 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 113.204 0.816 . . . . 75.3 113.204 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.89 22.64 22.77 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-O 118.099 -1.389 . . . . 44.11 113.52 167.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.68 151.5 97.21 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 119.629 1.715 . . . . 72.05 111.866 172.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.26 147.51 59.81 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.291 1.994 . . . . 64.41 111.789 172.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.401 ' HA ' HD12 ' A' ' 29' ' ' ILE . 44.1 tt0 -57.11 -29.64 63.69 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 115.028 1.492 . . . . 74.34 115.028 -177.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -62.27 -44.67 96.01 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.383 0.882 . . . . 73.54 113.383 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mp -65.8 -27.6 68.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.549 1.539 . . . . 75.44 112.763 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.542 HD13 ' HD2' ' A' ' 20' ' ' LYS . 68.5 mt -79.95 -47.5 21.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.64 1.176 . . . . 64.11 111.085 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -65.23 -40.56 94.22 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-O 117.76 -1.114 . . . . 53.41 113.395 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.62 -25.38 61.28 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 118.262 -0.875 . . . . 75.5 112.854 172.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.57 -37.45 46.28 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 123.894 0.759 . . . . 20.32 111.953 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -28.47 21.79 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.517 1.127 . . . . 72.43 113.203 175.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -72.86 -57.63 3.93 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.59 1.156 . . . . 75.45 111.059 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 39.8 mm -81.86 119.11 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 O-C-N 124.328 1.017 . . . . 62.42 109.195 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.481 ' HG3' HD13 ' A' ' 9' ' ' LEU . 0.6 OUTLIER -83.2 132.95 35.04 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 124.529 1.143 . . . . 63.21 111.054 177.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -97.75 -179.62 33.29 Favored Glycine 0 CA--C 1.533 1.182 0 O-C-N 124.917 1.385 . . . . 74.13 110.996 -178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.4 t -129.44 147.35 33.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.393 1.877 . . . . 70.24 107.881 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.4 t -145.69 107.69 4.34 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.356 0.662 . . . . 70.22 110.022 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -85.22 148.72 25.94 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 124.573 1.149 . . . . 72.33 110.723 176.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.6 mt -126.84 133.67 67.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 124.943 1.402 . . . . 62.45 107.356 175.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.5 t -140.57 97.85 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.661 -0.866 . . . . 74.23 108.661 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -80.56 140.62 35.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.289 0.636 . . . . 74.34 109.519 168.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -146.74 71.63 1.24 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.067 0.947 . . . . 73.54 109.198 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.56 -127.0 11.5 Favored Glycine 0 CA--C 1.532 1.142 0 N-CA-C 109.311 -1.516 . . . . 50.4 109.311 -177.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -65.49 -35.52 81.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.239 1.416 . . . . 73.31 113.843 174.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -76.42 156.31 33.26 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 124.166 0.986 . . . . 72.23 112.14 174.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -151.98 126.41 9.38 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.711 -1.218 . . . . 73.35 107.711 -172.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.5 mmtm -112.11 154.82 24.86 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.842 2.057 . . . . 75.04 109.926 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.95 143.15 25.04 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.535 1.534 . . . . 70.41 108.196 175.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.4 m -135.99 98.07 3.79 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.33 1.052 . . . . 45.21 108.564 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 72.1 mt -93.39 114.79 30.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.907 1.283 . . . . 74.15 109.368 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.0 m -104.92 118.1 35.69 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.831 1.653 . . . . 51.0 108.602 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -169.48 155.96 6.45 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.94 0.896 . . . . 75.3 111.462 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.39 -82.81 1.45 Allowed Glycine 0 CA--C 1.532 1.11 0 N-CA-C 110.071 -1.212 . . . . 43.33 110.071 175.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 82.9 p -157.0 12.4 0.24 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.584 1.554 . . . . 73.3 112.727 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.35 179.74 8.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.147 0.979 . . . . 75.41 111.577 -172.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.9 t -130.41 126.04 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 124.555 1.142 . . . . 63.15 108.723 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.3 mt -108.56 128.7 64.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 124.821 1.249 . . . . 74.53 108.827 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -114.5 133.61 55.64 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 124.859 1.35 . . . . 63.21 108.661 176.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -133.23 144.63 49.9 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.14 1.376 . . . . 63.35 108.694 174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -132.28 145.13 51.08 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 124.882 1.364 . . . . 73.05 109.778 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -157.17 151.07 24.57 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.568 1.547 . . . . 75.23 108.204 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.4 m -93.69 140.53 29.53 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.708 0.803 . . . . 72.31 108.928 167.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.6 t -68.06 107.1 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.986 0.914 . . . . 63.33 110.064 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 110.06 -4.42 30.24 Favored Glycine 0 CA--C 1.537 1.425 0 CA-C-O 117.533 -1.704 . . . . 75.31 113.17 -178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -98.25 147.69 24.38 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.903 1.851 . . . . 71.42 109.409 171.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -84.87 125.68 32.83 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.749 1.22 . . . . 72.15 109.616 172.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 2.1 m -146.24 151.72 38.03 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.924 1.29 . . . . 74.14 109.61 -178.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -90.55 116.59 28.57 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.905 1.282 . . . . 74.33 109.071 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.417 HD12 ' CG2' ' A' ' 81' ' ' THR . 83.0 mt -108.72 116.12 31.37 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.559 1.144 . . . . 71.33 109.848 -170.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -79.22 131.82 36.31 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.662 1.226 . . . . 63.54 111.484 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.8 p -90.82 169.67 10.75 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.572 1.549 . . . . 60.32 110.99 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 55.3 mtm -57.24 -27.47 62.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.929 1.692 . . . . 75.24 115.18 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 6.5 p -82.68 -14.55 54.43 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.246 1.818 . . . . 74.02 113.072 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.02 -4.55 59.0 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 125.289 1.423 . . . . 62.43 112.341 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 -69.85 135.48 49.65 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 119.099 1.449 . . . . 74.34 110.439 173.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -138.41 136.5 36.34 Favored 'General case' 0 CA--C 1.534 0.329 0 O-C-N 123.969 0.793 . . . . 71.12 109.693 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.0 m -149.1 138.66 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.231 1.412 . . . . 71.33 110.089 -170.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.03 136.19 46.61 Favored 'General case' 0 C--N 1.346 0.416 0 O-C-N 124.213 0.946 . . . . 75.51 112.081 177.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.417 ' CG2' HD12 ' A' ' 71' ' ' LEU . 6.4 t -164.8 149.49 9.4 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.552 1.541 . . . . 74.2 109.384 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.3 t -99.32 138.48 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.516 1.126 . . . . 42.04 108.582 173.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 52.7 t -108.73 125.32 65.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 O-C-N 124.451 1.095 . . . . 70.35 108.254 172.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -120.15 157.16 29.6 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.892 1.677 . . . . 65.02 110.978 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.742 HD23 ' H ' ' A' ' 87' ' ' GLY . 6.7 tt -124.63 125.59 44.38 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.937 1.295 . . . . 64.15 108.137 -175.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -84.01 13.08 5.34 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.307 1.443 . . . . 62.4 114.87 -173.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.742 ' H ' HD23 ' A' ' 85' ' ' LEU . . . 75.13 8.25 83.0 Favored Glycine 0 CA--C 1.539 1.56 0 C-N-CA 125.247 1.403 . . . . 63.34 113.031 -178.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -142.28 61.77 1.44 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.978 1.311 . . . . 62.51 108.858 -171.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 48.02 35.24 4.88 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 127.155 2.182 . . . . 73.45 115.929 167.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -143.8 139.8 29.53 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.664 1.586 . . . . 74.52 108.691 -172.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 95.5 mt -113.56 122.63 47.82 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 124.362 1.039 . . . . 65.32 109.684 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 98.4 t -105.63 134.93 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.472 1.509 . . . . 61.13 108.92 177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 t -163.38 144.98 9.57 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.237 1.415 . . . . 63.33 109.969 -171.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 83.9 m -147.86 129.35 14.92 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.809 0.844 . . . . 75.11 110.105 -177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -69.37 -75.12 0.12 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.831 1.252 . . . . 65.02 111.261 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -138.32 -41.07 0.51 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.328 1.851 . . . . 65.23 110.447 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -154.92 21.16 0.44 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.25 1.42 . . . . 74.45 111.825 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.478 HG13 HD13 ' A' ' 115' ' ' LEU . 5.1 mp -120.89 91.05 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.069 1.347 . . . . 51.44 107.697 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -70.06 109.49 4.59 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.051 0.94 . . . . 74.33 111.313 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.6 m -116.88 114.45 23.9 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 124.872 1.358 . . . . 52.41 109.332 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 97.1 t -117.46 110.16 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.962 1.305 . . . . 53.11 107.898 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.2 m -86.17 153.14 22.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.369 1.468 . . . . 54.15 109.688 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -148.11 138.88 23.07 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.816 1.246 . . . . 73.43 109.802 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.0 tp -116.28 126.57 53.74 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.824 2.05 . . . . 75.03 107.704 175.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -126.46 70.42 1.25 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.001 1.721 . . . . 71.04 106.766 170.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.41 -110.14 3.31 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.913 1.244 . . . . 53.43 110.417 176.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -79.03 4.51 14.24 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.476 1.511 . . . . 71.13 113.903 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.8 mm -123.92 140.5 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.118 0.967 . . . . 60.11 109.165 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 35.7 mm -120.3 137.27 54.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 125.123 1.369 . . . . 74.23 107.966 172.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.7 m -134.65 115.61 14.01 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 124.671 1.232 . . . . 65.21 107.84 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -106.08 139.64 40.3 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.436 -0.95 . . . . 75.33 108.436 171.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 81.7 m -131.28 120.69 23.54 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 124.873 1.358 . . . . 75.43 108.358 174.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 5.4 mtm -112.72 150.19 31.89 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.884 1.674 . . . . 74.34 109.594 173.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.1 m -138.87 96.3 3.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.556 1.142 . . . . 60.32 108.862 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.478 HD13 HG13 ' A' ' 98' ' ' ILE . 9.2 tp -104.73 111.01 23.57 Favored 'General case' 0 C--N 1.344 0.344 0 C-N-CA 125.443 1.497 . . . . 71.2 108.883 175.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 64.34 -112.87 5.36 Favored Glycine 0 CA--C 1.533 1.193 0 O-C-N 124.574 1.171 . . . . 63.24 110.413 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -110.9 18.74 19.23 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.91 1.684 . . . . 71.45 111.29 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.4 mt -129.4 136.88 58.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 125.015 1.326 . . . . 75.42 109.026 179.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.6 t -121.99 95.69 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 124.237 0.961 . . . . 64.21 109.565 -177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -75.05 128.24 35.09 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.814 1.245 . . . . 74.24 112.317 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.04 153.34 34.88 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 124.094 0.871 . . . . 63.24 110.835 169.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -135.29 139.06 44.07 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 126.362 1.865 . . . . 62.53 108.199 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -124.32 133.71 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 O-C-N 124.802 1.314 . . . . 74.22 107.622 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.9 m -137.37 158.51 44.24 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.122 1.369 . . . . 75.33 110.116 176.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -139.11 142.77 38.08 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.583 1.153 . . . . 63.23 110.755 -176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -68.06 136.82 54.38 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.969 2.108 . . . . 72.42 113.005 -168.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 6' ' ' LYS . 17.5 mt . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 105.494 -2.039 . . . . 72.13 105.494 -174.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 74.2 m80 . . . . . 0 N--CA 1.501 2.082 0 N-CA-C 103.149 -2.908 . . . . 74.42 103.149 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 49.5 m80 55.52 -157.29 0.24 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.707 2.003 . . . . 63.42 113.662 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -98.83 76.66 2.18 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.947 1.299 . . . . 55.23 109.25 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -89.41 93.03 9.37 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.908 0.883 . . . . 74.33 110.019 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 13.0 t-160 -162.96 128.69 3.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.67 1.188 . . . . 71.43 108.565 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 6.9 m80 56.98 84.5 0.09 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.91 2.084 . . . . 75.21 113.023 -176.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 26.9 m -105.06 19.64 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 125.114 1.365 . . . . 73.0 112.405 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -161.61 167.03 25.99 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.479 1.512 . . . . 33.23 110.622 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptm -67.8 161.74 25.5 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.575 1.55 . . . . 64.11 112.259 171.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.0 t -153.05 151.47 30.27 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.719 0.808 . . . . 72.34 110.078 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -68.18 -30.95 70.18 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 117.625 -1.179 . . . . 74.21 113.621 169.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.5 p -58.88 103.1 0.14 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.488 1.515 . . . . 75.25 112.968 179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 169.75 174.11 37.77 Favored Glycine 0 CA--C 1.532 1.14 0 N-CA-C 108.958 -1.657 . . . . 65.11 108.958 -174.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.53 146.11 48.36 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 107.686 -1.227 . . . . 74.12 107.686 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.435 ' CE1' HD11 ' A' ' 109' ' ' ILE . 8.1 m-85 -143.1 130.24 20.78 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.798 0.839 . . . . 74.24 110.397 -168.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -87.9 149.21 24.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.988 0.915 . . . . 63.35 110.532 174.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 36' ' ' LYS . 61.0 tp -68.64 132.31 46.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.6 0.76 . . . . 71.32 111.131 173.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -106.08 -53.53 2.62 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 124.67 1.231 . . . . 65.5 110.829 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.25 157.66 15.61 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 124.447 1.092 . . . . 73.05 110.382 -175.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.412 ' HG3' HD11 ' A' ' 9' ' ' LEU . 3.5 mp0 -135.98 137.69 41.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.562 1.145 . . . . 74.35 108.582 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -112.86 137.15 51.64 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.217 1.407 . . . . 71.15 108.406 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 57.39 30.19 18.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.124 1.77 . . . . 63.12 112.964 -171.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -61.21 -58.36 8.63 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 124.177 0.991 . . . . 74.25 112.111 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -52.59 -52.15 56.57 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.344 1.858 . . . . 60.04 112.42 173.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.96 -48.78 77.54 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.332 1.453 . . . . 53.45 114.037 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -67.72 -45.7 74.29 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.862 1.265 . . . . 70.13 113.593 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 7.3 mmt -65.38 -40.22 93.23 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 124.699 1.25 . . . . 61.43 112.829 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -67.84 -28.3 67.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.187 0.995 . . . . 62.13 113.052 172.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.63 -34.71 40.33 Favored 'General case' 0 C--N 1.348 0.53 0 N-CA-C 114.099 1.148 . . . . 71.32 114.099 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.0 pt -77.12 -6.82 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 113.065 0.765 . . . . 75.3 113.065 169.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.59 31.24 24.96 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-O 118.604 -1.109 . . . . 44.11 112.345 169.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.486 HD21 HG21 ' A' ' 75' ' ' THR . 0.1 OUTLIER -68.01 151.57 97.09 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 118.636 1.218 . . . . 72.05 111.774 177.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.51 139.48 59.03 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 122.01 1.807 . . . . 64.41 110.763 169.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.452 ' HA ' HD12 ' A' ' 29' ' ' ILE . 20.3 tt0 -63.45 -20.33 65.48 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.4 1.259 . . . . 74.34 114.4 -174.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.58 -45.71 91.66 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 117.881 -1.057 . . . . 73.54 113.435 168.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.8 mt -66.81 -26.96 67.19 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 124.212 1.005 . . . . 75.44 113.518 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 26' ' ' GLU . 22.5 mt -75.93 -51.22 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.033 0.933 . . . . 64.11 111.376 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -62.08 -48.24 81.07 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.111 -0.947 . . . . 53.41 112.646 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.87 -27.03 68.59 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.426 0.898 . . . . 75.5 113.426 174.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.23 -29.23 51.04 Favored Glycine 0 CA--C 1.536 1.393 0 CA-C-O 118.69 -1.061 . . . . 20.32 112.395 -176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.37 -30.6 13.83 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.471 1.135 . . . . 72.43 112.732 175.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -72.9 -39.39 66.39 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.687 1.195 . . . . 75.45 113.335 173.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 34.6 mt -111.06 130.05 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.483 -0.932 . . . . 62.42 108.483 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HA ' HD23 ' A' ' 9' ' ' LEU . 12.1 mptt -88.02 134.13 33.81 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.928 1.291 . . . . 63.21 110.642 172.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.7 -168.15 26.38 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 109.683 -1.367 . . . . 74.13 109.683 175.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.2 t -134.97 153.96 35.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.885 1.274 . . . . 70.24 108.317 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.4 p -128.6 160.48 32.28 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.465 1.506 . . . . 70.22 110.622 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -133.75 148.84 51.44 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 107.452 -1.314 . . . . 72.33 107.452 169.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.422 HG12 ' CE2' ' A' ' 50' ' ' PHE . 7.8 mt -138.72 129.91 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 105.963 -1.866 . . . . 62.45 105.963 176.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.2 m -139.28 138.95 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 O-C-N 123.426 0.454 . . . . 74.23 110.029 175.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -109.94 117.17 33.09 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 126.083 1.753 . . . . 74.34 107.277 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -116.08 51.33 0.97 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.181 1.392 . . . . 73.54 109.162 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.95 -116.62 5.67 Favored Glycine 0 CA--C 1.534 1.227 0 N-CA-C 107.977 -2.049 . . . . 50.4 107.977 -171.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -72.59 -34.91 67.73 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 114.154 1.168 . . . . 73.31 114.154 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -74.44 161.75 29.51 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 123.856 0.723 . . . . 72.23 111.829 173.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -159.26 131.46 6.58 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 106.886 -1.524 . . . . 73.35 106.886 -173.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -121.07 149.2 43.08 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.978 1.311 . . . . 75.04 108.824 178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.422 ' CE2' HG12 ' A' ' 41' ' ' ILE . 5.5 t80 -141.82 119.75 11.98 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.351 -1.352 . . . . 70.41 107.351 177.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 34.3 m -96.09 134.07 39.58 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.592 1.157 . . . . 45.21 108.909 172.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.58 107.0 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.939 -1.504 . . . . 74.15 106.939 176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 m -99.33 100.63 11.73 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.717 1.207 . . . . 51.0 108.426 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.94 178.02 7.08 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.238 1.015 . . . . 75.3 111.325 175.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -80.47 29.55 2.57 Favored Glycine 0 CA--C 1.542 1.733 0 C-N-CA 125.216 1.388 . . . . 43.33 113.356 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.8 t -158.28 -33.48 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.35 1.575 . . . . 73.3 112.566 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.68 170.05 19.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.953 1.301 . . . . 75.41 110.37 -176.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.487 HG12 HE21 ' A' ' 60' ' ' GLN . 21.9 t -119.23 132.47 68.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 O-C-N 124.173 0.921 . . . . 63.15 109.181 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.4 mt -122.97 135.29 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.292 1.437 . . . . 74.53 107.926 172.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.487 HE21 HG12 ' A' ' 58' ' ' VAL . 3.4 mp0 -119.6 143.34 47.71 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 124.175 0.922 . . . . 63.21 108.812 176.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -133.38 132.0 40.7 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.627 1.171 . . . . 63.35 109.734 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -113.02 143.57 44.08 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 125.427 1.704 . . . . 73.05 109.476 175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -148.19 164.73 33.05 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.186 1.394 . . . . 75.23 108.659 173.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.7 m -113.51 131.28 56.12 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 108.434 -0.95 . . . . 72.31 108.434 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 43.0 t -62.76 119.37 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 125.011 1.324 . . . . 63.33 111.213 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.438 ' HA2' HE21 ' A' ' 84' ' ' GLN . . . 92.91 -10.47 73.85 Favored Glycine 0 CA--C 1.541 1.663 0 CA-C-O 117.906 -1.497 . . . . 75.31 113.668 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -107.52 139.46 42.01 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.64 1.72 . . . . 71.42 109.355 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.77 120.14 13.02 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 123.606 0.762 . . . . 72.15 111.736 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 92.5 m -138.92 140.58 38.37 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.263 1.425 . . . . 74.14 108.28 -177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -67.44 131.11 45.04 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 123.87 0.731 . . . . 74.33 111.214 168.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.479 HD12 ' CG2' ' A' ' 81' ' ' THR . 19.6 mt -120.77 109.31 15.01 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.543 1.537 . . . . 71.33 107.921 177.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -74.82 154.52 38.25 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.536 1.135 . . . . 63.54 111.178 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 62.9 m -110.59 169.56 8.67 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.882 1.673 . . . . 60.32 109.208 175.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -53.06 -25.68 13.49 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.769 1.628 . . . . 75.24 115.022 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.486 HG21 HD21 ' A' ' 24' ' ' LEU . 66.5 p -82.09 -18.74 41.97 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 128.548 2.739 . . . . 74.02 113.968 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 100.56 0.63 55.47 Favored Glycine 0 CA--C 1.543 1.786 0 CA-C-O 118.549 -1.139 . . . . 62.43 112.564 -174.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -75.63 105.06 6.46 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.525 1.53 . . . . 74.34 111.98 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -99.93 133.2 44.64 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 124.54 1.136 . . . . 71.12 111.079 176.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -147.03 131.47 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.455 1.502 . . . . 71.33 109.908 -172.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.6 ttpt -79.47 129.61 34.63 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.577 1.551 . . . . 75.51 110.218 -172.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.479 ' CG2' HD12 ' A' ' 71' ' ' LEU . 14.6 t -162.69 159.24 24.11 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 124.25 0.969 . . . . 74.2 111.146 -173.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.9 m -104.15 146.31 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 125.287 1.435 . . . . 42.04 109.872 167.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.509 HG12 HD22 ' A' ' 91' ' ' LEU . 40.5 t -122.57 126.84 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 106.962 -1.496 . . . . 70.35 106.962 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.438 HE21 ' HA2' ' A' ' 66' ' ' GLY . 2.4 mt-30 -129.22 139.98 51.65 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 124.632 1.173 . . . . 65.02 111.522 -178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 11.7 tp -84.78 136.97 33.46 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.832 1.332 . . . . 64.15 109.567 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.95 16.12 5.26 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.198 0.999 . . . . 62.4 113.208 173.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.76 12.4 78.26 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.159 1.362 . . . . 63.34 113.081 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -143.91 57.29 1.34 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.862 1.265 . . . . 62.51 108.491 -171.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.276 0.8 OUTLIER 49.49 32.71 4.97 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.84 2.056 . . . . 73.45 115.327 169.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mttm -142.48 127.57 18.52 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.478 1.911 . . . . 74.52 108.275 -172.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.509 HD22 HG12 ' A' ' 83' ' ' VAL . 49.3 mt -107.17 134.24 50.58 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.593 1.157 . . . . 65.32 109.647 177.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 93.8 t -118.91 135.65 58.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.817 1.247 . . . . 61.13 109.181 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.5 t -155.92 142.4 18.57 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.211 1.004 . . . . 63.33 111.576 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.8 p -143.68 136.96 27.87 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.625 1.57 . . . . 75.11 110.121 -176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -102.78 -61.2 1.43 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.927 1.291 . . . . 65.02 109.613 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -140.88 -63.84 0.46 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 125.881 1.672 . . . . 65.23 109.15 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -140.78 10.63 2.22 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.673 1.589 . . . . 74.45 112.283 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.494 HG12 HD13 ' A' ' 115' ' ' LEU . 65.2 mt -111.53 108.79 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 125.477 1.511 . . . . 51.44 106.95 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -101.58 99.94 10.29 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 124.404 1.082 . . . . 74.33 110.306 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.63 127.5 35.92 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.091 1.356 . . . . 52.41 108.561 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.3 t -130.41 104.73 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.201 -1.407 . . . . 53.11 107.201 174.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.3 m -82.68 150.57 26.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.488 1.515 . . . . 54.15 109.842 174.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -147.09 139.93 25.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.979 1.311 . . . . 73.43 108.933 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.41 124.32 39.9 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.543 1.537 . . . . 75.03 107.418 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -127.55 84.76 2.28 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 126.555 1.942 . . . . 71.04 106.518 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 61.69 -114.89 7.19 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.266 1.412 . . . . 53.43 110.461 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -88.18 15.48 7.48 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.77 1.628 . . . . 71.13 114.087 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.8 mm -129.25 132.05 67.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.248 1.019 . . . . 60.11 108.815 178.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.435 HD11 ' CE1' ' A' ' 7' ' ' TYR . 46.1 mm -104.83 140.14 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 107.792 -1.188 . . . . 74.23 107.792 169.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.2 m -133.98 112.29 11.1 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.077 -1.453 . . . . 65.21 107.077 174.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -103.14 146.91 27.68 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.419 -0.586 . . . . 75.33 109.419 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 92.0 m -140.45 99.77 3.72 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.975 1.31 . . . . 75.43 109.265 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 2.6 mmm -92.19 150.59 20.82 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.103 1.761 . . . . 74.34 110.241 170.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.8 m -140.44 105.38 4.97 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.306 1.042 . . . . 60.32 108.898 175.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.494 HD13 HG12 ' A' ' 98' ' ' ILE . 12.6 tp -113.88 110.75 20.6 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.871 1.668 . . . . 71.2 108.583 177.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.31 -123.33 29.32 Favored Glycine 0 CA--C 1.535 1.299 0 N-CA-C 109.776 -1.33 . . . . 63.24 109.776 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -97.49 12.68 32.52 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.248 1.419 . . . . 71.45 113.18 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 98.4 mt -119.28 136.82 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.992 0.917 . . . . 75.42 109.865 178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.5 t -119.72 96.71 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 124.33 1.019 . . . . 64.21 109.068 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -75.45 127.41 33.06 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.322 1.049 . . . . 74.24 111.475 172.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 157.21 29.58 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 123.921 0.763 . . . . 63.24 110.065 168.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.5 ttt-85 -149.36 129.53 13.63 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.261 1.024 . . . . 62.53 109.099 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -112.63 137.36 45.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 124.93 1.292 . . . . 74.22 108.565 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.6 m -134.97 158.39 44.46 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.432 1.093 . . . . 75.33 110.136 172.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 49.8 tttp -123.09 134.9 54.22 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 125.345 1.458 . . . . 63.23 108.931 177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -68.83 146.83 52.52 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.912 1.685 . . . . 72.42 112.745 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 105.653 -1.981 . . . . 72.13 105.653 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 19.6 p80 . . . . . 0 N--CA 1.501 2.086 0 N-CA-C 103.88 -2.637 . . . . 74.42 103.88 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -150.92 163.96 37.46 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.187 1.795 . . . . 63.42 109.998 176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -132.46 -33.52 1.26 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.006 1.322 . . . . 55.23 111.679 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -67.28 170.28 7.45 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.226 1.411 . . . . 74.33 112.302 174.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 75.34 -61.21 0.48 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 127.658 2.383 . . . . 71.43 112.622 -172.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -66.4 145.87 55.2 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.714 1.206 . . . . 75.21 112.835 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.6 m -135.44 47.83 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 125.625 1.57 . . . . 73.0 110.372 -175.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -160.4 155.93 25.31 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 124.526 1.13 . . . . 33.23 111.345 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ppp? -92.98 166.54 12.32 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.456 1.502 . . . . 64.11 110.559 168.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -165.39 147.9 7.81 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.278 1.031 . . . . 72.34 109.527 173.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -78.35 56.38 1.72 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.056 1.743 . . . . 74.21 112.056 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.9 m -129.02 120.6 26.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.982 1.313 . . . . 75.25 109.515 -175.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 144.72 164.44 10.58 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 110.022 -1.231 . . . . 65.11 110.022 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.26 142.85 32.09 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.178 1.391 . . . . 74.12 110.213 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -136.53 150.46 48.64 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.426 1.09 . . . . 74.24 109.818 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -121.75 143.82 49.15 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.6 1.16 . . . . 63.35 108.839 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 36' ' ' LYS . 31.9 tp -55.17 137.91 45.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.477 1.511 . . . . 71.32 112.937 175.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -122.3 -50.88 1.99 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.44 1.496 . . . . 65.5 111.204 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.1 153.88 41.19 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 124.405 1.066 . . . . 73.05 111.719 -172.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -140.66 132.67 27.79 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.761 1.624 . . . . 74.35 108.997 -170.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 -138.54 133.73 32.96 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.32 1.048 . . . . 71.15 109.255 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 54.72 27.73 9.15 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.097 1.759 . . . . 63.12 113.178 -173.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -62.55 -54.5 38.83 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-O 117.84 -1.076 . . . . 74.25 112.131 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -61.1 -47.0 88.32 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-O 118.072 -0.966 . . . . 60.04 113.257 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.54 -47.05 73.64 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.669 1.187 . . . . 53.45 113.667 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -69.83 -45.48 67.76 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.669 1.187 . . . . 70.13 113.419 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 11.7 mmt -62.83 -48.2 80.09 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 124.502 1.126 . . . . 61.43 112.717 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.483 ' HD2' HD13 ' A' ' 29' ' ' ILE . 1.6 mptm? -59.84 -31.15 69.48 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 113.468 0.914 . . . . 62.13 113.468 172.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.26 -36.2 54.63 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.469 1.285 . . . . 71.32 114.469 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 48.3 pt -79.73 -7.87 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 113.344 0.868 . . . . 75.3 113.344 172.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.68 24.08 37.07 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.736 -1.035 . . . . 44.11 112.72 172.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.65 141.01 98.18 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.851 1.26 . . . . 72.05 110.264 172.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -66.04 143.01 70.49 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.434 2.089 . . . . 64.41 111.901 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.426 ' HA ' HD12 ' A' ' 29' ' ' ILE . 37.1 tt0 -57.44 -27.07 62.11 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.664 1.357 . . . . 74.34 114.664 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.4 tt0 -64.51 -45.44 87.22 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 117.885 -1.055 . . . . 73.54 113.568 172.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 37.8 mt -64.76 -25.12 67.78 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.154 0.981 . . . . 75.44 113.291 173.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.483 HD13 ' HD2' ' A' ' 20' ' ' LYS . 64.7 mt -80.63 -50.86 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.298 1.039 . . . . 64.11 110.802 177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -61.94 -42.76 99.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 117.816 -1.087 . . . . 53.41 113.007 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.97 -27.18 62.6 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 118.236 -0.888 . . . . 75.5 112.728 173.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.67 -27.42 61.01 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-O 118.846 -0.975 . . . . 20.32 112.382 -176.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.01 -26.05 14.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.846 1.258 . . . . 72.43 113.147 174.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -80.33 -44.45 19.48 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.041 0.936 . . . . 75.45 111.156 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 40.7 mt -102.67 127.64 56.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.351 1.06 . . . . 62.42 108.165 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HA ' HD23 ' A' ' 9' ' ' LEU . 4.3 tmmm? -76.96 118.16 19.27 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.896 1.278 . . . . 63.21 109.975 177.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.2 170.16 37.13 Favored Glycine 0 CA--C 1.531 1.091 0 O-C-N 124.247 0.967 . . . . 74.13 110.72 177.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.8 t -124.58 149.93 29.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 C-N-CA 125.081 1.352 . . . . 70.24 108.819 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.0 p -126.41 165.95 18.11 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.73 1.612 . . . . 70.22 110.164 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -152.3 141.64 21.53 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 107.801 -1.185 . . . . 72.33 107.801 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.1 mt -136.14 132.69 50.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 106.395 -1.706 . . . . 62.45 106.395 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.7 t -140.09 100.98 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.827 0.851 . . . . 74.23 108.96 -174.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -87.29 141.58 28.54 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.494 1.118 . . . . 74.34 109.229 174.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -152.03 77.13 1.2 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.018 0.927 . . . . 73.54 109.002 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.37 -120.52 8.41 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 109.377 -1.489 . . . . 50.4 109.377 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.2 mmtm -75.48 -32.17 60.47 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.717 1.207 . . . . 73.31 114.073 174.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -75.56 148.83 38.57 Favored 'General case' 0 C--N 1.346 0.425 0 O-C-N 124.124 0.89 . . . . 72.23 111.861 175.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -138.26 133.08 32.67 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.95 1.7 . . . . 73.35 106.674 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -125.41 160.05 30.37 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.87 1.668 . . . . 75.04 110.37 173.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -155.97 145.94 21.35 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.559 -1.275 . . . . 70.41 107.559 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 8.6 m -129.05 117.86 21.58 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 124.235 0.959 . . . . 45.21 109.849 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.414 HG23 ' C23' ' A' ' 201' ' ' 2VN . 72.4 mt -90.56 139.49 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.045 1.338 . . . . 74.15 108.456 172.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.2 m -135.9 112.75 10.24 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.616 1.166 . . . . 51.0 108.079 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -120.15 74.76 1.06 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.465 1.106 . . . . 75.3 109.988 -174.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.82 -91.21 1.39 Allowed Glycine 0 CA--C 1.532 1.126 0 N-CA-C 108.847 -1.701 . . . . 43.33 108.847 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.8 m -105.67 -43.09 5.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.94 1.296 . . . . 73.3 112.08 -176.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -72.72 146.02 46.74 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.95 1.3 . . . . 75.41 112.215 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.2 t -133.92 130.31 55.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 124.644 1.177 . . . . 63.15 108.78 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 94.7 mt -130.71 111.62 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.743 1.217 . . . . 74.53 108.581 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.54 149.47 24.07 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.379 0.672 . . . . 63.21 110.975 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -139.31 153.67 47.79 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.084 1.753 . . . . 63.35 108.245 177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -137.08 141.1 42.38 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 124.815 1.322 . . . . 73.05 109.072 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -145.74 168.01 21.76 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.443 1.097 . . . . 75.23 109.851 173.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.2 m -118.92 130.0 55.48 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 107.685 -1.228 . . . . 72.31 107.685 172.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.5 t -65.15 123.15 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.298 1.039 . . . . 63.33 110.782 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.431 ' HA2' HE21 ' A' ' 84' ' ' GLN . . . 89.31 2.07 77.58 Favored Glycine 0 CA--C 1.538 1.502 0 CA-C-O 118.267 -1.296 . . . . 75.31 113.396 -177.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -115.31 152.16 33.27 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.571 1.548 . . . . 71.42 109.701 171.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -77.11 127.63 33.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.73 1.612 . . . . 72.15 110.61 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.7 m -146.59 149.47 33.61 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.153 1.381 . . . . 74.14 109.739 -176.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -77.5 145.62 36.89 Favored 'General case' 0 C--N 1.349 0.545 0 N-CA-C 112.688 0.625 . . . . 74.33 112.688 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.488 HD22 ' C55' ' A' ' 201' ' ' 2VN . 15.3 mt -122.35 127.85 50.27 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.605 1.562 . . . . 71.33 108.291 173.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -95.29 142.66 27.44 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.43 1.092 . . . . 63.54 110.313 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 p -103.26 -177.57 3.41 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.385 1.474 . . . . 60.32 111.663 173.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.7 mtt -60.02 -38.43 82.68 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.74 1.616 . . . . 75.24 115.04 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.4 p -89.84 -1.63 58.03 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.454 1.502 . . . . 74.02 112.838 175.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.59 19.24 32.74 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-O 118.249 -1.306 . . . . 62.43 112.722 172.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -69.37 113.98 7.19 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.152 1.476 . . . . 74.34 109.963 177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -104.24 125.44 50.51 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 124.153 0.908 . . . . 71.12 109.092 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.4 m -146.12 123.27 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 124.427 1.079 . . . . 71.33 110.983 -170.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -72.8 140.59 47.78 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 124.3 1.04 . . . . 75.51 112.351 174.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.8 t -171.09 163.02 7.26 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.493 1.517 . . . . 74.2 109.692 177.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 60.1 t -103.06 136.0 37.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.259 1.024 . . . . 42.04 108.461 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.9 t -103.52 127.8 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 107.996 -1.112 . . . . 70.35 107.996 171.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.431 HE21 ' HA2' ' A' ' 66' ' ' GLY . 22.8 mm-40 -125.51 151.67 46.01 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 125.264 1.425 . . . . 65.02 111.647 -178.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 8.4 tp -101.33 137.02 40.23 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 124.757 1.286 . . . . 64.15 109.509 176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -87.54 15.56 6.55 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.567 1.147 . . . . 62.4 113.258 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.96 13.83 80.62 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.95 1.262 . . . . 63.34 113.257 177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -143.22 57.11 1.39 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.727 1.211 . . . . 62.51 108.561 -173.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.274 0.3 OUTLIER 44.15 37.0 1.67 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.198 2.199 . . . . 73.45 114.97 175.194 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -140.88 121.99 14.7 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 125.622 1.569 . . . . 74.52 109.02 -170.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.3 mt -95.99 142.84 27.73 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 124.718 1.262 . . . . 65.32 109.721 176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.9 t -132.56 137.92 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.471 1.508 . . . . 61.13 108.653 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 t -155.13 149.99 26.65 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.865 0.866 . . . . 63.33 110.734 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 24.0 p -143.56 130.74 20.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.942 1.297 . . . . 75.11 109.708 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -95.08 -60.2 1.73 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.312 1.045 . . . . 65.02 110.373 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -143.78 -75.57 0.25 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.682 1.593 . . . . 65.23 108.631 -173.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -116.95 -17.03 10.49 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.245 1.818 . . . . 74.45 111.232 178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.5 ' CG1' HD13 ' A' ' 115' ' ' LEU . 21.5 mt -88.86 111.21 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 124.935 1.294 . . . . 51.44 108.455 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.0 tmmt? -101.27 115.41 30.43 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 124.389 1.075 . . . . 74.33 108.974 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.4 m -117.03 124.36 49.12 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 124.846 1.341 . . . . 52.41 109.073 -169.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.8 t -131.89 117.14 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.528 1.131 . . . . 53.11 109.407 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.1 m -102.92 155.13 18.56 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.769 1.228 . . . . 54.15 109.643 173.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -139.15 144.89 38.81 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.639 1.976 . . . . 73.43 109.661 178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.6 tp -124.85 118.06 25.5 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.863 2.065 . . . . 75.03 106.994 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -122.0 69.2 0.94 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.041 1.337 . . . . 71.04 108.136 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.11 -110.96 3.63 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 110.065 -1.214 . . . . 53.43 110.065 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -79.51 -6.58 57.27 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 117.254 -1.355 . . . . 71.13 113.461 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.2 mm -112.65 136.94 47.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 119.91 1.232 . . . . 60.11 109.385 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 47.9 mm -115.54 142.69 27.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.041 1.337 . . . . 74.23 108.151 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 85.0 m -133.43 124.83 27.79 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.371 1.045 . . . . 65.21 108.235 172.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -108.46 134.95 50.54 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.555 1.142 . . . . 75.33 107.946 170.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 62.6 m -136.41 117.79 14.68 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.303 1.441 . . . . 75.43 108.255 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 33.1 mtm -123.17 142.45 50.89 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.09 0.956 . . . . 74.34 109.715 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 63.9 m -125.54 113.44 17.44 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.332 1.453 . . . . 60.32 108.662 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.5 HD13 ' CG1' ' A' ' 98' ' ' ILE . 11.6 tp -121.18 107.5 12.65 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 125.361 1.464 . . . . 71.2 108.048 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.37 -111.67 4.21 Favored Glycine 0 CA--C 1.533 1.199 0 O-C-N 124.837 1.336 . . . . 63.24 110.442 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -99.6 1.36 43.62 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.733 2.013 . . . . 71.45 113.665 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 91.4 mt -120.68 139.51 47.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.677 1.191 . . . . 75.42 109.967 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.2 t -125.19 101.08 7.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 124.187 0.929 . . . . 64.21 109.772 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -68.55 138.45 55.14 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.307 1.443 . . . . 74.24 112.099 169.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.5 mppt? -136.37 157.33 47.06 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 124.486 1.116 . . . . 63.24 110.778 167.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.03 141.84 12.88 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.846 1.258 . . . . 62.53 108.996 -177.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.21 139.7 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 124.702 1.201 . . . . 74.22 108.368 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 45.0 m -133.05 160.56 36.81 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.479 1.512 . . . . 75.33 109.312 173.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -138.64 144.91 39.9 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.63 1.172 . . . . 63.23 110.695 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 18.5 ttp180 -63.03 145.34 55.65 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.79 2.036 . . . . 72.42 113.7 -171.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.8 mt . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 103.886 -2.635 . . . . 72.13 103.886 -175.126 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' 2VN . . . . . 0.488 ' C55' HD22 ' A' ' 71' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -7' ' ' HIS . . . . . . . . . . . . . 22.8 t-160 . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 102.296 -3.224 . . . . 74.42 102.296 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -6' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -166.61 -45.38 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.334 1.054 . . . . 63.42 111.032 178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -5' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -67.04 155.55 38.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.646 1.179 . . . . 55.23 112.444 175.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -4' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -130.25 -83.34 0.54 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.698 1.199 . . . . 74.33 109.385 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -165.38 161.54 18.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.316 1.446 . . . . 71.43 110.026 -175.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -157.46 71.97 0.66 Allowed 'General case' 0 CA--C 1.538 0.482 0 O-C-N 123.942 0.776 . . . . 75.21 110.005 174.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 92.3 t 69.29 -71.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 128.26 2.624 . . . . 73.0 112.085 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' ALA . . . . . . . . . . . . . . . -85.29 179.46 7.2 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.915 1.686 . . . . 33.23 111.065 169.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -112.32 157.41 21.01 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.86 1.264 . . . . 64.11 111.518 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 71.4 p -118.12 108.83 15.67 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.326 1.85 . . . . 72.34 109.658 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -63.3 -30.82 71.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.265 1.426 . . . . 74.21 114.271 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 92.1 p -52.72 121.62 7.54 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.063 2.145 . . . . 75.25 113.933 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.49 166.23 14.85 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 109.522 -1.431 . . . . 65.11 109.522 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.16 144.51 37.14 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.378 1.071 . . . . 74.12 108.65 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -137.48 155.82 48.86 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.855 1.262 . . . . 74.24 110.437 -172.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -129.0 146.17 51.05 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.473 1.109 . . . . 63.35 109.581 -179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.82 129.6 41.16 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.7 1.2 . . . . 71.32 111.517 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 65.6 mm-40 -111.36 -56.59 2.36 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.035 1.334 . . . . 65.5 110.743 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -141.37 155.47 45.91 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 124.615 1.197 . . . . 73.05 112.056 -170.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -142.38 122.62 13.86 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.087 1.755 . . . . 74.35 107.797 -168.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -129.09 140.94 51.37 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.524 0.73 . . . . 71.15 109.668 170.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 56.17 33.48 22.14 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.632 1.973 . . . . 63.12 112.46 -171.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -65.0 -62.37 1.6 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.103 -0.951 . . . . 74.25 111.676 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.99 -34.04 75.44 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 113.671 0.989 . . . . 60.04 113.671 175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.66 -52.7 64.38 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.079 0.951 . . . . 53.45 112.652 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -67.34 -49.53 63.67 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.656 1.182 . . . . 70.13 113.165 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 5.1 mmt -67.1 -36.94 83.05 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 124.745 1.278 . . . . 61.43 113.139 -173.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -77.95 -25.52 48.28 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 118.047 -0.978 . . . . 62.13 112.534 173.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.37 -35.96 63.54 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 113.739 1.015 . . . . 71.32 113.739 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.6 pt -77.44 -10.27 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 O-C-N 123.917 0.76 . . . . 75.3 112.966 170.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.72 29.43 23.86 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.382 -1.232 . . . . 44.11 113.073 167.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.6 mt -65.39 152.17 92.67 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 119.125 1.463 . . . . 72.05 111.718 172.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -64.61 140.69 69.72 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.244 1.963 . . . . 64.41 111.269 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.59 -21.63 53.79 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.686 1.365 . . . . 74.34 114.686 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -59.54 -52.21 66.53 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 117.586 -1.197 . . . . 73.54 113.328 166.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 43.6 mt -61.12 -30.36 70.32 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.943 1.09 . . . . 75.44 113.943 177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 mp -73.13 -54.2 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 O-C-N 124.17 0.919 . . . . 64.11 111.707 171.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 97.0 mm-40 -66.92 -27.55 67.58 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.961 1.467 . . . . 53.41 114.961 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.17 -21.25 31.37 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.759 1.224 . . . . 75.5 112.257 171.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.44 -15.7 52.25 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-O 118.564 -1.131 . . . . 20.32 112.275 -176.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.12 -31.8 15.37 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 118.739 1.269 . . . . 72.43 113.079 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -83.48 -45.55 13.49 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.954 0.797 . . . . 75.45 111.032 177.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.4 mm -89.71 125.4 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.06 0.944 . . . . 62.42 109.402 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -85.42 146.46 26.96 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.531 1.144 . . . . 63.21 110.248 166.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -101.84 -168.85 27.38 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 109.753 -1.339 . . . . 74.13 109.753 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 97.4 t -129.86 158.47 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 126.693 1.997 . . . . 70.24 108.583 177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.0 t -137.4 161.04 37.38 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.071 1.349 . . . . 70.22 110.125 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -143.35 147.81 35.26 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 123.76 0.824 . . . . 72.33 109.287 173.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 18.7 mt -132.03 126.01 55.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 N-CA-C 106.461 -1.681 . . . . 62.45 106.461 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.9 t -136.87 92.2 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 108.197 -1.038 . . . . 74.23 108.197 -176.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -79.98 138.68 37.12 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.128 0.971 . . . . 74.34 109.577 171.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -148.6 74.79 1.29 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.094 0.958 . . . . 73.54 109.298 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.43 -125.02 11.37 Favored Glycine 0 CA--C 1.533 1.172 0 N-CA-C 109.277 -1.529 . . . . 50.4 109.277 -177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.6 mmpp? -70.26 -32.36 70.16 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.894 1.277 . . . . 73.31 114.377 173.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.0 157.22 31.33 Favored 'General case' 0 C--N 1.345 0.399 0 O-C-N 124.046 0.841 . . . . 72.23 111.893 173.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -157.05 127.33 6.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.039 -1.467 . . . . 73.35 107.039 -173.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -115.75 151.55 34.93 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.873 1.669 . . . . 75.04 109.886 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -147.44 119.81 8.42 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 108.057 -1.09 . . . . 70.41 108.057 -176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.1 m -102.07 129.97 48.53 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 124.49 1.119 . . . . 45.21 108.576 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.0 mt -113.63 120.16 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 106.839 -1.541 . . . . 74.15 106.839 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 91.5 m -113.88 104.07 11.81 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 124.644 1.215 . . . . 51.0 107.799 175.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.2 -162.29 0.11 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.813 1.645 . . . . 75.3 111.933 172.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -62.94 -27.03 69.65 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-O 118.788 -1.006 . . . . 43.33 113.738 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 83.0 p -163.75 25.37 0.08 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.429 1.492 . . . . 73.3 112.648 177.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -139.47 142.58 37.35 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.408 1.083 . . . . 75.41 109.967 -176.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.29 128.89 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 O-C-N 124.293 0.996 . . . . 63.15 108.823 177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 84.8 mt -130.95 123.11 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 125.766 1.626 . . . . 74.53 107.467 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.43 138.81 49.55 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.125 0.97 . . . . 63.21 109.034 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -134.48 145.19 48.58 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.037 1.335 . . . . 63.35 108.658 174.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -125.05 145.98 49.66 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 124.817 1.323 . . . . 73.05 109.195 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -149.21 161.02 42.84 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.65 1.18 . . . . 75.23 109.88 176.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 56.3 m -108.86 130.0 55.41 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 124.347 1.03 . . . . 72.31 108.467 172.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 80.3 t -66.78 115.27 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.763 1.225 . . . . 63.33 110.578 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.25 -9.56 50.02 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-O 117.971 -1.46 . . . . 75.31 112.963 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -114.52 149.13 36.9 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 119.422 1.611 . . . . 71.42 109.916 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -71.41 133.37 45.88 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.93 0.769 . . . . 72.15 110.725 175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.5 m -139.02 168.16 20.45 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.717 1.607 . . . . 74.14 108.936 177.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -110.89 133.26 53.51 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.867 0.867 . . . . 74.33 109.901 -178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -122.02 138.48 54.42 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.443 1.497 . . . . 71.33 109.292 -171.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -109.75 141.86 41.78 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.327 1.451 . . . . 63.54 111.912 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.2 m -99.63 167.06 10.81 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.91 1.684 . . . . 60.32 111.61 177.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 65.3 mtm -57.56 -26.75 61.9 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.947 1.699 . . . . 75.24 114.986 170.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.1 t -83.62 -10.83 57.97 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.645 1.178 . . . . 74.02 113.557 174.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 91.84 4.46 67.32 Favored Glycine 0 CA--C 1.537 1.414 0 CA-C-O 118.457 -1.19 . . . . 62.43 113.296 174.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -71.06 136.48 48.3 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.277 1.538 . . . . 74.34 109.648 172.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 mtpt -120.66 135.38 55.13 Favored 'General case' 0 CA--C 1.534 0.327 0 O-C-N 124.295 0.997 . . . . 71.12 108.609 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.14 132.1 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 124.591 1.156 . . . . 71.33 110.562 -171.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -74.42 141.2 45.06 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 124.283 0.989 . . . . 75.51 111.85 173.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.5 t -164.94 154.05 12.73 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.586 1.555 . . . . 74.2 110.003 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.4 t -107.73 133.61 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 107.865 -1.161 . . . . 42.04 107.865 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.7 t -112.17 129.04 68.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 108.311 -0.996 . . . . 70.35 108.311 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -141.11 147.39 38.42 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.054 1.342 . . . . 65.02 111.712 -173.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.6 tp -75.54 138.63 41.64 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.349 1.059 . . . . 64.15 111.492 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -89.45 6.35 41.17 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.889 1.275 . . . . 62.4 112.415 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.74 16.55 77.96 Favored Glycine 0 CA--C 1.54 1.651 0 C-N-CA 124.798 1.19 . . . . 63.34 112.948 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -150.22 48.25 0.9 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.249 1.42 . . . . 62.51 108.86 -172.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . 0.302 0.0 OUTLIER 53.13 33.51 15.28 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.642 1.577 . . . . 73.45 114.079 178.059 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -130.5 141.56 50.49 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 125.787 1.635 . . . . 74.52 108.748 -171.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 83.1 mt -117.66 113.27 21.65 Favored 'General case' 0 C--N 1.343 0.312 0 O-C-N 124.539 1.149 . . . . 65.32 109.414 175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.0 t -95.01 136.93 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.877 1.671 . . . . 61.13 109.137 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.13 147.32 22.38 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.54 1.536 . . . . 63.33 110.62 -174.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 12.6 p -150.67 132.78 15.3 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.392 1.477 . . . . 75.11 109.725 -175.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -98.15 -70.15 0.73 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.09 1.356 . . . . 65.02 108.895 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -135.3 -57.17 0.8 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.702 1.601 . . . . 65.23 108.887 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -149.09 10.29 0.79 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.415 1.486 . . . . 74.45 112.564 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.472 HG13 HD13 ' A' ' 115' ' ' LEU . 4.3 mp -108.48 104.8 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.549 -1.278 . . . . 51.44 107.549 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -86.88 106.64 17.9 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 124.121 0.888 . . . . 74.33 109.253 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 55.7 p -111.45 123.55 50.45 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.757 1.285 . . . . 52.41 111.141 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.5 t -126.1 105.32 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 126.037 1.735 . . . . 53.11 107.495 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.6 m -82.13 152.42 26.53 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.012 1.325 . . . . 54.15 109.769 172.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -142.28 139.06 31.78 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.856 1.662 . . . . 73.43 108.953 174.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.1 tp -117.71 126.73 53.0 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.917 2.087 . . . . 75.03 106.734 173.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -133.97 81.19 1.9 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 126.474 1.91 . . . . 71.04 106.285 175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 65.13 -116.62 9.08 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 110.202 -1.159 . . . . 53.43 110.202 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -88.52 17.74 5.14 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.205 1.802 . . . . 71.13 114.221 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 33.4 mm -129.99 132.79 65.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.178 0.991 . . . . 60.11 108.932 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 49.8 mm -111.36 136.2 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 125.09 1.356 . . . . 74.23 107.849 171.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 51.8 m -127.34 122.88 34.93 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.151 -1.425 . . . . 65.21 107.151 173.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -113.75 134.04 55.0 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.274 -1.009 . . . . 75.33 108.274 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 96.2 m -133.69 108.12 8.34 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 124.539 1.15 . . . . 75.43 108.533 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.1 mtp -108.27 146.52 32.75 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.541 1.937 . . . . 74.34 109.246 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 98.4 m -137.59 94.38 2.91 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.293 1.037 . . . . 60.32 109.587 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.472 HD13 HG13 ' A' ' 98' ' ' ILE . 8.2 tp -98.77 109.1 21.91 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.32 1.448 . . . . 71.2 108.846 173.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 62.45 -111.1 3.73 Favored Glycine 0 CA--C 1.533 1.204 0 O-C-N 124.807 1.317 . . . . 63.24 110.817 175.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -101.53 1.37 37.94 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.722 2.009 . . . . 71.45 113.648 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 89.5 mt -120.85 143.78 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.123 1.369 . . . . 75.42 110.143 -177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.7 t -123.01 91.3 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 O-C-N 124.23 0.956 . . . . 64.21 110.24 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -68.47 127.14 31.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.334 1.054 . . . . 74.24 112.1 173.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -125.2 146.38 49.54 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.738 1.215 . . . . 63.24 110.465 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -142.94 132.54 23.75 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.896 1.278 . . . . 62.53 108.326 -174.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.69 133.26 67.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.556 -1.276 . . . . 74.22 107.556 175.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 39.1 m -134.55 150.18 50.72 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 124.626 1.204 . . . . 75.33 110.025 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -120.01 141.42 49.73 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.547 1.539 . . . . 63.23 109.727 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -67.74 141.18 56.68 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.264 1.826 . . . . 72.42 112.103 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.4 mt . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 106.295 -1.742 . . . . 72.13 106.295 -173.351 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' 2VN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_